"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,WO,A1,WO 1996/016445 A1,064-311-987-803-397,1996-05-30,1996,EP 9504601 W,1995-11-22,GB 9423630 A;;GB 9425570 A,1994-11-23,INTEGRATED CIRCUIT STRUCTURE WITH SECURITY FEATURE,"An integrated circuit (10) is formed with at least a top circuit layer (20) having a passivation layer (19) provided on and around the circuit layer (20). A shielding layer (18) is provided on the passivation layer (19) and a top passivation layer (17) is provided on the shielding layer (18). The shielding layer (18) and the passivation layer (19) are provided with respective corresponding apertures (13 and 16) which are formed over essential portions of the top circuit layer (20) so as to expose the top circuit layer (20). The top circuit layer (20) and the shielding layer (18) have the same or similar chemical properties and the shielding layer (18) is opaque to light so that the top circuit layer (20) cannot be simply analysed by visible inspection. Thus, attempts to remove the shielding layer (18) by chemical means, for example etching, will also remove or damage the top circuit layer (20) exposed through the apertures (16 and 13).",MOTOROLA LTD;;BEAUMONT ANDREW,BEAUMONT ANDREW,,https://lens.org/064-311-987-803-397,Patent Application,yes,1,3,1,3,0,H01L23/573;;H01L27/02;;H01L2924/0002,H01L27/02,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 013, no. 437 (E - 826) 29 September 1989 (1989-09-29);;PATENT ABSTRACTS OF JAPAN vol. 018, no. 556 (E - 1620) 24 October 1994 (1994-10-24)",PENDING
2,GB,A,GB 2246389 A,116-776-196-368-40X,1992-01-29,1992,GB 9016168 A,1990-07-24,GB 9016168 A,1990-07-24,Strap adjuster,"A strap adjuster comprises an adjustor body 10 having a belt guide surface 36, and a pivotally mounted clamping member 38 with an eccentric clamping surface 42. The clearance between the guide surface 36 and the clamping surface 42 reduces with angular movement of the clamping member. Movement of a strap 50 in one direction causes angular movement of the clamping member 38 in a direction to reduce this clearance so as to wedge the strap between the clamping surface 42 and the guide surface 36 thereby inhibiting further movement of the strap 50 in said one direction. An additional guide member 48 is mounted on the adjuster body 10 so as to hold the strap 50 out of engagement with the clamping surface 42 when the clamping member 38 is displaced from its clamping position by more than a predetermined angle, as shown in Figure 5. <IMAGE>",BRITAX EXCELSIOR,BEAUMONT ANDREW PATRICK,,https://lens.org/116-776-196-368-40X,Patent Application,no,1,1,2,2,0,A44B11/12,A44B11/12,E2A AGKD          AGKD/B;;E2A A370          AGKD/B;;E2A A375          AGKD/B;;E2A A430          AGKD/B,0,0,,,,DISCONTINUED
3,DE,T2,DE 69226835 T2,086-879-874-647-017,1999-01-14,1999,DE 69226835 T,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A;;US 9202191 W,1991-03-15,"VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON DIABETES MELLITUS, HYPOGLYKÄMIE UND ANDERER KRANKHAFTER ZUSTÄNDE","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW,,https://lens.org/086-879-874-647-017,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
4,GB,B,GB 2295722 B,115-884-822-208-844,1997-12-17,1997,GB 9424178 A,1994-11-30,GB 9424178 A,1994-11-30,Method of packaging integrated circuits,,MOTOROLA LTD,THOMSON DEREK;;BEAUMONT ANDREW,,https://lens.org/115-884-822-208-844,Granted Patent,no,5,0,3,3,0,H01L23/3135;;H01L24/48;;H01L2224/48091;;H01L2224/48247;;H01L2224/8592;;H01L2924/00014;;H01L2924/14;;H01L2924/181,H01L23/31,H1K KPF           PF;;H1K K5A5          PF;;H1K K5BX          PF;;H1K K5C3D         PF,0,0,,,,EXPIRED
5,DE,D1,DE 69226835 D1,024-128-410-362-842,1998-10-08,1998,DE 69226835 T,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A;;US 9202191 W,1991-03-15,"VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON DIABETES MELLITUS, HYPOGLYKÄMIE UND ANDERER KRANKHAFTER ZUSTÄNDE","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW,,https://lens.org/024-128-410-362-842,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
6,GB,A,GB 2126437 A,040-156-226-893-932,1984-03-21,1984,GB 8224706 A,1982-08-27,GB 8224706 A,1982-08-27,Semiconductor switching circuit,"The circuit is for switching an alternating current supply to a load and comprises a thyristor (1, 2, 3) with a first terminal connected to the load and a second terminal connected with an alternating current supply and a gate electrode which is connected with the output of a gate control circuit, an input of said gate control circuit being connected to said alternating current supply and a switching means (29) included in the gate control circuit operable to enable current to flow through the gate circuit, the gate control circuit providing an output signal which turns on the thyristor to connect the supply to the load upon said alternating current flowing through said gate control circuit. In one example, the load comprises a three phase motor 30 connected to the supply through three triacs 1,2,3. The triacs are fired by a circuit which includes a start button 25, a stop button 24, and thyristor 29 and a transformer 19. The invention thus provides a semi-conductor switching circuit of ""solid state"" construction which enables stopping and starting of, for example, a three phase motor and which overcomes one of the major problems of hitherto available mechanical motor starters, that is, contact wear due to repeated sparking of the contacts resulting from the inductive load being switched. <IMAGE>",ELECTRONIC MANUFACTURING LIMIT,BRADEN STEELE ANDREW BEAUMONT,,https://lens.org/040-156-226-893-932,Patent Application,no,7,0,1,1,0,H03K17/735,H03K17/735,H2F FSF           FSF(H3);;H2F FSX           FSX;;H2F F12           FSF(H3);;H2F F9G1          FSF(H3);;H2F F9J18         FSF(H3);;H2F F9L3          FSF(H3);;H2F F9PX          FSF(H3);;H2F F9Q           FSF(H3);;H2F F9R14C        FSF(H3);;H2F F9R26C        FSF(H3);;H2F F9R48C        FSF(H3);;H2F F9R5C         FSF(H3);;H2J JRA           JRA;;H2J JRAC          JRAC;;H2J J1N1          JRA;;H2J J12N          JRA;;U1S S2247,0,0,,,,DISCONTINUED
7,GB,A,GB 2403606 A,022-788-058-498-433,2005-01-05,2005,GB 0315528 A,2003-07-03,GB 0315528 A,2003-07-03,Salient pole rotor with embedded heat sink,"An electrical machine rotor (200b) of the salient pole type has a number of wound poles (100b), each pole's principle axis being radially oriented with respect to the rotational centre of the rotor. Each pole comprises a magnetic core with layers of conductor (CS1) wound around it. The pole windings incorporate heat sinks in the form of cooling tongues (204a), arranged so that part (208a) of each tongue lies between adjacent conductor layers in the windings. The parts of the tongues (208a) between the conductor layers extend parallel to the principle axis of each pole, whereas the other parts (210a) project into cooling channels (203) between adjacent poles, where they are exposed to cooling air. The parts (210a) of the cooling tongues exposed to cooling air may have their surfaces ribbed, finned or otherwise roughened to increase heat transfer to the cooling air.",ALSTOM,DENTON-BEAUMONT ANDREW ROBERT,,https://lens.org/022-788-058-498-433,Patent Application,no,6,1,2,2,0,A62B35/04;;H02K3/527;;H02K9/227;;H02K9/227,A62B35/04;;H02K3/52;;H02K9/22,H2A ARD4          D4;;H2A ARK3          K3;;H2A AR120         D4;;H2A AR120         K3;;H2A AR121         D4;;H2A AR121         K3;;H2A AR122         D4;;H2A AR122         K3;;H2A AR125         D4;;H2A AR125         K3;;H2A AR214R        D4;;H2A AR214R        K3;;H2A AR215R        D4;;H2A AR215R        K3;;H2A AR216R        D4;;H2A AR216R        K3;;H2A AR220R        D4;;H2A AR220R        K3;;H2A AR302R        D4;;H2A AR315R        D4;;H2A AR601R        D4;;H2A AR601R        K3;;H2A AR607R        D4;;H2A AR607R        K3;;H2A AR609         D4;;H2A AR609         K3;;H2A AR611         D4;;H2A AR611         K3,0,0,,,,DISCONTINUED
8,AU,A,AU 1980/055642 A,128-528-814-454-763,1980-08-28,1980,AU 1980/055642 A,1980-02-18,NZ 18923179 A,1979-02-19,TRIAC SWITCHING CIRCUIT,,ELECTRONIC MFG LTD,BRADEN STEELE ANDREW BEAUMONT,,https://lens.org/128-528-814-454-763,Patent Application,no,0,0,2,2,0,H02M3/135;;H03K17/723,H02M3/135;;H03K17/723,,0,0,,,,DISCONTINUED
9,AU,A,AU 1982/087739 A,174-603-646-285-07X,1984-03-01,1984,AU 1982/087739 A,1982-08-26,AU 1982/087739 A,1982-08-26,SEMICONDUCTOR SWITCHING CIRCUIT FOR CONTROL SYSTEMS,,ELECTRONIC MFG LTD,BRADEN STEELE ANDREW BEAUMONT,,https://lens.org/174-603-646-285-07X,Patent Application,no,0,1,1,1,0,,H02H7/08;;H02M1/08;;H02P1/26;;H03K17/725,,0,0,,,,DISCONTINUED
10,GB,A,GB 2295722 A,160-699-802-928-999,1996-06-05,1996,GB 9424178 A,1994-11-30,GB 9424178 A,1994-11-30,Packaging integrated circuits,"An integrated circuit (12) is mounted on a flag portion (11) of a leadframe. The leadframe also includes lead posts (10) to which are connected electrical connectors or bond wires (13) extending between the posts (10) and the integrated circuit (12). A plastic package (A) is moulded around the lead posts (10), the flag (11), the integrated circuit (12) and the bond wires (13). A polymer material is coated on all surfaces exposed prior to moulding of the package (A). The polymer material used for this encapsulation is is of very low molecular weight and viscosity and provides protection of the integrated circuit from corrosion by being chemisorbed onto its surface. This effectively seals any problem in the integrity of the passivation layer preventing moisture ingress, collection and therefore corrosion. <IMAGE>",MOTOROLA LTD,THOMSON DEREK;;BEAUMONT ANDREW,,https://lens.org/160-699-802-928-999,Patent Application,no,5,7,3,3,0,H01L23/3135;;H01L24/48;;H01L2224/48091;;H01L2224/48247;;H01L2224/8592;;H01L2924/00014;;H01L2924/14;;H01L2924/181,H01L23/31,H1K KPF           PF;;H1K K5A5          PF;;H1K K5BX          PF;;H1K K5C3D         PF,0,0,,,,EXPIRED
11,MX,A,MX 9201110 A,061-126-320-865-254,1993-07-01,1993,MX 9201110 A,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"COMPOSICION PARA EL TRATAMIENTO DE LA DIABETES MELLITUS, LA HYPOGLICEMIA Y DE OTROS PADECIMIENTOS RELACIONADOS.","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN CORP,YOUNG KEVIN BEAUMONT ANDREW A,,https://lens.org/061-126-320-865-254,Patent Application,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,PENDING
12,EP,B1,EP 0533898 B1,028-660-368-671-591,1998-09-02,1998,EP 92909629 A,1992-03-13,US 9202191 W;;US 77441191 A;;US 70499591 A;;US 67023191 A,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/028-660-368-671-591,Granted Patent,yes,2,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,6,0,,,"BIOLOGICAL ABSTRACTS vol. 69, no. 12 Philadelphia, PA, US; abstract no. 80405, PETRALITO A. ET AL. 'Effects of salmon calcitonin on insulin induced growth hormone release in man' page 8527-8528;;BIOLOGICAL ABSTRACTS vol. 87, no. 4 Philadelphia, PA, US; abstract no. 36313, LOOIJ B. ET AL 'The effect of calcitonin on growth hormone secretion in man' page 313;;BIOLOGICAL ABSTRACTS vol. 72, no. 3 Philadelphia, PA, US; abstract no. 19203, CONDON J. ET AL 'Control of osteitis deformans using glucagon calcitonin and mithramycin' page 2015;;Diabetes, Volume 39, issued July 1990, T. MORISHITA et al., ""Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes"", pages 875-877, see the Abstract.;;Nature, Volume 335, issued 13 October 1988, B. LEIGHTON et al., ""Pancreatic amylin and calcitonin gene related peptide cause resistance ot insulin in skeletal muscle in vitro"", pages 632-635, see the Abstract.;;Diabetes, Volume 40, issued March 1991, T.W. STEPHENS et al., ""Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin"", pages 395-400, see the Abstract.",EXPIRED
13,ZA,B,ZA 921884 B,060-350-278-600-964,1993-08-03,1993,ZA 921884 A,1992-03-13,US 67023191 A,1991-03-15,"Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions","Methods for identifying or screening or characterizing or assaying or isolating known or candidate agonists and antagonists of amylin, comprising binding assays utilizing preparations containing specific receptors for amylin. Membranes from the brain that contain high density receptors for amylin are particularly useful for the methods of this invention, and as a source of amylin receptors.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/060-350-278-600-964,Granted Patent,no,0,0,21,95,0,A61K38/28;;A61K38/28,A61K38/28;;C07K14/575;;C07K14/00;;C07K14/585;;C07K14/705;;C07K16/00;;C07K19/00;;C12P21/08;;G01N/;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
14,EP,A2,EP 1302362 A2,169-265-952-511-143,2003-04-16,2003,EP 02256925 A,2002-10-07,GB 0124785 A,2001-10-16,Child safety seat,"A child safety seat comprising a seat body (10) and a base (30) having the seat body (10) mounted thereon. The base (30) includes a bottom surface (32) adapted to rest on a vehicle seat, an abutment member (38) adapted to abut against the vehicle seat back, and a respective lateral belt guide (47, 48) on each side of the base (30) located above said bottom surface (32) and in front of said abutment member (38). At least one of the lateral belt guides comprises an open-ended slot (47) in the side of the base (30) and means (60) for varying the depth of the slot (47).",BRITAX EXCELSIOR,BEAUMONT ANDREW PATRICK;;LOVIE DAVID,,https://lens.org/169-265-952-511-143,Patent Application,yes,0,0,3,3,0,B60N2/2821;;B60N2/2806,B60N2/28,,0,0,,,,DISCONTINUED
15,EP,A3,EP 1302362 A3,064-435-081-180-837,2004-04-28,2004,EP 02256925 A,2002-10-07,GB 0124785 A,2001-10-16,Child safety seat,"A child safety seat comprising a seat body (10) and a base (30) having the seat body (10) mounted thereon. The base (30) includes a bottom surface (32) adapted to rest on a vehicle seat, an abutment member (38) adapted to abut against the vehicle seat back, and a respective lateral belt guide (47, 48) on each side of the base (30) located above said bottom surface (32) and in front of said abutment member (38). At least one of the lateral belt guides comprises an open-ended slot (47) in the side of the base (30) and means (60) for varying the depth of the slot (47).",BRITAX EXCELSIOR,BEAUMONT ANDREW PATRICK;;LOVIE DAVID,,https://lens.org/064-435-081-180-837,Search Report,yes,5,0,3,3,0,B60N2/2806;;B60N2/2821,B60N2/28,,0,0,,,,DISCONTINUED
16,GB,B,GB 2128581 B,074-036-208-297-878,1985-11-06,1985,GB 8309602 A,1983-04-08,GB 8309602 A;;GB 8227605 A,1982-09-28,SELF-ADHESIVE TRANSPARENT FILM,,BDK IND PROD LTD,FALCONER GRAHAM JOHN;;BEAUMONT ANDREW,,https://lens.org/074-036-208-297-878,Granted Patent,no,0,0,2,4,0,B42D25/24;;B42D25/24;;B42D25/00;;B42D25/309;;B42D25/309;;B42D25/318;;B42D25/318;;B42D25/382;;B42D25/387;;B42D25/47;;B42D2033/04;;B42D2033/06;;B42D2033/20;;B42D2033/28;;B42D2033/40;;B42D2035/02;;B42D2035/06,B42D15/10,B6AC13;;B6AC43;;B6ATC;;B6C618;;B6C686;;B6CGBA;;B8F25;;B8FBG;;U1S2271;;U1SB6A;;U1SB6C;;U1SB8F,0,0,,,,EXPIRED
17,CA,A1,CA 2082928 A1,097-103-844-841-047,1992-09-16,1992,CA 2082928 A,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A;;US 9202191 W,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/097-103-844-841-047,Patent Application,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
18,US,A,US 5321008 A,118-378-209-557-592,1994-06-14,1994,US 77441191 A,1991-10-10,US 77441191 A;;US 64047891 A;;US 67023191 A;;US 70499591 A,1991-01-10,"Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,AMYLIN CORPORATION A CORP. OF DELAWARE (1991-10-10),https://lens.org/118-378-209-557-592,Granted Patent,yes,2,41,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,514/4;;514/12;;514/21,26,20,030-342-284-616-69X;;034-196-418-828-130;;159-149-530-346-888;;071-353-575-038-798;;049-346-962-788-633;;106-805-993-318-568;;119-404-383-352-632;;040-980-926-099-225;;151-809-364-471-826;;032-675-612-234-315;;089-949-305-554-54X;;019-565-706-541-182;;039-587-035-574-479;;046-309-558-273-53X;;041-660-500-700-152;;011-185-783-044-934;;019-165-215-267-542;;063-007-529-483-848;;010-124-514-872-728;;019-890-558-358-181,10.1007/978-3-642-74734-2_1;;10.1210/jcem-53-2-318;;7019230;;1009903;;10.1210/jcem-51-2-354;;7400300;;6395913;;10.1152/ajpendo.1982.242.3.e206;;7039348;;10.1007/bf03350629;;3886770;;7024392;;10.1007/bf03350449;;10.1016/0167-0115(91)90383-r;;7029989;;10.1007/bf02047895;;10.1007/bf00252763;;7026328;;10.1055/s-0029-1210632;;2885208;;2894137;;6751866;;10.1055/s-2007-1019357;;7030900;;2227123;;10.2337/diab.39.2.168;;10.1248/cpb.29.1455;;7028288;;7344951;;10.1507/endocrj1954.28.643;;589721;;10.1248/cpb.25.2189;;10.1055/s-0028-1097084;;4622099,"Azria et al., Calcitonins Physiological and Pharmacological Aspects, pp. 1 34, Springer Verlag (1989).;;BioWorld Today , vol. 2, No. 125 (1991).;;Evans et al., Lancet 1:280 (1978) (cited in the application on p. 23).;;Passariello et al., J. Clinical Endocrinology and Metabolism 53:318 23 (1981) (cited in the application on p. 23).;;Blahos et al., Endokrinologie , Band 68, Heft 2, 226 30, (1976).;;Gattereau et al., J. Clinical Endocrinology and Metabolism 51:354 57 (1980).;;Giugliano, Biomedicine & Pharmacotherapy 38:273 77 (1984).;;Giugliano et al., Am. J. Physiol. 242:E206 13 (1982).;;Giugliano et al., Diabete & Metabolisme 8:213 16 (1982).;;Giustina et al., J. Endocrinol. Invest. 8:19 23 (1985).;;Lunetta et al., J. Endocrinol. Invest. 4: 185 88 (1981).;;MacIntyre, Regulatory Peptides 34:81 (1991); Passeri et al.;;G. Clin. Med. 55:362 70 (1973); Sgambato et al.;;Acta Diabet. Lat. 18:235 41 (1981).;;Starke et al., Diabetologic 20:547 52 (1981).;;Zofkova et al., Exp. Clin. Endocrinol. 89:91 96 (1987).;;Zofkova et al., Horm. Metabol. Res. 19:655 60 (1987).;;Zofkova, Acta. Univ. Carol. Med. 32:319 25 (1986).;;Ferlito et al., Il Farmaco Ed. Pr. vol. 37 fasc. 7:239 44 (1982).;;Zamrazil et al., Horm. Metab. Res. 13:631 35 (1981).;;Yamaguchi et al., Diabetes 39:168 74 (1990).;;Stracca et al., Calcitonin 1984; Yamaguchi, Chem. Pharm. Bull. 29:1455 58 (1981).;;Yamaguchi, Endocrinol. Japon. 28:643 46 (1981).;;Yamaguchi, Endocrinol. Japon. 28:51 57 (1980).;;Yamaguchi et al., Chem. Pharm. Bull. 25:2189 94 (1977).;;Ziegler et al., Horm. Metab. Res. 4:60 (1972).",EXPIRED
19,AU,B2,AU 648895 B2,171-466-904-599-753,1994-05-05,1994,AU 1992/016873 A,1992-03-13,US 9202191 W;;US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/171-466-904-599-753,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
20,US,A,US 5508260 A,189-125-048-142-555,1996-04-16,1996,US 25975594 A,1994-06-10,US 25975594 A;;US 77441191 A;;US 67023191 A;;US 64047891 A;;US 70499591 A,1991-01-10,"Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,AMYLIN PHARMACEUTICALS LLC (2012-08-08),https://lens.org/189-125-048-142-555,Granted Patent,yes,0,33,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,514/4;;530/303;;530/304,26,22,030-342-284-616-69X;;034-196-418-828-130;;159-149-530-346-888;;071-353-575-038-798;;049-346-962-788-633;;106-805-993-318-568;;119-404-383-352-632;;040-980-926-099-225;;151-809-364-471-826;;038-390-027-647-775;;032-675-612-234-315;;089-949-305-554-54X;;019-165-215-267-542;;063-007-529-483-848;;010-124-514-872-728;;019-890-558-358-181;;019-565-706-541-182;;037-038-003-533-168;;039-587-035-574-479;;046-309-558-273-53X;;041-660-500-700-152;;011-185-783-044-934,10.1007/978-3-642-74734-2_1;;10.1210/jcem-53-2-318;;7019230;;1009903;;10.1210/jcem-51-2-354;;7400300;;6395913;;10.1152/ajpendo.1982.242.3.e206;;7039348;;10.1007/bf03350629;;3886770;;7024392;;10.1007/bf03350449;;10.1016/0167-0115(91)90383-r;;4620164;;7029989;;10.1007/bf02047895;;10.1007/bf00252763;;7026328;;10.1248/cpb.29.1455;;7028288;;7344951;;10.1507/endocrj1954.28.643;;589721;;10.1248/cpb.25.2189;;10.1055/s-0028-1097084;;4622099;;10.1055/s-0029-1210632;;2885208;;2894341;;10.1055/s-2007-1011902;;2894137;;6751866;;10.1055/s-2007-1019357;;7030900;;2227123;;10.2337/diab.39.2.168,"Azria et al., Calcitonins Physiological and Pharmacological Aspects, pp. 1 34, Springer Verlag (1989).;;BioWorld Today, vol. 2., No. 125 (1991).;;Evans et al., Lancet 1:280 (1978) (cited in the application on p. 23).;;Passariello et al., J. Clinical Endocrinology and Metabolism 53:318 23 (1981) (cited in the application on p. 23).;;Blahos et al., Endokrinologie, Band 68, Heft 2, 226 30 (1976).;;Gattereau et al., J. Clinical Endocrinology and Metabolism 51:354 57 (1980).;;Giugliano, Biomedicine & Pharmacotherapy 38:273 77 (1984).;;Giugliano et al., Am. J. Physiol. 242:E206 13 (1982).;;Giugliano et al., Diabete & Metabolisme 8:213 16 (1982).;;Giustina et al., J. Endocrinol. Invest., 8:19 23 (1985).;;Lunetta et al., J. Endocrinol. Invest. 4:185 88 (1981).;;MacIntyre, Regulatory Peptides 34:81 (1991).;;Passeri et al., G. Clin. Med. 55:362 70 (1973).;;Sgambato et al., Acta Diabet. Lat. 18:235 41 (1981).;;Starke et al., Diabetologia 20:547 52 (1981).;;Stracca et al., Calcitonin 1984; Yamaguchi, Chem. Pharm. Bull. 29:145558 (1981).;;Yamaguchi, Endocrinol. Japon. 28:643 46 (1981).;;Yamaguchi, Endocrinol. Japon. 28:51 57 (1980).;;Yamaguchi et al., Chem. Pharm. Bull. 25:2189 94 (1977).;;Ziegler et al., Horm. Metab. Res. 4:60 (1972).;;Zofkova et al., Exp. Clin. Endocrinol. 89:91 96 (1987).;;Zofkova et al., Horm. Metabol. Res. 19:656 60 (1987).;;Zofkova, Acta. Univ. Carol. Med. 32:319 25 (1986).;;Ferlito et al., Il Framaco Ed. Pr. vol. 37 fasc. 7:239 44 (1982).;;Zamrazil et al., Horm. Metab. Res. 13:631 35 (1981).;;Yamaguchi et al., Diabetes 39:168 74 (1990).",EXPIRED
21,WO,A1,WO 1992/016222 A1,035-295-286-189-006,1992-10-01,1992,US 9202191 W,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/035-295-286-189-006,Patent Application,yes,2,1,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,3,3,018-467-520-815-688;;028-392-579-118-595;;050-330-706-318-447,2162304;;10.2337/diabetes.39.7.875;;3050530;;10.1038/335632a0;;10.2337/diab.40.3.395;;10.2337/diabetes.40.3.395;;1847887,"Diabetes, Volume 39, issued July 1990, T. MORISHITA et al., ""Activation of adenylate cyclase by islet amyloid polypeptide with COOH-terminal amide via calcitonin gene-related peptide receptors on rat liver plasma membranes"", pages 875-877, see the Abstract.;;Nature, Volume 335, issued 13 October 1988, B. LEIGHTON et al., ""Pancreatic amylin and calcitonin gene related peptide cause resistance ot insulin in skeletal muscle in vitro"", pages 632-635, see the Abstract.;;Diabetes, Volume 40, issued March 1991, T.W. STEPHENS et al., ""Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin"", pages 395-400, see the Abstract.",PATENTED
22,GB,A,GB 2128581 A,007-470-974-326-473,1984-05-02,1984,GB 8309602 A,1983-04-08,GB 8309602 A;;GB 8227605 A,1982-09-28,Self-adhesive transparent film,"A transparent film 10 has translucent markings 18 printed on it at well-spaced positions. The film has a pressure sensitive adhesive on the same face as said markings so that it may be stuck over information presented on a sheet of paper e.g. a photograph 22 in a passport, to prevent that information being tampered with. The pressure sensitive adhesive used, is chosen so that attempted removal of the film leads to irreparable damage to either the substrate or the film itself, or both. <IMAGE>",BDK IND PROD LTD,FALCONER GRAHAM JOHN;;BEAUMONT ANDREW,,https://lens.org/007-470-974-326-473,Patent Application,no,4,27,2,4,0,B42D25/24;;B42D25/24;;B42D25/00;;B42D25/309;;B42D25/309;;B42D25/318;;B42D25/318;;B42D25/382;;B42D25/387;;B42D25/47;;B42D2033/04;;B42D2033/06;;B42D2033/20;;B42D2033/28;;B42D2033/40;;B42D2035/02;;B42D2035/06,B42D15/10,B6A AC13          ATC;;B6A AC43          ATC;;B6A ATC           ATC;;B6C CGBA          GBA;;B6C C618          GBA;;B6C C686          GBA;;B8F FBG           FBG;;B8F F25           FBG;;U1S S2271,0,0,,,,EXPIRED
23,US,A,US 5527771 A,069-961-923-072-229,1996-06-18,1996,US 26049394 A,1994-06-14,US 26049394 A;;US 12956993 A;;US 77441191 A;;US 67023191 A;;US 64047891 A;;US 70499591 A,1991-01-10,"Methods and Compositions for treatment of diabetes mellitus, hypoglycemia & other conditions","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,AMYLIN PHARMACEUTICALS LLC (2012-08-08),https://lens.org/069-961-923-072-229,Granted Patent,yes,1,25,1,95,0,A61K38/22;;A61K38/26;;A61K49/0008;;A61K38/23;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/00,514/12;;530/307;;530/308,28,24,046-309-558-273-53X;;041-660-500-700-152;;030-342-284-616-69X;;034-196-418-828-130;;159-149-530-346-888;;071-353-575-038-798;;049-346-962-788-633;;106-805-993-318-568;;119-404-383-352-632;;040-980-926-099-225;;151-809-364-471-826;;038-390-027-647-775;;032-675-612-234-315;;089-949-305-554-54X;;019-165-215-267-542;;063-007-529-483-848;;010-124-514-872-728;;019-890-558-358-181;;019-565-706-541-182;;037-038-003-533-168;;039-587-035-574-479;;046-309-558-273-53X;;041-660-500-700-152;;011-185-783-044-934,6751866;;10.1055/s-2007-1019357;;7030900;;10.1007/978-3-642-74734-2_1;;10.1210/jcem-53-2-318;;7019230;;1009903;;10.1210/jcem-51-2-354;;7400300;;6395913;;10.1152/ajpendo.1982.242.3.e206;;7039348;;10.1007/bf03350629;;3886770;;7024392;;10.1007/bf03350449;;10.1016/0167-0115(91)90383-r;;4620164;;7029989;;10.1007/bf02047895;;10.1007/bf00252763;;7026328;;10.1248/cpb.29.1455;;7028288;;7344951;;10.1507/endocrj1954.28.643;;589721;;10.1248/cpb.25.2189;;10.1055/s-0028-1097084;;4622099;;10.1055/s-0029-1210632;;2885208;;2894341;;10.1055/s-2007-1011902;;2894137;;6751866;;10.1055/s-2007-1019357;;7030900;;2227123;;10.2337/diab.39.2.168,"Fertilo et al. Farmaco (Prat) vol. 37 (7) pp. 239 244 (1982).;;Zamrazil et al Horm. Metab. Res. 13(1981) pp. 631 635.;;Azria et al., Calcitonins Physiological and Pharmacological Aspects, pp. 1 34, Springer Verlag (1989).;;BioWorld Today, vol. 2., No. 125 (1991).;;Evans et al., Lancet 1:280 (1978) (cited in the application on p. 23).;;Passariello et al., J. Clinical Endocrinology and Metabolism, 53:318 23 (1981) (cited in the application on p. 23).;;Blahos et al., Endokinologie, Band 68, Heft 2, 226 30 (1976).;;Gattereau et al., J. Clinical Endocrinology and Metabolism 51:354 57 (1980).;;Giugliano, Biomedicine & Pharmacotherapy 38:273 77 (1984).;;Giugliano et al., Am. J. Physiol. 242:E206 13 (1982).;;Giugliano et al., Diabete & Metabolisme 8:213 16 (1982).;;Giustina et al., J. Endocrinol. Invest. 8:19 23 (1985).;;Lunetta et al., J. Endocrinol. Invest. 4:185 88 (1981).;;MacIntyre, Regulatory Peptides 34:81 (1991).;;Passeri et al., G. Clin. Med. 55:362 70 (1973).;;Sgambato et al., Acta Diabet. Lat. 18:235 41 (1981).;;Starke et al., Diabetologia 20:547 52 (1981).;;Stracca et al., Calcitonin 1984; Yamaguchi, Chem. Pharm. Bull. 29:1455 58 (1981).;;Yamaguchi, Endocrinol. Japon. 28:643 46 (1981).;;Yamaguchi, Endocrinol. Japon. 28:51 57 (1980).;;Yamaguchi et al., Chem. Pharm. Bull. 25:2189 94 (1977).;;Ziegler et al., Horm. Metab. Res. 4:60 (1972).;;Zofkova et al., Exp. Clin. Endocrinol. 89:91 96 (1987).;;Zofkova et al., Horm. Metabol. Res. 19:656 60 (1987).;;Zofkova, Acta. Univ. Carol. Med. 32:319 25 (1986).;;Ferlito et al., I1 Farmaco Ed. Pr. vol. 37 fasc. 7:239 44 (1982).;;Zamrazil et al., Horm. Metab. Res. 13:631 35 (1981).;;Yamaguchi et al., Diabetes 39:168 74 (1990).",EXPIRED
24,AU,A,AU 1992/016873 A,115-319-445-026-401,1992-10-21,1992,AU 1992/016873 A,1992-03-13,US 9202191 W;;US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,KEVIN BEAUMONT;;ANDREW A YOUNG,,https://lens.org/115-319-445-026-401,Patent Application,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
25,ES,T3,ES 2122995 T3,199-292-565-129-173,1999-01-01,1999,ES 92909629 T,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"PROCEDIMIENTOS Y COMPOSICIONES PARA EL TRATAMIENTO DE LA DIABETES MELLITUS, HIPOGLICEMIA Y OTROS ESTADOS PATOLOGICOS.","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/199-292-565-129-173,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
26,CA,C,CA 2082928 C,132-355-871-475-87X,2000-09-05,2000,CA 2082928 A,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A;;US 9202191 W,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/132-355-871-475-87X,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
27,DK,T3,DK 0533898 T3,016-035-237-732-279,1999-05-31,1999,DK 92909629 T,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A;;US 9202191 W,1991-03-15,"Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/016-035-237-732-279,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
28,EP,A4,EP 0533898 A4,030-771-783-784-239,1993-10-13,1993,EP 92909629 A,1992-03-13,US 9202191 W;;US 77441191 A;;US 70499591 A;;US 67023191 A,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.","AMYLIN PHARMACEUTICALS, INC.","BEAUMONT, KEVIN;;YOUNG, ANDREW, A.",,https://lens.org/030-771-783-784-239,Search Report,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,3,1,137-682-594-186-550,10.1136/pgmj.57.664.84;;6455656;;pmc2424817,"BIOLOGICAL ABSTRACTS vol. 69, no. 12 Philadelphia, PA, US; abstract no. 80405, PETRALITO A. ET AL. 'Effects of salmon calcitonin on insulin induced growth hormone release in man' page 8527-8528;;BIOLOGICAL ABSTRACTS vol. 87, no. 4 Philadelphia, PA, US; abstract no. 36313, LOOIJ B. ET AL 'The effect of calcitonin on growth hormone secretion in man' page 313;;BIOLOGICAL ABSTRACTS vol. 72, no. 3 Philadelphia, PA, US; abstract no. 19203, CONDON J. ET AL 'Control of osteitis deformans using glucagon calcitonin and mithramycin' page 2015",EXPIRED
29,AT,T1,AT E170401 T1,127-955-490-687-439,1998-09-15,1998,AT 92909629 T,1992-03-13,US 67023191 A;;US 70499591 A;;US 77441191 A,1991-03-15,"VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON DIABETES MELLITUS, HYPOGLYKÄMIE UND ANDERER KRANKHAFTER ZUSTÄNDE","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/127-955-490-687-439,Granted Patent,no,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,DISCONTINUED
30,EP,A1,EP 0533898 A1,198-222-014-188-636,1993-03-31,1993,EP 92909629 A,1992-03-13,US 9202191 W;;US 77441191 A;;US 70499591 A;;US 67023191 A,1991-03-15,"METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES MELLITUS, HYPOGLYCEMIA, AND OTHER CONDITIONS.","Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.",AMYLIN PHARMACEUTICALS INC,BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/198-222-014-188-636,Patent Application,yes,0,0,17,95,0,A61K38/22;;A61K38/26;;A61K38/28;;A61K49/0008;;A61K38/23;;A61P3/06;;A61K38/28;;A61K49/0008;;A61K38/22;;A61K38/26;;A61K38/23,A61K38/22;;A61K38/23;;A61K38/26;;A61K38/28;;A61K49/00;;A61P3/06,,0,0,,,,EXPIRED
31,HK,A,HK 22186 A,030-063-067-738-170,1986-04-04,1986,HK 22186 A,1986-03-27,GB 8227605 A,1982-09-28,SELF-ADHESIVE TRANSPARENT FILM,,BDK IND PROD LTD,FALCONER GRAHAM JOHN;;BEAUMONT ANDREW,,https://lens.org/030-063-067-738-170,Granted Patent,no,0,0,2,4,0,,B42D15/00,,0,0,,,,EXPIRED
32,US,B2,US 8555040 B2,024-656-401-714-286,2013-10-08,2013,US 78593910 A,2010-05-24,US 78593910 A,2010-05-24,Indirect branch target predictor that prevents speculation if mispredict is expected,"In one embodiment, a processor implements an indirect branch target predictor to predict target addresses of indirect branch instructions. The indirect branch target predictor may store target addresses generated during previous executions of indirect branches, and may use the stored target addresses as predictions for current indirect branches. The indirect branch target predictor may also store a validation tag corresponding to each stored target address. The validation tag may be compared to similar data corresponding to the current indirect branch being predicted. If the validation tag does not match, the indirect branch is presumed to be mispredicted (since the branch target address actually belongs to a different instruction). The indirect branch target predictor may inhibit speculative execution subsequent to the mispredicted indirect branch until the redirect is signalled for the mispredicted indirect branch.",BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,APPLE INC (2010-05-18),https://lens.org/024-656-401-714-286,Granted Patent,yes,18,9,2,2,0,G06F9/3848;;G06F9/3848;;G06F9/30061;;G06F9/30061;;G06F9/3806;;G06F9/3806,G06F9/32,712/238,2,0,,,"Pattern, David. Hennessy, John. ""Computer Architecture: A Quantitative Approach"". Morgan Kaufmann Publishers, Inc. 1996, pp. 271-278.;;Kozyrakis, Christos. ""EE382A Lecture 5: Branch Prediction"". 2009, 10 pages.",ACTIVE
33,DE,T9,DE 60120522 T9,046-015-701-334-603,2007-03-01,2007,DE 60120522 T,2001-02-02,GB 0003170 A,2000-02-12,Kindersicherheitssitz,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,"BRITAX EXCELSIOR LTD., ANDOVER, HAMPSHIRE, GB (2006-11-02)",https://lens.org/046-015-701-334-603,Amended Patent,no,0,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
34,DE,A1,DE 2628177 A1,008-377-546-856-216,1977-01-20,1977,DE 2628177 A,1976-06-23,US 59033175 A,1975-06-25,WAERMETAUSCHER FUER WIRBELSCHICHTREAKTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/008-377-546-856-216,Patent Application,no,0,3,18,18,0,B01J8/1836;;B01J8/1872;;B01J2208/00141;;B01J2208/00495;;F28D13/00;;F28D13/00;;B01J8/1872;;B01J8/1836;;B01J2208/00495;;B01J2208/00141,B01J8/18;;C04B11/028;;B01J8/24;;F28D13/00,,0,0,,,,DISCONTINUED
35,BR,A2,BR PI0916778 A2,024-102-048-446-721,2018-02-14,2018,BR PI0916778 A,2009-07-03,EP 2009058400 W;;EP 08160688 A,2008-07-18,"processo para produzir gás purificado a partir de uma corrente de gás de alimentação, e, gás natural liquefeito",,SHELL INTERNATIONALE RES MAARTSCHAPPIJ B V,ANDREW MALCOLM BEAUMONT;;HENRICUS ABRAHAM GEERS,,https://lens.org/024-102-048-446-721,Patent Application,no,0,0,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,C10L3/10;;F25J3/02,,0,0,,,,DISCONTINUED
36,KR,A,KR 20140010906 A,107-315-346-663-976,2014-01-27,2014,KR 20130084436 A,2013-07-17,AU 2012/903051 A,2012-07-17,IMPROVED TETHER STRAP ARRANGEMENT,The present invention relates to a safety device for children which includes a safety belt including a body part and at least one shoulder strap for fixing a user to the body part; and a link unit which operates to form a load passage for applying a load applied to the at least one shoulder strap or each shoulder strap to a tethering unit which substantially detours the body part and fixes the safety device for children on a fixing point.,BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/107-315-346-663-976,Patent Application,no,1,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60R22/10;;B60N2/26;;B60R22/12;;B60R22/18,,0,0,,,,ACTIVE
37,AU,A1,AU 2013/207593 A1,117-837-307-865-402,2014-02-06,2014,AU 2013/207593 A,2013-07-17,AU 2012/903051 A;;AU 2013/207593 A,2012-07-17,IMPROVED TETHER STRAP ARRANGEMENT,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and link means operative to create a load path which substantially bypasses the body and transfers loads borne by the shoulder strap to a tethering means for tethering the child restraint with respect to an anchor point. 40 30 42 72 Figure 2",BRITAX CHILDCARE PTY LTD,PURCHAS MARK;;LUMLEY MIKE;;BEAUMONT ANDREW,,https://lens.org/117-837-307-865-402,Patent Application,no,0,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/28;;B60N2/26;;B60R22/00;;B60R22/18;;B60R22/26,,0,0,,,,ACTIVE
38,DE,T2,DE 60120522 T2,112-951-778-677-616,2006-11-23,2006,DE 60120522 T,2001-02-02,GB 0003170 A,2000-02-12,Kindersicherheitssitz,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,"BRITAX EXCELSIOR LTD., ANDOVER, HAMPSHIRE, GB (2006-11-02)",https://lens.org/112-951-778-677-616,Granted Patent,no,0,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
39,US,B2,US 6471298 B2,123-679-014-504-191,2002-10-29,2002,US 77851901 A,2001-02-07,GB 0003170 A,2000-02-12,Child safety seat,"
    A child safety seat for use in a vehicle has a seat body and a harness including a pair of shoulder straps which extend through respective slots in the seat back to a mechanism for adjusting the length of the shoulder straps. The height at which the shoulder straps project from the seat back can be varied by threading them through different slots. A pad is slidably mounted on each shoulder strap and has a cover formed of high friction material on the side thereof facing the child occupant's body. A tether strap has one end attached to each pad and projects through the same slot in the seat back as the corresponding shoulder strap for limiting movement of the corresponding chest pad along the shoulder strap to a predetermined limit distance away from the seat back. Such limit distance increases as the height at which the shoulder straps project from the seat back is increased. 
",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,BRITAX EXCELSIOR LIMITED (2001-01-22),https://lens.org/123-679-014-504-191,Granted Patent,yes,15,90,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/28;;B60N2/26;;B60R22/10;;B60R22/26,297/483;;297/482;;297/484,0,0,,,,EXPIRED
40,EP,A3,EP 2687401 A3,128-266-418-375-177,2017-12-27,2017,EP 13003602 A,2013-07-17,AU 2012/903051 A,2012-07-17,A tensioning arrangement for a child restraint,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and a link means for linking the shoulder strap to a tethering means for anchoring the child restraint with respect to an anchor point, and wherein the link means is operative to tension the or each shoulder strap responsive to any loading of the tethering means.
",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/128-266-418-375-177,Search Report,yes,3,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/26;;B60N2/28;;B60R22/10,,0,0,,,,DISCONTINUED
41,AU,B2,AU 2013/207593 B2,193-336-419-705-228,2017-06-08,2017,AU 2013/207593 A,2013-07-17,AU 2012/903051 A;;AU 2013/207593 A,2012-07-17,IMPROVED TETHER STRAP ARRANGEMENT,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and link means operative to create a load path which substantially bypasses the body and transfers loads borne by the shoulder strap to a tethering means for tethering the child restraint with respect to an anchor point. 40 30 42 72 Figure 2",BRITAX CHILDCARE PTY LTD,PURCHAS MARK;;LUMLEY MIKE;;BEAUMONT ANDREW,,https://lens.org/193-336-419-705-228,Granted Patent,no,3,0,19,19,0,B60N2/2809;;B60N2/2812;;B60R22/105;;B60R22/18;;B60R22/10;;B60R22/12;;B60R22/18;;B60N2/26,B60N2/28;;B60N2/26;;B60R22/10,,0,0,,,,ACTIVE
42,RU,C2,RU 2556267 C2,161-177-650-303-639,2015-07-10,2015,RU 2013133394 A,2013-07-18,AU 2012/903051 A,2012-07-17,CHILD-RESTRAINT DEVICE (VERSIONS),"FIELD: personal use articles.SUBSTANCE: group of inventions relates to a child-restraint device. The child-restraint device comprises a housing, safety belts, including a shoulder strap for attachment of the passenger to the housing, a tethered means designed for tying the child-restraint device relative to the point of attachment, and the connection means. The connection means comprises a structural element, which is fixed with respect to the tethered means. The shoulder strap passes over the structural element, whereby the said connection means enables the creation of the load path which substantially avoids the housing and transfers the load experienced by the shoulder strap to the tethered means.EFFECT: improvement of safety of passengers carried in a child seat is achieved.13 cl, 9 dwg",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/161-177-650-303-639,Granted Patent,no,0,5,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/26;;B60N2/28;;B60R22/10,,0,0,,,,INACTIVE
43,AU,A1,AU 2013/207594 A1,169-181-665-335-943,2014-02-06,2014,AU 2013/207594 A,2013-07-17,AU 2012/903051 A;;AU 2013/207594 A,2012-07-17,A TENSIONING ARRANGEMENT FOR A CHILD RESTRAINT,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and a link means for linking the shoulder strap to a tethering means for anchoring the child restraint with respect to an anchor point, and wherein the link means is operative to tension the or each shoulder strap responsive to any loading of the tethering means. 1- 70 Figure 1",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/169-181-665-335-943,Patent Application,no,0,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/28;;B60R22/10,,0,0,,,,ACTIVE
44,GB,A,GB 1242359 A,183-099-116-751-13X,1971-08-11,1971,GB 553770 A,1970-02-05,GB 553770 A,1970-02-05,HEAT EXCHANGER OF THE SHELL AND THE TUBE TYPE,"1,242,359. Tubular heat exchangers; Incinerators. DORR-OLIVER Inc. 5 Feb., 1970, No. 5537/70. Headings F4B and F4S. A heat exchange unit 10 for preheating combustion air to be supplied as underblast to a fluidized bed type refuse incinerator 11 comprises an L-shaped tube bundle 34 of loop tubes connected to a tube plate T and contained within a easing having an inlet 47 and outlet 48 for hot combustion gases supplied from the incinerator 11. Air to be preheated is supplied to the lower chamber 61 of header 59 by a blower 12, is heated on passing through the loop tubes, and thereafter fed to the windbox 16 of the incinerator from the upper header chamber 62. Horizontal transverse support bars 65 are provided for securing the horizontal outlet portion of each loop tube against lateral deflection while allowing unrestricted thermal elongation. The tube bundle comprises a plurality of vertical assemblies of loop tubes 53, 54, 55, proper spacing of these assemblies being ensured by means of inverted U-shaped spacer elements (67, Fig. 8). The casing corner section bounded by flanges 35, 36 is removable for inspection and cleaning purposes. Soot blowers 68a in the form of transversely extending blower tubes are provided for periodic cleaning of the tubes. The refuse incinerator 11 comprises a combustion chamber 15 separated from the windbox by a member 14. Material to be burnt, e.g. dewatered sewage sludge, is fed at 17 into the fluidized bed B of sand. A burner R provides hot fluidizing gas at start-up whereafter, when combustion in the bed is self-sustaining, preheated combustion air from the heat exchange unit 10 provides the bulk of the fluidizing gas. Supplementary fuel may be added if required.",DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/183-099-116-751-13X,Granted Patent,no,0,0,1,1,0,F28D7/08,F28D7/08,B1F FCD           CD;;B1F FC1D          C1D;;B1F FC1P          C1P;;B1F F414          CD;;B1F F415          CD;;B1F F611          CD;;F4B BA17          BA17;;F4B B3A           B3A;;F4S S10A          S10A;;F4S S23D1         S23D;;F4S S5D1          S5D1,0,0,,,,EXPIRED
45,EP,B1,EP 1104717 B1,004-282-264-824-489,2003-10-22,2003,EP 00310668 A,2000-12-01,GB 9928628 A,1999-12-04,Child safety seat,"A child safety seat has a bottom zone (16) adapted to rest on the vehicle seat cushion and guide surfaces (23) for engagement by the vehicle seat belt (22) for holding the child seat in place on the vehicle seat. Two rigid protuberances (26, 28) project downwardly below the bottom zone (16) at an intermediate location between on quarter and half way back from the front edge of the bottom zone (16). The area the protuberances (26, 28) in contact with the vehicle seat is less than 10% of the area bounded by the perimeter of said bottom zone (16). <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SEAN;;BEAUMONT ANDREW PATRICK,,https://lens.org/004-282-264-824-489,Granted Patent,yes,7,0,6,6,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286,B60N2/28,,0,0,,,,EXPIRED
46,US,A,US 3982901 A,096-196-855-342-672,1976-09-28,1976,US 59014175 A,1975-06-25,US 59014175 A,1975-06-25,Heat transfer element and tuyere for fluidized bed reactor,"A fluidized bed reactor is provided with heat exchange coils for controllng the temperature of the fluidized bed. The heat exchange coils are vertically oriented and elements thereof pass through the constriction plate of the reactor. Multiple function Tuyere elements are provided which admit air into the reaction chamber from the windbox, provide for passage of elements of the heat exchange coils through the constriction plate, structurally support the heat exchange coils in position and constitute thermal sleeves for accommodating differential thermal expansion of the heat exchange coils and the constriction plate.",DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,TAMPELLA KEELER INCORPORATED (1989-10-27),https://lens.org/096-196-855-342-672,Granted Patent,yes,3,41,19,19,0,B01J8/1836;;B01J8/1872;;B01J2208/00132;;B01J2208/00141;;B01J2208/00495;;B01J2208/00504;;B01J2219/00018;;F28D13/00;;F28D13/00;;B01J2208/00132;;B01J2208/00495;;B01J2208/00504;;B01J2208/00141;;B01J8/1836;;B01J2219/00018;;B01J8/1872,B01J8/18;;C04B11/028;;B01J8/24;;F28D13/00,23/284,0,0,,,,EXPIRED
47,US,A,US 4073064 A,104-571-217-208-153,1978-02-14,1978,US 67585876 A,1976-04-12,US 67585876 A,1976-04-12,Refractory construction dome for fluidized bed reactor,"A refractory constriction dome for a fluidized bed reactor is constructed to resist the upward thrust of pressure in the windbox as well as the weight of the fluidized bed. A reverse arch of refractory brick or tiles, forming the upper surface of the dome, is the structural feature which functions to resist upward thrust.",DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;SVENCER RICHARD ERNEST,,https://lens.org/104-571-217-208-153,Granted Patent,yes,5,14,11,11,0,B01J8/44;;F23C10/20;;B01J8/44;;F23C10/20,B01J8/44;;F23C10/20;;F27B15/02,34 57A,0,0,,,,EXPIRED
48,EP,A1,EP 2602711 A1,034-383-604-372-492,2013-06-12,2013,EP 12185670 A,2012-09-24,US 201113313691 A,2011-12-07,Next fetch predictor training with hysteresis,"A system and method for efficient branch prediction. A processor includes two branch predictors. A first branch predictor quickly generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.
",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,,https://lens.org/034-383-604-372-492,Patent Application,yes,2,1,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/38,,1,1,074-348-116-913-904,10.1109/ispass.2006.1620790,"LOH G H: ""Revisiting the performance impact of branch predictor latencies"", PERFORMANCE ANALYSIS OF SYSTEMS AND SOFTWARE, 2006 IEEE INTERNATIONAL SYMPOSIUM ON AUSTIN, TX, USA MARCH 19-21, 2006, PISCATAWAY, NJ, USA,IEEE, 19 March 2006 (2006-03-19), pages 59 - 69, XP010910194, ISBN: 978-1-4244-0186-4, DOI: 10.1109/ISPASS.2006.1620790",ACTIVE
49,MX,A,MX 144090 A,195-953-527-560-894,1981-08-26,1981,MX 16771477 A,1977-01-17,US 67585876 A,1976-04-12,MEJORAS EN REACTOR DE LECHO FLUIDIZADO,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;SVENCER RICHARD ERNEST,,https://lens.org/195-953-527-560-894,Granted Patent,no,0,0,11,11,0,B01J8/44;;F23C10/20;;B01J8/44;;F23C10/20,B01J8/44;;F27B15/02;;F23C10/20,16-30,0,0,,,,EXPIRED
50,AT,T1,AT E329786 T1,019-841-091-009-699,2006-07-15,2006,AT 01300967 T,2001-02-02,GB 0003170 A,2000-02-12,KINDERSICHERHEITSSITZ,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,,https://lens.org/019-841-091-009-699,Granted Patent,no,0,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
51,WO,A1,WO 2010/019114 A1,020-252-426-561-195,2010-02-18,2010,US 2008/0009638 W,2008-08-11,US 2008/0009638 W,2008-08-11,A METHOD OF IMAGE MANIPULATION TO FADE BETWEEN TWO FRAMES OF A DUAL FRAME IMAGE,A process to fade between two frames of a dual frame digital TIFF image of an organ taken during an examination with a colposcope to use in computer-aided- diagnosis (CAD) systems.,STI MEDICAL SYSTEMS LLC;;WHITESELL ANDREW BEAUMONT;;OFIESH GREG RAYMOND,WHITESELL ANDREW BEAUMONT;;OFIESH GREG RAYMOND,,https://lens.org/020-252-426-561-195,Patent Application,yes,2,0,1,1,0,G06T15/503;;G06T13/80,A61B5/00,,0,0,,,,PENDING
52,EP,A2,EP 1123833 A2,038-429-023-783-898,2001-08-16,2001,EP 01300967 A,2001-02-02,GB 0003170 A,2000-02-12,Child safety seat,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased.",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,BRITAX EXCELSIOR LIMITED (2006-06-07),https://lens.org/038-429-023-783-898,Patent Application,yes,3,11,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
53,US,A1,US 2001/0013719 A1,055-151-330-985-791,2001-08-16,2001,US 77851901 A,2001-02-07,GB 0003170 A,2000-02-12,Child safety seat,"
   A child safety seat for use in a vehicle has a seat body and a harness including a pair of shoulder straps which extend through respective slots in the seat back to a mechanism for adjusting the length of the shoulder straps. The height at which the shoulder straps project from the seat back can be varied by threading them through different slots. A pad is slidably mounted on each shoulder strap and has a cover formed of high friction material on the side thereof facing the child occupant's body. A tether strap has one end attached to each pad and projects through the same slot in the seat back as the corresponding shoulder strap for limiting movement of the corresponding chest pad along the shoulder strap to a predetermined limit distance away from the seat back. Such limit distance increases as the height at which the shoulder straps project from the seat back is increased. 
",CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,BRITAX EXCELSIOR LIMITED (2001-01-22),https://lens.org/055-151-330-985-791,Patent Application,yes,0,20,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60N2/26;;B60R22/26,297/484;;297/250.1,0,0,,,,EXPIRED
54,EP,A2,EP 1104717 A2,124-900-363-374-459,2001-06-06,2001,EP 00310668 A,2000-12-01,GB 9928628 A,1999-12-04,Child safety seat,"A child safety seat has a bottom zone (16) adapted to rest on the vehicle seat cushion and guide surfaces (23) for engagement by the vehicle seat belt (22) for holding the child seat in place on the vehicle seat. Two rigid protuberances (26, 28) project downwardly below the bottom zone (16) at an intermediate location between on quarter and half way back from the front edge of the bottom zone (16). The area the protuberances (26, 28) in contact with the vehicle seat is less than 10% of the area bounded by the perimeter of said bottom zone (16).",BRITAX EXCELSIOR,CARINE DAVID SEAN;;BEAUMONT ANDREW PATRICK,,https://lens.org/124-900-363-374-459,Patent Application,yes,1,0,6,6,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286,B60N2/28,,0,0,,,,EXPIRED
55,AU,B2,AU 2013/207594 B2,122-599-833-247-639,2018-03-01,2018,AU 2013/207594 A,2013-07-17,AU 2012/903051 A;;AU 2013/207594 A,2012-07-17,A TENSIONING ARRANGEMENT FOR A CHILD RESTRAINT,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and a link means for linking the shoulder strap to a tethering means for anchoring the child restraint with respect to an anchor point, and wherein the link means is operative to tension the or each shoulder strap responsive to any loading of the tethering means. 1- 70 Figure 1",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/122-599-833-247-639,Granted Patent,no,2,0,19,19,0,B60N2/2809;;B60N2/2812;;B60R22/105;;B60R22/18;;B60R22/10;;B60R22/12;;B60R22/18;;B60N2/26,B60N2/28;;B60R22/10,,0,0,,,,ACTIVE
56,KR,A,KR 20140010907 A,145-647-974-384-029,2014-01-27,2014,KR 20130084437 A,2013-07-17,AU 2012/903051 A,2012-07-17,A TENSIONING ARRANGEMENT FOR A CHILD RESTRAINT,The present invention relates to a tensioning device for a child protection device including: a body; a safety belt having one or more shoulder straps for making a user seated on the body; and a link unit for connecting the shoulder straps to a tethering unit for fixing a child protection device to a fixing point. The link unit applies tension to the shoulder straps based on a load applied to the tethering unit.,BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/145-647-974-384-029,Patent Application,no,1,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60R22/10;;B60N2/26;;B60R22/12;;B60R22/18,,0,0,,,,ACTIVE
57,EP,B1,EP 1123833 B1,189-274-425-636-972,2006-06-14,2006,EP 01300967 A,2001-02-02,GB 0003170 A,2000-02-12,Child safety seat,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,BRITAX EXCELSIOR LIMITED (2006-06-07),https://lens.org/189-274-425-636-972,Granted Patent,yes,3,4,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
58,WO,A2,WO 2010/006934 A2,019-496-398-275-620,2010-01-21,2010,EP 2009058400 W,2009-07-03,EP 08160688 A,2008-07-18,TWO STAGE PROCESS FOR PRODUCING PURIFIED GAS,"The present invention provides a process for producing purified gas from a feed gas stream comprising methane and gaseous contaminants, the process comprising the steps of : 1) providing the feed gas stream; 2) cooling the feed gas stream to a temperature at which at least part of the feed gas stream is present in the liquid phase; 3) separating the cooled feed gas stream by means of cryogenic distillation into a bottom stream rich in contaminants and lean in methane, and into a top stream rich in methane and lean in gaseous contaminants, in which the bottom stream contains between 0.5 and 15 % of the methane present in the feed gas stream; 4) cooling the stream rich in methane to a temperature at which solid and/or liquid phase contaminants are formed; 5) introducing the cooled stream of step 4) into a gas/liquid/solids separation vessel, and 6) removing from the gas/liquid/solids separation vessel the purified gas and a stream rich in contaminants.",SHELL INT RESEARCH;;BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,,https://lens.org/019-496-398-275-620,Patent Application,yes,0,11,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,F25J3/02;;C10L3/10,,0,0,,,,PENDING
59,ES,T3,ES 2266111 T3,081-270-022-122-905,2007-03-01,2007,ES 01300967 T,2001-02-02,GB 0003170 A,2000-02-12,ASIENTO DE SEGURIDAD INFANTIL.,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,,https://lens.org/081-270-022-122-905,Granted Patent,no,0,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
60,DE,D1,DE 60006055 D1,156-781-819-183-127,2003-11-27,2003,DE 60006055 T,2000-12-01,GB 9928628 A,1999-12-04,Kindersicherheitssitz,"A child safety seat has a bottom zone (16) adapted to rest on the vehicle seat cushion and guide surfaces (23) for engagement by the vehicle seat belt (22) for holding the child seat in place on the vehicle seat. Two rigid protuberances (26, 28) project downwardly below the bottom zone (16) at an intermediate location between on quarter and half way back from the front edge of the bottom zone (16). The area the protuberances (26, 28) in contact with the vehicle seat is less than 10% of the area bounded by the perimeter of said bottom zone (16). <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SEAN;;BEAUMONT ANDREW PATRICK,,https://lens.org/156-781-819-183-127,Granted Patent,no,0,0,6,6,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286,B60N2/28,,0,0,,,,EXPIRED
61,EP,B1,EP 2602711 B1,115-459-897-486-243,2014-12-24,2014,EP 12185670 A,2012-09-24,US 201113313691 A,2011-12-07,Next fetch predictor training with hysteresis,,APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,,https://lens.org/115-459-897-486-243,Granted Patent,yes,2,0,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/38,,1,0,,,"LOH G H: ""Revisiting the performance impact of branch predictor latencies"", PERFORMANCE ANALYSIS OF SYSTEMS AND SOFTWARE, 2006 IEEE INTERNATIONAL SYMPOSIUM ON AUSTIN, TX, USA MARCH 19-21, 2006, PISCATAWAY, NJ, USA,IEEE, 19 March 2006 (2006-03-19), pages 59-69, XP010910194, DOI: 10.1109/ISPASS.2006.1620790 ISBN: 978-1-4244-0186-4",ACTIVE
62,US,B2,US 7127483 B2,138-552-750-392-606,2006-10-24,2006,US 3611601 A,2001-12-26,US 3611601 A,2001-12-26,Method and system of a microprocessor subtraction-division floating point divider,"The specification discloses a structure of and a method of operating a subtractive division (SD) cell where a portion of the partial remainder or estimated partial remainder directly indicates the next quotient digit. More particularly, by sufficiently constraining the prescaled range for each possible divisor, only a few bits of the partial remainder (the exact number dependent upon the radix), along with their related carries (if any), directly indicate the value of the next quotient digit. Because fewer bits of the partial remainder are needed to make this determination than needed in related art devices, and further because no look-up table or hard-coded decision tree is required, calculation time within each SD cell is shorter than related art devices. Having a shorter calculation time within each SD cell allows for either completion of a greater number of SD cells within each clock cycle, or completion of the calculation to full precision in less time.",HEWLETT PACKARD DEVELOPMENT CO,BEAUMONT-SMITH ANDREW J;;SAMUDRALA SRIDHAR,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2001-12-19),https://lens.org/138-552-750-392-606,Granted Patent,yes,11,10,2,2,0,G06F7/4873;;G06F7/49936;;G06F7/535;;G06F7/5375;;G06F7/535;;G06F7/5375;;G06F7/49936;;G06F7/4873,G06F7/44;;G06F7/52;;G06F7/535,708/504;;708/655,5,5,170-746-406-473-162;;003-577-374-008-601;;038-886-165-598-157;;046-315-062-680-706;;122-261-211-300-898,10.1109/12.713319;;10.1109/12.272428;;10.1109/tc.1968.229150;;10.1109/12.559806;;10.1109/12.57060,"Luis A. Montalvo et al., Brief Contributions; New Svoboda-Tung Division, IEEE Transactions on Computers, vol. 47, No. 9, Sep. 1998, pp. 1014-1020.;;Paolo Montuschi et al., Over-Redundant Digit Sets and the Design of Digit-by-Digit Division Units, IEEE Transactions on Computers, vol. 43, No. 3, Mar. 1994, pp. 269-277.;;Chin Tung, A Division Algorithm for Signed-Digit Arithmetic, IEEE Transactions On Computers, Sep. 1968, pp. 887-889.;;Hosahalli R. Srinivas et al., Radix 2 Division with Over-Redundant Quotient Selection, IEEE Transactions on Computers, vol. 46, No. 1, Jan. 1997, pp. 85-92.;;Milos D. Ercegovac et al., Correspondence; Simple Radix -4 Division with Operands Scaling, IEEE Transactions on Computers, vol. 39, No. 9, Sep. 1990, pp. 1204-1207.",EXPIRED
63,AU,A1,AU 2009/272889 A1,012-866-587-952-88X,2010-01-21,2010,AU 2009/272889 A,2009-07-03,EP 08160688 A;;EP 2009058400 W,2008-07-18,Two stage process for producing purified gas,,SHELL INT RESEARCH,GEERS HENRICUS ABRAHAM;;BEAUMONT ANDREW MALCOLM,,https://lens.org/012-866-587-952-88X,Patent Application,no,0,1,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,F25J3/02;;C10L3/10,,0,0,,,,ACTIVE
64,US,A1,US 2011/0289300 A1,041-004-219-053-787,2011-11-24,2011,US 78593910 A,2010-05-24,US 78593910 A,2010-05-24,Indirect Branch Target Predictor that Prevents Speculation if Mispredict Is Expected,"In one embodiment, a processor implements an indirect branch target predictor to predict target addresses of indirect branch instructions. The indirect branch target predictor may store target addresses generated during previous executions of indirect branches, and may use the stored target addresses as predictions for current indirect branches. The indirect branch target predictor may also store a validation tag corresponding to each stored target address. The validation tag may be compared to similar data corresponding to the current indirect branch being predicted. If the validation tag does not match, the indirect branch is presumed to be mispredicted (since the branch target address actually belongs to a different instruction). The indirect branch target predictor may inhibit speculative execution subsequent to the mispredicted indirect branch until the redirect is signalled for the mispredicted indirect branch.",BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,APPLE INC (2010-05-18),https://lens.org/041-004-219-053-787,Patent Application,yes,3,31,2,2,0,G06F9/3848;;G06F9/3848;;G06F9/30061;;G06F9/30061;;G06F9/3806;;G06F9/3806,G06F9/38;;G06F9/30,712/205;;712/240;;X712E09045;;X712E0906;;X712E09016,2,0,,,"Pattern, David. Hennessy, John. ""Computer Architecture: A Quantitative Approach"". Morgan Kaufmann Publishers, Inc. 1996, Pages 271-278.;;Kozyrakis, Christos. ""EE382A Lecture 5: Branch Prediction"". 2009, 10 pages.",ACTIVE
65,DE,A1,DE 2628180 A1,064-674-067-662-432,1977-01-20,1977,DE 2628180 A,1976-06-23,US 59014175 A,1975-06-25,WAERMEUEBERTRAGUNGSELEMENT UND DUESE FUER EINEN WIRBELSCHICHTREAKTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/064-674-067-662-432,Patent Application,no,0,1,19,19,0,B01J8/1836;;B01J8/1872;;B01J2208/00132;;B01J2208/00141;;B01J2208/00495;;B01J2208/00504;;B01J2219/00018;;F28D13/00;;F28D13/00;;B01J2208/00132;;B01J2208/00495;;B01J2208/00504;;B01J2208/00141;;B01J8/1836;;B01J2219/00018;;B01J8/1872,B01J8/18;;B01J8/24;;C04B11/028;;F28D13/00,,0,0,,,,DISCONTINUED
66,JP,A,JP 2001287576 A,102-299-198-951-079,2001-10-16,2001,JP 2001035131 A,2001-02-13,GB 0003170 A,2000-02-12,CHILD SAFETY SEAT,"PROBLEM TO BE SOLVED: To provide a child safety seat to be used in a vehicle. SOLUTION: In this child safety seat, pads 50 are slidably mounted on shoulder straps 16 and 18, and each pad has a cover formed of a highly frictional material on a side 52 facing the body of a child sitting on the seat. One end of a mooring strap 54 is mounted on each pad 50. The mooring strap is protruded through the same slots 28, 32 and 36 as the corresponding shoulder straps 16 and 18 of a seat back 26 to limit the movement of the corresponding chest pads 50 along the shoulder straps 16 and 18 to a prescribed limit distance in the direction leaving the seat back 26. Such a limit distance is increased as the height protruded from the seat back 26 of the shoulder straps 16 and 18 is increased.",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,,https://lens.org/102-299-198-951-079,Patent Application,no,0,8,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,PENDING
67,CH,A,CH 503964 A,150-993-358-285-345,1971-02-28,1971,CH 225670 A,1970-02-17,CH 225670 A,1970-02-17,Wärmeaustauscher,,DORR OLIVER INC,BEAUMONT STEEVER ANDREW;;WALFRED WILHELM JUKKOLA,,https://lens.org/150-993-358-285-345,Granted Patent,no,0,0,1,1,0,F23L15/04;;F28D7/08;;Y02E20/34,F23L15/04;;F28D7/08,,0,0,,,,EXPIRED
68,AU,A,AU 1976/014283 A,002-598-050-853-645,1977-12-01,1977,AU 1976/014283 A,1976-05-26,US 59014175 A,1975-06-25,HEAT TRANSFER ELEMENT AND TUYERE FOR FLUIDIZED BED REACTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/002-598-050-853-645,Patent Application,no,0,0,19,19,0,B01J8/1836;;B01J8/1872;;B01J2208/00132;;B01J2208/00141;;B01J2208/00495;;B01J2208/00504;;B01J2219/00018;;F28D13/00;;F28D13/00;;B01J2208/00132;;B01J2208/00495;;B01J2208/00504;;B01J2208/00141;;B01J8/1836;;B01J2219/00018;;B01J8/1872,C04B11/028;;B01J8/18;;B01J8/24;;F28D13/00,,0,0,,,,EXPIRED
69,AU,A,AU 1973/051648 A,013-949-069-003-967,1974-08-01,1974,AU 1973/051648 A,1973-02-01,US 28615772 A,1972-09-05,FUEL GUN FOR FLUIDIZED BED REACTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/013-949-069-003-967,Patent Application,no,0,0,9,9,0,F23C5/02;;F23C5/02;;F27B15/10;;F27B15/10;;F27B15/14;;F27B15/14,B01J8/18;;B01J8/24;;F23C5/02;;F23C10/22;;F27B15/10;;F27B15/12;;F27B15/14,,0,0,,,,EXPIRED
70,GB,A,GB 2620557 A,039-933-714-115-062,2024-01-17,2024,GB 202209881 A,2022-07-05,GB 202209881 A,2022-07-05,Improvements in or relating to data integrity,"A method and system for verifying transactions involves assigning trusted status to a subset of users 101. The trusted users 102 may be private organisations, individuals, government entities, regulars and/or other stakeholders. The trusted users 102 define a centralised root of trust. One or more tokens are issued from the centralised root of trust to users 101. A transaction is submitted involving at least one token for verification by each of the trusted users 102. It is determined whether or not a transaction is centrally verified based on whether or not a predetermined proportion of the trusted users 102 have individually verified the transaction or not. The proportion may be a simple majority or may be variable. If the transaction is centrally verified the transaction is recorded to a centralised ledger 104. If the transaction is not centrally verified, the transaction is not recorded to the centralised ledger 104.",TOKENCERTIFY LTD,ADAM BEAUMONT;;ANDREW MORRIS;;BILL BRIDGDEN,TOKENCERTIFY LIMITED (2023-05-03),https://lens.org/039-933-714-115-062,Patent Application,no,3,0,3,3,0,G06Q20/02;;G06Q20/065;;G06Q20/223;;G06Q20/3678;;G06Q20/3827;;G06Q20/3829;;G06Q20/389;;G06Q20/401;;G06Q20/4016;;G06Q20/02;;G06F21/64;;G06Q20/3825;;G06Q20/401,G06Q20/02;;G06F21/64;;G06Q20/38;;G06Q20/40,,0,0,,,,PENDING
71,DE,D1,DE 60120522 D1,088-612-078-723-269,2006-07-27,2006,DE 60120522 T,2001-02-02,GB 0003170 A,2000-02-12,Kindersicherheitssitz,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased. <IMAGE> <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,"BRITAX EXCELSIOR LTD., ANDOVER, HAMPSHIRE, GB (2006-11-02)",https://lens.org/088-612-078-723-269,Granted Patent,no,0,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
72,CN,A,CN 103538554 A,175-421-219-644-954,2014-01-29,2014,CN 201310299975 A,2013-07-17,AU 2012/903051 A,2012-07-17,An improved tensioning arrangement for a child restraint,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and link means operative to create a load path which substantially bypasses the body and transfers loads borne by the shoulder strap to a tethering means for tethering the child restraint with respect to an anchor point.",BRITAX CHILDCARE PTY LTD,MIKE LUMLEY;;MARK PURCHAS;;ANDREW BEAUMONT,,https://lens.org/175-421-219-644-954,Patent Application,no,5,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60R22/10;;B60R22/18,,0,0,,,,ACTIVE
73,AU,B2,AU 2009/272889 B2,007-062-949-421-775,2013-03-21,2013,AU 2009/272889 A,2009-07-03,EP 08160688 A;;EP 2009058400 W,2008-07-18,Two stage process for producing purified gas,"The present invention provides a process for producing purified gas from a feed gas stream comprising methane and gaseous contaminants, the process comprising the steps of : 1) providing the feed gas stream; 2) cooling the feed gas stream to a temperature at which at least part of the feed gas stream is present in the liquid phase; 3) separating the cooled feed gas stream by means of cryogenic distillation into a bottom stream rich in contaminants and lean in methane, and into a top stream rich in methane and lean in gaseous contaminants, in which the bottom stream contains between 0.5 and 15 % of the methane present in the feed gas stream; 4) cooling the stream rich in methane to a temperature at which solid and/or liquid phase contaminants are formed; 5) introducing the cooled stream of step 4) into a gas/liquid/solids separation vessel, and 6) removing from the gas/liquid/solids separation vessel the purified gas and a stream rich in contaminants.",SHELL INT RESEARCH,BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,,https://lens.org/007-062-949-421-775,Granted Patent,no,6,0,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,F25J3/02;;C10L3/10,,0,0,,,,ACTIVE
74,DE,C2,DE 2101148 C2,135-674-036-218-527,1984-05-10,1984,DE 2101148 A,1971-01-12,US 234970 A,1970-01-12,DE 2101148 C2,,"MOBIL OIL CORP., NEW YORK, N.Y., US","HORODYSKY, ANDREW GENE, BEAUMONT, TEX., US",,https://lens.org/135-674-036-218-527,Granted Patent,no,0,0,10,10,0,C07C319/14;;C07C319/14;;C08G75/00;;C08G75/00;;C10M135/04;;C10M135/04;;C10M2219/022;;C10M2219/022;;C10N2050/10;;C10N2050/10,C07B45/06;;C07B31/00;;C07C67/00;;C07C309/80;;C07C313/00;;C07C319/14;;C07C321/18;;C08G75/00;;C10M135/04,,0,0,,,,EXPIRED
75,AU,A,AU 1976/014282 A,020-074-970-045-179,1977-12-01,1977,AU 1976/014282 A,1976-05-26,US 59033175 A,1975-06-25,HEAT EXCHANGER FOR FLUID BED REACTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,,https://lens.org/020-074-970-045-179,Patent Application,no,0,0,18,18,0,B01J8/1836;;B01J8/1872;;B01J2208/00141;;B01J2208/00495;;F28D13/00;;F28D13/00;;B01J8/1872;;B01J8/1836;;B01J2208/00495;;B01J2208/00141,C04B11/028;;B01J8/18;;B01J8/24;;F28D13/00,,0,0,,,,EXPIRED
76,CN,A,CN 103538553 A,072-989-784-948-501,2014-01-29,2014,CN 201310299943 A,2013-07-17,AU 2012/903051 A,2012-07-17,Improved tether strap arrangement,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and link means operative to create a load path which substantially bypasses the body and transfers loads borne by the shoulder strap to a tethering means for tethering the child restraint with respect to an anchor point.",BRITAX CHILDCARE PTY LTD,MIKE LUMLEY;;MARK PURCHAS;;ANDREW BEAUMONT,,https://lens.org/072-989-784-948-501,Patent Application,no,7,2,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60R22/10,,0,0,,,,ACTIVE
77,CN,A,CN 103150142 A,101-925-790-390-273,2013-06-12,2013,CN 201210543904 A,2012-09-28,US 201113313691 A,2011-12-07,Next fetch predictor training with hysteresis,"The invention relates to next fetch predictor training with hysteresis.A system and a method for efficient branch prediction are disclosed. A processor includes two branch predictors. A first branch predictor quickly generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH,,https://lens.org/101-925-790-390-273,Patent Application,no,4,5,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/30,,1,1,074-348-116-913-904,10.1109/ispass.2006.1620790,"LOH,G.H: ""Revisiting the performance impact of branch predictor latencies"", 《PERFORMACE ANALYSIS OF SYSTEMS AND SOFTWARE,2006 IEEE INTERNATIONAL SYMPOSIUM ON》, 21 March 2006 (2006-03-21), pages 59 - 69, XP010910194, DOI: 10.1109/ISPASS.2006.1620790",ACTIVE
78,AT,T1,AT E252466 T1,112-742-583-147-868,2003-11-15,2003,AT 00310668 T,2000-12-01,GB 9928628 A,1999-12-04,KINDERSICHERHEITSSITZ,"A child safety seat has a bottom zone (16) adapted to rest on the vehicle seat cushion and guide surfaces (23) for engagement by the vehicle seat belt (22) for holding the child seat in place on the vehicle seat. Two rigid protuberances (26, 28) project downwardly below the bottom zone (16) at an intermediate location between on quarter and half way back from the front edge of the bottom zone (16). The area the protuberances (26, 28) in contact with the vehicle seat is less than 10% of the area bounded by the perimeter of said bottom zone (16). <IMAGE>",BRITAX EXCELSIOR,CARINE DAVID SEAN;;BEAUMONT ANDREW PATRICK,,https://lens.org/112-742-583-147-868,Granted Patent,no,0,0,6,6,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286,B60N2/28,,0,0,,,,DISCONTINUED
79,US,A1,US 2003/0135531 A1,187-625-463-079-977,2003-07-17,2003,US 3611601 A,2001-12-26,US 3611601 A,2001-12-26,Microprocessor floating point divider,"
   The specification discloses a structure of and a method of operating a subtractive division (SD) cell where a portion of the partial remainder or estimated partial remainder directly indicates the next quotient digit. More particularly, by sufficiently constraining the prescaled range for each possible divisor, only a few bits of the partial remainder (the exact number dependent upon the radix), along with their related carries (if any), directly indicate the value of the next quotient digit. Because fewer bits of the partial remainder are needed to make this determination than needed in related art devices, and further because no look-up table or hard-coded decision tree is required, calculation time within each SD cell is shorter than related art devices. Having a shorter calculation time within each SD cell allows for either completion of a greater number of SD cells within each clock cycle, or completion of the calculation to full precision in less time. 
",BEAUMONT-SMITH ANDREW J.;;SAMUDRALA SRIDHAR,BEAUMONT-SMITH ANDREW J;;SAMUDRALA SRIDHAR,HEWLETT-PACKARD DEVELOPMENT COMPANY L.P (2001-12-19),https://lens.org/187-625-463-079-977,Patent Application,yes,11,2,2,2,0,G06F7/4873;;G06F7/49936;;G06F7/535;;G06F7/5375;;G06F7/535;;G06F7/5375;;G06F7/49936;;G06F7/4873,G06F7/52;;G06F7/535,708/504;;708/655,0,0,,,,EXPIRED
80,EP,A3,EP 1104717 A3,187-738-469-942-63X,2002-12-11,2002,EP 00310668 A,2000-12-01,GB 9928628 A,1999-12-04,Child safety seat,"A child safety seat has a bottom zone (16) adapted to rest on the vehicle seat cushion and guide surfaces (23) for engagement by the vehicle seat belt (22) for holding the child seat in place on the vehicle seat. Two rigid protuberances (26, 28) project downwardly below the bottom zone (16) at an intermediate location between on quarter and half way back from the front edge of the bottom zone (16). The area the protuberances (26, 28) in contact with the vehicle seat is less than 10% of the area bounded by the perimeter of said bottom zone (16).",BRITAX EXCELSIOR,CARINE DAVID SEAN;;BEAUMONT ANDREW PATRICK,,https://lens.org/187-738-469-942-63X,Search Report,yes,7,0,6,6,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286,B60N2/28,,0,0,,,,EXPIRED
81,RU,C2,RU 2547733 C2,036-513-857-711-89X,2015-04-10,2015,RU 2013133396 A,2013-07-17,AU 2012/903051 A,2012-07-17,SAFETY BELT FOR KIDS (VERSIONS),"FIELD: transport.SUBSTANCE: set of inventions relates to safety belts for kids. this device comprises case, system of safety belts including at least one shoulder belt for fastening of passenger to said case and connector to tension said or every shoulder belt in response to whatever load. In compliance with first version, said connector serves to fasten shoulder belt to fastener including fastening belt to fasten kid retainer relative to fastening point. In compliance with second version, said fastener is intended for fastening of kid retainer relative to fastening point. Said connector is intended for fastening of said belt of every shoulder belt to fastening means.EFFECT: possibility to use said safety belt with various safety seats for kids.20 cl, 4 dwg",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/036-513-857-711-89X,Granted Patent,no,0,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60R22/10;;B60N2/26,,0,0,,,,INACTIVE
82,US,A1,US 2011/0132034 A1,126-540-429-685-222,2011-06-09,2011,US 200913002966 A,2009-07-03,EP 08160688 A;;EP 2009058400 W,2008-07-18,TWO STAGE PROCESS FOR PRODUCING PURIFIED GAS,"The present invention provides a process for producing purified gas from a feed gas stream comprising methane and gaseous contaminants, the process comprising the steps of: 1) providing the feed gas stream; 2) cooling the feed gas stream to a temperature at which at least part of the feed gas stream is present in the liquid phase; 3) separating the cooled feed gas stream by means of cryogenic distillation into a bottom stream rich in contaminants and lean in methane, and into a top stream rich in methane and lean in gaseous contaminants, in which the bottom stream contains between 0.5 and 15% of the methane present in the feed gas stream; 4) cooling the stream rich in methane to a temperature at which solid and/or liquid phase contaminants are formed; 5) introducing the cooled stream of step 4) into a gas/liquid/solids separation vessel, and 6) removing from the gas/liquid/solids separation vessel the purified gas and a stream rich in contaminants.",BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,SHELL OIL COMPANY (2010-12-02),https://lens.org/126-540-429-685-222,Patent Application,yes,5,23,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,F25J3/02;;F25J3/08,62/620,1,0,,,"Perry's Handbook for Chemical Engineer's, 8th Ed. Ch. 10 (2007)",DISCONTINUED
83,US,A1,US 2010/0033501 A1,140-043-285-371-717,2010-02-11,2010,US 22829808 A,2008-08-11,US 22829808 A,2008-08-11,Method of image manipulation to fade between two images,A process to fade between two frames of a dual frame digital TIFF image of an organ taken during an examination with a colposcope to use in computer-aided-diagnosis (CAD) systems.,STI MEDICAL SYSTEMS LLC,WHITESELL ANDREW BEAUMONT;;OFIESH GREG RAYMOND,STI MEDICAL SYSTEMS LLC (2008-08-11),https://lens.org/140-043-285-371-717,Patent Application,yes,12,20,1,1,0,G06T13/80;;G06T15/503;;G09G2340/10;;G09G2380/08;;G06T7/30;;G06T15/503;;G06T13/80;;G09G2380/08;;G09G2340/10;;G06T7/30,G09G5/00,345/634,0,0,,,,DISCONTINUED
84,EP,A2,EP 2687401 A2,182-493-568-227-944,2014-01-22,2014,EP 13003602 A,2013-07-17,AU 2012/903051 A,2012-07-17,A tensioning arrangement for a child restraint,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and a link means for linking the shoulder strap to a tethering means for anchoring the child restraint with respect to an anchor point, and wherein the link means is operative to tension the or each shoulder strap responsive to any loading of the tethering means.
",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/182-493-568-227-944,Patent Application,yes,1,0,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/26,,0,0,,,,DISCONTINUED
85,EP,A2,EP 2687400 A2,013-988-221-641-659,2014-01-22,2014,EP 13003601 A,2013-07-17,AU 2012/903051 A,2012-07-17,Improved tether strap arrangement,"The present invention relates to a child restraint comprising a body, a safety harness including at least one shoulder strap for securing an occupant to the body, and link means operative to create a load path which substantially bypasses the body and transfers loads borne by the shoulder strap to a tethering means for tethering the child restraint with respect to an anchor point.
",BRITAX CHILDCARE PTY LTD,LUMLEY MIKE;;PURCHAS MARK;;BEAUMONT ANDREW,,https://lens.org/013-988-221-641-659,Patent Application,yes,1,1,19,19,0,B60N2/2809;;B60R22/10;;B60N2/26;;B60N2/2812;;B60R22/105;;B60R22/12;;B60R22/18;;B60R22/18,B60N2/26,,0,0,,,,DISCONTINUED
86,WO,A1,WO 2024/009098 A1,017-770-155-897-376,2024-01-11,2024,GB 2023051779 W,2023-07-05,GB 202209881 A,2022-07-05,IMPROVEMENTS IN OR RELATING TO DATA INTEGRITY,"There is disclosed a method of verifying transactions comprising assigning 'trusted status' a subset of users, the subset of trusted users defining a centralised root of trust, issuing one or more tokens from the centralised root of trust to users, submitting a transaction involving at least one token for verification by each of the subset of trusted users, determining whether or not a transaction is centrally verified based on whether or not a predetermined proportion of the trusted users have individually verified the transaction or not, and wherein if the transaction is centrally verified the transaction is recorded to a centralised ledger, and wherein if the transaction is not centrally verified, the transaction is not recorded to the centralised ledger. There is also disclosed a system for verifying transactions according to the above method.",TOKENCERTIFY LTD,BEAUMONT ADAM;;MORRIS ANDREW;;BRIGDEN BILL,,https://lens.org/017-770-155-897-376,Patent Application,yes,0,0,3,3,0,G06Q20/02;;G06Q20/065;;G06Q20/223;;G06Q20/3678;;G06Q20/3827;;G06Q20/3829;;G06Q20/389;;G06Q20/401;;G06Q20/4016;;G06Q20/02;;G06F21/64;;G06Q20/3825;;G06Q20/401,G06Q20/02;;G06Q20/06;;G06Q20/22;;G06Q20/36;;G06Q20/38;;G06Q20/40,,1,0,,,"KERNER SEAN MICHAEL: ""Amazon Quantum Ledger Database brings immutable transactions | TechTarget"", 12 September 2019 (2019-09-12), pages 1 - 4, XP093072450, Retrieved from the Internet <URL:https://www.techtarget.com/searchdatamanagement/news/252470642/Amazon-Quantum-Ledger-Database-brings-immutable-transactions> [retrieved on 20230809]",PENDING
87,AU,A,AU 1976/020816 A,192-388-491-898-587,1978-06-29,1978,AU 1976/020816 A,1976-12-22,US 67585876 A,1976-04-12,REFRACTORY CONSTRICTION DOME FOR FLUIDIZED BED REACTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;SVENCER RICHARD ERNEST,,https://lens.org/192-388-491-898-587,Patent Application,no,0,0,11,11,0,B01J8/44;;F23C10/20;;B01J8/44;;F23C10/20,F27B15/02;;B01J8/44;;F23C10/20,,0,0,,,,EXPIRED
88,WO,A3,WO 2010/006934 A3,001-016-021-910-242,2014-10-23,2014,EP 2009058400 W,2009-07-03,EP 08160688 A,2008-07-18,TWO STAGE PROCESS FOR PRODUCING PURIFIED GAS,"The present invention provides a process for producing purified gas from a feed gas stream comprising methane and gaseous contaminants, the process comprising the steps of : 1) providing the feed gas stream; 2) cooling the feed gas stream to a temperature at which at least part of the feed gas stream is present in the liquid phase; 3) separating the cooled feed gas stream by means of cryogenic distillation into a bottom stream rich in contaminants and lean in methane, and into a top stream rich in methane and lean in gaseous contaminants, in which the bottom stream contains between 0.5 and 15 % of the methane present in the feed gas stream; 4) cooling the stream rich in methane to a temperature at which solid and/or liquid phase contaminants are formed; 5) introducing the cooled stream of step 4) into a gas/liquid/solids separation vessel, and 6) removing from the gas/liquid/solids separation vessel the purified gas and a stream rich in contaminants.",SHELL INT RESEARCH;;BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,BEAUMONT ANDREW MALCOLM;;GEERS HENRICUS ABRAHAM,,https://lens.org/001-016-021-910-242,Search Report,yes,3,0,7,7,0,C10L3/10;;C10L3/10;;C10L3/106;;C10L3/106;;F25J3/0209;;F25J3/0209;;F25J3/0233;;F25J3/0233;;F25J3/0266;;F25J3/0266;;F25J2200/02;;F25J2200/02;;F25J2200/72;;F25J2200/72;;F25J2205/02;;F25J2205/02;;F25J2205/10;;F25J2205/10;;F25J2205/20;;F25J2205/20;;F25J2210/62;;F25J2210/62;;F25J2235/80;;F25J2235/80;;F25J2240/02;;F25J2240/02;;F25J2260/20;;F25J2260/20;;F25J2270/12;;F25J2270/12;;F25J2270/60;;F25J2270/60;;F25J2270/66;;F25J2270/66;;F25J2270/904;;F25J2270/904;;Y02C20/40;;Y02C20/40,F25J3/02;;C10L3/10,,3,2,098-903-572-416-363;;015-098-767-954-372,10.2118/17700-pa;;10.1016/0950-4214(88)80017-3,"HAUT R C ET AL: ""DEVELOPMENT AND APPLICATION OF THE CONTROLLED-FREEZE-ZONE PROCESS"", SPE PRODUCTION ENGINEERING, THE SOCIETY, RICHARDSON, TX, GB, vol. 4, no. 3, 1 August 1989 (1989-08-01), pages 265 - 271, XP009044764, ISSN: 0885-9221;;NORTHROP P S ET AL: ""CRYOGENIC SOUR GAS PROCESS ATTRACTIVE FOR ACID GAS INJECTION APPLICATIONS"", PROCEEDINGS GAS PROCESSORS ASSOCIATION. GPA MEETING/ANNUALCONVENTION, XX, XX, 14 March 2004 (2004-03-14), pages 1 - 08, XP001223962;;THOMAS E R ET AL: ""CONCEPTUAL STUDIES FOR CO2/NATURAL GAS SEPARATION USING THE CONTROLLED FREEZE ZONE (CFZ) PROCESS"", GAS SEPARATION & PURIFICATION, GUILDFORD, SURREY, GB, vol. 2, 1 June 1988 (1988-06-01), pages 84 - 89, XP001223902, DOI: 10.1016/0950-4214(88)80017-3",PENDING
89,IN,B,IN 155828 B,020-633-246-682-538,1985-03-16,1985,IN 2248CA1976 A,1976-12-22,US 67585876 A,1976-04-12,IMPROVEMENTS IN REFRACTORY CONSTRICTION DOME FOR FLUIDIZED BED REACTOR,,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;SVENCER RICHARD ERNEST,,https://lens.org/020-633-246-682-538,Granted Patent,no,0,0,11,11,0,B01J8/44;;F23C10/20;;B01J8/44;;F23C10/20,F27B15/02;;B01J8/44;;F23C10/20,,0,0,,,,EXPIRED
90,DE,B,DE 1202427 B,023-266-206-907-816,1965-10-07,1965,DE B0064451 A,1961-10-20,US 1202427X A,1960-10-27,Brennereinrichtung,,BABCOCK & WILCOX CO,MARSHALL DAVID MCLAREN;;STEEVER ANDREW BEAUMONT,,https://lens.org/023-266-206-907-816,Patent Application,no,3,0,1,1,0,F23D14/00,F23D14/00,,0,0,,,,DISCONTINUED
91,EP,A3,EP 1123833 A3,044-619-879-318-787,2002-06-12,2002,EP 01300967 A,2001-02-02,GB 0003170 A,2000-02-12,Child safety seat,"A child safety seat for use in a vehicle has a seat body (10) and a harness (16-22) including a pair of shoulder straps (16, 18) which extend through respective slots (28, 32, 36) in the seat back (26) to a mechanism for adjusting the length of the shoulder straps (16, 18). The height at which the shoulder straps (16, 18) project from the seat back (26) can be varied by threading them through different slots. A pad (50) is slidably mounted on each shoulder strap (16, 18) and has a cover formed of high friction material on the side (52) thereof facing the child occupant's body. A tether strap (54) has one end attached to each pad (50) and projects through the same slot (28, 32, 36) in the seat back (26) as the corresponding shoulder strap (16, 18) for limiting movement of the corresponding chest pad (50) along the shoulder strap (16, 18) to a predetermined limit distance away from the seat back (26). Such limit distance increases as the height at which the shoulder straps (16, 18) project from the seat back (26) is increased.",BRITAX EXCELSIOR,CARINE DAVID SHAUN;;BEAUMONT ANDREW PATRICK,BRITAX EXCELSIOR LIMITED (2006-06-07),https://lens.org/044-619-879-318-787,Search Report,yes,3,0,12,12,0,B60N2/2806;;B60N2/2809;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2809;;B60N2/286;;B60N2/2821;;B60N2/2806;;B60N2/2812,B60N2/26;;B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
92,US,A,US 3983927 A,071-736-005-865-722,1976-10-05,1976,US 59033175 A,1975-06-25,US 59033175 A,1975-06-25,HEAT EXCHANGER FOR FLUIDIZED BED REACTOR,A fluidized bed reactor is provided with vertically oriented heat exchange coils for controlling the temperature of the fluidized bed. Tuyere elements discharge fluidizing gas at a level substantially above the constriction plate. The bed solids below the level of the tuyere ports constitute a static layer during fluidization and the lower return bends of the heat exchange coils are embedded in this layer and so are shielded from erosion by the fluidized solids of the bed proper.,DORR OLIVER INC,STEEVER ANDREW BEAUMONT;;JUKKOLA WALFRED WILHELM,TAMPELLA KEELER INCORPORATED (1989-10-27),https://lens.org/071-736-005-865-722,Granted Patent,yes,5,25,18,18,0,B01J8/1836;;B01J8/1872;;B01J2208/00141;;B01J2208/00495;;F28D13/00;;F28D13/00;;B01J8/1872;;B01J8/1836;;B01J2208/00495;;B01J2208/00141,B01J8/18;;C04B11/028;;B01J8/24;;F28D13/00,165/1,0,0,,,,EXPIRED
93,TW,A,TW 201324343 A,014-216-420-086-463,2013-06-16,2013,TW 101135374 A,2012-09-26,US 201113313691 A,2011-12-07,Next fetch predictor training with hysteresis,"A system and method for efficient branch prediction. A processor includes two branch predictors. A first branch predictor quickly generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,,https://lens.org/014-216-420-086-463,Patent of Addition,no,0,0,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/30,,0,0,,,,ACTIVE
94,US,A1,US 2010/0205384 A1,002-866-125-047-153,2010-08-12,2010,US 36683609 A,2009-02-06,US 36683609 A,2009-02-06,Store Hit Load Predictor,"In one embodiment, a processor implements a store hit load predictor. The store hit load predictor is configured to monitor fetched ops in the processor, and is configured to detect stores that may have previously caused store hit load events. The store hit load predictor is configured to predict that the store will cause a store hit load event again, and is further configured to monitor subsequent fetched ops for the load. The store hit load predictor may locate the load using, e.g., an offset from the store to the load in the code sequence. In response to locating the load, the store hit load predictor may create a dependency of the load on the store, preventing the load from executing out of order with respect to the store. A store hit load event may be avoided in this fashion, at least in some cases.",BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H,BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H,APPLE INC (2009-02-04),https://lens.org/002-866-125-047-153,Patent Application,yes,4,27,2,2,0,G06F12/0862;;G06F9/3017;;G06F9/3834;;G06F9/3838;;G06F9/384;;G06F12/0862;;G06F9/3017;;G06F9/3838;;G06F9/3834;;G06F9/384,G06F12/00,711/154;;X711E12001,0,0,,,,ACTIVE
95,JP,A,JP 2013120597 A,134-176-447-644-813,2013-06-17,2013,JP 2012230298 A,2012-09-28,US 201113313691 A,2011-12-07,NEXT FETCH PREDICTOR TRAINING ACCOMPANIED BY HYSTERESIS,"PROBLEM TO BE SOLVED: To provide a system and method for performing efficient branch prediction.SOLUTION: A processor includes two branch predictors. The first branch predictor quickly generates branch prediction data such as a branch direction and a branch target address. The second branch predictor generates branch prediction data with much higher prediction accuracy in the following time. A control logic determines whether or not the branch prediction data from the first and second branch predictors is coincident with each other. When the branch prediction data is not coincident, the first predictor is trained with the branch prediction data generated by the second branch predictor. An indication in which hysteresis is stored indicates that a predetermined branch instruction shows a pattern to be frequently replaced concerning the branch direction. Such a behavior causes consistent branch prediction mistakes since training cannot follow up a changing branch direction.",APPLE INC,ANDREW J BEAUMONT-SMITH;;RAMESH B GUNNA,,https://lens.org/134-176-447-644-813,Patent Application,no,3,0,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/38,,1,0,,,"JPN6013059957; Ｇａｂｒｉｅｌ Ｈ． Ｌｏｈ: 'Ｒｅｖｉｓｉｔｉｎｇ ｔｈｅ Ｐｅｒｆｏｒｍａｎｃｅ Ｉｍｐａｃｔ ｏｆ Ｂｒａｎｃｈ Ｐｒｅｄｉｃｔｏｒ Ｌａｔｅｎｃｉｅｓ' Ｐｒｏｃｅｅｄｉｎｇｓ ｏｆ ２００６ ＩＥＥＥ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓｙｍｐｏｓｉｕｍ ｏｎ Ｐｅｒｆｏｒｍａｎｃｅ Ａｎａｌｙｓｉｓ ｏｆ Ｓｙｓｔｅｍｓ ａｎｄ Ｓｏｆｔｗａｒｅ , 20060319, Ｐａｇｅｓ：５９-６９, ＩＥＥＥ",ACTIVE
96,US,B2,US 8285947 B2,044-141-724-289-723,2012-10-09,2012,US 36683609 A,2009-02-06,US 36683609 A,2009-02-06,Store hit load predictor,"In one embodiment, a processor implements a store hit load predictor. The store hit load predictor is configured to monitor fetched ops in the processor, and is configured to detect stores that may have previously caused store hit load events. The store hit load predictor is configured to predict that the store will cause a store hit load event again, and is further configured to monitor subsequent fetched ops for the load. The store hit load predictor may locate the load using, e.g., an offset from the store to the load in the code sequence. In response to locating the load, the store hit load predictor may create a dependency of the load on the store, preventing the load from executing out of order with respect to the store. A store hit load event may be avoided in this fashion, at least in some cases.",BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;APPLE INC,BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H,APPLE INC (2009-02-04),https://lens.org/044-141-724-289-723,Granted Patent,yes,4,24,2,2,0,G06F12/0862;;G06F9/3017;;G06F9/3834;;G06F9/3838;;G06F9/384;;G06F12/0862;;G06F9/3017;;G06F9/3838;;G06F9/3834;;G06F9/384,G06F12/00,711/154;;X711E12001,0,0,,,,ACTIVE
97,US,A1,US 2013/0151823 A1,077-384-142-160-333,2013-06-13,2013,US 201113313691 A,2011-12-07,US 201113313691 A,2011-12-07,NEXT FETCH PREDICTOR TRAINING WITH HYSTERESIS,"A system and method for efficient branch prediction. A processor includes two branch predictors. A first branch predictor generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.",BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,APPLE INC (2011-11-30),https://lens.org/077-384-142-160-333,Patent Application,yes,6,13,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/38;;G06F9/312,712/240;;X712E09033;;X712E09051,0,0,,,,ACTIVE
98,WO,A1,WO 2000/004037 A1,198-077-966-254-946,2000-01-27,2000,US 9915861 W,1999-07-13,US 9273798 P,1998-07-14,UNCOUPLING PROTEIN 4 (UCP-4) AND METHODS OF USE,"A novel uncoupling protein, which we have designated UCP-4, that is expressed in various tissues, including brain, heart, pancreas, and muscle tissue, and nucleic acid molecules which encode for said novel protein, are described. Methods of screening for compounds that regulate the expression and the activity of UCP-4 are described, as well as methods of treating diseases or conditions in which the regulation of thermogenesis or respiratory ATP synthesis is desired. Such conditions include obesity, diabetes, malignant hyperthermia, and fever. The construction of cell lines that express UCP-4 is also described.",AMYLIN PHARMACEUTICALS INC;;ALBRANDT KEITH;;BEAUMONT KEVIN;;YOUNG ANDREW A,ALBRANDT KEITH;;BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/198-077-966-254-946,Patent Application,yes,1,2,3,3,0,A61K48/00;;A61K48/00;;C07K14/47;;C07K14/47,A61K48/00;;C07K14/47,,3,3,003-118-265-303-510;;043-444-918-245-27X;;008-362-085-612-603,10.1111/j.1365-2958.1992.tb01479.x;;1552849;;10.1016/s0014-5793(97)00384-0;;9180264;;9062928;;10.1038/nbt0397-269;;10.1038/ng0397-269;;09054939;;9054939,"BATHGATE B. ET AL: ""Functional expression of the rat brown adipose tissue uncoupling protein in Saccharomyces cerevisiae"", MOLECULAR MICROBIOLOGY, vol. 6, no. 3, 1992, pages 363 - 370, XP002924910;;BOSS O. ET AL: ""Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression"", FEBS LETT., vol. 408, 12 May 1997 (1997-05-12), pages 39 - 42, XP002924911;;FLEURY C. ET AL: ""Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia"", NATURE GENETICS, vol. 15, 15 March 1997 (1997-03-15), pages 269 - 272, XP002924912",PENDING
99,TW,B,TW I499975 B,196-924-930-962-088,2015-09-11,2015,TW 101135374 A,2012-09-26,US 201113313691 A,2011-12-07,Next fetch predictor training with hysteresis,,APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,,https://lens.org/196-924-930-962-088,Granted Patent,no,4,0,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,,,0,0,,,,ACTIVE
100,WO,A1,WO 2013/085599 A1,076-928-570-372-611,2013-06-13,2013,US 2012/0056983 W,2012-09-25,US 201113313691 A,2011-12-07,NEXT FETCH PREDICTOR TRAINING WITH HYSTERESIS,"A system and method for efficient branch prediction. A processor includes two branch predictors. A first branch predictor quickly generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.",APPLE INC;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,,https://lens.org/076-928-570-372-611,Patent Application,yes,1,2,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F7/38,,2,0,,,"GAO: ""Improving Branch Prediction Accuracy via Effective Source Information and Prediction Algorithms"", December 2008 (2008-12-01), Retrieved from the Internet <URL:http://etd.fda.edu/CF/CFE0002283/Gao_Hongliang_200808_PhD.pdf> [retrieved on 20121109];;LOH: ""Microarchitecture for Billion-Transistor VLSI Superscalar Processors"", 2002, Retrieved from the Internet <URL:citeseerx.ist.psu.edu> [retrieved on 20121109]",PENDING
101,US,B1,US 6602694 B1,136-292-749-477-302,2003-08-05,2003,US 74384701 A,2001-06-27,US 74384701 A;;US 9273798 P;;US 9915861 W,1998-07-14,Uncoupling protein 4 (UCP-4),"
    A novel uncoupling protein, which we have designated UCP-4, that is expressed in various tissues, including brain, heart, pancreas, and muscle tissue, and nucleic acid molecules which encode for said novel protein, are described. Methods of screening for compounds that regulate the expression and the activity of UCP-4 are described, as well as methods of treating diseases or conditions in which the regulation of thermogenesis or respiratory ATP synthesis is desired. Such conditions include obesity, diabetes, malignant hyperthermia, and fever. The construction of cell lines that express UCP-4 is also described. 
",AMYLIN PHARMACEUTICALS INC,ALBRANDT KEITH;;BEAUMONT KEVIN;;YOUNG ANDREW A,AMYLIN PHARMACEUTICALS LLC (2001-11-13),https://lens.org/136-292-749-477-302,Granted Patent,yes,2,37,3,3,5,A61K48/00;;A61K48/00;;C07K14/47;;C07K14/47,A61K48/00;;C07K14/47,435/183;;530/350;;530/333,33,32,077-526-675-000-536;;018-374-269-793-93X;;037-583-970-207-273;;007-260-063-128-542;;003-118-265-303-510;;032-847-448-914-033;;043-444-918-245-27X;;101-179-610-253-094;;068-896-654-858-244;;008-362-085-612-603;;099-413-950-222-887;;047-294-079-836-486;;056-983-781-858-570;;005-208-786-133-029;;005-754-646-170-387;;014-030-783-162-781;;015-215-432-655-901;;017-862-031-033-531;;055-220-372-480-157;;012-579-094-961-890;;016-212-578-092-796;;019-012-260-918-802;;082-545-168-283-61X;;009-852-354-311-269;;029-935-929-100-147;;071-127-698-544-353;;062-966-463-953-647;;020-291-044-686-023;;038-637-039-996-19X;;136-545-353-539-709;;046-593-074-817-212;;132-576-368-347-108,9852133;;10.1074/jbc.273.51.34611;;10025957;;10.1016/s0014-5793(98)01713-x;;10.1038/ng0498-313;;9537411;;pmc146371;;9016539;;10.1093/nar/25.1.217;;10.1111/j.1365-2958.1992.tb01479.x;;1552849;;3192531;;10.1016/s0021-9258(19)81340-6;;10.1016/s0014-5793(97)00384-0;;9180264;;10.1002/j.1460-2075.1994.tb06468.x;;pmc395041;;8168495;;3052274;;10.1146/annurev.biochem.57.1.285;;10.1146/annurev.bi.57.070188.001441;;9062928;;10.1038/nbt0397-269;;10.1038/ng0397-269;;09054939;;9054939;;10.1074/jbc.271.5.2615;;8576230;;pmc324219;;6159584;;10.1093/nar/8.18.4057;;10.1111/j.1432-1033.1996.0445u.x;;8706753;;10.1016/0958-1669(95)80082-4;;7579660;;2158156;;10.1016/0968-0004(90)90194-g;;7738999;;10.1021/jm00009a001;;10.1172/jci118363;;pmc186003;;8675663;;10.1006/bbrc.1997.7636;;9367914;;10.1056/nejm199503093321001;;7632212;;10.1006/geno.1996.0177;;8617505;;10.1038/366740a0;;8264795;;10.1097/00019052-199510000-00013;;8542047;;8618963;;10.1152/physrev.1996.76.2.537;;1608446;;10.1038/357455a0;;7838736;;10.1093/nar/22.25.5767;;pmc310147;;10.1016/s0021-9258(18)99038-1;;2050682;;10.1016/s0021-9258(17)37304-0;;8125963;;10.1152/physrev.1984.64.1.1;;6320232;;1697859;;10.1016/s0021-9258(17)46245-4;;3021720;;10.1016/s0021-9258(18)66957-1;;551265;;10.1038/281031a0;;8962927;;10.1055/s-2007-995932,"Sanchis et al. BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of human and rodents and respiration uncoupling activity in recombinant yeast. J. Biol. Chem. 273:34611-34615, 1998.*;;Mao et al. UCP4, a novel brain-specific mitochondrial protein that reduces membrane potential in mammalian cells. FEBS Letters 443:326-330, 1999.*;;Apoorva Mandavilli, Protein folds shield different Roles, BioMednet News, Nov. 1, 2001.*;;Peer Bork and Eugene V. Koonin, Predicting functions from protein sequences-where are the bottlenecks? Nature Genetics 18:313-318, 1998.*;;Bairoch, A., et al, ""The PROSITE database, its status in 1997,"" Nucleic Acids Research, 25(1):217-221 (1997).;;Bathgate, B., et al., ""Functional expression of the rat brown adipose tissue uncoupling protein in Saccharomyces cerevisiae,"" Molecular Microbiology, 6(3):363-370 (1992).;;Bianco, A.C., et al, ""Triiodothyronine Amplifies Norepinephrine Stimulation of Uncoupling Protein Gene Transcription by a Mechanism Not Requiring Protein Synthesis,"" Journal of Biological Chemistry, 263(34):18168-18175 (1988).;;Boss, O., et al, ""Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression,"" FEBS Letters, 408:39-42 (1997).;;Bouillaud, F., et al, ""A sequence related to a DNA recognition element is essential for the inhibition by nucleotides of proton transport through the mitochondrial uncoupling protein,"" EMBO Journal, 13(8):1990-1997 (1994).;;Ferguson, M.A.J., et al. ""Cell-Surface Anchoring of Proteins Via Glycosylphosphatidylinositol Structures"", Annu. Rev. Biochem. 57:285-320 (1988).;;Fleury, C., et al, ""Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia,"" Nature Genetics 15:269-272 (1997).;;Garlid, K.D., et al, ""On the Mechanism of Fatty Acid-induced Proton Transport by Mitochondrial Uncoupling Protein,"" Journal of Biological Chemistry, 271(5):2615-2620 (1996).;;Goeddel, D.V., et al, ""Synthesis of human fibroblast interferon by E. coli,"" Nucleic Acids Research, 8(18):4057-4075 (1980).;;Gonzalez-Barroso, M.M., et al, ""Activation of the uncoupling protein by fatty acids is modulated by mutations in the C-terminal region of the protein,"" Eur J Biochem 239:445-450 (1996).;;Kane, J.F., ""Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli,"" Current Opinion in Biotechnology, 6:494-500 (1995).;;Klingenberg, M., ""Mechanism and evolution of the uncoupling protein of brown adipose tissue,"" Trends Biochem. Sci., 15:108-112 (1990).;;Knopfel, T., et al, ""Metabotropic Glutamate Receptors: Novel Targets for Drug Development,"" J Medicinal Chemistry, 38(9):1417-1426 (1995).;;Kopecky, J., et al, ""Expression of the Mitochondrial Uncoupling Protein Gene from the aP2 Gene Promoter Prevents Genetic Obesity,"" J Clinical Investigation, 96:2914-2923 (1995).;;Larkin, S., et al, ""Regulation of the Third Member of the Uncoupling Protein Family, UCP3, by Cold and Thyroid Hormone,"" Biochem Biophys Res Comm, 240:222-227 (1997).;;Leibel, R.L., et al, ""Changes in Energy Expenditure Resulting from Altered Body Weight,"" New England Journal of Medicine 332(10):621-628 (1995).;;Lennon, G., et al, ""The I.M.A.G.E. Consortium: An Integrated Molecular Analysis of Genomes and Their Expression,"" Genomics, 33:151-152 (1996).;;Lowell, B.B., ""Development of obesity in transfenic mice after genetic ablation of brown adipose tissue,"" Nature 366:740-742 (1993).;;MacLennan, D.H., et al, ""Discordance between phenotype and genotype inmalignant hyperthermia,"" Curr. Opin. Neurol., 8:397-401 (1995).;;Mickelson, J.R., et al., ""Malignant Hyperthermia: Excitation-Contraction Coupling, CA2+ Release Channel, and Cell CA2+ Regulation Defects,"" Physiol. Rev., 76:537-92 (1996).;;Miller, D.A., ""Human gene therapy comes of age,"" Nature 357(6378): 455-460 (1992).;;Mumberg, D., et al, ""Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression,"" Nucleic Acids Research, 22(25):5767-5768 (1994).;;Murdza-Inglis, D.L., et al, ""Functional Reconsitution of Rat Uncoupling Protein Following Its High Level Expression in Yeast,"" J Biol Chem, 260(18):11871-11875 (1991).;;Murdza-Inglis, D.L., et al, ""A Single Mutation in Uncoupling Protein of Rat Brown Adipose Tissue Mitochondria Abolishes GDP Sensitivity of H Transport,"" J Biol Chem 269(10):7435-7438 (1994).;;Nicholls, D.G., et al, ""Thermogenic Mechanisms in Brown Fat,"" Physiological Reviews, 64:2-40 (1984).;;Rehnmark, S., et al, ""alpha- and beta-Adrenergic Induction of the Expression of the Uncoupling Protein Thermogenin in Brown Adipocytes Differentiated in Culture,"" J Biol Chem, 265(27):16464-16471 (1990).;;Ricquier, D., et al, ""Expression of Uncoupling Protein mRNA in Thermogenic or Weakly Thermogenic Brown Adipose Tissue,"" J Biol Chem, 261(30):13905-13910 (1996).;;Rothwell, N.J., et al, ""A role for brown adipose tissue in diet-induced thermogenesis,"" Nature 281:31-35 (1979).;;Steinfath, et al., Anasthesiol. Intensivmed Notfallmed Schmerzther, 31:334-43 (1996) [English abstract only] Article in German.",EXPIRED
102,AU,A,AU 1999/049922 A,097-539-716-911-589,2000-02-07,2000,AU 1999/049922 A,1999-07-13,US 9273798 P;;US 9915861 W,1998-07-14,Uncoupling protein 4 (ucp-4) and methods of use,,AMYLIN PHARMACEUTICALS INC,ALBRANDT KEITH;;BEAUMONT KEVIN;;YOUNG ANDREW A,,https://lens.org/097-539-716-911-589,Patent Application,no,0,0,3,3,0,A61K48/00;;A61K48/00;;C07K14/47;;C07K14/47,A61K48/00;;C07K14/47,,0,0,,,,DISCONTINUED
103,US,B2,US 8959320 B2,037-509-680-765-394,2015-02-17,2015,US 201113313691 A,2011-12-07,US 201113313691 A,2011-12-07,Preventing update training of first predictor with mismatching second predictor for branch instructions with alternating pattern hysteresis,"A system and method for efficient branch prediction. A processor includes two branch predictors. A first branch predictor generates branch prediction data, such as a branch direction and a branch target address. The second branch predictor generates branch prediction data at a later time and with higher prediction accuracy. Control logic may determine whether the branch prediction data from each of the first and the second branch predictors match. If a mismatch occurs, the first predictor may be trained with the branch prediction data generated by the second branch predictor. A stored indication of hysteresis may indicate a given branch instruction exhibits a frequently alternating pattern regarding its branch direction. Such behavior may lead to consistent branch mispredictions due to the training is unable to keep up with the changing branch direction. When such a condition is determined to occur, the control logic may prevent training of the first predictor.",BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B;;APPLE INC,BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B,APPLE INC (2011-11-30),https://lens.org/037-509-680-765-394,Granted Patent,yes,14,5,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/38,712/239;;712/240;;X712 E9051,10,1,074-348-116-913-904,10.1109/ispass.2006.1620790,"Extended European Search Report in Application No. 12185670.2-1954, Mar. 14, 2013, pp. 1-11.;;Loh, Gabriel H.; ""Revisiting the Performance Impact of Branch Predictor Latencies;"" IEEE International Symposium on Performance Analysis of Systems and Software, Mar. 19, 2006, ISBN: 978-1-4244-0186-4; pp. 59-69.;;Office Action from Japanese Application No. 2012-230298, mailed Dec. 4, 2013, pp. 1-26.;;Gao. Improving Branch Prediction Accuracy via Effective Source Information and Prediction Algorithms. Dec. 2008. Downloaded from etd.fcla.edu/CF/CFE0002283/Gao-Hongliang-200808-PhD.pdf on Nov. 9, 2012 pp. 1-113.;;Loh. ""Microarchitecture for Billion-Transistor VLSI Superscalar Processors."" Dec. 2002. Downloaded from citeseerx.ist.psu.edu on Nov. 9, 2012 pp. 1-268.;;International Search Report and Written Opinion in application No. PCT/US 12/56983 mailed Dec. 17, 2012.;;Office Action from Korean Application No. 10-2012-109481, mailed Oct. 28, 2013, pp. 1-5.;;Final Office Action in Japanese Patent Application No. 2012-230298, mailed Jun. 11, 2014, 11 pages.;;Notification of the First Office Action in Chinese Application No. 201210543904.X, mailed Nov. 4, 2014, 32 pages.;;Reconsideration Report in Japanese Patent Application No. 2012-230298, mailed Nov. 12, 2014, 15 pages.",ACTIVE
104,KR,A,KR 20130064002 A,126-307-951-440-438,2013-06-17,2013,KR 20120109481 A,2012-09-28,US 201113313691 A,2011-12-07,NEXT FETCH PREDICTOR TRAINING WITH HYSTERESIS,PURPOSE: A method for training the next withdrawal predictor with histories is provided to prevent consistent branch prediction errors by following a branch direction having changed training. CONSTITUTION: A first branch predictor(150) provides the display of histories of a branch command and generates first branch prediction data about the branch command. A second branch predictor(130) generates second branch prediction data about the branch command. A control logic unit generates an output based on the display of the histories and the first and second branch prediction data in response to a determination about mismatch between the first and second branch prediction data. The output is used for determining whether to train the first prediction predictor. [Reference numerals] (100) Processor pipeline; (110) Address selection; (112) Incrementer; (120) i-cache; (130) Next withdrawal predictor; (132) Next withdrawal table; (134) Next withdrawal control logic; (140) Decode unit; (150) Branch predictor; (160) Command processing unit; (AA) Pipe stage 1; (BB) Pipe stage 2; (CC) Pipe stage 3; (DD) Pipe stage 4; (EE) Pipe stage N,APPLE INC,BEAUMONT SMITH ANDREW J;;GUNNA RAMESH B,,https://lens.org/126-307-951-440-438,Patent Application,no,0,0,13,13,0,G06F1/00;;G06F9/3848;;G06F9/3848;;G06F9/30;;G06F9/38,G06F9/30;;G06F9/38,,0,0,,,,ACTIVE
105,AU,B2,AU 522375 B2,191-276-716-482-61X,1982-06-03,1982,AU 1978/036438 A,1978-05-24,US 81662977 A,1977-07-18,ASPIRATING FEED FUNNEL FOR FLUIDIZED REACTOR,,DORR OLIVER INC,JUKKOLA WALFRED WILHELM;;STEEVER ANDREW BEAUMONT;;TOMASICCHIO GIORGIO,,https://lens.org/191-276-716-482-61X,Granted Patent,no,0,0,8,8,0,Y02E30/30,B01J8/24;;B01J/;;B01J4/00;;F26B3/08;;F27B15/08;;G21C/,,0,0,,,,EXPIRED
106,CA,A1,CA 2078604 A1,171-808-301-639-610,1993-03-22,1993,CA 2078604 A,1992-09-18,EP 91116092 A,1991-09-21,PROCESS FOR THE PREPARATION OF CHLORINATED AND FLUORINATED BENZENE COMPOUNDS BY SELECTIVE NUCLEOPHILIC FLUORODENITRATION,"1 HOE 91/F 306 A process for the preparation of chlorinated and fluorinated benzene compounds of the general formula (1) in which R denotes -CN or -COOalkyl(C1-C6), and X and Y each denote chlorine or fluorine, X and Y being not identical, by fluorodenitration, which comprises reacting a compound of the formula (2) in which R is defined as above, and X' and Y' each denote chlorine or nitro, X' and Y' being nor identical, with potassium fluoride in a dipolar aprotic solvent in the presence of a transfer catalyst at a temperature from about 50.degree.C to about 250.degree.C.",HOECHST AG,CLARK JAMES H;;BEAUMONT ANDREW J;;BOECHAT NUBIA,,https://lens.org/171-808-301-639-610,Patent Application,no,0,0,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,0,0,,,,DISCONTINUED
107,US,A,US 5237087 A,083-542-426-641-321,1993-08-17,1993,US 94903192 A,1992-09-21,EP 91116092 A,1991-09-21,PROCESS FOR THE PREPARATION OF CHLORINATED AND FLUORINATED BENZENE COMPOUNDS BY SELECTIVE NUCLEOPHILIC FLUORODENITRATION,"A process for the preparation of chlorinated and fluorinated benzene compounds of the general formula (1) ##STR1## in which R denotes --CN or --COOalkyl(C.sub.1 -C.sub.6), and X and Y each denote chlorine or fluorine, X and Y being not identical, by fluorodenitration, which comprises reacting a compound of the formula (2) ##STR2## in which R is defined as above, and X' and Y' each denote chlorine or nitro, X' and Y' being nor identical, with potassium fluoride in a dipolar aprotic solvent in the presence of a transfer catalyst at a temperature from about 50.degree. C. to about 250.degree. C.",HOECHST AG,CLARK JAMES H;;BEAUMONT ANDREW J;;BOECHAT NUBIA,HOECHST AG (1992-08-17),https://lens.org/083-542-426-641-321,Granted Patent,yes,6,3,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,558/425;;560/111,4,2,031-591-291-788-696;;039-117-025-220-961,10.1016/s0040-4039(00)98970-6;;10.1021/jo00294a015,"Clark, J. H. et al, Tetrahedron Letters 26: pp. 2233 2236, (1985).;;Jilek, J., et al, Chem. Abs. 109:170051d, p. 682, (1988).;;Jilek, J., et al. Chem. Abs. 109:230547g, p. 814, (1988).;;Soundararajan, N., et al, J. Org. Chem. 55: pp. 2034 2044, (1990).",EXPIRED
108,AU,A,AU 1978/036438 A,194-939-134-141-640,1979-11-29,1979,AU 1978/036438 A,1978-05-24,US 81662977 A,1977-07-18,ASPIRATING FEED FUNNEL FOR FLUIDIZED REACTOR,,DORR OLIVER INC,JUKKOLA WALFRED WILHELM;;STEEVER ANDREW BEAUMONT;;TOMASICCHIO GIORGIO,,https://lens.org/194-939-134-141-640,Patent Application,no,0,0,8,8,0,Y02E30/30,B01J8/24;;B01J/;;B01J4/00;;F26B3/08;;F27B15/08;;G21C/,,0,0,,,,EXPIRED
109,IN,B,IN 174793 B,057-296-259-331-92X,1995-03-11,1995,IN 644CA1992 A,1992-09-07,IN 644CA1992 A,1992-09-07,Process for the preparation of chlorinated and fluorinated benzene compounds by selective nucleophilic fluorodenitration,,HOECHST AG,CLARK JAMES HANLEY;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/057-296-259-331-92X,Granted Patent,no,0,0,1,1,0,,C07C71/00,,0,0,,,,EXPIRED
110,EP,A1,EP 0534317 A1,030-052-012-108-784,1993-03-31,1993,EP 92115926 A,1992-09-17,EP 91116092 A,1991-09-21,Process for the preparation of chlorinated and fluorinated benzene compounds by selective nucleophilic fluorodenitration.,"A process for the preparation of chlorinated and fluorinated benzene compounds of the general formula (1)
  
 in which R denotes -CN or -COOalkyl(C₁-C₆), and X and Y each denote chlorine or fluorine, X and Y being not identical, by fluorodenitration, which comprises reacting a compound of the formula (2)
  
 in which R is defined as above, and X' and Y' each denote chlorine or nitro, X' and Y' being nor identical, with potassium fluoride in a dipolar aprotic solvent in the presence of a transfer catalyst at a temperature from about 50°C to about 250°C.",HOECHST AG,CLARK JAMES HANLEY DR;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/030-052-012-108-784,Patent Application,yes,2,4,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,1,1,031-591-291-788-696,10.1016/s0040-4039(00)98970-6,"TETRAHEDRON LETTERS. vol. 26, no. 18, 1985, OXFORD GB pages 2233 - 2236 J.H.CLARK 'FLUORODENITRATIONS USING TETRABUTYLAMMONIUM FLUORIDE'",EXPIRED
111,DE,D1,DE 69207133 D1,126-578-286-654-86X,1996-02-08,1996,DE 69207133 T,1992-09-17,EP 91116092 A,1991-09-21,Verfahren zur Herstellung von Chlor- oder Fluorbenzolverbindungen durch selektive nucleophile Fluordenitrierung,,HOECHST AG,CLARK JAMES HANLEY DR;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/126-578-286-654-86X,Granted Patent,no,0,0,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,0,0,,,,EXPIRED
112,EP,B1,EP 0534317 B1,116-006-215-712-376,1995-12-27,1995,EP 92115926 A,1992-09-17,EP 91116092 A,1991-09-21,Process for the preparation of chlorinated and fluorinated benzene compounds by selective nucleophilic fluorodenitration,,HOECHST AG,CLARK JAMES HANLEY DR;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/116-006-215-712-376,Granted Patent,yes,2,0,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,1,0,,,"TETRAHEDRON LETTERS, vol. 26, no. 18, 1985, Oxford, GB; pages 2233 - 2236, J. H. CLARK et al, ""Fluorodenitrations using tetrabutylammonium fluoride""",EXPIRED
113,NO,D0,NO 892039 D0,170-360-857-617-24X,1989-05-22,1989,NO 892039 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,VIDEO-KODER.,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/170-360-857-617-24X,Patent Application,no,0,0,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
114,NO,C,NO 175558 C,197-478-078-167-191,1994-10-26,1994,NO 892039 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Video-koder,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/197-478-078-167-191,Granted Patent,no,0,0,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
115,AT,T1,AT E91837 T1,000-636-874-501-310,1993-08-15,1993,AT 88308875 T,1988-09-23,EP 88308875 A;;GB 8722394 A,1987-09-23,VIDEOKODER.,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/000-636-874-501-310,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,DISCONTINUED
116,NO,L,NO 892039 L,034-935-960-002-378,1989-07-21,1989,NO 892039 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,VIDEO-KODER.,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/034-935-960-002-378,Abstract,no,0,0,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
117,WO,A1,WO 1989/003153 A1,054-614-633-034-602,1989-04-06,1989,GB 8800789 W,1988-09-23,GB 8722394 A,1987-09-23,VIDEO CODER,"A coder assembles bursts of blocks of image data (e.g. transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21), (22). The blocks of transform coded coefficients have a ""last coefficient"" flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the ""end-of-block"" flag. The ""last coefficient"" flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/054-614-633-034-602,Patent Application,yes,7,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,PATENTED
118,AU,A,AU 1992/015919 A,101-553-308-739-197,1992-06-25,1992,AU 1992/015919 A,1992-04-30,GB 8722394 A,1987-09-23,VIDEO CODER,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/101-553-308-739-197,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
119,EP,A1,EP 0309280 A1,028-158-246-996-693,1989-03-29,1989,EP 88308875 A,1988-09-23,GB 8722394 A,1987-09-23,Video coder.,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.  ",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY (1989-12-20),https://lens.org/028-158-246-996-693,Patent Application,yes,7,28,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,2,0,,,"IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, Denver, Colorado, 14th-18th June 1981, vol. 2 of 4, pages 22.4.1 - 22.4.5, IEEE, New York, US; A. JALALI et al.: ""An architecture for hybrid coding of NTSC TV signals"";;JAPAN TELECOMMUNICATIONS REVIEW, vol. 21, no. 2, April 1979, pages 109-117; M. MIZUI et al.: ""Commercialized interframe CODEC for NTSC color video signals""",EXPIRED
120,DE,T2,DE 69207133 T2,055-632-609-649-08X,1996-06-27,1996,DE 69207133 T,1992-09-17,EP 91116092 A,1991-09-21,Verfahren zur Herstellung von Chlor- oder Fluorbenzolverbindungen durch selektive nucleophile Fluordenitrierung,,HOECHST AG,CLARK JAMES HANLEY DR;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/055-632-609-649-08X,Granted Patent,no,0,0,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,0,0,,,,EXPIRED
121,DE,D1,DE 3882469 D1,108-545-507-970-628,1993-08-26,1993,DE 3882469 T,1988-09-23,GB 8722394 A,1987-09-23,VIDEOKODER.,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/108-545-507-970-628,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
122,EP,B1,EP 0309280 B1,125-941-102-370-385,1993-07-21,1993,EP 88308875 A,1988-09-23,GB 8722394 A,1987-09-23,VIDEO CODER,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY,"MORRISON, DAVID GEOFFREY;;HERON, ANDREW PETER;;BEAUMONT, DAVID OWEN",BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY (1989-12-20),https://lens.org/125-941-102-370-385,Granted Patent,yes,7,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,2,0,,,"IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, Denver, Colorado, 14th-18th June 1981, vol. 2 of 4, pages 22.4.1 - 22.4.5, IEEE, New York, US; A. JALALI et al.: ""An architecture for hybrid coding of NTSC TV signals"";;JAPAN TELECOMMUNICATIONS REVIEW, vol. 21, no. 2, April 1979, pages 109-117; M. MIZUI et al.: ""Commercialized interframe CODEC for NTSC color video signals""",EXPIRED
123,NL,B,NL 185615 B,135-842-439-176-114,1990-01-02,1990,NL 7904155 A,1979-05-28,NL 7904155 A,1979-05-28,WERKWIJZE EN INRICHTING VOOR HET EXTRUDEREN VAN EEN MATERIAAL.,,UNILEVER NV,HENDERSON JOHN ANDREW;;LINDLEY RAYMOND HUGHES;;WHITELEY KEITH BEAUMONT,,https://lens.org/135-842-439-176-114,Patent Application,no,0,0,3,3,0,B30B11/201;;B30B11/005,B30B11/00;;B30B11/20,,0,0,,,,EXPIRED
124,NL,C,NL 185615 C,194-929-869-333-134,1990-06-01,1990,NL 7904155 A,1979-05-28,NL 7904155 A,1979-05-28,WERKWIJZE EN INRICHTING VOOR HET EXTRUDEREN VAN EEN MATERIAAL.,,UNILEVER NV,HENDERSON JOHN ANDREW;;LINDLEY RAYMOND HUGHES;;WHITELEY KEITH BEAUMONT,,https://lens.org/194-929-869-333-134,Granted Patent,no,0,0,3,3,0,B30B11/201;;B30B11/005,B30B11/00;;B30B11/20,,0,0,,,,EXPIRED
125,WO,A3,WO 2006/004439 A3,029-516-557-731-143,2006-03-16,2006,NZ 2005000154 W,2005-07-01,NZ 53398404 A,2004-07-07,PULSE MODULE FOR BREATHING ASSISTANCE APPARATUS,"A device (7), or a respiratory support system that includes a device, and a method of using the device, for introducing pulses to a patient breathing cycle which is at least partially assisted by a respiratory support system. The device has a body, with a passage running through the body between the inlet (8) and the outlet (9). A valve (15) is located in the passage, and cycles between open and at least partially closed. The cycle frequency is greater than the frequency of the patient breathing cycle. The device is connected to the patient respiratory support system in such a manner that at least a portion of the expiratory gases from a patient pass through the passage (12, 13).",FISHER & PAYKEL HEALTHCARE LTD;;NICCOL ANDREW GRANT;;BEAUMONT CHRISTOPHER LEIGH;;BAIN ALASTAIR NORMAN,NICCOL ANDREW GRANT;;BEAUMONT CHRISTOPHER LEIGH;;BAIN ALASTAIR NORMAN,,https://lens.org/029-516-557-731-143,Search Report,yes,4,0,2,2,0,A61M16/20;;A61M16/0006;;A61M16/024;;A61M16/109;;A61M16/16;;A61M16/205;;A61M16/209;;A61M2205/103;;A61M2205/106;;A61M2205/3368,A61M16/00,,0,0,,,,PENDING
126,AU,A,AU 1988/024892 A,087-988-089-666-035,1989-04-18,1989,AU 1988/024892 A,1988-09-23,GB 8800789 W;;GB 8722394 A,1987-09-23,VIDEO CODER,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;BEAUMONT DAVID OWEN;;HERON ANDREW PETER,,https://lens.org/087-988-089-666-035,Patent Application,no,0,0,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
127,US,A,US 4985766 A,082-156-757-552-444,1991-01-15,1991,US 35837089 A,1989-05-17,GB 8722394 A,1987-09-23,Video coder,"A coder assembles bursts of blocks of image data (e.g. transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21), (22). The blocks of transform coded coefficients have a `last coefficient` flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the `end-of-block` flag. The `last coefficient` flag and the SWITCH word are recognized by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID G;;HERON ANDREW P;;BEAUMONT DAVID O,BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY A BRITISH COMPANY (1989-05-08),https://lens.org/082-156-757-552-444,Granted Patent,yes,14,179,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,358/133;;358/135;;358/136,5,1,073-791-345-940-076,10.1109/tassp.1984.1164293,"IEEE Conference on Communications, Denver Colo., Jun. 14 18, 1981, Conference Record, pp. 22.4.1 22.4.5, An Architecture for Hybrid Coding of NTSC TV Signals , A. Jalali, K. R. Rao.;;Japan Telecommunications Review, vol. 21, No. 2, Apr. 1979, M. Mizui et al.: Commercialized Interframe CODEC for NTSC Color Video Signals , pp. 109 117.;;IEEE International Conference on Communications, Jun. 22 25, 1986, Toronto, CA, vol. 1, IEEE (New York, U.S.), J. Guichard et al: Intra and Interframe Transform Coding for Moving Pictures Transmission , pp. 381 834.;;IEEE Global Telecommunications Conference, Dec. 1 4, 1986, Houston, Tex., vol. 1, IEEE (New York, U.S.), M. Ohta et al: Adaptive VWL Coding of Transform Coefficients for Sub Primary Rate Video Transmission, pp. 271 275.;;IEEE Transaction on Acoustics, Speech, and Signal Processing, vol. ASSP 32, No. 1, Feb. 1984, IEEE (New York), K. N. Nagan: Image Display Techniques Using the Cosine Transform , pp. 173 177.",EXPIRED
128,AU,B2,AU 619504 B2,094-518-008-898-908,1992-01-30,1992,AU 1988/024892 A,1988-09-23,GB 8800789 W;;GB 8722394 A,1987-09-23,VIDEO CODER,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;BEAUMONT DAVID OWEN;;HERON ANDREW PETER,,https://lens.org/094-518-008-898-908,Granted Patent,no,3,1,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
129,FI,A0,FI 892460 A0,130-140-311-282-227,1989-05-22,1989,FI 892460 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Videokooderi,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/130-140-311-282-227,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
130,FI,A,FI 892460 A,008-006-136-949-476,1989-05-22,1989,FI 892460 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Videokooderi,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/008-006-136-949-476,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
131,DE,A1,DE 2917453 A1,125-762-140-003-515,1980-11-13,1980,DE 2917453 A,1979-04-30,DE 2917453 A,1979-04-30,Roller impeller extrusion press - in which slip between the roller and die is monitored to indicate blockage,"In an extruder in which material is fed into the nip between a press roll and a die having extrusion orifices, through which the material is forced, either the roll or die is positively driven causing the other of the roll or die to rotate, and slip between the roll and die is detected. When the slip, or the rate of change of slip, attains a predetermined value the feed of material to the nip is varied. Used partic. in the extrusion of animal feed pellets. Presses can easily block, choke, or flood, necessitating plant shut down to remove material from the nip, or even removal of the die to clear the orifices. By monitoring slip, conditions leading to blockage of the die can easily be detected and remedied.",UNILEVER NV,HENDERSON JOHN ANDREW;;LINDLEY RAYMOND HUGHES;;WHITELEY KEITH BEAUMONT,,https://lens.org/125-762-140-003-515,Patent Application,no,3,7,2,2,0,B30B11/006;;B30B11/201,B30B11/20,,0,0,,,,EXPIRED
132,US,S,US D0393463 S,054-846-306-183-793,1998-04-14,1998,US 6552397 F,1997-01-27,US 6552397 F,1997-01-27,Fixed wireless terminal enclosure,,MOTOROLA INC,BEAUMONT THOMAS GLENN;;STEVENS PAUL SYLVESTER;;HUSLIG MARK ANDREW,MOTOROLA MOBILITY INC (2010-07-31);;MOTOROLA INC (1997-01-27),https://lens.org/054-846-306-183-793,Design Right,yes,10,7,1,1,0,,,D14/149;;1403,0,0,,,,EXPIRED
133,NO,B,NO 175558 B,061-312-546-914-660,1994-07-18,1994,NO 892039 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Video-koder,,BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/061-312-546-914-660,Unknown,no,0,0,6,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242,G06T9/00;;H04N/;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
134,ES,T3,ES 2082310 T3,071-138-039-324-350,1996-03-16,1996,ES 92115926 T,1992-09-17,EP 91116092 A,1991-09-21,PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS BENCENICOS CLORADOS Y FLUORADOS POR FLUORODESNITRACION NUCLEOFILA SELECTIVA.,"UN PROCESO PARA LA PREPARACION DE COMPUESTOS DE BENCENO CLORADOS Y FLUORADOS DE LA FORMULA GENERAL (1) EN QUE R DENOTA -CN O -COOALKILO(C1-C6) Y X E Y DENOTAN CADA UNO CLORO O FLUOR, NO SIENDO X E Y IDENTICOS, MEDIANTE FLUORODESNITRACION, QUE CONSISTE EN HACER REACCIONAR A UN COMPUESTOS DE LA FORMULA (2) EN QUE R QUEDA DEFINIDO COMO ARRIBA Y X'' E Y'' DENOTAN CADA UNO CLORO O NITRO, NO SIENDO X'' E Y'' IDENTICOS, CON FLUORURO POTASICO EN UN SOLVENTE APROTICO DIPOLAR ANTE LA PRESENCIA DE UN CATALIZADOR DE TRANSFERENCIA A UNA TEMPERATURA ENTRE 50 (GRADOS) C APROXIMADAMENTE Y 250 (GRADOS) C APROXIMADAMENTE.",HOECHST AG,CLARK JAMES HANLEY DR;;BEAUMONT ANDREW JONATHON;;BOECHAT NUBIA,,https://lens.org/071-138-039-324-350,Granted Patent,no,0,0,9,9,0,C07B39/00;;C07C67/307;;C07C253/30;;C07C67/307;;C07C253/30;;C07C67/307;;C07B39/00,B01J31/02;;C07B39/00;;C07B61/00;;C07C67/307;;C07C67/317;;C07C69/76;;C07C253/30;;C07C255/50,,0,0,,,,EXPIRED
135,DE,T2,DE 3882469 T2,194-680-614-099-007,1993-11-11,1993,DE 3882469 T,1988-09-23,GB 8722394 A,1987-09-23,Videokoder.,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/194-680-614-099-007,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
136,DK,D0,DK 248289 D0,002-879-813-870-584,1989-05-22,1989,DK 248289 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,VIDEOKODER,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/002-879-813-870-584,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,DISCONTINUED
137,HK,A,HK 134196 A,029-438-636-620-31X,1996-08-02,1996,HK 134196 A,1996-07-25,GB 8722394 A,1987-09-23,Video coder,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/029-438-636-620-31X,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
138,FI,C,FI 91474 C,103-213-434-518-709,1994-06-27,1994,FI 892460 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Videokooderi,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/103-213-434-518-709,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
139,DK,A,DK 248289 A,096-321-866-712-368,1989-05-22,1989,DK 248289 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,VIDEOKODER,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/096-321-866-712-368,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,DISCONTINUED
140,WO,A2,WO 2006/004439 A2,031-547-816-659-566,2006-01-12,2006,NZ 2005000154 W,2005-07-01,NZ 53398404 A,2004-07-07,PULSE MODULE FOR BREATHING ASSISTANCE APPARATUS,"A device (7), or a respiratory support system that includes a device, and a method of using the device, for introducing pulses to a patient breathing cycle which is at least partially assisted by a respiratory support system. The device has a body, with a passage running through the body between the inlet (8) and the outlet (9). A valve (15) is located in the passage, and cycles between open and at least partially closed. The cycle frequency is greater than the frequency of the patient breathing cycle. The device is connected to the patient respiratory support system in such a manner that at least a portion of the expiratory gases from a patient pass through the passage (12, 13).",FISHER & PAYKEL HEALTHCARE LTD;;NICCOL ANDREW GRANT;;BEAUMONT CHRISTOPHER LEIGH;;BAIN ALASTAIR NORMAN,NICCOL ANDREW GRANT;;BEAUMONT CHRISTOPHER LEIGH;;BAIN ALASTAIR NORMAN,,https://lens.org/031-547-816-659-566,Patent Application,yes,0,12,2,2,0,A61M16/20;;A61M16/0006;;A61M16/024;;A61M16/109;;A61M16/16;;A61M16/205;;A61M16/209;;A61M2205/103;;A61M2205/106;;A61M2205/3368,A61M16/00,,0,0,,,,PENDING
141,AU,B2,AU 637284 B2,125-604-311-498-046,1993-05-20,1993,AU 1992/015919 A,1992-04-30,GB 8722394 A,1987-09-23,VIDEO CODER,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY,DAVID GEOFFREY MORRISON;;ANDREW PETER HERON;;DAVID OWEN BEAUMONT,,https://lens.org/125-604-311-498-046,Granted Patent,no,3,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
142,FI,B,FI 91474 B,107-113-764-471-55X,1994-03-15,1994,FI 892460 A,1989-05-22,GB 8722394 A;;GB 8800789 W,1987-09-23,Videokooderi,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/107-113-764-471-55X,Patent Application,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
143,CA,C,CA 1330122 C,124-061-851-462-234,1994-06-07,1994,CA 578355 A,1988-09-23,GB 8722394 A,1987-09-23,VIDEO CODER,"VIDEO CODER A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores. The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognized by a toggle controller which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer in a desired sequence. The buffer is followed by a variable length coder which supplies the output of the coder at a constant bit rate. Provision is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID G;;HERON ANDREW P;;BEAUMONT DAVID O,,https://lens.org/124-061-851-462-234,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,D23500033    M,0,0,,,,EXPIRED
144,US,E,US RE034824 E,186-490-000-084-321,1995-01-10,1995,US 408293 A,1993-01-13,US 408293 A;;GB 8722394 A;;GB 8800789 W;;US 35837088 A,1987-09-23,Video coder,"A coder assembles bursts of blocks of image data (e.g. transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21), (22). The blocks of transform coded coefficients have a `last coefficient` flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the `end-of-block` flag. The `last coefficient` flag and the SWITCH word are recognized by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID G;;HERON ANDREW P;;BEAUMONT DAVID O,,https://lens.org/186-490-000-084-321,Amended Patent,yes,14,20,1,29,0,H04N21/242;;H04N21/242;;H04N19/13;;H04N19/13;;H04N19/132;;H04N19/132;;H04N19/152;;H04N19/152;;H04N19/50;;H04N19/50;;H04N19/503;;H04N19/503;;H04N19/587;;H04N19/587;;H04N19/60;;H04N19/60;;H04N19/91;;H04N19/91,G06T9/00;;H04N7/26;;H04N7/30;;H04N7/32;;H04N7/36;;H04N7/46;;H04N21/242,348/419;;348/400;;348/423,5,1,073-791-345-940-076,10.1109/tassp.1984.1164293,"IEEE Conference on Communications, Denver Colo., Jun. 14 18, 1981, Conference Record, pp. 22.4.1 22.4.5, An Architecture for Hybrid Coding of NTSC TV Signals , A. Jalali, K. R. Rao.;;Japan Telecommunications Review, vol. 21, No. 2, Apr. 1979, M. Mizui et al. Commercialized Interframe CODEC for NTSC Color Video Signals , pp. 109 117.;;IEEE International Conference on Communications, Jun. 22 25, 1986, Toronto, Calif., vol. 1, IEEE (New York, U.S.), J. Guichard et al: Intra and Interframe Transform Coding for Moving Pictures Transmission , pp. 381 834.;;IEEE Global Telecommunications Conference, Dec. 1 4, 1986, Houston, Tex., vol. 1, IEEE (New York, U.S.), M. Ohta et al: Adaptive VWL Coding of Transform Coefficients for Sub Primary Rate Video Transmission, pp. 271 275.;;IEEE Transaction on Acoustics, Speed and Signal Processing, vol. ASSP 32, No. 1, Feb. 1984, IEEE (New York), K. N. Nagan: Image Display Techniques Using the Cosine Transform , pp. 173 177.",PENDING
145,IE,B1,IE 61540 B1,156-139-674-186-440,1994-11-16,1994,IE 288788 A,1988-09-23,GB 8722394 A,1987-09-23,Video coder,"A coder assembles bursts of blocks of image data (eg transform coded coefficients) and associated overhead data into a sequence of data which are then transmitted. Both the transform coded coefficients and the overhead data are initially stored in separate FIFO memory stores (21)(22). The blocks of transform coded coefficients have a 'last coefficient' flag accompanying the last coefficient, and the overhead information contains a unique word SWITCH, after the header information but before the 'end-of-block' flag. The 'last coefficient' flag and the SWITCH word are recognised by a toggle controller (29) which controls the reading of the stores so that the coefficient data and overhead data are selectively passed to a buffer (30) in a desired sequence. The buffer (30) is followed by a variable length coder (31) which supplies the output of the coder at a constant bit rate. Provision (34-38) is made to calculate the quantity of output data represented at any time by the contents of the buffer and the result is used to control the rate of generation of image data.",BRITISH TELECOMM,MORRISON DAVID GEOFFREY;;HERON ANDREW PETER;;BEAUMONT DAVID OWEN,,https://lens.org/156-139-674-186-440,Granted Patent,no,0,0,22,29,0,H04N21/242;;H04N19/50;;H04N19/503;;H04N19/13;;H04N19/60;;H04N19/91;;H04N19/132;;H04N19/152;;H04N19/587;;H04N21/242;;H04N19/152;;H04N19/13;;H04N19/60;;H04N19/50;;H04N19/587;;H04N19/132;;H04N19/503;;H04N19/91,G06T9/00;;H04N7/60;;H04N7/62;;H04N19/00;;H04N19/50;;H04N21/242,,0,0,,,,EXPIRED
146,GB,A,GB 2307811 A,086-603-559-226-004,1997-06-04,1997,GB 9622859 A,1996-11-01,GB 9522378 A,1995-11-01,Thickness measurement,,BRITISH GAS PLC,CORDES PAUL BEAUMONT;;MCGONNELL PHILIP;;WARD PETER;;FRASER ANDREW JOHN,,https://lens.org/086-603-559-226-004,Patent Application,no,5,4,12,12,0,G01B15/02;;G01B15/02,G01B15/02,H4D DRPW          RPW;;H4D D255          RPW;;H4D D257          RPW;;H4D D352          RPW;;H4D D398          RPW;;U1S S1743,0,0,,,,EXPIRED
147,PL,T3,PL 2540820 T3,072-457-342-203-476,2018-05-30,2018,PL 12175198 T,2006-12-08,EP 06076211 A;;EP 12175198 A;;EP 06824300 A;;NL 2005000848 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/072-457-342-203-476,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,0,0,,,,PENDING
148,PL,T3,PL 1974017 T3,076-668-763-154-655,2014-04-30,2014,PL 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;EP 06824300 A;;NL 2006000625 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/076-668-763-154-655,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,PENDING
149,US,A1,US 2010/0242362 A1,092-168-796-471-277,2010-09-30,2010,US 74140810 A,2007-11-08,EP 2007062096 W,2007-11-08,TREATING A CRUDE AND NATURAL GAS STREAM,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream ( 10 ) through an inlet ( 12 ) into a stabilization unit ( 14 ) to provide a stabilizer content ( 20 ); (b) passing an overhead gaseous stream ( 30 ) separated from the stabilizer content ( 20 ) through a first outlet ( 16 ); and (c) passing a bottom stream ( 40 ) comprising crude liquid hydrocarbons separated from the stabilizer content ( 20 ) and free water through a second outlet ( 18 ).",VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOM;;CLINTON PAUL;;GAFONOVA OLGA,VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOM;;CLINTON PAUL;;GAFONOVA OLGA,SHELL OIL COMPANY (2010-03-08),https://lens.org/092-168-796-471-277,Patent Application,yes,18,4,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C01B3/32,48/127.3,0,0,,,,INACTIVE
150,EP,A1,EP 3327117 A1,179-904-543-537-829,2018-05-30,2018,EP 18150705 A,2006-12-08,NL 2005000848 W;;EP 06076211 A;;EP 12175198 A;;EP 06824300 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp-1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (2021-07-21);;KLING BIOTHERAPEUTICS B.V. (2021-07-21),https://lens.org/179-904-543-537-829,Patent Application,yes,5,0,45,52,6,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,23,20,060-444-328-354-958;;006-356-109-248-313;;023-494-641-477-915;;041-194-807-252-395;;006-650-342-000-012;;007-990-945-290-343;;056-175-384-903-897;;040-589-760-023-703;;055-393-327-080-459;;120-309-713-911-530;;071-096-561-751-483;;126-885-632-235-01X;;007-990-945-290-343;;050-899-251-631-539;;057-834-837-645-791;;004-990-229-260-144;;006-309-985-160-125;;078-191-037-400-337;;041-194-807-252-395;;030-214-658-445-99X,pmc155362;;10.1101/gad.929302;;11914273;;9927205;;10.1038/sj.onc.1202334;;10.1016/s0022-1759(01)00559-2;;11861062;;10.1038/nm1080;;15247913;;pmc7095806;;15210829;;10.4049/jimmunol.173.1.657;;10.1038/ni1172;;15711548;;8898945;;10.1002/eji.1830261013;;10.4049/jimmunol.173.9.5361;;15494482;;10.4049/jimmunol.175.12.7867;;16339522;;20023635;;10.1038/nm.2071;;pmc2861345;;20957227;;pmc2949385;;10.1371/journal.pone.0013137;;8705856;;10.1038/nm0896-876;;10.1038/ni1172;;15711548;;1702555;;10.1126/science.1702555;;10.1016/0092-8674(93)90508-n;;8358789;;10.1073/pnas.032665099;;11830667;;pmc122219;;pmc2192363;;10.1084/jem.183.3.937;;8642297;;16369535;;10.1038/ni1285;;10.1038/nm1080;;15247913;;pmc7095806;;10.1038/ng0697-161;;9171827,"SHVARTS AVI ET AL: ""A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling"", GENES AND DEVELOPMENT, vol. 16, no. 6, 15 March 2002 (2002-03-15), pages 681 - 686, XP002385891, ISSN: 0890-9369;;YAMOCHI TADANORI ET AL: ""Adenovirus-mediated high expression of BCL-6 CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL"", ONCOGENE, vol. 18, no. 2, 14 January 1999 (1999-01-14), pages 487 - 494, XP009079150, ISSN: 0950-9232;;YOO E M ET AL: ""Myeloma expression systems"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 261, no. 1-2, 1 March 2002 (2002-03-01), pages 1 - 20, XP004341264, ISSN: 0022-1759;;TRAGGIAI ELISABETTA ET AL: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, August 2004 (2004-08-01), pages 871 - 875, XP002385893, ISSN: 1078-8956;;JIN HAOLI ET AL: ""Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or bim-dependent apoptosis"", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. d173, no. 1, 1 July 2004 (2004-07-01), pages 657 - 665, XP002407522, ISSN: 0022-1767;;SCHEEREN FERENC A ET AL: ""STAT5 REGULATES THE SELF-RENEWAL CAPACITY AND DIFFERENTIATION OF HUMAN MEMORY B CELLS AND CONTROLS BCL-6 EXPRESSION"", NATURE IMMUNOLOGY, NATURE PUBLISHING GROUP, GB, vol. 6, no. 3, 1 March 2005 (2005-03-01), pages 303 - 313, XP009074930, ISSN: 1529-2908, DOI: 10.1038/NI1172;;NING Z-Q ET AL: ""DISTINCT MECHANISMS FOR RESCUE FROM APOPTOSIS IN RAMOS HUMAN B CELLS BY SIGNALING THROUGH CD40 AND INTERLEUKIN-4 RECEPTOR: ROLE FOR INHIBITION OF AN EARLY RESPONE GENE, BERG36"", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 26, no. 10, 1 January 1996 (1996-01-01), pages 2356 - 2363, XP009013662, ISSN: 0014-2980, DOI: 10.1002/EJI.1830261013;;OZAKI K ET AL: ""Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6"", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 173, no. 9, 1 November 2004 (2004-11-01), pages 5361 - 5371, XP002335928, ISSN: 0022-1767;;ETTINGER R ET AL: ""IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells"", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 175, no. 12, 15 December 2005 (2005-12-15), pages 7867 - 7879, XP002530783, ISSN: 0022-1767;;MARK J KWAKKENBOS ET AL: ""Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming"", NATURE MEDICINE, vol. 16, no. 1, 1 January 2010 (2010-01-01), pages 123 - 128, XP055019451, ISSN: 1078-8956, DOI: 10.1038/nm.2071;;PABLO D BECKER ET AL: ""Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated Human Immune System Mice"", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, SAN FRANCISCO, CA; US, vol. 5, no. 10, 4 October 2010 (2010-10-04), pages e13137 - 1, XP002634132, ISSN: 1932-6203, [retrieved on 20101004], DOI: 10.1371/JOURNAL.PONE.0013137;;HANENBERG H., NAT., MED., 1996;;ARIYOSHI K., JBC, 2000;;HEEMSKERK M.H., JEM, 1997;;HEEMSKERK M.H., CELL IMMUNOL, 1999;;SCHEEREN F.A., NAT IMMUNOL, 2005;;BANCHEREAU, J.; DE PAOLI, P.; VALLE, A.; GARCIA, E.; ROUSSET, F.: ""Long term human B cell lines dependent on interleukin-4 and antibody to CD40"", SCIENCE, vol. 251, 1991, pages 70 - 2, XP002576462;;BOISE, L. H.; M. GONZALEZ-GARCIA; C. E. POSTEMA; L. DING; T. LINDSTEN; L. A. TURKA; X. MAO; G. NUNEZ; C. B. THOMPSON: ""Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death"", CELL, vol. 74, 1993, pages 597, XP024246088, DOI: doi:10.1016/0092-8674(93)90508-N;;DADGOSTAR, H.; ZARNEGAR, B.; HOFFMANN, A.; QIN, X. F.; TRUONG, U.; RAO, G.; BALTIMORE, D.; CHENG, G.: ""Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes"", PROC.NATL.ACAD.SCI USA, vol. 99, 2002, pages 1497 - 1502;;MALISAN, F.; BRIERE, F.; BRIDON, J.M.; HARINDRANATH, N.; MILLS, F. C.; MAX, E. E.; BANCHEREAU, J.; MARTINEZ-VALDEZ, H.: ""Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes"", J.EXP.MED., vol. 183, 1996, pages 937 - 47;;MATHAS S; JANZ M; HUMMEL F; HUMMEL M; WOLLERT-WULF B; LUSATIS S; ANAGNOSTOPOULOS I; LIETZ A; SIGVARDSSON M; JUNDT F: ""Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma"", NAT IMMUNOL, vol. 7, 2006, pages 207 - 215, XP009079152, DOI: doi:10.1038/ni1285;;TRAGGIAI, E.; BECKER, S.; SUBBARAO, K.; KOLESNIKOVA, L.; UEMATSU, Y.; GISMONDO, M.R.; MURPHY, B.R.; RAPPUOLI, R.; LANZAVECCHIA, A.: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, 2004, pages 871 - 875, XP002385893;;YE, B. H.; CATTORETTI, G.; SHEN, Q.; ZHANG, J.; HAWE, N.; DE WAARD, R.; LEUNG, C.; NOURI-SHIRAZI, M.; ORAZI, A.; CHAGANTI, R. S. E: ""The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation"", NAT GENET, vol. 16, 1997, pages 161 - 170, XP055022334, DOI: doi:10.1038/ng0697-161",PENDING
151,EP,B2,EP 1974017 B2,060-751-581-730-558,2023-06-21,2023,EP 06824300 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A;;EP 06824300 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V.; NL (2021-08-05);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM; NL (2021-08-16);;AIMM THERAPEUTICS B.V., NL (2021-12-20);;AIMM THERAPEUTICS B.V. (2013-10-16);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN (2013-10-16);;KLING BIOTHERAPEUTICS B.V., NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM (2021-07-20);;KLING BIOTHERAPEUTICS B.V. (2021-07-20)",https://lens.org/060-751-581-730-558,Granted Patent,yes,1,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,15,12,073-409-050-702-37X;;007-990-945-290-343;;057-834-837-645-791;;077-563-580-153-954;;073-113-889-375-834;;034-790-241-471-333;;096-964-380-154-633;;012-641-124-922-53X;;022-496-932-592-799;;040-394-034-991-590;;035-807-573-955-11X;;024-937-768-741-556,11120780;;pmc2213502;;10.1084/jem.192.12.1841;;10.1038/ni1172;;15711548;;10.1016/0092-8674(93)90508-n;;8358789;;pmc2192442;;10.1084/jem.183.2.381;;8627151;;10.1006/cimm.1996.0260;;8871610;;9529324;;pmc2212200;;10.1084/jem.187.7.1081;;10.1023/a:1008186302600;;pmc3449729;;19003387;;10.1002/bit.10279;;12115434;;8168136;;10.1016/0092-8674(94)90321-2;;10.1128/mcb.22.13.4771-4780.2002;;pmc133916;;12052884;;10.4049/jimmunol.172.9.5427;;15100284;;14563324;;10.1016/s1074-7613(03)00267-x,"Reljic et al., 2000. J. Exp. Med, 192:1841-1847;;Scheeren et al., 2005. Nat. Immunol., 6:303-313;;Boise et al., 1993. Cell, 74: 597-608;;Grillot et al., 1996. J. Exp. Med., 183:381-391;;Zhang et al., 1996. Cellular Immunology, 173:149-154;;Solvason et al., 1998. J. Exp. Med., 187:1081-1091;;Charbonneau and Gauthier, 2000. Cytotechnology, 34:131-139;;Jung et al., 2002. Biotechnology and Bioengineering, 79:180-187;;Turner et al., 1994. Cell, 77: 297-306;;Lin et al., 2002. Mol. Cell Biol., 22: 4771-4780;;Sciammas and Davis, 2004. J. Immunol., 172:5427-5440;;Abstract of Ettinger presentation at GARN 2005, September 15-18,Vienna, Austria;;Shapiro-Shelef et al., 2003. Immunity, 19:607-620;;Antibody Engineering, Borrebaeck, 1985, Ch9, p267-293;;Supplementary figurs of D13",ACTIVE
152,NZ,A,NZ 569543 A,061-633-944-192-680,2012-12-21,2012,NZ 56954306 A,2006-12-08,EP 06076211 A;;NL 2005000848 W;;NL 2006000625 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,"Provided is an in vitro method for increasing the stability and/or replicative life span of an antibody producing cell, comprising directly or indirectly influencing the amount of Blimp-1 expression product within said antibody producing cell, wherein BCL6 and Blimp-1 are co-expressed in said antibody producing cell.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V., NL (2021-08-03);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NZ (2021-08-03)",https://lens.org/061-633-944-192-680,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,PENDING
153,CA,C,CA 2633157 C,073-539-108-676-246,2018-10-09,2018,CA 2633157 A,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/073-539-108-676-246,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C07K16/00;;C12N5/078;;C12N5/0781;;C12N15/12;;C12P21/00;;C12P21/08,,0,0,,,,ACTIVE
154,EP,B1,EP 1974017 B1,156-151-112-460-067,2013-11-06,2013,EP 06824300 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A;;EP 06824300 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V.; NL (2021-08-05);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM; NL (2021-08-16);;AIMM THERAPEUTICS B.V., NL (2021-12-20);;AIMM THERAPEUTICS B.V. (2013-10-16);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN (2013-10-16);;KLING BIOTHERAPEUTICS B.V., NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM (2021-07-20);;KLING BIOTHERAPEUTICS B.V. (2021-07-20)",https://lens.org/156-151-112-460-067,Granted Patent,yes,4,4,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,10,0,,,"SHVARTS AVI ET AL: ""A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling"" GENES AND DEVELOPMENT, vol. 16, no. 6, 15 March 2002 (2002-03-15), pages 681-686, XP002385891 ISSN: 0890-9369;;YAMOCHI TADANORI ET AL: ""Adenovirus-mediated high expression of BCL-6 CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL"" ONCOGENE, vol. 18, no. 2, 14 January 1999 (1999-01-14), pages 487-494, XP009079150 ISSN: 0950-9232;;OZAKI KATSUTOSHI ET AL: ""Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6."" JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 NOV 2004, vol. 173, no. 9, 1 November 2004 (2004-11-01), pages 5361-5371, XP002335928 ISSN: 0022-1767;;MEHTA D S ET AL: ""IL-21 induces the apoptosis of resting and activated primary B cells"" JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 170, no. 8, 15 April 2003 (2003-04-15), pages 4111-4118, XP002335927 ISSN: 0022-1767;;TRAGGIAI ELISABETTA ET AL: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"" NATURE MEDICINE, vol. 10, no. 8, August 2004 (2004-08), pages 871-875, XP002385893 ISSN: 1078-8956 cited in the application;;SHAFFER A L ET AL: ""Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program"" IMMUNITY, vol. 17, no. 1, July 2002 (2002-07), pages 51-62, XP002385892 ISSN: 1074-7613;;KNÖDEL M ET AL: ""Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching"" EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 31, no. 7, 2001, pages 1972-1980, XP002903679 ISSN: 0014-2980;;SHAPIRO-SHELEF MIRIAM ET AL: ""Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow."" THE JOURNAL OF EXPERIMENTAL MEDICINE. 5 DEC 2005, vol. 202, no. 11, 5 December 2005 (2005-12-05), pages 1471-1476, XP002385969 ISSN: 0022-1007;;SHEN CHUN-PYN ET AL: ""B-cell-specific DNA binding by an E47 homodimer"" MOLECULAR AND CELLULAR BIOLOGY, vol. 15, no. 8, 1995, pages 4518-4524, XP009079292 ISSN: 0270-7306;;MATHAS STEPHAN ET AL: ""Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma"" NATURE IMMUNOLOGY, vol. 7, no. 2, February 2006 (2006-02), pages 207-215, XP009079152 ISSN: 1529-2908",ACTIVE
155,PT,E,PT 1974017 E,165-184-597-962-694,2014-02-11,2014,PT 06824300 T,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/165-184-597-962-694,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
156,GB,B,GB 2465945 B,139-501-056-073-273,2012-06-20,2012,GB 201006016 A,2007-11-08,EP 2007062096 W,2007-11-08,Treating a crude and natural gas stream,,SHELL INT RESEARCH,AMELSVOORT JAN VAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,,https://lens.org/139-501-056-073-273,Granted Patent,no,3,0,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
157,PL,T5,PL 1974017 T5,162-561-348-112-80X,2023-10-23,2023,PL 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;EP 06824300 A;;NL 2006000625 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/162-561-348-112-80X,Unknown,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,PENDING
158,US,A1,US 2013/0138931 A1,165-867-246-640-389,2013-05-30,2013,US 201113304885 A,2011-11-28,US 201113304885 A,2011-11-28,MAINTAINING THE INTEGRITY OF AN EXECUTION RETURN ADDRESS STACK,"A processor and method for maintaining the integrity of an execution return address stack (RAS). The execution RAS is maintained in an accurate state by storing information regarding branch instructions in a branch information table. The first time a branch instruction is executed, an entry is allocated and populated in the table. If the branch instruction is re-executed, a pointer address is retrieved from the corresponding table entry and the execution RAS pointer is repositioned to the retrieved pointer address. The execution RAS can also be used to restore a speculative RAS due to a mis-speculation.",GUNNA RAMESH B;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J,GUNNA RAMESH B;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J,APPLE INC (2011-11-21),https://lens.org/165-867-246-640-389,Patent Application,yes,10,17,2,2,0,G06F9/3861;;G06F9/3806;;G06F9/3856;;G06F9/3861;;G06F9/3856;;G06F9/3806,G06F9/38,712/234;;X712E09045,0,0,,,,ACTIVE
159,NZ,A,NZ 600075 A,171-338-638-024-204,2013-12-20,2013,NZ 60007506 A,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,"600075 Discloses a method for increasing the stability and/or life span of an antibody producing cell comprising; providing an antibody producing cell with the Bcl-2 (bcl2) gene and/or culturing said antibody in the presence of a compound of the Bcl-2 family, where the compound is not Bcl-xL; and providing the antibody with a compound capable of enhancing Bcl-6 or (bcl6) expression.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;BEAUMONT TIM;;SCHEEREN FERENC ALEXANDER;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V., NL (2021-08-03);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NZ (2021-08-03)",https://lens.org/171-338-638-024-204,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C07K16/00;;C12N5/0781;;C12P21/08,,0,0,,,,PENDING
160,AU,A1,AU 2006/323315 A1,194-135-287-881-97X,2007-06-14,2007,AU 2006/323315 A,2006-12-08,EP 06076211 A;;NL 2005000848 W;;NL 2006000625 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,,AMC AMSTERDAM;;AIMM THERAPEUTICS,BEAUMONT TIM;;SCHEEREN FERENC ALEXANDER;;SPITS HERGEN;;DIEHL SEAN ANDREW,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (2021-09-23);;KLING BIOTHERAPEUTICS B.V. (2021-09-23),https://lens.org/194-135-287-881-97X,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
161,AU,B2,AU 2014/202709 B2,198-361-441-090-457,2016-09-08,2016,AU 2014/202709 A,2014-05-19,AU 2006/323315 A;;AU 2014/202709 A;;EP 06076211 A;;NL 2005000848 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,Abstract The invention relates to means and methods for influencing the stability of antibody producing cells.,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (2021-09-23);;KLING BIOTHERAPEUTICS B.V. (2021-09-23),https://lens.org/198-361-441-090-457,Granted Patent,no,1,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,2,2,056-175-384-903-897;;060-444-328-354-958,8898945;;10.1002/eji.1830261013;;pmc155362;;10.1101/gad.929302;;11914273,"Ning et al (1996) Eur J Imm, vol. 26, pps 2356-2363;;Shvarts et al (2002) Genes and Development, vol. 16 pps 681-686",ACTIVE
162,US,B2,US 9109166 B2,030-971-951-988-780,2015-08-18,2015,US 74140810 A,2007-11-08,EP 2007062096 W,2007-11-08,Treating a crude and natural gas stream,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream ( 10 ) through an inlet ( 12 ) into a stabilization unit ( 14 ) to provide a stabilizer content ( 20 ); (b) passing an overhead gaseous stream ( 30 ) separated from the stabilizer content ( 20 ) through a first outlet ( 16 ); and (c) passing a bottom stream ( 40 ) comprising crude liquid hydrocarbons separated from the stabilizer content ( 20 ) and free water through a second outlet ( 18 ).",VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOM;;CLINTON PAUL;;GAFONOVA OLGA;;SHELL OIL CO,VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOM;;CLINTON PAUL;;GAFONOVA OLGA,SHELL OIL COMPANY (2010-03-08),https://lens.org/030-971-951-988-780,Granted Patent,yes,21,2,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D3/14;;B01D3/34;;B01D19/00;;C10G7/02;;C10L3/10,,0,0,,,,INACTIVE
163,HU,T2,HU E037580 T2,131-219-182-343-238,2018-09-28,2018,HU E12175198 A,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/131-219-182-343-238,Amended Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,PENDING
164,CA,A1,CA 2633157 A1,136-615-061-403-536,2007-06-14,2007,CA 2633157 A,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",ACADEMISCH MEDISCH CT BIJ DE UNIVERSITEIT;;AIMM THERAPEUTICS,BEAUMONT TIM;;DIEHL SEAN ANDREW;;SCHEEREN FERENC ALEXANDER;;SPITS HERGEN,,https://lens.org/136-615-061-403-536,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
165,FI,T4,FI 1974017 T4,003-372-369-143-607,2023-09-14,2023,FI 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/003-372-369-143-607,Unknown,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,PENDING
166,AU,A,AU 1998/065854 A,020-544-764-903-332,1998-10-30,1998,AU 1998/065854 A,1998-03-25,US 4340797 P;;US 4615497 P;;US 9805892 W,1997-04-04,Novel uncoupling protein and methods of use,,AMYLIN PHARMACEUTICALS INC,LARKIN SARAH;;MOORE CANDACE;;ALBRANDT KEITH;;YOUNG ANDREW;;BEAUMONT KEVIN,,https://lens.org/020-544-764-903-332,Patent Application,no,0,0,2,2,0,A61K38/00;;C07K14/47,A61K38/00;;C07K14/47,,0,0,,,,PENDING
167,DK,T3,DK 2540820 T3,098-798-439-107-770,2018-03-12,2018,DK 12175198 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;EP 06824300 A,2005-12-09,MIDLER OG FREMGANGSMÅDER TIL PÅVIRKNING AF STABILITETEN AF ANTISTOFPRODUCERENDE CELLER,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/098-798-439-107-770,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
168,EP,A1,EP 2540820 A1,096-708-993-409-122,2013-01-02,2013,EP 12175198 A,2006-12-08,EP 06824300 A;;EP 06076211 A;;NL 2005000848 W;;EP 12175198 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides methods for increasing the replicative life span and/or stability of an antibody producing cell, comprising 
- providing said antibody producing cell with a compound capable of directly or indirectly enhancing BCL6 expression and/or culturing said antibody producing cell in the presence of a compound capable of directly or indirectly enhancing BCL6 expression; and 
- directly or indirectly increasing the amount of Bcl-xL or another anti-apoptotic gene expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.
",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V.; NL (2021-08-05);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM; NL (2021-08-16);;AIMM THERAPEUTICS B.V., NL (2021-12-20);;AIMM THERAPEUTICS B.V. (2013-10-16);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN (2013-10-16);;KLING BIOTHERAPEUTICS B.V., NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM (2021-07-05);;KLING BIOTHERAPEUTICS B.V. (2022-03-03)",https://lens.org/096-708-993-409-122,Patent Application,yes,4,4,45,52,6,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,20,16,060-444-328-354-958;;006-356-109-248-313;;041-194-807-252-395;;023-494-641-477-915;;056-175-384-903-897;;120-309-713-911-530;;071-096-561-751-483;;126-885-632-235-01X;;007-990-945-290-343;;050-899-251-631-539;;057-834-837-645-791;;004-990-229-260-144;;006-309-985-160-125;;078-191-037-400-337;;041-194-807-252-395;;030-214-658-445-99X,pmc155362;;10.1101/gad.929302;;11914273;;9927205;;10.1038/sj.onc.1202334;;10.1038/nm1080;;15247913;;pmc7095806;;10.1016/s0022-1759(01)00559-2;;11861062;;8898945;;10.1002/eji.1830261013;;20023635;;10.1038/nm.2071;;pmc2861345;;20957227;;pmc2949385;;10.1371/journal.pone.0013137;;8705856;;10.1038/nm0896-876;;10.1038/ni1172;;15711548;;1702555;;10.1126/science.1702555;;10.1016/0092-8674(93)90508-n;;8358789;;10.1073/pnas.032665099;;11830667;;pmc122219;;pmc2192363;;10.1084/jem.183.3.937;;8642297;;16369535;;10.1038/ni1285;;10.1038/nm1080;;15247913;;pmc7095806;;10.1038/ng0697-161;;9171827,"SHVARTS AVI ET AL: ""A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling"", GENES AND DEVELOPMENT, vol. 16, no. 6, 15 March 2002 (2002-03-15), pages 681 - 686, XP002385891, ISSN: 0890-9369;;YAMOCHI TADANORI ET AL: ""Adenovirus-mediated high expression of BCL-6 CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL"", ONCOGENE, vol. 18, no. 2, 14 January 1999 (1999-01-14), pages 487 - 494, XP009079150, ISSN: 0950-9232;;TRAGGIAI ELISABETTA ET AL: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, August 2004 (2004-08-01), pages 871 - 875, XP002385893, ISSN: 1078-8956;;YOO E M ET AL: ""Myeloma expression systems"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 261, no. 1-2, 1 March 2002 (2002-03-01), pages 1 - 20, XP004341264, ISSN: 0022-1759;;NING Z-Q ET AL: ""DISTINCT MECHANISMS FOR RESCUE FROM APOPTOSIS IN RAMOS HUMAN B CELLS BY SIGNALING THROUGH CD40 AND INTERLEUKIN-4 RECEPTOR: ROLE FOR INHIBITION OF AN EARLY RESPONE GENE, BERG36"", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 26, no. 10, 1 January 1996 (1996-01-01), pages 2356 - 2363, XP009013662, ISSN: 0014-2980, DOI: 10.1002/EJI.1830261013;;MARK J KWAKKENBOS ET AL: ""Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming"", NATURE MEDICINE, vol. 16, no. 1, 1 January 2010 (2010-01-01), pages 123 - 128, XP055019451, ISSN: 1078-8956, DOI: 10.1038/nm.2071;;PABLO D BECKER ET AL: ""Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated Human Immune System Mice"", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, SAN FRANCISCO, CA; US, vol. 5, no. 10, 4 October 2010 (2010-10-04), pages e13137 - 1, XP002634132, ISSN: 1932-6203, [retrieved on 20101004], DOI: 10.1371/JOURNAL.PONE.0013137;;HANENBERG H., NAT., MED., 1996;;ARIYOSHI K., JBC, 2000;;T. KITAMURA, IMSUT, TOKYO, JAPAN;;HEEMSKERK M.H., JEM, 1997;;HEEMSKERK M.H., CELL IMMUNOL., 1999;;SCHEEREN F.A., NAT IMMUNOL, 2005;;BANCHEREAU, J.; DE PAOLI, P.; VALLE, A.; GARCIA, E.; ROUSSET, F.: ""Long term human B cell lines dependent on interleukin-4 and antibody to CD40"", SCIENCE, vol. 251, 1991, pages 70 - 2, XP002576462;;BOISE, L. H.; M. GONZALEZ-GARCIA; C. E. POSTEMA; L. DING; T. LINDSTEN; L. A. TURKA; X. MAO; G. NUNEZ; C. B. THOMPSON: ""Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death"", CELL, vol. 74, 1993, pages 597, XP024246088, DOI: doi:10.1016/0092-8674(93)90508-N;;DADGOSTAR, H.; ZARNEGAR, B.; HOFFMANN, A.; QIN, X. F.; TRUONG, U.; RAO, G.; BALTIMORE, D.; CHENG, G.: ""Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes"", PROC.NATL.ACAD.SCI USA, vol. 99, 2002, pages 1497 - 1502;;MALISAN, F.; BRIERE, F.; BRIDON, J.M.; HARINDRANATH, N.; MILLS, F. C.; MAX, E. E.; BANCHEREAU, J.; MARTINEZ-VALDEZ, H.: ""Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes"", J.EXP.MED., vol. 183, 1996, pages 937 - 47;;MATHAS S; JANZ M; HUMMEL F; HUMMEL M; WOLLERT-WULF B; LUSATIS S; ANAGNOSTOPOULOS I; LIETZ A; SIGVARDSSON M; JUNDT F: ""Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma"", NAT IMMUNOL., vol. 7, 2006, pages 207 - 215, XP009079152, DOI: doi:10.1038/ni1285;;TRAGGIAI, E.; BECKER, S.; SUBBARAO, K.; KOLESNIKOVA, L.; UEMATSU, Y.; GISMONDO, M.R.; MURPHY, B.R.; RAPPUOLI, R.; LANZAVECCHIA, A.: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, 2004, pages 871 - 875, XP002385893;;YE, B. H.; CATTORETTI, G.; SHEN, Q.; ZHANG, J.; HAWE, N.; DE WAARD, R.; LEUNG, C.; NOURI-SHIRAZI, M.; ORAZI, A.; CHAGANTI, R. S. E: ""The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation"", NAT GENET, vol. 16, 1997, pages 161 - 170, XP055022334, DOI: doi:10.1038/ng0697-161",ACTIVE
169,CA,A1,CA 3015416 A1,160-326-072-133-200,2007-06-14,2007,CA 3015416 A,2006-12-08,NL 2005000848 W;;EP 06076211 A;;CA 2633157 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp-1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/160-326-072-133-200,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C12N5/0781;;C12N15/12;;C12N15/24;;C12P21/00;;C12P21/08,,0,0,,,,PENDING
170,WO,A1,WO 2007/067046 A1,158-415-687-447-567,2007-06-14,2007,NL 2006000625 W,2006-12-08,NL 2005000848 W;;EP 06076211 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",AMC AMSTERDAM;;AIMM THERAPEUTICS;;SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/158-415-687-447-567,Patent Application,yes,5,44,45,52,6,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,10,10,060-444-328-354-958;;006-356-109-248-313;;040-589-760-023-703;;047-875-464-057-476;;041-194-807-252-395;;010-173-637-288-194;;060-755-225-271-621;;016-672-433-469-908;;012-208-063-955-102;;078-191-037-400-337,pmc155362;;10.1101/gad.929302;;11914273;;9927205;;10.1038/sj.onc.1202334;;10.4049/jimmunol.173.9.5361;;15494482;;12682241;;10.4049/jimmunol.170.8.4111;;10.1038/nm1080;;15247913;;pmc7095806;;12150891;;10.1016/s1074-7613(02)00335-7;;11449349;;10.1002/1521-4141(200107)31:7&#60;1972::aid-immu1972&#62;3.0.co;2-t;;10.1002/1521-4141(200107)31:7<1972::aid-immu1972>3.0.co;2-t;;10.1002/1521-4141(200107)31:7<1972::aid-immu1972>3.3.co;2-k;;pmc2213334;;16314438;;10.1084/jem.20051611;;10.1128/mcb.15.8.4518;;7623842;;pmc230691;;16369535;;10.1038/ni1285,"SHVARTS AVI ET AL: ""A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling"", GENES AND DEVELOPMENT, vol. 16, no. 6, 15 March 2002 (2002-03-15), pages 681 - 686, XP002385891, ISSN: 0890-9369;;YAMOCHI TADANORI ET AL: ""Adenovirus-mediated high expression of BCL-6 CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL"", ONCOGENE, vol. 18, no. 2, 14 January 1999 (1999-01-14), pages 487 - 494, XP009079150, ISSN: 0950-9232;;OZAKI KATSUTOSHI ET AL: ""Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6."", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 NOV 2004, vol. 173, no. 9, 1 November 2004 (2004-11-01), pages 5361 - 5371, XP002335928, ISSN: 0022-1767;;MEHTA D S ET AL: ""IL-21 induces the apoptosis of resting and activated primary B cells"", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 170, no. 8, 15 April 2003 (2003-04-15), pages 4111 - 4118, XP002335927, ISSN: 0022-1767;;TRAGGIAI ELISABETTA ET AL: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, August 2004 (2004-08-01), pages 871 - 875, XP002385893, ISSN: 1078-8956;;SHAFFER A L ET AL: ""Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program"", IMMUNITY, vol. 17, no. 1, July 2002 (2002-07-01), pages 51 - 62, XP002385892, ISSN: 1074-7613;;KNÖDEL M ET AL: ""Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching"", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, vol. 31, no. 7, 2001, pages 1972 - 1980, XP002903679, ISSN: 0014-2980;;SHAPIRO-SHELEF MIRIAM ET AL: ""Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow."", THE JOURNAL OF EXPERIMENTAL MEDICINE. 5 DEC 2005, vol. 202, no. 11, 5 December 2005 (2005-12-05), pages 1471 - 1476, XP002385969, ISSN: 0022-1007;;SHEN CHUN-PYN ET AL: ""B-cell-specific DNA binding by an E47 homodimer"", MOLECULAR AND CELLULAR BIOLOGY, vol. 15, no. 8, 1995, pages 4518 - 4524, XP009079292, ISSN: 0270-7306;;MATHAS STEPHAN ET AL: ""Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma"", NATURE IMMUNOLOGY, vol. 7, no. 2, February 2006 (2006-02-01), pages 207 - 215, XP009079152, ISSN: 1529-2908",PENDING
171,WO,A1,WO 1998/045313 A1,086-948-481-250-162,1998-10-15,1998,US 9805892 W,1998-03-25,US 4340797 P;;US 4615497 P,1997-04-04,NOVEL UNCOUPLING PROTEIN AND METHODS OF USE,"A novel uncoupling protein, which we have designated UCP-3, that is expressed in skeletal muscle and brown adipose tissue (BAT), and nucleic acid molecules which encode for said novel protein, are described. Methods of screening for compounds that regulate the expression and the activity of UCP-3 are described, as well as methods of treating diseases or conditions in which the regulation of thermogenesis or respiratory ATP synthesis is desired. Such conditions include obesity, diabetes, malignant hyperthermia, and fever. The construction of cell lines that express UCP-3 is also described.",AMYLIN PHARMACEUTICALS INC;;LARKIN SARAH;;MOORE CANDACE;;ALBRANDT KEITH;;YOUNG ANDREW;;BEAUMONT KEVIN,LARKIN SARAH;;MOORE CANDACE;;ALBRANDT KEITH;;YOUNG ANDREW;;BEAUMONT KEVIN,,https://lens.org/086-948-481-250-162,Patent Application,yes,0,30,2,2,0,A61K38/00;;C07K14/47,A61K38/00;;C07K14/47,,3,3,062-762-845-171-304;;145-011-334-462-806;;058-237-544-298-707,9498661;;10.1007/s001250050897;;9511737;;10.1016/s0378-1119(97)00596-9;;9196039;;10.1006/bbrc.1997.6740,"URHAMMER S. A., ET AL.: ""ORGANISATION OF THE CODING EXONS AND MUTATIONAL SCREENING OF THE UNCOUPLING PROTEIN 3 GENE IN SUBJECTS WITH JUVENILE-ONSET OBESITY."", DIABETOLOGIA, SPRINGER, BERLIN, DE, vol. 41., 1 January 1998 (1998-01-01), BERLIN, DE, pages 241 - 244., XP002914181, ISSN: 0012-186X, DOI: 10.1007/s001250050897;;LIU Q., ET AL.: ""UNCOUPLING PROTEIN-3: A MUSCLE-SPECIFIC GENE UPREGULATED BY LEPTIN IN OB/OB MICE."", GENE., ELSEVIER, AMSTERDAM., NL, vol. 207., 1 January 1998 (1998-01-01), NL, pages 01 - 07., XP002914182, ISSN: 0378-1119, DOI: 10.1016/S0378-1119(97)00596-9;;VIDAL-PUIG A., ET AL.: ""UCP3: AN UNCOUPLING PROTEIN HOMOLOGUE EXPRESSED PREFERENTIALLY AND ABUNDANTLY IN SKELETAL MUSCLE AND BROWN ADIPOSE TISSUE."", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 235., 1 January 1997 (1997-01-01), US, pages 79 - 82., XP002914183, ISSN: 0006-291X, DOI: 10.1006/bbrc.1997.6740",PENDING
172,BR,B1,BR PI0619579 B1,131-094-295-869-782,2021-07-20,2021,BR PI0619579 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A,2005-12-09,"métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse","métodos para influenciar a estabilidade de uma célula produtora de anticorpo e para produzir uma célula produtora de anticorpo, célula produtora de anticorpo, e, métodos para produzir linhagem de células b e para produzir anticorpos. a invenção provê um método para influenciar a estabilidade de uma célula produtora de anticorpo, compreendendo influenciar direta ou indiretamente a quantidade de produto de expressão de bcl6 e/ou blimp 1 dentro da referida célula produtora de anticorpo. as células e linhagens de células de células produzindo anticorpos estáveis são também providas, assim como métodos para produzir anticorpos usando tais células e/ou linhagens de células.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,FERENE ALEXANDER SCHEEREN;;HERGEN SPITS;;SEAN ANDREW DIEHL;;TIM BEAUMONT,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) ; KLING BIOTHERAPEUTICS B.V. (NL) (2022-02-01),https://lens.org/131-094-295-869-782,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781,,0,0,,,,ACTIVE
173,ES,T3,ES 2660899 T3,165-519-140-073-303,2018-03-26,2018,ES 12175198 T,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,Medios y métodos para influir en la estabilidad de las células productoras de anticuerpos,"Un método para aumentar la vida útil de replicación y/o la estabilidad de una célula productora de anticuerpos, que comprende - proporcionar dicha célula productora de anticuerpos con una secuencia de ácido nucleico que codifica BCL6 o una parte funcional de la misma capaz de aumentar la vida útil de replicación de una célula productora de anticuerpos; y - proporcionar dicha célula productora de anticuerpo con una secuencia de ácido nucleico que codifica Bcl-xL.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/165-519-140-073-303,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
174,WO,A1,WO 2009/059641 A1,002-842-889-781-36X,2009-05-14,2009,EP 2007062096 W,2007-11-08,EP 2007062096 W,2007-11-08,TREATING A CRUDE AND NATURAL GAS STREAM,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream (10) through an inlet (12) into a stabilization unit (14) to provide a stabilizer content (20); (b) passing an overhead gaseous stream (30) separated from the stabilizer content (20) through a first outlet (16); and (c) passing a bottom stream (40) comprising crude liquid hydrocarbons separated from the stabilizer content (20) and free water through a second outlet (18).",SHELL INT RESEARCH;;VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,,https://lens.org/002-842-889-781-36X,Patent Application,yes,3,1,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,PENDING
175,AU,B2,AU 2006/323315 B2,017-187-993-767-126,2014-02-20,2014,AU 2006/323315 A,2006-12-08,EP 06076211 A;;NL 2005000848 W;;NL 2006000625 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp 1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,BEAUMONT TIM;;SPITS HERGEN;;DIEHL SEAN ANDREW;;SCHEEREN FERENC ALEXANDER,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (2021-09-23);;KLING BIOTHERAPEUTICS B.V. (2021-09-23),https://lens.org/017-187-993-767-126,Granted Patent,no,1,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,2,2,060-444-328-354-958;;006-356-109-248-313,pmc155362;;10.1101/gad.929302;;11914273;;9927205;;10.1038/sj.onc.1202334,"SHVARTS et al, (2002) GENES AND DEVELOPMENT, vol. 16, pages 681-686;;YAMOCHI et al, (1999) ONCOGENE, vol. 18, pages 487-494",ACTIVE
176,DK,T3,DK 1974017 T3,041-678-829-476-315,2014-02-10,2014,DK 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler,,AIMM THERAPEUTICS BV;;AMC AMSTERDAM,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/041-678-829-476-315,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
177,AU,A1,AU 2014/202709 A1,064-631-110-707-49X,2014-06-12,2014,AU 2014/202709 A,2014-05-19,AU 2006/323315 A;;AU 2014/202709 A;;EP 06076211 A;;NL 2005000848 W,2005-12-09,Means and methods for influencing the stability of antibody producing cells,Abstract The invention relates to means and methods for influencing the stability of antibody producing cells.,AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (2021-09-23);;KLING BIOTHERAPEUTICS B.V. (2021-09-23),https://lens.org/064-631-110-707-49X,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
178,AU,B2,AU 2007/361218 B2,112-999-930-376-387,2011-09-08,2011,AU 2007/361218 A,2007-11-08,EP 2007062096 W,2007-11-08,Treating a crude and natural gas stream,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream (10) through an inlet (12) into a stabilization unit (14) to provide a stabilizer content (20); (b) passing an overhead gaseous stream (30) separated from the stabilizer content (20) through a first outlet (16); and (c) passing a bottom stream (40) comprising crude liquid hydrocarbons separated from the stabilizer content (20) and free water through a second outlet (18).",SHELL INT RESEARCH,OLGA GAFONOVA;;MALCOLM BEAUMONT ANDREW;;PAUL CLINTON;;JAN AMELSVOORT VAN,,https://lens.org/112-999-930-376-387,Granted Patent,no,3,0,13,13,0,B01D3/14;;B01D3/34;;B01D19/0015;;C10G7/02;;C10L3/10;;C10G2300/1025;;C10G2300/1033;;C10G2300/805;;C10G7/00;;B01D19/0005;;C10G7/00;;C10G7/02;;F25J3/0209;;B01D3/14;;B01D3/34;;B01D19/0015;;C10G7/02;;C10L3/10;;C10G2300/1025;;C10G2300/1033;;C10G2300/805;;C10G7/00,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
179,EP,A1,EP 2309913 A1,003-889-391-659-222,2011-04-20,2011,EP 08876680 A,2008-11-14,US 2008/0012792 W;;US 13768408 P,2008-08-01,HIGH RESOLUTION DIGITAL VIDEO COLPOSCOPE WITH BUILT-IN POLARIZED LED ILLUMINATION AND COMPUTERIZED CLINICAL DATA MANAGEMENT SYSTEM,,STI MEDICAL SYSTEMS LLC,SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,,https://lens.org/003-889-391-659-222,Patent Application,yes,0,0,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,A61B1/06;;A61B1/04,,0,0,,,,DISCONTINUED
180,EA,B1,EA 017512 B1,002-764-921-523-539,2013-01-30,2013,EA 201000772 A,2007-11-08,EP 2007062096 W,2007-11-08,TREATING A CRUDE AND NATURAL GAS STREAM,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream (10) through an inlet (12) into a stabilization unit (14) to provide a stabilizer content (20); (b) passing an overhead gaseous stream (30) separated from the stabilizer content (20) through a first outlet (16); and (c) passing a bottom stream (40) comprising crude liquid hydrocarbons separated from the stabilizer content (20) and free water through a second outlet (18).",SHELL INT RESEARCH,VAN AMELSVOORT JAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,,https://lens.org/002-764-921-523-539,Granted Patent,no,3,1,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,ACTIVE
181,CN,A,CN 102215732 A,031-275-157-044-616,2011-10-12,2011,CN 200880131435 A,2008-11-14,US 2008/0012792 W;;US 13768408 P,2008-08-01,High resolution digital video colposcope with built-in polarized led illumination and computerized clinical data management system,"This invention uses LEDs and cross-polarization to produce bright, high- resolution digital images, both with and without glint (which adversely affects the clarity of standard colposcopic images), as well as streaming video at lower resolution. The invention allows for deeper layers of the tissue to be more efficiently visualized at multiple magnifications, thereby enhancing the invention's diagnostic capabilities, and it includes a focusing subsystem and a computerized data management system to archive and annotate still image data.",STI MEDICAL SYSTEMS LLC,ESTEBAN SOTO-THOMPSON MARCELO;;BEAUMONT WHITESELL ANDREW;;PETER GUSTAFSSON ULF,,https://lens.org/031-275-157-044-616,Patent Application,no,0,3,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,A61B1/00,,0,0,,,,DISCONTINUED
182,PT,T,PT 2540820 T,150-873-626-210-176,2018-03-02,2018,PT 12175198 T,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,TIM BEAUMONT;;HERGEN SPITS;;FERENC ALEXANDER SCHEEREN;;SEAN ANDREW DIEHL,,https://lens.org/150-873-626-210-176,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,PENDING
183,GB,A,GB 2465945 A,192-196-635-287-739,2010-06-09,2010,GB 201006016 A,2007-11-08,EP 2007062096 W,2007-11-08,Treating a crude and natural gas stream,"A process for treating a crude and natural gas stream, which at least comprises the steps of: (a) passing a crude and natural gas stream (10) through an inlet (12) into a stabilization unit (14) to provide a stabilizer content (20); (b) passing an overhead gaseous stream (30) separated from the stabilizer content (20) through a first outlet (16); and (c) passing a bottom stream (40) comprising crude liquid hydrocarbons separated from the stabilizer content (20) and free water through a second outlet (18).",SHELL INT RESEARCH,AMELSVOORT JAN VAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,,https://lens.org/192-196-635-287-739,Patent Application,no,3,0,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
184,US,A1,US 2010/0026785 A1,014-797-487-589-733,2010-02-04,2010,US 29189008 A,2008-11-14,US 29189008 A;;US 13768408 P,2008-08-01,High resolution digital video colposcope with built-in polarized LED illumination and computerized clinical data management system,"This invention uses LEDs and cross-polarization to produce bright, high-resolution digital images, both with and without glint (which adversely affects the clarity of standard colposcopic images), as well as streaming video at lower resolution. The invention allows for deeper layers of the tissue to be more efficiently visualized at multiple magnifications, thereby enhancing the invention's diagnostic capabilities, and it includes a focusing subsystem and a computerized data management system to archive and annotate still image data.",STI MEDICAL SYSTEMS LLC,SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,STI MEDICAL SYSTEMS LLC (2009-02-10),https://lens.org/014-797-487-589-733,Patent Application,yes,4,20,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,H04N13/02,348/47;;X348E13074,0,0,,,,INACTIVE
185,ES,T3,ES 2444465 T3,114-407-747-839-68X,2014-02-25,2014,ES 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,Medios y procedimientos para influenciar la estabilidad de las células productoras de anticuerpos,"Un procedimiento para aumentar el ciclo de vida de replicación de una célula productora de anticuerpos, quecomprende aumentar o mantener la cantidad del producto de expresión BCL6 y Blimp-1 en comparación con unlinfocito B de memoria o un linfocito B no expuesto previamente dentro de dicha célula productora de anticuerpos - proporcionar dicha célula productora de anticuerpos con un compuesto capaz de potenciar la expresión deBCL6 y/o cultivar dicha célula productora de anticuerpos en presencia de un compuesto capaz de potenciar laexpresión de BCL6, y - proporcionar dicha célula productora de anticuerpos con un compuesto capaz de aumentar la expresión deBlimp-1 y/o cultivar dicha célula productora de anticuerpos en presencia de un compuesto capaz de incrementarla expresión de Blimp-1.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/114-407-747-839-68X,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
186,US,B2,US 9354886 B2,171-606-042-466-368,2016-05-31,2016,US 201113304885 A,2011-11-28,US 201113304885 A,2011-11-28,Maintaining the integrity of an execution return address stack,"A processor and method for maintaining the integrity of an execution return address stack (RAS). The execution RAS is maintained in an accurate state by storing information regarding branch instructions in a branch information table. The first time a branch instruction is executed, an entry is allocated and populated in the table. If the branch instruction is re-executed, a pointer address is retrieved from the corresponding table entry and the execution RAS pointer is repositioned to the retrieved pointer address. The execution RAS can also be used to restore a speculative RAS due to a mis-speculation.",GUNNA RAMESH B;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;APPLE INC,GUNNA RAMESH B;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J,APPLE INC (2011-11-21),https://lens.org/171-606-042-466-368,Granted Patent,yes,29,1,2,2,0,G06F9/3861;;G06F9/3806;;G06F9/3856;;G06F9/3861;;G06F9/3856;;G06F9/3806,G06F9/38,,4,2,098-199-690-522-531;;068-280-613-604-584,10.1109/micro.2001.991105;;10.1109/micro.1998.742787,"International Search Report in Application No. PCT/US2006/028196, Mailed Jan. 8, 2007.;;Powell, et al., ""Reducing Set-Associative Cache Energy via Way-Prediction and Selective Direct-Mapping"", Microarchitecture, 2001. Micro-34 Proceedings, 34th ACM/IEEE International Symposium on Dec. 1-5, 2001, Piscataway, NJ, USA, IEEE, pp. 54-65, XP010583671 ISBN: 0-7965-1369-7.;;Skadron, et al., ""Improving Prediction for Procedure Returns with Return-Address-Stack Repair Mechanisms"", Published in the Proceedings of the 31st Annual ACM/IEEE International Symposium on Microarchitecture, Nov. 30-Dec. 2, 1998, Dallas, Texas, USA, IEEE, pp. 259-271.;;Non-Final Office Action in U.S. Appl. No. 13/893,898, mailed Dec. 18, 2015, 10 pages.",ACTIVE
187,DK,T4,DK 1974017 T4,191-267-210-093-065,2023-09-25,2023,DK 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,Midler og fremgangsmåder til at påvirke stabiliteten af antistof producerende celler,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/191-267-210-093-065,Amended Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
188,NZ,A,NZ 592159 A,058-752-828-833-587,2012-12-21,2012,NZ 59215906 A,2006-12-08,EP 06076211 A;;NL 2005000848 W,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"Provided is an in vitro method for influencing the stability of an antibody producing cell, wherein the BCL6 expression is enhanced by expression of an exogenous BCL6 coding sequence and/or by providing the antigen producing cell with STAT5 directly or via expression of an exogenous STAT5 coding sequence and or culturing the antigen producing cell with IL-2 and/or IL-4; and increasing Bcl-xL expression by various means. The antigen producing cells can be stable for at least one week and as long as six months. Further provided are antibodies obtained by the method.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V., NL (2021-08-03);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NZ (2021-08-03)",https://lens.org/058-752-828-833-587,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C07K16/00;;C12N5/0781;;C12P21/08,,0,0,,,,PENDING
189,WO,A1,WO 2010/014072 A1,083-590-092-764-909,2010-02-04,2010,US 2008/0012792 W,2008-11-14,US 13768408 P,2008-08-01,HIGH RESOLUTION DIGITAL VIDEO COLPOSCOPE WITH BUILT-IN POLARIZED LED ILLUMINATION AND COMPUTERIZED CLINICAL DATA MANAGEMENT SYSTEM,"This invention uses LEDs and cross-polarization to produce bright, high- resolution digital images, both with and without glint (which adversely affects the clarity of standard colposcopic images), as well as streaming video at lower resolution. The invention allows for deeper layers of the tissue to be more efficiently visualized at multiple magnifications, thereby enhancing the invention's diagnostic capabilities, and it includes a focusing subsystem and a computerized data management system to archive and annotate still image data.",STI MEDICAL SYSTEMS LLC;;SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,,https://lens.org/083-590-092-764-909,Patent Application,yes,8,1,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,A61B1/00,,1,0,,,See also references of EP 2309913A4,PENDING
190,BR,A2,BR PI0722197 A2,006-540-305-825-560,2014-05-06,2014,BR PI0722197 A,2007-11-08,EP 2007062096 W,2007-11-08,"PROCESSO PARA TRATAR UMA CORRENTE DE GÁS BRUTO E NATURAL, E, CORRENTE DE FUNDO",,SHELL INT RESEARCH,AMELSVOORT JAN VAN;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;GAFONOVA OLGA,,https://lens.org/006-540-305-825-560,Patent Application,no,0,0,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
191,BR,A2,BR PI0619579 A2,000-381-559-625-311,2011-10-04,2011,BR PI0619579 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A,2005-12-09,"métodos para influenciar a estabilidade de uma célula produtora de anticorpo e para produzir uma célula produtora de anticorpo, célula produtora de anticorpo, e, métodos para produzir linhagem de células b e para produzir anticorpos","MéTODOS PARA INFLUENCIAR A ESTABILIDADE DE UMA CéLULA PRODUTORA DE ANTICORPO E PARA PRODUZIR UMA CéLULA PRODUTORA DE ANTICORPO, CéLULA PRODUTORA DE ANTICORPO, E, MéTODOS PARA PRODUZIR LINHAGEM DE CéLULAS B E PARA PRODUZIR ANTICORPOS. A invenção provê um método para influenciar a estabilidade de uma célula produtora de anticorpo, compreendendo influenciar direta ou indiretamente a quantidade de produto de expressão de BCL6 e/ou Blimp 1 dentro da referida célula produtora de anticorpo. As células e linhagens de células de células produzindo anticorpos estáveis são também providas, assim como métodos para produzir anticorpos usando tais células e/ou linhagens de células.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENE ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) ; KLING BIOTHERAPEUTICS B.V. (NL) (2022-02-01),https://lens.org/000-381-559-625-311,Patent Application,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781;;C12N5/10;;C12P21/08,,0,0,,,,ACTIVE
192,NO,L,NO 20100818 L,010-451-763-997-570,2010-06-07,2010,NO 20100818 A,2010-06-07,EP 2007062096 W,2007-11-08,Behandling av en ragass- og naturstrom,"Fremgangsmåte for å behandle rågass- og naturgasstrøm, omfattende minst trinnene: (a) en rågass- og naturgasstrøm (10) føres gjennom et innløp (12) inn i en stabiliseringsenhet (14) for å oppnå et stabilisatorinnhold (20), (b) en gassformig toppstrøm (30) skilt fra stabilisatorinnholdet (20) føres gjennom et første utløp (16), og (c) en bunnstrøm (40) som omfatter flytende råhydrokarboner skilt fra stabilisatorinnholdet (20) og fritt vann, føres gjennom et andre utløp (18).",SHELL INT RESEARCH,CLINTON PAUL;;AMELSVOORT JAN VAN;;BEAUMONT ANDREW MALCOLM;;GAFONOVA OLGA,,https://lens.org/010-451-763-997-570,Abstract,no,0,0,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,B01D19/00;;C10G7/00;;C10G7/02;;F25J3/02,,0,0,,,,DISCONTINUED
193,EP,A1,EP 1974017 A1,012-833-636-608-102,2008-10-01,2008,EP 06824300 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A;;EP 06824300 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V.; NL (2021-08-05);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM; NL (2021-08-16);;AIMM THERAPEUTICS B.V., NL (2021-12-20);;AIMM THERAPEUTICS B.V. (2013-10-16);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN (2013-10-16);;KLING BIOTHERAPEUTICS B.V., NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM (2021-07-20);;KLING BIOTHERAPEUTICS B.V. (2021-07-20)",https://lens.org/012-833-636-608-102,Patent Application,yes,0,2,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
194,US,B2,US 8289378 B2,023-031-473-577-077,2012-10-16,2012,US 29189008 A,2008-11-14,US 29189008 A;;US 13768408 P,2008-08-01,High resolution digital video colposcope with built-in polarized LED illumination and computerized clinical data management system,"This invention uses LEDs and cross-polarization to produce bright, high-resolution digital images, both with and without glint (which adversely affects the clarity of standard colposcopic images), as well as streaming video at lower resolution. The invention allows for deeper layers of the tissue to be more efficiently visualized at multiple magnifications, thereby enhancing the invention's diagnostic capabilities, and it includes a focusing subsystem and a computerized data management system to archive and annotate still image data.",SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER;;STI MEDICAL SYSTEMS LLC,SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,STI MEDICAL SYSTEMS LLC (2009-02-10),https://lens.org/023-031-473-577-077,Granted Patent,yes,4,1,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,H04N132/02,348/47;;348/57;;348/58,8,3,082-082-382-983-07X;;000-432-173-003-20X;;050-212-407-437-641,10.1117/1.2208987;;16822059;;10.1586/17434440.4.2.121;;17359219;;10.1016/j.ygyno.2007.07.016;;17825397,"D. G. Ferris, et al., ""Modern Colposcopy-Textbook and Atlas,"" pp. 250-662, American Society for Colposcopy and Cervical Pathology Kendall/Hunt Publishing Co., Dubuque, Iowa.;;B.S. Apgar et al., ""Colposcopy: Principles and Practice,"" pp. 115-132, W.B. Saunders Company, Philadelphia, PA 2002.;;K. T. Schomacker et al., Novel optical detection system for in vivo identification and localization of cervical intra-epithelial neoplasia, J. Biomed Optics 11(3), pp. 034009-1 to 034009-02, 2006.;;J.E. Kendrick et al., ""LUMA(TM) Cervical Imaging System,"" Expert Rev. Med. Devices 4(2), pp. 121-129, 2007.;;E. Hecht., ""Optics,"" pp. 270-332, Addison-Wesley, 2nd edition 1987.;;Welch Allyn, ""Video Colposcope,"" Directions for Use, 2007.;;S. Nakappan et al., ""Methodology of real time quality control for the multispectral digital colposcope,"" Gynecologic Oncology 107, S21-S222, 2008.;;Acgih, ""Electromagnetic Radiation and Fields,"" pp. 13-43, 2007, Cincinati, OH.",INACTIVE
195,EP,B1,EP 2540820 B1,064-981-854-539-142,2018-01-10,2018,EP 12175198 A,2006-12-08,EP 06824300 A;;EP 06076211 A;;NL 2005000848 W;;EP 12175198 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,"KLING BIOTHERAPEUTICS B.V.; NL (2021-08-05);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM; NL (2021-08-16);;AIMM THERAPEUTICS B.V., NL (2021-12-20);;AIMM THERAPEUTICS B.V. (2013-10-16);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN (2013-10-16);;KLING BIOTHERAPEUTICS B.V., NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT, NL (2022-02-18);;ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN  AMSTERDAM (2021-07-05);;KLING BIOTHERAPEUTICS B.V. (2022-03-03)",https://lens.org/064-981-854-539-142,Granted Patent,yes,3,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C07K16/00;;C12N5/10;;C12P21/08,,7,0,,,"SHVARTS AVI ET AL: ""A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19ARF-p53 signaling"", GENES AND DEVELOPMENT, vol. 16, no. 6, 15 March 2002 (2002-03-15) , pages 681-686, XP002385891, ISSN: 0890-9369;;YAMOCHI TADANORI ET AL: ""Adenovirus-mediated high expression of BCL-6 CV-1 cells induces apoptotic cell death accompanied by down-regulation of BCL-2 and BCL-XL"", ONCOGENE, vol. 18, no. 2, 14 January 1999 (1999-01-14), pages 487-494, XP009079150, ISSN: 0950-9232;;TRAGGIAI ELISABETTA ET AL: ""An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus"", NATURE MEDICINE, vol. 10, no. 8, August 2004 (2004-08), pages 871-875, XP002385893, ISSN: 1078-8956;;YOO E M ET AL: ""Myeloma expression systems"", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, vol. 261, no. 1-2, 1 March 2002 (2002-03-01), pages 1-20, XP004341264, ISSN: 0022-1759;;NING Z-Q ET AL: ""DISTINCT MECHANISMS FOR RESCUE FROM APOPTOSIS IN RAMOS HUMAN B CELLS BY SIGNALING THROUGH CD40 AND INTERLEUKIN-4 RECEPTOR: ROLE FOR INHIBITION OF AN EARLY RESPONE GENE, BERG36"", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 26, no. 10, 1 January 1996 (1996-01-01), pages 2356-2363, XP009013662, ISSN: 0014-2980, DOI: 10.1002/EJI.1830261013;;MARK J KWAKKENBOS ET AL: ""Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming"", NATURE MEDICINE, vol. 16, no. 1, 1 January 2010 (2010-01-01), pages 123-128, XP055019451, ISSN: 1078-8956, DOI: 10.1038/nm.2071;;PABLO D BECKER ET AL: ""Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated Human Immune System Mice"", PLOS ONE, PUBLIC LIBRARY OF SCIENCE, SAN FRANCISCO, CA; US, vol. 5, no. 10, 4 October 2010 (2010-10-04), pages e13137-1, XP002634132, ISSN: 1932-6203, DOI: 10.1371/JOURNAL.PONE.0013137 [retrieved on 2010-10-04]",ACTIVE
196,BR,B1,BR 122021001906 B1,106-449-487-990-53X,2022-03-29,2022,BR 122021001906 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A;;BR PI0619579 A,2005-12-09,"Método para aumentar a estabilidade de uma célula produtora de anticorpo, método para produzir uma célula produtora de anticorpo que é estável durante pelo menos uma semana, método para produzir linhagem de células b, e método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse","a invenção provê um método para influenciar a estabilidade de uma célula produtora de anticorpo, compreendendo influenciar direta ou indiretamente a quantidade de produto de expressão de bcl6 e/ou blimp 1 dentro da referida célula produtora de anticorpo. as células e linhagens de células de células produzindo anticorpos estáveis são também providas, assim como métodos para produzir anticorpos usando tais células e/ou linhagens de células.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV;;KLING BIOTHERAPEUTICS B V,FERENC ALEXANDER SCHEEREN;;SPITS HERGEN;;SEAN ANDREW DIEHL;;BEAUMONT TIM,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) ; KLING BIOTHERAPEUTICS B.V. (NL) (2022-02-01),https://lens.org/106-449-487-990-53X,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781,,0,0,,,,ACTIVE
197,EP,A4,EP 2309913 A4,124-983-933-466-061,2014-07-02,2014,EP 08876680 A,2008-11-14,US 2008/0012792 W;;US 13768408 P,2008-08-01,HIGH RESOLUTION DIGITAL VIDEO COLPOSCOPE WITH BUILT-IN POLARIZED LED ILLUMINATION AND COMPUTERIZED CLINICAL DATA MANAGEMENT SYSTEM,,STI MEDICAL SYSTEMS LLC,SOTO-THOMPSON MARCELO ESTEBAN;;WHITESELL ANDREW BEAUMONT;;GUSTAFSSON ULF PETER,,https://lens.org/124-983-933-466-061,Search Report,no,6,0,7,7,0,A61B1/042;;A61B1/303;;A61B5/0084;;A61B1/00186;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/042;;A61B5/0084;;A61B1/303;;A61B1/0607;;A61B1/0646;;A61B1/0684;;A61B1/00186,A61B1/06;;A61B1/04,,1,0,,,See also references of WO 2010014072A1,DISCONTINUED
198,CA,C,CA 3015416 C,133-270-031-253-338,2022-10-11,2022,CA 3015416 A,2006-12-08,NL 2005000848 W;;EP 06076211 A;;CA 2633157 A,2005-12-09,MEANS AND METHODS FOR INFLUENCING THE STABILITY OF ANTIBODY PRODUCING CELLS,"The invention provides a method for influencing the stability of an antibody producing cell, comprising directly or indirectly influencing the amount of BCL6 and/or Blimp-1 expression product within said antibody producing cell. Stable antibody producing cells and cell lines are also provided, as well as methods for producing antibodies using such cells and/or cell lines.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/133-270-031-253-338,Granted Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C12N5/0781;;C12N15/12;;C12N15/24;;C12P21/00;;C12P21/08,,0,0,,,,PENDING
199,BR,B1,BR PI0722197 B1,151-593-795-225-07X,2017-05-09,2017,BR PI0722197 A,2007-11-08,EP 2007062096 W,2007-11-08,"processo para tratar uma corrente de gás bruto e natural, e, corrente de fundo",,SHELL INT RESEARCH,ANDREW MALCOLM BEAUMONT;;JAN VAN AMELSVOORT;;OLGA GAFONOVA;;PAUL CLINTON,,https://lens.org/151-593-795-225-07X,Granted Patent,no,0,0,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,B01D19/00;;C10G7/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
200,GB,B,GB 2307811 B,102-236-977-926-122,1999-12-08,1999,GB 9622859 A,1996-11-01,GB 9522378 A,1995-11-01,Measurement arrangement,,BRITISH GAS PLC,CORDES PAUL BEAUMONT;;MCGONNELL PHILIP;;WARD PETER;;FRASER ANDREW JOHN,,https://lens.org/102-236-977-926-122,Granted Patent,no,5,0,12,12,0,G01B15/02;;G01B15/02,G01B15/02,H4D DRPW          RPW;;H4D D255          RPW;;H4D D257          RPW;;H4D D352          RPW;;H4D D398          RPW;;U1S S1743,0,0,,,,EXPIRED
201,MY,A,MY 155281 A,147-218-227-789-847,2015-09-30,2015,MY PI20101589 A,2007-11-08,MY PI20101589 A,2007-11-08,TREATING A CRUDE AND NATURAL GAS STREAM,"A PROCESS FOR TREATING A CRUDE AND NATURAL GAS STREAM, WHICH AT LEAST COMPRISES THE STEPS OF: (A) PASSING A CRUDE AND NATURAL GAS STREAM (10) THROUGH AN INLET (12) INTO A STABILIZATION UNIT (14) TO PROVIDE A STABILIZER CONTENT (20); (B) PASSING AN OVERHEAD GASEOUS STREAM (30) SEPARATED FROM THE STABILIZER CONTENT (20) THROUGH A FIRST OUTLET (16); AND (C) PASSING A BOTTOM STREAM (40) COMPRISING CRUDE LIQUID HYDROCARBONS SEPARATED FROM THE STABILIZER CONTENT (20) AND FREE WATER THROUGH A SECOND OUTLET (18). (FIG. 1)",SHELL INT RESEARCH,JAN AMELSVOORT VAN;;MALCOLM BEAUMONT ANDREW;;PAUL CLINTON;;OLGA GAFONOVA,,https://lens.org/147-218-227-789-847,Granted Patent,no,0,0,1,1,0,,C10G7/00,,0,0,,,,ACTIVE
202,AU,A1,AU 2007/361218 A1,157-649-596-803-621,2009-05-14,2009,AU 2007/361218 A,2007-11-08,EP 2007062096 W,2007-11-08,Treating a crude and natural gas stream,,SHELL INT RESEARCH,GAFONOVA OLGA;;BEAUMONT ANDREW MALCOLM;;CLINTON PAUL;;AMELSVOORT JAN VAN,,https://lens.org/157-649-596-803-621,Patent Application,no,0,1,13,13,0,B01D19/0005;;B01D3/14;;B01D3/14;;B01D3/34;;B01D3/34;;B01D19/0015;;B01D19/0015;;C10G7/00;;C10G7/02;;C10G7/00;;C10G7/00;;C10G7/02;;C10G7/02;;C10G2300/1025;;C10G2300/1025;;C10G2300/1033;;C10G2300/1033;;C10G2300/805;;C10G2300/805;;C10L3/10;;C10L3/10;;F25J3/0209,C10G7/00;;B01D19/00;;C10G7/02;;F25J3/02,,0,0,,,,INACTIVE
203,BR,B8,BR PI0619579 B8,169-796-889-508-832,2022-01-25,2022,BR PI0619579 A,2006-12-08,NL 2006000625 W;;NL 2005000848 W;;EP 06076211 A,2005-12-09,"Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse","métodos para influenciar a estabilidade de uma célula produtora de anticorpo e para produzir uma célula produtora de anticorpo, célula produtora de anticorpo, e, métodos para produzir linhagem de células b e para produzir anticorpos. a invenção provê um método para influenciar a estabilidade de uma célula produtora de anticorpo, compreendendo influenciar direta ou indiretamente a quantidade de produto de expressão de bcl6 e/ou blimp 1 dentro da referida célula produtora de anticorpo. as células e linhagens de células de células produzindo anticorpos estáveis são também providas, assim como métodos para produzir anticorpos usando tais células e/ou linhagens de células.",ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;AIMM THERAPEUTICS BV,FERENC ALEXANDER SCHEEREN;;SPITS HERGEN;;SEAN ANDREW DIEHL;;BEAUMONT TIM,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM (NL) ; KLING BIOTHERAPEUTICS B.V. (NL) (2022-02-01),https://lens.org/169-796-889-508-832,Amended Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C07K16/00;;C12N5/0781,,0,0,,,,ACTIVE
204,ES,T5,ES 2444465 T5,188-302-647-431-867,2023-11-30,2023,ES 06824300 T,2006-12-08,NL 2005000848 W;;EP 06076211 A;;NL 2006000625 W,2005-12-09,Medios y procedimientos para influenciar la estabilidad de las células productoras de anticuerpos,,ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM;;KLING BIOTHERAPEUTICS B V,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/188-302-647-431-867,Amended Patent,no,0,0,45,52,0,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/0781;;C12N5/10,,0,0,,,,ACTIVE
205,JP,A,JP 2013099358 A,196-917-636-805-449,2013-05-23,2013,JP 2013020744 A,2013-02-05,NL 2005000848 W;;EP 06076211 A,2005-12-09,MEANS AND METHOD FOR INFLUENCING STABILITY OF ANTIBODY PRODUCING CELL,"PROBLEM TO BE SOLVED: To provide a method for influencing stability of antibody producing cells.SOLUTION: There is provided the method for influencing the stability of antibody producing cells, associated with the stability of the antibody producing cell, comprising a step of directly or indirectly influencing the amount of BCL6 and/or Blimp-1 expression product within the antibody producing cell for extending replication life of the antibody producing cell. There are also provided stable antibody producing cells and cell lines, as well as methods for producing antibodies using such cells and/or cell lines.",AMC AMSTERDAM;;AIMM THERAPEUTICS BV,SPITS HERGEN;;SCHEEREN FERENC ALEXANDER;;BEAUMONT TIM;;DIEHL SEAN ANDREW,,https://lens.org/196-917-636-805-449,Patent Application,no,9,2,45,52,6,C12N5/0635;;C07K16/00;;C12N2501/23;;C12N2501/231;;C12N2501/2321;;C12N2501/52;;C12N2501/60;;C12N2502/99;;C12N2510/02;;C12N2510/04;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N2502/99;;C12N5/0635;;C12N2502/99;;C07K16/00;;C12N2501/23;;C12N2501/52;;C12N2501/60;;C12N2510/02;;C12N2510/04;;C12N5/0635;;C12N2501/231;;C12N2501/2321,C12N5/10;;C12N5/0781;;C12N15/09;;C12P21/08,,3,0,,,"JPN6014031544; Ｃｅｌｌ Ｉｍｍｕｎｏｌ． Ｖｏｌ．１７３， Ｎｏ．１, 1996, ｐ．１４９-１５４;;JPN6014017056; Ｎａｔｕｒｅ Ｒｅｖｉｅｗｓ Ｉｍｍｕｎｏｌｏｇｙ Ｖｏｌ．２, 2002, ｐ．９２０-９３３;;JPN6014031545; Ｉｍｍｕｎｅ Ｎｅｔｗ． Ｖｏｌ．１４， Ｎｏ．１, 2014, ｐ．２１-２９",ACTIVE
206,WO,A2,WO 1997/017591 A2,164-288-509-502-701,1997-05-15,1997,GB 9602781 W,1996-11-11,GB 9522949 A,1995-11-09,ULTRASONIC MONITORING TECHNIQUE FOR CONTAINERS AND APPARATUS TO CARRY IT OUT,"The invention provides an apparatus and method for fill level monitoring in which the height of contents in a container (10) is monitored. The apparatus comprises an ultrasound receiver (30) and signal processing means (50-56) adapted to receive signals from the receiver, the arrangement being such that the signal processing means (50-56) identifies a first signal (32), in use, which is representative of a wavefront (26) transmitted through the contents of the container (10) independently of the height of the contents in the container (10), and a second signal (34) that is representative of a wavefront (24) that is reflected from the interface (22) between the surface of the contents in the container (10) and the environment above the contents, and in which the signal processing means (50-56) uses the difference in travel time for the two wavefronts (24, 26) to provide a measurement of the level of the contents in the container (10). A plasma generation system comprising a pulsed laser (99) and a target (101) in front of the container (102) is also disclosed, the plasma (103) creating ultrasound in the container (102).",M & A PACKAGING SERV LTD;;UNIV WARWICK;;COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/164-288-509-502-701,Patent Application,no,0,2,7,7,0,B67C3/284;;B67C3/284;;G01F23/2962;;G01F23/2962;;G01F23/2968;;G01F23/2968;;G01N29/2418;;G01N29/2418;;G01N2291/011;;G01N2291/011;;G01N2291/02836;;G01N2291/02836;;G01N2291/02854;;G01N2291/02854;;G01N2291/0421;;G01N2291/0421;;G01N2291/0422;;G01N2291/0422;;G01N2291/048;;G01N2291/048;;G01N2291/102;;G01N2291/102,B67C3/28;;G01F23/296;;G01N29/24,,0,0,,,,PENDING
207,CA,A1,CA 2237270 A1,079-677-669-498-973,1997-05-15,1997,CA 2237270 A,1996-11-11,GB 9522949 A,1995-11-09,ULTRASONIC MONITORING TECHNIQUE FOR CONTAINERS AND APPARATUS TO CARRY IT OUT,"The invention provides an apparatus and method for fill level monitoring in which the height of contents in a container (10) is monitored. The apparatus comprises an ultrasound receiver (30) and signal processing means (50-56) adapted to receive signals from the receiver, the arrangement being such that the signal processing means (50-56) identifies a first signal (32), in use, which is representative of a wavefront (26) transmitted through the contents of the container (10) independently of the height of the contents in the container (10), and a second signal (34) that is representative of a wavefront (24) that is reflected from the interface (22) between the surface of the contents in the container (10) and the environment above the contents, and in which the signal processing means (50-56) uses the difference in travel time for the two wavefronts (24, 26) to provide a measurement of the level of the contents in the container (10). A plasma generation system comprising a pulsed laser (99) and a target (101) in front of the container (102) is also disclosed, the plasma (103) creating ultrasound in the container (102).",M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;PALMER STUART BEAUMONT;;EDWARDS CHRISTOPHER,,https://lens.org/079-677-669-498-973,Patent Application,no,0,0,7,7,0,B67C3/284;;B67C3/284;;G01F23/2962;;G01F23/2962;;G01F23/2968;;G01F23/2968;;G01N29/2418;;G01N29/2418;;G01N2291/011;;G01N2291/011;;G01N2291/02836;;G01N2291/02836;;G01N2291/02854;;G01N2291/02854;;G01N2291/0421;;G01N2291/0421;;G01N2291/0422;;G01N2291/0422;;G01N2291/048;;G01N2291/048;;G01N2291/102;;G01N2291/102,B67C3/28;;G01F23/296;;G01N29/24,,0,0,,,,DISCONTINUED
208,CA,A1,CA 2205005 A1,155-284-781-773-071,1996-05-23,1996,CA 2205005 A,1995-11-09,GB 9422801 A;;GB 9422800 A,1994-11-11,NON-MECHANICAL CONTACT ULTRASOUND SYSTEM FOR MONITORING CONTENTS OF A MOVING CONTAINER,"A non-contact apparatus for monitoring the contents of a container, especially but not exclusively for quality control monitoring purposes associated with high speed packaging processes, comprises non-contact ultrasound generation means, adapted so as to generate an ultrasound signal within the container (1). A non-contact detection scheme is employed to enable the contents of the container to be monitored by analysing ultrasound signals that have propagated through or round the container (1) either transmitted through or reflected from the containers contents. In use, the apparatus may be adapted to provide information about container fill level (h) or the presence or absence of an insert (14) such as a head forming device by analysing the measured signal profiles generated by the ultrasound detection means (3).",UNIV WARWICK;;M & A PACKAGING SERV LTD,DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;COLLINS ANDREW PETER;;PALMER STUART BEAUMONT,,https://lens.org/155-284-781-773-071,Patent Application,no,0,0,6,9,0,B65B57/18;;G01N29/2418;;G01N29/2412;;G01N29/4436;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695,B65B57/18;;G01N29/24,,0,0,,,,DISCONTINUED
209,WO,A1,WO 1996/014943 A1,058-838-907-572-474,1996-05-23,1996,GB 9502630 W,1995-11-09,GB 9422800 A;;GB 9422801 A,1994-11-11,NON-MECHANICAL CONTACT ULTRASOUND SYSTEM FOR MONITORING CONTENTS OF A MOVING CONTAINER,"A non-contact apparatus for monitoring the contents of a container, especially but not exclusively for quality control monitoring purposes associated with high speed packaging processes, comprises non-contact ultrasound generation means, adapted so as to generate an ultrasound signal within the container (1). A non-contact detection scheme is employed to enable the contents of the container to be monitored by analysing ultrasound signals that have propagated through or round the container (1) either transmitted through or reflected from the containers contents. In use, the apparatus may be adapted to provide information about container fill level (h) or the presence or absence of an insert (14) such as a head forming device by analysing the measured signal profiles generated by the ultrasound detection means (3).",M & A PACKAGING SERV LTD;;UNIV WARWICK;;COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/058-838-907-572-474,Patent Application,yes,7,5,6,9,0,B65B57/18;;G01N29/2418;;G01N29/2412;;G01N29/4436;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695,B65B57/18;;G01N29/24,,0,0,,,,PATENTED
210,EP,B1,EP 0790865 B1,058-219-080-905-898,2001-03-14,2001,EP 95936648 A,1995-11-09,GB 9502630 W;;GB 9422800 A;;GB 9422801 A,1994-11-11,NON-MECHANICAL CONTACT ULTRASOUND SYSTEM FOR MONITORING CONTENTS OF A MOVING CONTAINER,,M & A PACKAGING SERVICES LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/058-219-080-905-898,Granted Patent,yes,7,0,6,9,0,B65B57/18;;G01N29/2418;;G01N29/2412;;G01N29/4436;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695,B65B57/18;;G01N29/24,,0,0,,,,EXPIRED
211,US,A1,US 2023/0061419 A1,164-804-118-902-394,2023-03-02,2023,US 202117538939 A,2021-11-30,US 202117538939 A;;US 202163239349 P,2021-08-31,Debug Trace of Cache Memory Requests,"An apparatus includes a plurality of processor circuits, a cache memory circuit, and a trace control circuit. The trace control circuit may be configured, in response to activation of a mode to record information indicative of program execution of at least one processor circuit of the plurality of processor circuits, to monitor memory requests transmitted between ones of the plurality of processor circuits and the cache memory circuit, and then to select a particular memory request of monitored memory requests using an arbitration algorithm. The trace control circuit may be further configured to allocate space in a trace buffer to the particular memory request, and to store, in the trace buffer, information associated with the particular memory request.",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUPTA SANDEEP;;POTNURU KRISHNA C;;KNOTH MATTHIAS,APPLE INC (2021-11-30),https://lens.org/164-804-118-902-394,Patent Application,yes,11,0,3,3,0,G06F11/3648;;G06F12/0895;;G06F11/348;;G06F2212/1008;;G06F11/3037;;G06F12/0223,G06F11/34;;G06F11/30;;G06F12/02,,0,0,,,,ACTIVE
212,AU,A,AU 1995/038504 A,006-282-423-172-485,1996-06-06,1996,AU 1995/038504 A,1995-11-09,GB 9422800 A;;GB 9422801 A;;GB 9502630 W,1994-11-11,Non-mechanical contact ultrasound system for monitoring contents of a moving container,,M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/006-282-423-172-485,Patent Application,no,0,0,6,9,0,B65B57/18;;G01N29/2418;;G01N29/2412;;G01N29/4436;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695,B65B57/18;;G01N29/24,,0,0,,,,PENDING
213,EP,A1,EP 0790865 A1,028-900-154-082-142,1997-08-27,1997,EP 95936648 A,1995-11-09,GB 9502630 W;;GB 9422800 A;;GB 9422801 A,1994-11-11,NON-MECHANICAL CONTACT ULTRASOUND SYSTEM FOR MONITORING CONTENTS OF A MOVING CONTAINER,,M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/028-900-154-082-142,Patent Application,yes,0,0,6,9,0,B65B57/18;;G01N29/2418;;G01N29/2412;;G01N29/4436;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695,B65B57/18;;G01N29/24,,1,0,,,See references of WO 9614943A1,EXPIRED
214,US,A,US 5929337 A,044-308-467-295-445,1999-07-27,1999,US 85424497 A,1997-05-09,GB 9422800 A;;GB 9422801 A;;GB 9502630 W,1994-11-11,Non-mechanical contact ultrasound system for monitoring contents of a moving container,"A non-contact apparatus for monitoring the contents of a container, especially but not exclusively for quality control monitoring purposes associated with high speed packaging processes, comprises a non-contact ultrasound generation member, adapted so as to generate an ultrasound signal within the container (1). A non-contact detection scheme is employed to enable the contents of the container to be monitored by analysing ultrasound signals that have propagated through or round the container (1) either transmitted through or reflected from the containers contents. In use, the apparatus may be adapted to provide information about container fill level (h) or the presence or absence of an insert (14) such as a head forming device by analysing the measured signal profiles generated by a ultrasound detection member (3).",M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,M & A PACKAGING SERVICES LIMITED (1997-05-19);;UNIVERSITY OF WARWICK THE (1997-05-19),https://lens.org/044-308-467-295-445,Granted Patent,yes,14,54,1,9,0,B65B57/00;;G01N29/2412;;G01N29/2418;;G01N2291/0421;;G01N2291/0422;;G01N2291/2695;;G01N29/2418;;B65B57/00;;G01N2291/2695;;G01N2291/0422;;G01N2291/0421;;G01N29/2412,B65B57/00;;G01N29/24,73/597;;209/590;;73/602;;73/643;;73/628;;73/629,0,0,,,,EXPIRED
215,US,A1,US 2023/0418724 A1,144-604-379-511-98X,2023-12-28,2023,US 202318344170 A,2023-06-29,US 202318344170 A;;US 202117538939 A;;US 202163239349 P,2021-08-31,Debug Trace of Cache Memory Requests,"An apparatus includes a plurality of processor circuits, a cache memory circuit, and a trace control circuit. The trace control circuit may be configured, in response to activation of a mode to record information indicative of program execution of at least one processor circuit of the plurality of processor circuits, to monitor memory requests transmitted between ones of the plurality of processor circuits and the cache memory circuit, and then to select a particular memory request of monitored memory requests using an arbitration algorithm. The trace control circuit may be further configured to allocate space in a trace buffer to the particular memory request, and to store, in the trace buffer, information associated with the particular memory request.",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUPTA SANDEEP;;POTNURU KRISHNA C;;KNOTH MATTHIAS,,https://lens.org/144-604-379-511-98X,Patent Application,yes,0,0,3,3,0,G06F11/3648;;G06F12/0895;;G06F11/348;;G06F2212/1008;;G06F11/3037;;G06F12/0223,G06F11/34;;G06F11/30;;G06F12/02,,0,0,,,,PENDING
216,US,A1,US 2020/0272467 A1,144-656-512-957-513,2020-08-27,2020,US 201916286213 A,2019-02-26,US 201916286213 A,2019-02-26,Coprocessor with Distributed Register,"In an embodiment, a coprocessor includes multiple processing elements arranged in a grid of one or more rows and one or more columns. A given processing element includes an arithmetic/logic unit (ALU) circuit configured to perform an ALU operation specified by an instruction executable by the coprocessor, wherein the ALU circuit is configured to produce a result. The given processing element further comprises a first memory coupled to the execute circuit. The first memory is configured to store results generated by the given processing element. The first memory includes a portion of a result memory implemented by the coprocessor, wherein locations in the result memory are specifiable as destination operands of instructions executable by the coprocessor. The portion of the result memory implemented by the first memory is the portion of the result memory that the given processing element is capable of updating.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;DUGGAL DEEPANKAR;;CHACHICK RAN A,APPLE INC (2019-02-25),https://lens.org/144-656-512-957-513,Patent Application,yes,5,4,2,2,0,G06F12/0811;;G06F12/0813;;G06F9/3877;;G06F9/3887;;G06F9/30036;;G06F9/3001;;G06F9/3838;;Y02D10/00;;G06F9/345;;G06F9/3824;;G06F9/3838;;G06F12/0802;;G06F9/30043;;G06F9/3877;;G06F9/4881;;G06F9/3001,G06F9/345;;G06F9/30;;G06F9/38,,0,0,,,,ACTIVE
217,US,B2,US 11740993 B2,157-891-727-798-371,2023-08-29,2023,US 202117538939 A,2021-11-30,US 202117538939 A;;US 202163239349 P,2021-08-31,Debug trace of cache memory requests,"An apparatus includes a plurality of processor circuits, a cache memory circuit, and a trace control circuit. The trace control circuit may be configured, in response to activation of a mode to record information indicative of program execution of at least one processor circuit of the plurality of processor circuits, to monitor memory requests transmitted between ones of the plurality of processor circuits and the cache memory circuit, and then to select a particular memory request of monitored memory requests using an arbitration algorithm. The trace control circuit may be further configured to allocate space in a trace buffer to the particular memory request, and to store, in the trace buffer, information associated with the particular memory request.",APPLE INC,BEAUMONT-SMITH ANDREW J;;GUPTA SANDEEP;;POTNURU KRISHNA C;;KNOTH MATTHIAS,APPLE INC (2021-11-30),https://lens.org/157-891-727-798-371,Granted Patent,yes,14,0,3,3,0,G06F11/3648;;G06F12/0895;;G06F11/348;;G06F2212/1008;;G06F11/3037;;G06F12/0223,G06F12/00;;G06F11/30;;G06F11/34;;G06F12/02,,0,0,,,,ACTIVE
218,EP,A2,EP 0859945 A2,095-194-993-581-473,1998-08-26,1998,EP 96938337 A,1996-11-11,GB 9602781 W;;GB 9522949 A,1995-11-09,ULTRASONIC MONITORING TECHNIQUE FOR CONTAINERS AND APPARATUS TO CARRY IT OUT,,M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/095-194-993-581-473,Patent Application,yes,0,0,7,7,0,B67C3/284;;B67C3/284;;G01F23/2962;;G01F23/2962;;G01F23/2968;;G01F23/2968;;G01N29/2418;;G01N29/2418;;G01N2291/011;;G01N2291/011;;G01N2291/02836;;G01N2291/02836;;G01N2291/02854;;G01N2291/02854;;G01N2291/0421;;G01N2291/0421;;G01N2291/0422;;G01N2291/0422;;G01N2291/048;;G01N2291/048;;G01N2291/102;;G01N2291/102,B67C3/28;;G01F23/296;;G01N29/24,,1,0,,,See references of WO 9717591A3,DISCONTINUED
219,WO,A3,WO 1997/017591 A3,056-000-278-634-000,1997-07-31,1997,GB 9602781 W,1996-11-11,GB 9522949 A,1995-11-09,ULTRASONIC MONITORING TECHNIQUE FOR CONTAINERS AND APPARATUS TO CARRY IT OUT,"The invention provides an apparatus and method for fill level monitoring in which the height of contents in a container (10) is monitored. The apparatus comprises an ultrasound receiver (30) and signal processing means (50-56) adapted to receive signals from the receiver, the arrangement being such that the signal processing means (50-56) identifies a first signal (32), in use, which is representative of a wavefront (26) transmitted through the contents of the container (10) independently of the height of the contents in the container (10), and a second signal (34) that is representative of a wavefront (24) that is reflected from the interface (22) between the surface of the contents in the container (10) and the environment above the contents, and in which the signal processing means (50-56) uses the difference in travel time for the two wavefronts (24, 26) to provide a measurement of the level of the contents in the container (10). A plasma generation system comprising a pulsed laser (99) and a target (101) in front of the container (102) is also disclosed, the plasma (103) creating ultrasound in the container (102).",M & A PACKAGING SERV LTD;;UNIV WARWICK;;COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/056-000-278-634-000,Search Report,yes,6,0,7,7,0,B67C3/284;;B67C3/284;;G01F23/2962;;G01F23/2962;;G01F23/2968;;G01F23/2968;;G01N29/2418;;G01N29/2418;;G01N2291/011;;G01N2291/011;;G01N2291/02836;;G01N2291/02836;;G01N2291/02854;;G01N2291/02854;;G01N2291/0421;;G01N2291/0421;;G01N2291/0422;;G01N2291/0422;;G01N2291/048;;G01N2291/048;;G01N2291/102;;G01N2291/102,B67C3/28;;G01F23/296;;G01N29/24,,1,1,012-483-258-321-253,10.1016/0041-624x(91)90025-4,"HUTCHINS ET AL: ""Non-contact ultrasonic inspection of diffusion bonds in titanium"", ULTRASONICS, no. 4, 29 July 1991 (1991-07-29), GUILFORD, SURREY, GB, pages 294 - 301, XP000208296",PENDING
220,US,B2,US 10846091 B2,149-345-241-683-007,2020-11-24,2020,US 201916286213 A,2019-02-26,US 201916286213 A,2019-02-26,Coprocessor with distributed register,"In an embodiment, a coprocessor includes multiple processing elements arranged in a grid of one or more rows and one or more columns. A given processing element includes an arithmetic/logic unit (ALU) circuit configured to perform an ALU operation specified by an instruction executable by the coprocessor, wherein the ALU circuit is configured to produce a result. The given processing element further comprises a first memory coupled to the execute circuit. The first memory is configured to store results generated by the given processing element. The first memory includes a portion of a result memory implemented by the coprocessor, wherein locations in the result memory are specifiable as destination operands of instructions executable by the coprocessor. The portion of the result memory implemented by the first memory is the portion of the result memory that the given processing element is capable of updating.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;DUGGAL DEEPANKAR;;CHACHICK RAN A,APPLE INC (2019-02-25),https://lens.org/149-345-241-683-007,Granted Patent,yes,7,0,2,2,0,G06F9/345;;G06F9/3877;;G06F9/3001;;G06F9/3001;;G06F9/30036;;G06F9/30043;;G06F9/3824;;G06F9/3838;;G06F9/3838;;G06F9/3877;;G06F9/3887;;G06F9/4881;;G06F12/0802;;G06F12/0811;;G06F12/0813;;Y02D10/00,G06F9/345;;G06F9/30;;G06F9/38;;G06F9/48;;G06F12/0802,,0,0,,,,ACTIVE
221,AU,A,AU 1996/075795 A,163-134-020-311-813,1997-05-29,1997,AU 1996/075795 A,1996-11-11,GB 9522949 A;;GB 9602781 W,1995-11-09,Ultrasonic monitoring technique for containers and apparatus to carry it out,,M & A PACKAGING SERV LTD;;UNIV WARWICK,COLLINS ANDREW PETER;;DIXON STEVEN MARK;;EDWARDS CHRISTOPHER;;PALMER STUART BEAUMONT,,https://lens.org/163-134-020-311-813,Patent Application,no,0,0,7,7,0,B67C3/284;;B67C3/284;;G01F23/2962;;G01F23/2962;;G01F23/2968;;G01F23/2968;;G01N29/2418;;G01N29/2418;;G01N2291/011;;G01N2291/011;;G01N2291/02836;;G01N2291/02836;;G01N2291/02854;;G01N2291/02854;;G01N2291/0421;;G01N2291/0421;;G01N2291/0422;;G01N2291/0422;;G01N2291/048;;G01N2291/048;;G01N2291/102;;G01N2291/102,B67C3/28;;G01F23/296;;G01N29/24,,0,0,,,,PENDING
222,EP,A1,EP 0375811 A1,136-489-368-298-30X,1990-07-04,1990,EP 88312134 A,1988-12-21,EP 88312134 A,1988-12-21,Inflatable flotation assembly.,"An inflatable flotation assembly includes a compressed gas cylinder (10) stored inside a split housing the parts (12,13) of which are held together by a releasable pivot (15) on one end and an interlocked pivoted arm at the other end which engages a flexible tab (17) aligned against the gas cylinder. The arm (43) overlies the housing to engage the releasable pivot and when unclasped from this engagement will rotate to pierce the cylinder (10) by deflecting the tab (17). Thereafter the expansion of a flotation bladder separates the housing while the arm remains interlocked to the tab to control the rate of gas release into the bladder by the angular inertia of the arm around its pivot.  ",RAMSAY ENGINEERING PTY LIMITED,BEAUMONT NICHOLAS GEORGE;;ANDERSON MALCOLM DONALD;;BROWN PAUL RUSSELL;;HADFIELD DONALD ANDREW,,https://lens.org/136-489-368-298-30X,Patent Application,yes,3,4,1,1,0,B63C9/23;;B63C9/08,B63C9/08;;B63C9/19;;B63C9/23,,0,0,,,,DISCONTINUED
223,US,B2,US 11650825 B2,151-846-889-765-571,2023-05-16,2023,US 202217668869 A,2022-02-10,US 202217668869 A;;US 202017077654 A;;US 202063077813 P,2020-09-14,Coprocessor synchronizing instruction suppression,"An instruction set architecture including instructions for a processor and instructions for a coprocessor may include synchronizing instructions that may be used to begin and end instruction sequences that include coprocessor instructions (coprocessor sequences). If a terminating synchronizing instruction is followed by an initial synchronizing instruction and the pair are detected in the coprocessor concurrently, the coprocessor may suppress execution of the pair of instructions.",APPLE INC,KESIRAJU ADITYA;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;BEAUMONT-SMITH ANDREW J,,https://lens.org/151-846-889-765-571,Granted Patent,yes,17,0,3,3,0,G06F9/30087;;G06F9/3877;;Y02D10/00;;G06F9/3877;;G06F9/3838;;G06F9/30087,G06F9/38;;G06F9/30,,0,0,,,,ACTIVE
224,US,A1,US 2023/0095072 A1,197-510-675-476-600,2023-03-30,2023,US 202117644016 A,2021-12-13,US 202117644016 A;;US 202163248239 P,2021-09-24,Coprocessor Register Renaming,"A coprocessor with register renaming is disclosed. An apparatus includes a plurality of processors and a coprocessor respectively configured to execute processor instructions and coprocessor instructions. The coprocessor receives coprocessor instructions from ones of the processors. The coprocessor includes an array of processing elements and a result register set comprising storage elements respectively distributed within the array of processing elements. For a given member of the array of processing elements, a corresponding storage element is configured to store coprocessor instruction results generated by the given member. The result register set implements a plurality of contexts to store respective coprocessor states corresponding to coprocessor instructions received from different processors. Based on a determination that one of the contexts is inactive, the coprocessor is configured to store coprocessor instruction results corresponding to an active context within storage elements of the result register set corresponding to the inactive context.",APPLE INC,CHACHICK RAN AHARON;;KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LEE JONG-SUK,APPLE INC (2021-12-07),https://lens.org/197-510-675-476-600,Patent Application,yes,8,0,3,3,0,G06F9/30123;;G06F9/3877;;G06F9/3001;;G06F9/30043;;G06F9/384;;Y02D10/00;;G06F9/30123;;G06F15/80;;G06F9/3877;;G06F9/384;;G06F9/3009,G06F9/30;;G06F9/38;;G06F15/80,,0,0,,,,ACTIVE
225,US,B2,US 11429555 B2,038-724-174-612-342,2022-08-30,2022,US 201916286170 A,2019-02-26,US 201916286170 A,2019-02-26,"Coprocessors with bypass optimization, variable grid architecture, and fused vector operations","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;BALASUBRAMANIAN SRIKANTH,APPLE INC (2019-02-25),https://lens.org/038-724-174-612-342,Granted Patent,yes,16,2,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F15/00;;G06F7/544;;G06F7/57;;G06F9/38;;G06F15/76;;G06F15/80,,4,1,055-752-709-506-314,10.1109/icces.2007.4447064,"MOSTAFA I. SOLIMAN: ""Mat-core: A matrix core extension for general-purpose processors"", COMPUTER ENGINEERING&SYSTEMS, 2007. ICCES '07. INTERNATIONAL CONFERENCE ON, IEEE, PI, 1 November 2007 (2007-11-01), Pi , pages 304 - 310, XP031212365, ISBN: 978-1-4244-1365-2;;ISRWO, PCT/US2020/019389, mailed Jun. 9, 2020, 14 pages.;;IPRP, PCT/US2020/019389, mailed Sep. 10, 2021, 8 pages.;;Examination Report; Indian Application No. 202117035971, dated Mar. 9, 2022, 6 pages.",ACTIVE
226,US,A1,US 2022/0214887 A1,060-497-822-077-385,2022-07-07,2022,US 202217668869 A,2022-02-10,US 202217668869 A;;US 202017077654 A;;US 202063077813 P,2020-09-14,Coprocessor Synchronizing Instruction Suppression,"An instruction set architecture including instructions for a processor and instructions for a coprocessor may include synchronizing instructions that may be used to begin and end instruction sequences that include coprocessor instructions (coprocessor sequences). If a terminating synchronizing instruction is followed by an initial synchronizing instruction and the pair are detected in the coprocessor concurrently, the coprocessor may suppress execution of the pair of instructions.",APPLE INC,KESIRAJU ADITYA;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;BEAUMONT-SMITH ANDREW J,,https://lens.org/060-497-822-077-385,Patent Application,yes,1,1,3,3,0,G06F9/30087;;G06F9/3877;;Y02D10/00;;G06F9/3877;;G06F9/3838;;G06F9/30087,G06F9/38;;G06F9/30,,0,0,,,,ACTIVE
227,US,B1,US 11249766 B1,091-290-191-332-322,2022-02-15,2022,US 202017077654 A,2020-10-22,US 202017077654 A;;US 202063077813 P,2020-09-14,Coprocessor synchronizing instruction suppression,"An instruction set architecture including instructions for a processor and instructions for a coprocessor may include synchronizing instructions that may be used to begin and end instruction sequences that include coprocessor instructions (coprocessor sequences). If a terminating synchronizing instruction is followed by an initial synchronizing instruction and the pair are detected in the coprocessor concurrently, the coprocessor may suppress execution of the pair of instructions.",APPLE INC,KESIRAJU ADITYA;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;BEAUMONT-SMITH ANDREW J,APPLE INC (2020-10-21),https://lens.org/091-290-191-332-322,Granted Patent,yes,15,3,3,3,0,G06F9/30087;;G06F9/3877;;Y02D10/00;;G06F9/3877;;G06F9/3838;;G06F9/30087,G06F9/38;;G06F9/30,,0,0,,,,ACTIVE
228,US,A1,US 2024/0045680 A1,018-547-145-644-513,2024-02-08,2024,US 202318453010 A,2023-08-21,US 202318453010 A;;US 202117644016 A;;US 202163248239 P,2021-09-24,Coprocessor Register Renaming,"A coprocessor with register renaming is disclosed. An apparatus includes a plurality of processors and a coprocessor respectively configured to execute processor instructions and coprocessor instructions. The coprocessor receives coprocessor instructions from ones of the processors. The coprocessor includes an array of processing elements and a result register set comprising storage elements respectively distributed within the array of processing elements. For a given member of the array of processing elements, a corresponding storage element is configured to store coprocessor instruction results generated by the given member. The result register set implements a plurality of contexts to store respective coprocessor states corresponding to coprocessor instructions received from different processors. Based on a determination that one of the contexts is inactive, the coprocessor is configured to store coprocessor instruction results corresponding to an active context within storage elements of the result register set corresponding to the inactive context.",APPLE INC,CHACHICK RAN AHARON;;KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LEE JONG-SUK,,https://lens.org/018-547-145-644-513,Patent Application,yes,0,0,3,3,0,G06F9/30123;;G06F9/3877;;G06F9/3001;;G06F9/30043;;G06F9/384;;Y02D10/00;;G06F9/30123;;G06F15/80;;G06F9/3877;;G06F9/384;;G06F9/3009,G06F9/30;;G06F9/38;;G06F15/80,,0,0,,,,PENDING
229,US,B2,US 11775301 B2,128-042-913-114-385,2023-10-03,2023,US 202117644016 A,2021-12-13,US 202117644016 A;;US 202163248239 P,2021-09-24,Coprocessor register renaming using registers associated with an inactive context to store results from an active context,"A coprocessor with register renaming is disclosed. An apparatus includes a plurality of processors and a coprocessor respectively configured to execute processor instructions and coprocessor instructions. The coprocessor receives coprocessor instructions from ones of the processors. The coprocessor includes an array of processing elements and a result register set comprising storage elements respectively distributed within the array of processing elements. For a given member of the array of processing elements, a corresponding storage element is configured to store coprocessor instruction results generated by the given member. The result register set implements a plurality of contexts to store respective coprocessor states corresponding to coprocessor instructions received from different processors. Based on a determination that one of the contexts is inactive, the coprocessor is configured to store coprocessor instruction results corresponding to an active context within storage elements of the result register set corresponding to the inactive context.",APPLE INC,CHACHICK RAN AHARON;;KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LEE JONG-SUK,APPLE INC (2021-12-07),https://lens.org/128-042-913-114-385,Granted Patent,yes,11,0,3,3,0,G06F9/30123;;G06F9/3877;;G06F9/3001;;G06F9/30043;;G06F9/384;;Y02D10/00;;G06F9/30123;;G06F15/80;;G06F9/3877;;G06F9/384;;G06F9/3009,G06F9/30;;G06F9/38;;G06F9/50;;G06F15/80,,0,0,,,,ACTIVE
230,US,A1,US 2022/0350776 A1,006-338-013-409-072,2022-11-03,2022,US 202217869617 A,2022-07-20,US 202217869617 A;;US 201916286170 A,2019-02-26,"Coprocessors with Bypass Optimization, Variable Grid Architecture, and Fused Vector Operations","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;CHACHICK RAN A,,https://lens.org/006-338-013-409-072,Patent Application,yes,3,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F15/80;;G06F7/544;;G06F7/57;;G06F9/38,,0,0,,,,PENDING
231,WO,A1,WO 2011/128703 A1,170-575-944-014-082,2011-10-20,2011,GB 2011050756 W,2011-04-15,GB 201008414 A;;US 32784310 P;;GB 201006312 A,2010-04-15,ION MOBILITY METHOD AND APPARATUS FOR IDENTIFYING AND/OR CHARACTERISING A SAMPLE COMPOUND,"A method of and apparatus for identifying and/or characterising a sample that may incorporate two or more isomeric or isobaric compounds such as hydroxylated metabolites. The method involves modelling an ensemble of possible structures for each of two or more known isomeric or isobaric compounds, calculating a theoretical collision cross-section for each modelled structure, averaging the calculated values for each known compound to provide a theoretical collision cross-section value for each known compound. A travelling wave ion mobility cell is used to measuring a collision cross-section value for the sample compound and the measured value is then compared with the theoretical values to identify which of the two or more known compounds the sample compound most closely resembles.",MICROMASS LTD;;CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOS,CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOS,,https://lens.org/170-575-944-014-082,Patent Application,yes,3,13,4,6,0,G16C20/20;;G16C10/00;;G01N27/623;;G16C10/00;;G16C20/20;;G01N27/623;;G01N27/64;;H01J49/0036,G06F19/00;;G01N27/64;;G06K9/00,,3,2,090-498-855-350-862;;029-223-638-732-392,10.1016/j.ijms.2009.09.011;;17512751;;10.1016/j.jasms.2007.04.003,"KNAPMAN T W ET AL: ""Considerations in experimental and theoretical collision cross-section measurements of small molecules using travelling wave ion mobility spectrometry-mass spectrometry"", INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 298, no. 1-3, 4 October 2009 (2009-10-04), pages 17 - 23, XP027492678, ISSN: 1387-3806, [retrieved on 20091004], DOI: DOI:10.1016/J.IJMS.2009.09.011;;TAO ET AL: ""A Collision Cross-Section Database of Singly-Charged Peptide Ions"", JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, ELSEVIER SCIENCE INC, US, vol. 18, no. 7, 26 June 2007 (2007-06-26), pages 1232 - 1238, XP022131654, ISSN: 1044-0305, DOI: DOI:10.1016/J.JASMS.2007.04.003;;HILL, ANAL CHEM, 2000",PENDING
232,DE,D1,DE 69604431 D1,186-021-379-018-502,1999-11-04,1999,DE 69604431 T,1996-02-07,GB 9503222 A,1995-02-18,Kindersicherheitssitz,,BRITAX EXCELSIOR;;BRITAX ROEMER KINDERSICHERHEIT GMBH,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,,https://lens.org/186-021-379-018-502,Granted Patent,no,0,0,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
233,EP,A3,EP 0732235 A3,195-553-502-907-588,1997-05-02,1997,EP 96300840 A,1996-02-07,GB 9503222 A,1995-02-18,Child safety seat,A child safety seat for use in a vehicle comprises a seat body (10) having a seat portion (14) and a backrest portion (16). Guides (52) on the seat body (10) define a strap path for a strap (50) of a vehicle seat belt which secures the seat body (10) to a vehicle seat. A strap deflecting lever (62) is movable between a first position clear of said strap path and a second position in which the strap (50) is deflected and thus tightened.,BRITAX ROEMER KINDERSICHERHEIT GMBH;;BRITAX EXCELSIOR,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,BRITAX EXCELSIOR LIMITED (1997-08-20);;BRITAX ROEMER KINDERSICHERHEIT GMBH (1997-08-20),https://lens.org/195-553-502-907-588,Search Report,yes,5,0,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
234,EP,B1,EP 2558850 B1,086-738-450-437-041,2017-03-08,2017,EP 11724438 A,2011-04-15,GB 201008414 A;;US 32784310 P;;GB 201006312 A;;GB 2011050756 W,2010-04-15,ION MOBILITY METHOD AND APPARATUS FOR IDENTIFYING A SAMPLE COMPOUND,,MICROMASS LTD,CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOS,MICROMASS UK LIMITED (2014-03-26),https://lens.org/086-738-450-437-041,Granted Patent,yes,1,1,4,6,0,G16C20/20;;G16C10/00;;G01N27/623;;G16C10/00;;G16C20/20;;G01N27/623;;G01N27/64;;H01J49/0036,G01N27/62;;G06F19/00;;G06K9/00,,2,0,,,"KNAPMAN T W ET AL: ""Considerations in experimental and theoretical collision cross-section measurements of small molecules using travelling wave ion mobility spectrometry-mass spectrometry"", INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 298, no. 1-3, 4 October 2009 (2009-10-04), pages 17-23, XP027492678, ISSN: 1387-3806, DOI: DOI:10.1016/J.IJMS.2009.09.011 [retrieved on 2009-10-04];;TAO ET AL: ""A Collision Cross-Section Database of Singly-Charged Peptide Ions"", JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, ELSEVIER SCIENCE INC, US, vol. 18, no. 7, 26 June 2007 (2007-06-26), pages 1232-1238, XP022131654, ISSN: 1044-0305, DOI: DOI:10.1016/J.JASMS.2007.04.003",ACTIVE
235,EP,B1,EP 0732235 B1,144-366-231-834-589,1999-09-29,1999,EP 96300840 A,1996-02-07,GB 9503222 A,1995-02-18,Child safety seat,,BRITAX ROEMER KINDERSICHERHEIT GMBH;;BRITAX EXCELSIOR,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,BRITAX EXCELSIOR LIMITED (1997-08-20);;BRITAX ROEMER KINDERSICHERHEIT GMBH (1997-08-20),https://lens.org/144-366-231-834-589,Granted Patent,yes,5,2,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
236,DE,T2,DE 69604431 T2,035-539-690-172-677,2000-01-20,2000,DE 69604431 T,1996-02-07,GB 9503222 A,1995-02-18,Kindersicherheitssitz,,BRITAX EXCELSIOR;;BRITAX ROEMER KINDERSICHERHEIT GMBH,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,,https://lens.org/035-539-690-172-677,Granted Patent,no,0,7,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
237,EP,A1,EP 2558850 A1,074-956-561-099-428,2013-02-20,2013,EP 11724438 A,2011-04-15,GB 201008414 A;;US 32784310 P;;GB 201006312 A;;GB 2011050756 W,2010-04-15,ION MOBILITY METHOD AND APPARATUS FOR IDENTIFYING A SAMPLE COMPOUND,,MICROMASS LTD,CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOS,MICROMASS UK LIMITED (2014-03-26),https://lens.org/074-956-561-099-428,Patent Application,yes,0,3,4,6,0,G16C20/20;;G16C10/00;;G01N27/623;;G16C10/00;;G16C20/20;;G01N27/623;;G01N27/64;;H01J49/0036,G01N27/62;;G06F19/00;;G06K9/00,,0,0,,,,ACTIVE
238,US,A1,US 2013/0218478 A1,071-389-156-125-533,2013-08-22,2013,US 201113640848 A,2011-04-15,GB 201006312 A;;GB 201008414 A;;GB 2011050756 W,2010-04-15,Method And System Of Identifying A Sample By Analysing A Mass Spectrum By The Use Of A Bayesian Inference Technique,"A method of and apparatus for identifying and/or characterising a sample that may incorporate two or more isomeric or isobaric compounds such as hydroxylated metabolites. The method involves modelling an ensemble of possible structures for each of two or more known isomeric or isobaric compounds, calculating a theoretical collision cross-section for each modelled structure, averaging the calculated values for each known compound to provide a theoretical collision cross-section value for each known compound. A travelling wave ion mobility cell is used to measuring a collision cross-section value for the sample compound and the measured value is then compared with the theoretical values to identify which of the two or more known compounds the sample compound most closely resembles.",CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOZ;;MICROMASS LTD,CAMPUZANO IAIN DAVID GRANT;;DEAR GORDON;;BEAUMONT CLAIRE;;ROBERTS ANDREW;;MURIEDAS JORDI MUNOZ,MICROMASS UK LIMITED (2013-03-05),https://lens.org/071-389-156-125-533,Patent Application,yes,3,9,4,6,0,G16C20/20;;G16C10/00;;G01N27/623;;G16C10/00;;G16C20/20;;G01N27/623;;G01N27/64;;H01J49/0036,G06F19/00;;G01N27/64;;H01J49/00,702/23;;702/27,2,2,090-498-855-350-862;;029-223-638-732-392,10.1016/j.ijms.2009.09.011;;17512751;;10.1016/j.jasms.2007.04.003,"Knapman et al. (Considerations in experimental and theoretical collision cross-section measurements of small molecules using travelling wave ion mobility spectrometry-mass spectrometry, International Journal of Mass Spectrometry, Volume 298, Issues 1-3, Available online 4 October 2009, Pages 17-23).;;Tao et al. (A Collision Cross-Section Database of Singly-Charged Peptide Ions, Journal of the American Society Mass Spectrom 2007, 18, 1232-1238, Published online April 15, 2007, [online], [retrieved on 2007-04-15]. Retrieved from the http://www.chem.tamu.edu/rgroup/russell/Publications_files/PDFs/180.pdf).",DISCONTINUED
239,DE,C5,DE 69604431 C5,051-405-032-660-27X,2005-10-20,2005,DE 69604431 T,1996-02-07,GB 9503222 A,1995-02-18,Kindersicherheitssitz,,BRITAX EXCELSIOR;;BRITAX ROEMER KINDERSICHERHEIT GMBH,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,,https://lens.org/051-405-032-660-27X,Amended Patent,no,0,0,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
240,JP,A,JP 2007106411 A,092-589-035-132-030,2007-04-26,2007,JP 2007004216 A,2007-01-12,GB 9503222 A,1995-02-18,SAFETY SEAT FOR CHILD,"<P>PROBLEM TO BE SOLVED: To prevent non-desirable movement of a seat for a child relative to a vehicle. <P>SOLUTION: The safety seat for the child used for the vehicle is provided with a seat body (10) having a seat part (14) and a back rest part (16). A guide (52) provided on the seat body (10) forms a strap passage for a strap (50) of the seat belt of the vehicle for fixing the seat body (10) to the seat of the vehicle. A strap deflection means (62) becomes movable between a first position left from the strap passage and a second position where the strap (50) is deflected and tensionedly stretched. <P>COPYRIGHT: (C)2007,JPO&INPIT",BRITAX EXCELSIOR;;BRITAX ROEMER KINDERSICHERHEIT GMBH,BARLEY GEOFFREY WILFRED;;BURLEIGH DAVID WILLIAM;;CARINE SHAUN;;BEAUMONT ANDREW P;;WETTER HERMANN,,https://lens.org/092-589-035-132-030,Patent Application,no,0,2,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60R22/10;;B60N2/28;;B60R22/26,,0,0,,,,PENDING
241,EP,A2,EP 0732235 A2,021-559-840-209-261,1996-09-18,1996,EP 96300840 A,1996-02-07,GB 9503222 A,1995-02-18,Child safety seat,A child safety seat for use in a vehicle comprises a seat body (10) having a seat portion (14) and a backrest portion (16). Guides (52) on the seat body (10) define a strap path for a strap (50) of a vehicle seat belt which secures the seat body (10) to a vehicle seat. A strap deflecting lever (62) is movable between a first position clear of said strap path and a second position in which the strap (50) is deflected and thus tightened.,BRITAX ROEMER KINDERSICHERHEIT GMBH;;BRITAX EXCELSIOR,WETTER HERMANN;;BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P,BRITAX EXCELSIOR LIMITED (1997-08-20);;BRITAX ROEMER KINDERSICHERHEIT GMBH (1997-08-20),https://lens.org/021-559-840-209-261,Patent Application,yes,0,39,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,,0,0,,,,EXPIRED
242,US,A,US 5611596 A,192-095-258-905-059,1997-03-18,1997,US 60527196 A,1996-02-06,GB 9503222 A,1995-02-18,Child safety seat,A child safety seat for use in a vehicle comprises a seat body having a seat portion and a backrest portion. Guides on the seat body define a strap path for a strap of an adult seat belt which secures the seat body to a vehicle seat. A strap deflecting lever is movable between a first position clear of said strap path and a second position in which the strap is deflected and thus tightened.,BRITAX EXCELSIOR,BARLEY GEOFFREY W;;BURLEIGH DAVID W;;CARINE SHAUN;;BEAUMONT ANDREW P;;WETTER HERMANN,BRITAZ ROMER KINDERSICHERHEIT GMBH (1996-01-26);;BRITAX-EXCELSIOR LIMITED (1996-01-19),https://lens.org/192-095-258-905-059,Granted Patent,yes,5,75,11,11,0,B60N2/2806;;B60N2/2812;;B60N2/2821;;B60N2/286;;B60N2/2821;;B60N2/286;;B60N2/2806;;B60N2/2812,B60N2/28;;B60R22/10;;B60R22/26,297/256.13;;397/354.12;;397/354.13;;397/363;;397/364;;397/368;;397/369,0,0,,,,EXPIRED
243,GB,A,GB 2621349 A,074-730-802-045-614,2024-02-14,2024,GB 202211605 A,2022-08-09,GB 202211605 A,2022-08-09,An attachment for a hair care appliance,"An attachment for a hair care appliance includes an air inlet (101, fig.4) for receiving an airflow from the hair care appliance, a main body (103, fig.4) arranged to receive the airflow from the air inlet, and a plurality of protrusions 112a-d arranged in a row. At least some of the protrusions are hollow. Each hollow protrusion extends from, and is configured to receive airflow from, the main body. Each hollow protrusion includes an air outlet 114. Each air outlet includes a through-hole 120a-c in a surface of the respective hollow protrusion and is arranged to emit airflow in an emittance direction non-orthogonal to the surface of the hollow protrusion around the through-hole. Each respective air outlet faces a neighbouring protrusion in the row. The attachment may include a plurality of solid protrusions 111a-d which may be arranged interstitially with respect to the hollow protrusions. A portion of the protrusion (1111k, fig 10a) may redirect flow emitted from the air outlets. Preferably, a portion of the protrusion surface (130, fig.4) is free from outlets.",DYSON TECHNOLOGY LTD,ROBERT MARK BRETT COULTON;;RORY WILLIAM BEAUMONT;;MURRAY JOCK MCKENDRICK;;DAVID ANDREW TIBBETTS,,https://lens.org/074-730-802-045-614,Patent Application,no,5,0,3,3,0,A45D20/50;;A45D20/122;;A45D20/12;;A45D20/12;;A45D20/10;;A45D20/50,A45D20/12;;A45D20/10;;A45D20/50,,0,0,,,,PENDING
244,WO,A1,WO 2021/248189 A1,147-365-277-118-97X,2021-12-16,2021,AU 2021/050582 W,2021-06-09,AU 2020/901895 A,2020-06-09,COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN PRECANCER,"The present invention relates, inter alia, to a method of preventing or treating skin cancer or skin precancer, the method comprising locally administering to the skin of a subject in need thereof an effective amount of a compound of Formula (I) or a prodrug thereof, Formula (I) wherein the subject is being administered an immunosuppressant agent that binds to FKBP12. The agent that binds to FKBP12 may be tacrolimus. The invention also relates to methods of preventing or treating a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12, and to uses of the compound of Formula (I) in treating skin cancer or skin precancer, or a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12.",UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE-ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,,https://lens.org/147-365-277-118-97X,Patent Application,yes,5,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/436;;A61K9/00;;A61K9/06;;A61P17/00;;A61P35/00,,1,1,020-232-030-066-763,pmc4294972;;10.1111/php.12318;;25039758,"MING MEI, ZHAO BAOZHONG, QIANG LEI, HE YU-YING: ""Effect of Immunosuppressants Tacrolimus and Mycophenolate Mofetil on the Keratinocyte UVB Response"", PHOTOCHEMISTRY AND PHOTOBIOLOGY, WILEY-BLACKWELL PUBLISHING, INC., US, vol. 91, no. 1, 1 January 2015 (2015-01-01), US , pages 242 - 247, XP055883491, ISSN: 0031-8655, DOI: 10.1111/php.12318",PENDING
245,KR,A,KR 20230022957 A,020-112-449-996-672,2023-02-16,2023,KR 20237000365 A,2021-06-09,AU 2020/901895 A;;AU 2021/050582 W,2020-06-09,피부암 또는 피부 전암의 예방 또는 치료를 위한 화합물,"본 발명은 특히 피부암 또는 피부 전암의 예방 또는 치료를 필요로 하는 대상체의 피부에 유효량의 화학식 (I)의 화합물 또는 그의 전구약물을 국부적으로 투여하는 것을 포함하는, 피부암 또는 피부 전암을 예방 또는 치료하는 방법이며, 여기서 대상체는 FKBP12에 결합하는 면역억제제를 투여받고 있는 것인 방법에 관한 것이다. TIFFpct00023.tif5255 FKBP12에 결합하는 작용제는 타크롤리무스일 수 있다. 본 발명은 또한 FKBP12에 결합하는 면역억제제의 투여와 연관된 피부 병태, 장애 또는 질환을 예방 또는 치료하는 방법, 및 피부암 또는 피부 전암, 또는 FKBP12에 결합하는 면역억제제의 투여와 연관된 피부 병태, 장애 또는 질환을 치료하는데 있어서 화학식 (I)의 화합물의 용도에 관한 것이다.",UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,,https://lens.org/020-112-449-996-672,Patent Application,no,0,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/439;;A61K9/00;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18,,0,0,,,,PENDING
246,CA,A1,CA 3180348 A1,151-229-236-114-751,2021-12-16,2021,CA 3180348 A,2021-06-09,AU 2020/901895 A;;AU 2021/050582 W,2020-06-09,COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN PRECANCER,"The present invention relates, inter alia, to a method of preventing or treating skin cancer or skin precancer, the method comprising locally administering to the skin of a subject in need thereof an effective amount of a compound of Formula (I) or a prodrug thereof, Formula (I) wherein the subject is being administered an immunosuppressant agent that binds to FKBP12. The agent that binds to FKBP12 may be tacrolimus. The invention also relates to methods of preventing or treating a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12, and to uses of the compound of Formula (I) in treating skin cancer or skin precancer, or a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12.",UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE-ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,,https://lens.org/151-229-236-114-751,Patent Application,no,0,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/436,,0,0,,,,PENDING
247,GB,A,GB 2567372 A,103-896-975-903-306,2019-04-10,2019,GB 201901910 A,2017-08-24,US 201615264002 A;;US 2017/0048453 W,2016-09-13,Outer product engine,"In an embodiment, an outer product engine is configured to perform outer product operations. The outer product engine may perform numerous multiplication operations in parallel on input vectors, in an embodiment, generating a resulting outer product matrix. In an embodiment, the outer product engine may be configured to accumulate results in a result matrix, performing fused multiply add (FMA) operations to produce the outer product elements (multiply) and to accumulate the outer product elements with previous elements from the result matrix memory (add). A processor may fetch outer product instructions, and may transmit the instructions to the outer product engine when the instructions become non-speculative in an embodiment. The processor may be configured to retire the outer product instructions responsive to transmitting them to the outer product engine.",APPLE INC,ALI SAZEGARI;;ERIC BAINVILLE;;JEFFRY E GONION;;GERARD R WILLIAMS;;ANDREW J BEAUMONT-SMITH,,https://lens.org/103-896-975-903-306,Patent Application,no,3,0,5,5,0,G06F9/30036;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/3001;;G06F9/3001;;G06F9/30036;;G06F9/30043;;G06F9/30101;;G06F9/3802;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/30101;;G06F9/3802;;G06F9/30043;;G06F9/3001;;G06F9/3867;;G06F9/30036;;G06F9/3893;;G06F9/3877,G06F9/30;;G06F9/38,,2,1,055-752-709-506-314,10.1109/icces.2007.4447064,"SHAOLI LIU ET AL, ""Cambricon"", ACM SIGARCH COMPUTER ARCHITECTURE NEWS, ACM SPECIAL INTEREST GROUP ON COMPUTER ARCHITECTURE, 2 PENN PLAZA, SUITE 701 NEW YORK NY 10121-0701 USA, (20160618), vol. 44, no. 3, doi:10.1145/3007787.3001179, ISSN 0163-5964, pages 393 - 405;;MOSTAFA I SOLIMAN ED - ANONYMOUS, ""Mat-core: A matrix core extension for general-purpose processors"", COMPUTER ENGINEERING&SYSTEMS, 2007. ICCES '07. INTERNATIONAL CONFERENCE ON, IEEE, PI, (20071101), ISBN 978-1-4244-1365-2, pages 304 - 310",DISCONTINUED
248,US,A1,US 2023/0218589 A1,001-451-614-414-929,2023-07-13,2023,US 202118009642 A,2021-06-09,AU 2020/901895 A;;AU 2021/050582 W,2020-06-09,COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN PRECANCER,"The present invention relates, inter alia, to a method of preventing or treating skin cancer or skin precancer, the method comprising locally administering to the skin of a subject in need thereof an effective amount of a compound of Formula (I) or a pro-drug thereof, Formula (I) wherein the subject is being administered an immunosuppressant agent that binds to FKBP12. The agent that binds to FKBP12 may be tacrolimus. The invention also relates to methods of preventing or treating a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12, and to uses of the compound of Formula (I) in treating skin cancer or skin precancer, or a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12.",UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE-ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,UNIQUEST PTY LTD (2022-05-12),https://lens.org/001-451-614-414-929,Patent Application,yes,0,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/436;;A61K9/00;;A61P17/00;;A61P35/00,,0,0,,,,PENDING
249,AU,A1,AU 2021/287071 A1,160-060-092-584-580,2023-01-05,2023,AU 2021/287071 A,2021-06-09,AU 2020/901895 A;;AU 2021/050582 W,2020-06-09,Compound for prevention or treatment of a skin cancer or skin precancer,"The present invention relates, inter alia, to a method of preventing or treating skin cancer or skin precancer, the method comprising locally administering to the skin of a subject in need thereof an effective amount of a compound of Formula (I) or a prodrug thereof, Formula (I) wherein the subject is being administered an immunosuppressant agent that binds to FKBP12. The agent that binds to FKBP12 may be tacrolimus. The invention also relates to methods of preventing or treating a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12, and to uses of the compound of Formula (I) in treating skin cancer or skin precancer, or a skin condition, disorder or disease associated with administration of an immunosuppressant agent that binds to FKBP12.",UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE-ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,,https://lens.org/160-060-092-584-580,Patent Application,no,0,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/436;;A61K9/00;;A61K9/06;;A61P17/00;;A61P35/00,,0,0,,,,PENDING
250,WO,A1,WO 2018/052684 A1,017-906-985-557-506,2018-03-22,2018,US 2017/0048453 W,2017-08-24,US 201615264002 A,2016-09-13,OUTER PRODUCT ENGINE,"In an embodiment, an outer product engine is configured to perform outer product operations. The outer product engine may perform numerous multiplication operations in parallel on input vectors, in an embodiment, generating a resulting outer product matrix. In an embodiment, the outer product engine may be configured to accumulate results in a result matrix, performing fused multiply add (FMA) operations to produce the outer product elements (multiply) and to accumulate the outer product elements with previous elements from the result matrix memory (add). A processor may fetch outer product instructions, and may transmit the instructions to the outer product engine when the instructions become non-speculative in an embodiment. The processor may be configured to retire the outer product instructions responsive to transmitting them to the outer product engine.",APPLE INC,SAZEGARI ALI;;BAINVILLE ERIC;;GONION JEFFRY E;;WILLIAMS GERARD R;;BEAUMONT-SMITH ANDREW J,,https://lens.org/017-906-985-557-506,Patent Application,yes,3,0,5,5,0,G06F9/30036;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/3001;;G06F9/3001;;G06F9/30036;;G06F9/30043;;G06F9/30101;;G06F9/3802;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/30101;;G06F9/3802;;G06F9/30043;;G06F9/3001;;G06F9/3867;;G06F9/30036;;G06F9/3893;;G06F9/3877,G06F9/30;;G06F9/38,,2,1,055-752-709-506-314,10.1109/icces.2007.4447064,"SHAOLI LIU ET AL: ""Cambricon"", ACM SIGARCH COMPUTER ARCHITECTURE NEWS, ACM SPECIAL INTEREST GROUP ON COMPUTER ARCHITECTURE, 2 PENN PLAZA, SUITE 701 NEW YORK NY 10121-0701 USA, vol. 44, no. 3, 18 June 2016 (2016-06-18), pages 393 - 405, XP058300636, ISSN: 0163-5964, DOI: 10.1145/3007787.3001179;;MOSTAFA I SOLIMAN ED - ANONYMOUS: ""Mat-core: A matrix core extension for general-purpose processors"", COMPUTER ENGINEERING&SYSTEMS, 2007. ICCES '07. INTERNATIONAL CONFERENCE ON, IEEE, PI, 1 November 2007 (2007-11-01), pages 304 - 310, XP031212365, ISBN: 978-1-4244-1365-2",PENDING
251,EP,A1,EP 4161510 A1,127-864-399-278-796,2023-04-12,2023,EP 21820995 A,2021-06-09,AU 2020/901895 A;;AU 2021/050582 W,2020-06-09,COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN PRECANCER,,UNIQUEST PTY LTD,WELLS JAMES;;DYMOCK BRIAN WILLIAM;;HARVEY ANDREW;;COCK TERRIE-ANNE;;POUWER REBECCA;;BEAUMONT KIMBERLEY,,https://lens.org/127-864-399-278-796,Patent Application,yes,0,0,7,7,0,A61K31/436;;A61K2300/00;;A61P17/00;;A61K9/0021;;A61K9/0014;;A61P35/00;;A61P17/00;;A61K31/436;;A61P35/00;;A61K9/0014;;A61K9/0021;;A61K45/06;;A61K38/13;;A61K31/439;;A61K9/0014;;A61K31/436;;A61K45/06;;A61P35/00;;C07D498/18;;A61K2300/00;;A61P17/00;;A61P35/00;;A61K9/0014;;A61K31/436,A61K31/436;;A61K9/00;;A61K9/06;;A61P17/00;;A61P35/00,,0,0,,,,PENDING
252,US,A1,US 2018/0074824 A1,099-216-661-438-371,2018-03-15,2018,US 201615264002 A,2016-09-13,US 201615264002 A,2016-09-13,Outer Product Engine,"In an embodiment, an outer product engine is configured to perform outer product operations. The outer product engine may perform numerous multiplication operations in parallel on input vectors, in an embodiment, generating a resulting outer product matrix. In an embodiment, the outer product engine may be configured to accumulate results in a result matrix, performing fused multiply add (FMA) operations to produce the outer product elements (multiply) and to accumulate the outer product elements with previous elements from the result matrix memory (add). A processor may fetch outer product instructions, and may transmit the instructions to the outer product engine when the instructions become non-speculative in an embodiment. The processor may be configured to retire the outer product instructions responsive to transmitting them to the outer product engine.",APPLE INC,SAZEGARI ALI;;BAINVILLE ERIC;;GONION JEFFRY E;;WILLIAMS III GERARD R;;BEAUMONT-SMITH ANDREW J,APPLE INC (2016-07-09),https://lens.org/099-216-661-438-371,Patent Application,yes,0,22,5,5,0,G06F9/30036;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/3001;;G06F9/3001;;G06F9/30036;;G06F9/30043;;G06F9/30101;;G06F9/3802;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/30101;;G06F9/3802;;G06F9/30043;;G06F9/3001;;G06F9/3867;;G06F9/30036;;G06F9/3893;;G06F9/3877,G06F9/30;;G06F9/38,,0,0,,,,DISCONTINUED
253,CN,A,CN 109564509 A,056-971-418-236-445,2019-04-02,2019,CN 201780047342 A,2017-08-24,US 201615264002 A;;US 2017/0048453 W,2016-09-13,Outer Product Engine,"In an embodiment, an outer product engine is configured to perform outer product operations. The outer product engine may perform numerous multiplication operations in parallel on input vectors, in anembodiment, generating a resulting outer product matrix. In an embodiment, the outer product engine may be configured to accumulate results in a result matrix, performing fused multiply add (FMA) operations to produce the outer product elements (multiply) and to accumulate the outer product elements with previous elements from the result matrix memory (add). A processor may fetch outer product instructions, and may transmit the instructions to the outer product engine when the instructions become non-speculative in an embodiment. The processor may be configured to retire the outer product instructions responsive to transmitting them to the outer product engine.",APPLE INC,SAZEGARI ALI;;BAINVILLE ERIC;;GONION JEFFRY E;;WILLIAMS III GERARD R;;BEAUMONT-SMITH ANDREW J,,https://lens.org/056-971-418-236-445,Patent Application,no,3,0,5,5,0,G06F9/30036;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/3001;;G06F9/3001;;G06F9/30036;;G06F9/30043;;G06F9/30101;;G06F9/3802;;G06F9/3867;;G06F9/3877;;G06F9/3893;;G06F9/30101;;G06F9/3802;;G06F9/30043;;G06F9/3001;;G06F9/3867;;G06F9/30036;;G06F9/3893;;G06F9/3877,G06F9/30;;G06F9/38,,1,0,,,"SHAOLI LIU等: ""Cambricon: An Instruction Set Architecture for Neural Networks"", 《2016 ACM/IEEE 43RD ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE》",DISCONTINUED
254,US,A1,US 2022/0358082 A1,104-493-604-609-183,2022-11-10,2022,US 202217869620 A,2022-07-20,US 202217869620 A;;US 201916286170 A,2019-02-26,"Coprocessors with Bypass Optimization, Variable Grid Architecture, and Fused Vector Operations","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A,,https://lens.org/104-493-604-609-183,Patent Application,yes,0,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F7/544;;G06F15/80;;G06F7/57;;G06F9/38,,0,0,,,,PENDING
255,US,B1,US 10831488 B1,196-476-925-384-109,2020-11-10,2020,US 201816105783 A,2018-08-20,US 201816105783 A,2018-08-20,Computation engine with extract instructions to minimize memory access,"In an embodiment, a computation engine may offload work from a processor (e.g. a CPU) and efficiently perform computations such as those used in LSTM and other workloads at high performance. In an embodiment, the computation engine may perform computations on input vectors from input memories in the computation engine, and may accumulate results in an output memory within the computation engine. The input memories may be loaded with initial vector data from memory, incurring the memory latency that may be associated with reading the operands. Compute instructions may be performed on the operands, generating results in an output memory. One or more extract instructions may be supported to move data from the output memory to the input memory, permitting additional computation on the data in the output memory without moving the results to main memory.",APPLE INC,BAINVILLE ERIC;;GONION JEFFRY E;;SAZEGARI ALI;;WILLIAMS III GERARD R;;BEAUMONT-SMITH ANDREW J,APPLE INC (2018-08-14),https://lens.org/196-476-925-384-109,Granted Patent,yes,53,2,1,1,0,G06F9/30032;;G06F9/322;;G06F9/30036;;G06F9/3012;;G06F9/30138;;G06F9/3877;;G06F2209/509,G06F9/30;;G06F9/32;;G06F9/38,,5,3,036-359-109-984-558;;136-793-719-386-325;;011-101-427-946-981,10.1145/3007787.3001179;;10.1109/arith.1991.145565;;10.1109/12.485571,"Song Han et al: EIE: Efficient Interence Engine on Compressed Deep Neural Networks, ACM SIGARCH Computer Architecture News, ACM Special Interset Group on Computer Archtecture, 2 Penn Plaza, Suite 701 New York NY 10121-0701 USA, Stanford University, 2016, 12 pages.;;ISR/WO, PCT/US2019/042744, dated Oct. 23, 2019, 15 pages.;;SHAOLI LIU ; ZIDONG DU ; JINHUA TAO ; DONG HAN ; TAO LUO ; YUAN XIE ; YUNJI CHEN ; TIANSHI CHEN: ""Cambricon"", ACM SIGARCH COMPUTER ARCHITECTURE NEWS, ACM SPECIAL INTEREST GROUP ON COMPUTER ARCHITECTURE, 2 PENN PLAZA, SUITE 701 NEW YORK NY 10121-0701 USA, vol. 44, no. 3, 18 June 2016 (2016-06-18), 2 Penn Plaza, Suite 701 New York NY 10121-0701 USA, pages 393 - 405, XP058300636, ISSN: 0163-5964, DOI: 10.1145/3007787.3001179;;Tang et al., “Table-Lookup Algorithms for Elementary Functions and Their Error Analysis”, 1991, pp. 232-236.;;Kantabutra, “On Hardware for Computing Exponental and Trigonometric Functions”, Mar. 1996, pp. 328-339.",ACTIVE
256,US,A1,US 2017/0206203 A1,181-808-388-960-564,2017-07-20,2017,US 201715477811 A,2017-04-03,US 201715477811 A;;US 201213495952 A,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/181-808-388-960-564,Patent Application,yes,1,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F17/30,,0,0,,,,ACTIVE
257,EP,B1,EP 0267708 B1,112-677-024-113-137,1994-09-14,1994,EP 87309373 A,1987-10-22,GB 8625486 A,1986-10-24,Optical signal modulation device.,,BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY (1989-12-20),https://lens.org/112-677-024-113-137,Granted Patent,yes,1,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,2,0,,,"IEEE JOURNAL OF QUANTUM ELECTRONICS, vol. QE-17, no. 6, June 1981, pages 946-959, IEEE, New York, US; R.C. ALFERNESS: ""Guided-wave devices for optical communication"";;OPTICS LETTERS, vol. 5, no. 5, May 1980, pages 176-178, Optical Society of America; C.H. BULMER et al.: ""Linear interferometric waveguide modulator for electromagnetic-field detection""",EXPIRED
258,US,A1,US 2013/0339351 A1,067-141-253-292-444,2013-12-19,2013,US 201213495952 A,2012-06-13,US 201213495952 A,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/067-141-253-292-444,Patent Application,yes,2,10,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F17/30,707/736,0,0,,,,ACTIVE
259,DE,D1,DE 3750539 D1,180-250-157-568-243,1994-10-20,1994,DE 3750539 T,1987-10-22,GB 8625486 A,1986-10-24,Vorrichtung zur Modulation von optischen Signalen.,,BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,,https://lens.org/180-250-157-568-243,Granted Patent,no,0,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,0,0,,,,EXPIRED
260,WO,A3,WO 2013/188158 A3,002-743-436-250-968,2014-02-27,2014,US 2013/0043960 W,2013-06-04,US 201213495952 A,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,,https://lens.org/002-743-436-250-968,Search Report,yes,1,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F17/21;;G06T13/00,,0,0,,,,PENDING
261,EP,A2,EP 2862147 A2,019-786-664-967-781,2015-04-22,2015,EP 13734536 A,2013-06-04,US 201213495952 A;;US 2013/0043960 W,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,,MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,,https://lens.org/019-786-664-967-781,Patent Application,yes,2,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06T13/00;;G06F17/21,,0,0,,,,DISCONTINUED
262,WO,A2,WO 2013/188158 A2,125-191-949-471-472,2013-12-19,2013,US 2013/0043960 W,2013-06-04,US 201213495952 A,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,,https://lens.org/125-191-949-471-472,Patent Application,yes,0,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F17/30,,0,0,,,,PENDING
263,EP,A1,EP 0267708 A1,139-333-440-982-367,1988-05-18,1988,EP 87309373 A,1987-10-22,GB 8625486 A,1986-10-24,Optical signal modulation device.,"An optical signal modulation device comprises first and second optical waveguides (1,2) fabricated on Z cut lithium niobate. The waveguides (1,2) are connected at one end to an optical signal splitter (7) and at the other end to a Y coupler (11). The output of the Y coupler (11) is connected to a single mode optical fibre (13). A first pair of modulator electrodes (3,4) are positioned across the waveguides (1,2) to cause relative phase shifts between signals in the two optical waveguides (1,2) in response to a first control signal V₁. These relative phase shifts are caused in both TM mode and TE mode signals. The device also includes a second pair of bias electrodes (14, 15) arranged to cause a relative phase shift between signals of the TE mode only whereby the transfer characteristics of the two modes may be shifted relatively to one another in use in accordance with the second control function. ",BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,BRITISH TELECOMMUNICATIONS PUBLIC LIMITED COMPANY (1989-12-20),https://lens.org/139-333-440-982-367,Patent Application,yes,1,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,2,2,007-913-682-857-969;;093-477-889-080-131,10.1109/jqe.1981.1071209;;10.1364/ol.5.000176;;19693163,"IEEE JOURNAL OF QUANTUM ELECTRONICS, vol. QE-17, no. 6, June 1981, pages 946-959, IEEE, New York, US; R.C. ALFERNESS: ""Guided-wave devices for optical communication"";;OPTICS LETTERS, vol. 5, no. 5, May 1980, pages 176-178, Optical Society of America; C.H. BULMER et al.: ""Linear interferometric waveguide modulator for electromagnetic-field detection""",EXPIRED
264,US,A1,US 2019/0034433 A1,140-771-698-675-976,2019-01-31,2019,US 201815990027 A,2018-05-25,US 201815990027 A;;US 201715477811 A;;US 201213495952 A,2012-06-13,USING CINEMATIC TECHNIQUES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/140-771-698-675-976,Patent Application,yes,11,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06T13/00,,0,0,,,,ACTIVE
265,DE,T2,DE 3750539 T2,152-029-446-192-045,1995-03-09,1995,DE 3750539 T,1987-10-22,GB 8625486 A,1986-10-24,Vorrichtung zur Modulation von optischen Signalen.,,BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,,https://lens.org/152-029-446-192-045,Granted Patent,no,0,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,0,0,,,,EXPIRED
266,US,B2,US 10521467 B2,050-375-340-562-62X,2019-12-31,2019,US 201815990027 A,2018-05-25,US 201815990027 A;;US 201715477811 A;;US 201213495952 A,2012-06-13,Using cinematic techniques to present data,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/050-375-340-562-62X,Granted Patent,yes,11,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F16/438;;G06F16/24;;G06F16/248;;G06F16/335;;G06F16/48;;G06F16/783;;G06T13/00,,0,0,,,,ACTIVE
267,US,B2,US 9390527 B2,111-060-574-489-597,2016-07-12,2016,US 201213495979 A,2012-06-13,US 201213495979 A,2012-06-13,Using cinematic technique taxonomies to present data,"The present invention extends to methods, systems, and computer program products for using cinematic technique taxonomies to present data. Embodiments of the invention can be used to infer and identify cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques from a cinematic technique hierarchy (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN;;MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/111-060-574-489-597,Granted Patent,yes,27,0,2,2,0,G06T11/206;;G06T11/206;;G06T13/80;;G06T13/80;;G06T19/20;;G06T19/20,G06T11/20;;G06T13/80;;G06T19/20,,16,3,032-463-259-122-587;;031-150-992-744-414;;023-774-560-651-252,10.1109/vlhcc.2004.2;;10.1002/9781444361506.wbiems144;;10.1109/tvcg.2007.70539;;17968070,"Wang, et al., ""Film Narrative Exploration Through the Analysis of Aesthetic Elements"", In Proceedings of the 13th International Multimedia Modeling Conference, vol. 4351, Jan. 9-12, 2007, pp. 606-615.;;Hsueh, Michael, ""PhotoVis: Visualization of Digital Photograph Metadata"", In Technical Report of Electrical Engineering and Computer Sciences University of California at Berkeley, May 9, 2011, 10 pages.;;Keim, Daniel A., ""Information Visualization and Visual Data Mining"", In Proceedings of IEEE Transactions on Visulization and Computer Graphics, vol. 7, Issue 1, Jan.-Mar. 2002, pp. 100-107.;;Gobel, et al., ""INVISIP: Metadata-based Information Visualization Techniques to Access Geodata Archives and to Support the Site Planning Process"", In Proceedings of 3rd CODATA Euro- American Workshop on Information Visualization Presentation and Design, Jul. 10-11, 2002, 4 pages.;;Cruz, et al., ""A Layered Architecture for the Exploration of Heterogeneous Information Using Coordinated Views"", In Proceedings of IEEE Symposium on Visual Languages-Human Centric Computing, Sep. 26-29, 2004, pp. 11-18.;;Manovich, Lev, ""Media Visualization: Visual Techniques for Exploring Large Media Collections"", Published on: Jun. 2011, Available at: http://manovich.net/DOCS/media-visualization.2011.pdf.;;Moroney, Laurence, ""Visualizing Information with .NET"", In MSDN Magazine, Aug. 2009.;;Bichler, Patrick, ""Visualization Framework for Information Graphs an Incremental Approach"", Published on: Feb. 2002, Available at: http://e-collection.library.ethz.ch/eserv/eth:25004/eth-25004-01.pdf.;;Gasser, Ray, ""Using MATLAB to Visualize Scientific Data"", Published on: Aug. 28, 2009, Available at: http://www.bu.edu/tech/research/training/tutorials/visualization-with-matlab/.;;Heer, et al., ""Animated Transistions in Statistical Data Graphics"", In IEEE Transactions on Visualization and Computer Graphics, vol. 13 No. 6, Nov.-Dec. 2007, pp. 1240-1247.;;Office Action dated Oct. 7, 2014 cited in U.S. Appl. No. 13/517,516.;;""International Search Report & Written Opinion for PCT Patent Application No. PCT/US2013/043960"", Mailed Date: Dec. 9, 2013, Filed Date: Jun. 4, 2013, 8 Pages.;;Office Action dated Apr. 16, 2015 cited in U.S. Appl. No. 13/495,952.;;Notice of Allowance dated May 5, 2015 cited in U.S. Appl. No. 13/517,516.;;Office Action dated Jul. 23, 2015 cited in U.S. Appl. No. 13/495,952.;;Office Action dated Nov. 5, 2015 cited in U.S. Appl. No. 13/495,952.",ACTIVE
268,ES,T3,ES 2058122 T3,184-760-028-106-646,1994-11-01,1994,ES 87309373 T,1987-10-22,GB 8625486 A,1986-10-24,DISPOSITIVO DE MODULACION DE SEÑAL OPTICA.,"DISPOSITIVO DE MODULACION DE SEÑAL OPTICA QUE CONSTA DE UNA PRIMERA Y UNA SEGUNDA GUIAS DE ONDA OPTICA (1,2) DE NIOBATO DE LITIO DE CORTE Z. LAS GUIAS DE ONDA (1,2) VAN CONECTADAS POR UN EXTREMO A UN DIVISOR DE SEÑAL OPTICA (7) Y POR EL OTRO A UN ACOPLADOR Y (11). LA SALIDA DEL ACOPLADOR Y (11) VA CONECTADA A UNA FIBRA OPTICA (13) DE UN SOLO MODO. UN PRIMER PAR DE ELECTRODOS MODULADORES (3,4) ESTAN SITUADOS EN LAS GUIAS DE ONDA (1,2) PARA PROVOCAR VARIACION DE FASE RELATIVA ENTRE SEÑALES DE LAS DOS GUIAS DE ONDA OPTICAS (1,2) EN RESPUESTA A UNA PRIMERA SEÑAL DE CONTROL V1. ESTAS VARIACIONES DE FASE SE PROVOCAN TANTO EN SEÑALES DE MODO MAGNETICO TRANSVERSAL COMO DE MODO ELECTRICO TRANSVERSAL. EL DISPOSITIVO INCLUYE TAMBIEN UN SEGUNDO PAR DE ELECTRODOS DE POLARIZACION (14,15) QUE PRODUCEN UNA VARIACION DE FASE RELATIVA SOLO ENTRE SEÑALES DE MODO ELECTRICO TRANSVERSAL, POR LO QUE LAS CARACTERISTICAS DE TRANSFERENCIA DE LOS DOS MODOS PUEDEN VARIARSE RELATIVAMENTE ENTRE SI DE ACUERDO CON LA SEGUNDA FUNCION DEL CONTROL.",BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,,https://lens.org/184-760-028-106-646,Granted Patent,no,0,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,0,0,,,,EXPIRED
269,US,B2,US 9984077 B2,141-471-114-318-847,2018-05-29,2018,US 201715477811 A,2017-04-03,US 201715477811 A;;US 201213495952 A,2012-06-13,Using cinematic techniques to present data,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT TECHNOLOGY LICENSING LLC;;MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/141-471-114-318-847,Granted Patent,yes,29,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F13/30;;G06F17/30,,25,4,032-463-259-122-587;;023-774-560-651-252;;051-107-565-123-180;;031-150-992-744-414,10.1109/vlhcc.2004.2;;10.1109/tvcg.2007.70539;;17968070;;10.1109/2945.981847;;10.1002/9781444361506.wbiems144,"“Final Office Action Issued in U.S. Appl. No. 13/495,952”, dated Jul. 23, 2015, 25 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/495,952”, dated Jun. 20, 2016, 29 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/495,952”, dated Apr. 16, 2015, 27 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/495,952”, dated Nov. 5, 2015, 29 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 13/495,952”, dated Dec. 5, 2016, 10 Pages.;;“Supplemental Notice of Allowance Issued in U.S. Appl. No. 13/495,952”, dated Dec. 22, 2016, 2 Pages.;;“Final Office Action Issued in U.S. Appl. No. 13/495,979”, dated Jun. 10, 2015, 21 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/495,979”, dated Oct. 26, 2015, 24 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/495,979”, dated Jan. 7, 2015, 21 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 13/495,979”, dated Mar. 14, 2016, 9 Pages.;;“Non Final Office Action Issued in U.S. Appl. No. 13/517,516”, dated Oct. 7, 2014, 11 Pages.;;“Notice of Allowance Issued in U.S. Appl. No. 13/517,516”, dated May 5, 2015, 9 Pages.;;“First Office Action and Search Report Issued in Chinese Patent Application No. 201380031177.1”, dated Nov. 22, 2016, 17 Pages.;;Bichler, Patrick, “Visualization Framework for Information Graphs an Incremental Approach”, In Master and Bachelor Thesis, Department of Computer Science, Database Research Group, Feb. 2002, 82 Pages.;;Cruz, et al., “A Layered Architecture for the Exploration of Heterogeneous Information Using Coordinated Views”, In Proceedings of IEEE Symposium on Visual Languages—Human Centric Computing, Sep. 26, 2004, 8 Pages.;;Gasser, Ray, “Using MATLAB to Visualize Scientific Data”, Retrieved from <<http://www.bu.edu/tech/support/research/training-consulting/online-tutorials/visualization-with-matlab/>>, Aug. 28, 2009, 31 Pages.;;Gobel, et al., “INVISIP: Metadata-based Information Visualization Techniques to Access Geodata Archives and to Support the Site Planning Process”, In Proceedings of 3rd CODATA Euro-American Workshop on Information Visualization Presentation and Design, Jul. 10, 2002, 4 Pages.;;Heer, et al., “Animated Transitions in Statistical Data Graphics”, In Proceedings of the IEEE Transactions on Visualization and Computer Graphics, vol. 13, Issue 6, Nov. 2007, pp. 1240-1247.;;Hsueh, Michael, “PhotoVis: Visualization of Digital Photograph Metadata”, In Technical Report of Electrical Engineering and Computer Sciences, University of California, May 9, 2011, 10 Pages.;;Keim, Daniel A., “Information Visualization and Visual Data Mining”, In Proceedings of IEEE Transactions on Visualization and Computer Graphics, vol. 7, Issue 1, Jan. 2002, pp. 100-107.;;Manovich, Lev, “Media Visualization: Visual Techniques for Exploring Large Media Collections”, Retrieved from <<<<https://web.archive.org/web/20110726055022/http://manovich.net/DOCS/media_visualization.2011.pdf>>, Jun. 2011, 21 Pages.;;Moroney, Laurence, “Visualizing Information With .NET”, In MSDN Magazine, Aug. 2009, 9 Pages.;;Wang, et al., “Film Narrative Exploration Through the Analysis of Aesthetic Elements”, In Proceedings of the 13th International Conference on Multimedia Modeling, vol. 4351, Jan. 9, 2007, pp. 606-615.;;“International Search Report and Written Opinion Issued in PCT Application No. PCT/US2013/043960”, dated Dec. 9, 2013, 8 Pages.;;“Office Action Issued in European Patent Application No. 13734536.9”, dated Sep. 8, 2017, 6 Pages.",ACTIVE
270,WO,A1,WO 1988/003278 A1,198-770-508-914-05X,1988-05-05,1988,GB 8700738 W,1987-10-20,GB 8625486 A,1986-10-24,OPTICAL SIGNAL MODULATION DEVICE,"An optical signal modulation device comprises first and second optical waveguides (1, 2) fabricated on Z cut lithium niobate. The waveguides (1, 2) are connected at one end to an optical signal splitter (7) and at the other end to a Y coupler (11). The output of the Y coupler (11) is connected to a single mode optical fibre (13). A first pair of modulator electrodes (3, 4) are positioned across the waveguides (1, 2) to cause relative phase shifts between signals in the two optical waveguides (1, 2) in response to a first control signal V1. These relative phase shifts are caused in both TM mode and TE mode signals. The device also includes a second pair of bias electrodes (14, 15) arranged to cause a relative phase shift between signals of the TE mode only whereby the transfer characteristics of the two modes may be shifted relatively to one another in use in accordance with the second control function.",BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;CUNNINGHAM DAVID GEORGE;;STALLARD WILLIAM ANDREW,,https://lens.org/198-770-508-914-05X,Patent Application,yes,1,5,12,12,0,G02F1/225;;G02F1/225,G02F1/03;;G02B6/12;;G02F1/035;;G02F1/225,G2F FCW           CW;;G2F F21X          CW;;G2F F23E          CW;;G2F F28W          CW,0,0,,,,PENDING
271,US,B2,US 9613084 B2,035-975-698-960-732,2017-04-04,2017,US 201213495952 A,2012-06-13,US 201213495952 A,2012-06-13,Using cinematic techniques to present data,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;MICROSOFT TECHNOLOGY LICENSING LLC,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/035-975-698-960-732,Granted Patent,yes,28,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06F13/30;;G06F17/30;;G06T13/00,,18,4,051-107-565-123-180;;032-463-259-122-587;;031-150-992-744-414;;023-774-560-651-252,10.1109/2945.981847;;10.1109/vlhcc.2004.2;;10.1002/9781444361506.wbiems144;;10.1109/tvcg.2007.70539;;17968070,"“International Search Report & Written Opinion for PCT Patent Application No. PCT/US2013/043960”, Mailed Date: Dec. 9, 2013, Filed Date: Jun. 4, 2013, 8 Pages.;;Wang, et al., “Film Narrative Exploration Through the Analysis of Aesthetic Elements”, In Proceedings of 13th International Multimedia Modeling Conference, vol. 4351, Jan. 9-12, 2007, pp. 606-615.;;Hsueh, Michael, “PhotoVis: Visualization of Digital Photograph Metadata”, In Technical Report of Electrical Engineering and Computer Sciences University of California at Berkeley, May 9, 2011, 10 pages.;;Keim, Daniel A., “Information Visualization and Visual Data Mining”, In Proceedings of IEEE Transactions on Visualization and Computer Graphics, vol. 7, Issue 1. Jan.-Mar. 2002, pp. 100-107.;;Gobel, et al., “INVISIP: Metadata-based Information Visualization Techniques to Access Geodata Archives and to Support the Site Planning Process”, In Proceedings of 3rd CODATA Euro—American Workshop on Information Visualization Presentation and Design, Jul. 10-11, 2002, 4 pages.;;Cruz, et al., “A Layered Architecture for the Exploration of Heterogeneous Information Using Coordinated Views”, In Proceedings of IEEE Symposium on Visual Languages—Human Centric Computing, Sep. 26-29, 2004, pp. 11-18.;;Manovich, Lev, “Media Visualization: Visual Techniques for Exploring Large Media Collections”, Published on: Jun. 2011, Available at: http://manovich.net/DOCS/media—visualization.2011.pdf.;;Moroney, Laurence, “Visualizing Information with .NET”, In MSDN Magazine, Aug. 2009.;;Bichler, Patrick, “Visualization Framework for Information Graphs an Incremental Approach”, Published on: Feb. 2002, Available at: http://e-collection.library.ethz.ch/eserv/eth:25004/eth-25004-01.pdf.;;Gasser, Ray, “Using MATLAB to Visualize Scientific Data”, Published on: Aug. 28, 2009, Available at: http://www.bu.edu/tech/research/training/tutorials/visualization-with-matlab/.;;Heer,et al., “Animated Transitions in Statistical Data Graphics”, In IEEE Transactions on Visualization and Computer Graphics, vol. 13, No. 6, Nov.-Dec. 2007, pp. 1240-1247.;;Office Action dated Oct. 7, 2014 cited in U.S. Appl. No. 13/517,516.;;Office Action dated Jan. 7, 2015 cited in U.S. Appl. No. 13/495,979.;;Notice of Allowance dated May 5, 2015 cited in U.S. Appl. No. 13/517,516.;;Office Action dated Jun. 10, 2015 cited in U.S. Appl. No. 13/495,979.;;Notice of Allowance dated Mar. 14, 2016 cited in U.S. Appl. No. 13/495,979.;;Office Action dated Oct. 26, 2015 cited in U.S. Appl. No. 13/495,979.;;Office Action cited in Chinese Application No. 201380031177.1 dated Nov. 22, 2016.",ACTIVE
272,CN,A,CN 104380345 A,063-086-598-358-483,2015-02-25,2015,CN 201380031177 A,2013-06-04,US 2013/0043960 W;;US 201213495952 A,2012-06-13,Using cinematic techniques to present data,"The present invention extends to methods, systems, and computer program products for using cinematic techniques to present data. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2015-04-01),https://lens.org/063-086-598-358-483,Patent Application,no,10,0,11,11,0,G06F16/248;;G06T13/00;;G06T13/00;;G06F16/4393;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06F16/4393;;G06F16/24;;G06F16/48;;G06F16/248;;G06F16/337;;G06F16/783;;G06T13/00,G06T13/00;;G06F17/21,,0,0,,,,ACTIVE
273,US,A1,US 2013/0335420 A1,063-317-034-725-757,2013-12-19,2013,US 201213495979 A,2012-06-13,US 201213495979 A,2012-06-13,USING CINEMATIC TECHNIQUE TAXONOMIES TO PRESENT DATA,"The present invention extends to methods, systems, and computer program products for using cinematic technique taxonomies to present data. Embodiments of the invention can be used to infer and identify cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention permit users (including non-programmers) to employ cinematic techniques from a cinematic technique hierarchy (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/063-317-034-725-757,Patent Application,yes,7,2,2,2,0,G06T11/206;;G06T11/206;;G06T13/80;;G06T13/80;;G06T19/20;;G06T19/20,G06T11/20,345/440,0,0,,,,ACTIVE
274,US,A1,US 2013/0339860 A1,066-319-953-733-035,2013-12-19,2013,US 201213517516 A,2012-06-13,US 201213517516 A,2012-06-13,ASSISTING USERS WITH PRESENTING DATA USING CINEMATIC TECHNIQUES,"The present invention extends to methods, systems, and computer program products for assisting users with presenting data using cinematic techniques. Embodiments of the invention can be used to infer and generate cinematic techniques or combinations thereof based on a model and user action. Cinematic techniques can be used to meet the data exploration and analysis requirements of a user. As such, embodiments of the invention assist users (including non-programmers) to employ cinematic techniques (possibly in combination with other techniques) to gain insights into their data and also convey appropriate emotional messages.",MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;MICROSOFT CORP,MITAL VIJAY;;POOZHIYIL SURAJ T;;RUBIN DARRYL;;NETZ AMIR;;COLLE OLIVIER;;REDDISH ANDREW DOUGLAS;;BEAUMONT CHRISTIAN,MICROSOFT TECHNOLOGY LICENSING LLC (2014-10-14);;MICROSOFT CORPORATION (2012-06-13),https://lens.org/066-319-953-733-035,Patent Application,yes,5,3,1,1,0,G06Q10/06;;G06F3/0484;;G06Q10/06,G06F3/0484,715/730,0,0,,,,DISCONTINUED
275,CN,A,CN 113490913 A,048-263-506-975-742,2021-10-08,2021,CN 202080016540 A,2020-02-23,US 201916286170 A;;US 2020/0019389 W,2019-02-26,"COPROCESSORS WITH BYPASS OPTIMIZATION, VARIABLE GRID ARCHITECTURE, AND FUSED VECTOR OPERATIONS","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A;;BALASUBRAMANIAN SRIKANTH,,https://lens.org/048-263-506-975-742,Patent Application,no,0,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F9/30;;G06F9/38,,0,0,,,,PENDING
276,KR,A,KR 20230170981 A,023-428-510-576-256,2023-12-19,2023,KR 20237041950 A,2020-02-23,US 201916286170 A;;KR 20217027301 A;;US 2020/0019389 W,2019-02-26,COPROCESSORS WITH BYPASS OPTIMIZATION VARIABLE GRID ARCHITECTURE AND FUSED VECTOR OPERATIONS,"일 실시예에서, 코프로세서는 주어진 프로세서 명령어에 의해 사용되지 않는 실행 회로를 식별하는 바이패스 표시를 포함할 수 있고, 따라서 바이패스될 수 있다. 대응하는 회로는 실행 동안 디스에이블되어, 회로의 출력이 명령어에 사용되지 않을 때 평가를 방지할 수 있다. 다른 실시예에서, 코프로세서는 행들 및 열들에서 프로세싱 요소들의 그리드를 구현할 수 있고, 여기서 주어진 코프로세서 명령어는 최대 모든 프로세싱 요소들이 입력 피연산자들의 벡터들 상에서 동작하게 하여 결과들을 생성하는 동작을 특정할 수 있다. 코프로세서의 구현들은 프로세싱 요소들의 부분을 구현할 수 있다. 코프로세서 제어 회로는 전체 그리드 또는 부분 그리드로 동작하도록 설계되어, 요청된 동작을 수행하기 위해 부분 그리드 케이스 내의 명령어들을 재발행할 수 있다. 또 다른 실시예에서, 코프로세서는 벡터 모드 동작들을 융합시킬 수 있다.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT SMITH ANDREW J;;ALVAREZ HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A;;BALASUBRAMANIAN SRIKANTH,,https://lens.org/023-428-510-576-256,Patent Application,no,0,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F9/38;;G06F7/544;;G06F7/57;;G06F9/30;;G06F15/80,,0,0,,,,PENDING
277,AT,T1,AT E111613 T1,088-645-492-645-260,1994-09-15,1994,AT 87309373 T,1987-10-22,GB 8625486 A,1986-10-24,VORRICHTUNG ZUR MODULATION VON OPTISCHEN SIGNALEN.,,BRITISH TELECOMM,BOOTH RICHARD CHARLES;;BEAUMONT ALAN ROY;;DAYMOND-JOHN BARBARA ELIZABETH;;ASHE;;CUNNINGHAM DAVID GEORGE;;STALLARD WILIAM ANDREW,,https://lens.org/088-645-492-645-260,Granted Patent,no,0,0,12,12,0,G02F1/225;;G02F1/225,G02B6/12;;G02F1/03;;G02F1/035;;G02F1/225,,0,0,,,,DISCONTINUED
278,US,A1,US 2010/0162262 A1,012-981-079-541-973,2010-06-24,2010,US 33876908 A,2008-12-18,US 33876908 A,2008-12-18,Split Scheduler,"In an embodiment, a scheduler implements a first dependency array that tracks dependencies on instruction operations (ops) within a distance N of a given op and which are short execution latency ops. Other dependencies are tracked in a second dependency array. The first dependency array may evaluate quickly, to support back-to-back issuance of short execution latency ops and their dependent ops. The second array may evaluate more slowly than the first dependency array.",BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,APPLE INC (2008-12-09),https://lens.org/012-981-079-541-973,Patent Application,yes,8,1,4,4,0,G06F9/3838;;G06F9/384;;G06F9/3858;;G06F9/3838;;G06F9/384;;G06F9/3858,G06F9/46,718/106,0,0,,,,ACTIVE
279,US,B2,US 8364936 B2,063-152-882-222-068,2013-01-29,2013,US 201213557725 A,2012-07-25,US 201213557725 A;;US 33876908 A,2008-12-18,"Processor employing split scheduler in which near, low latency operation dependencies are tracked separate from other operation dependencies","In an embodiment, a scheduler implements a first dependency array that tracks dependencies on instruction operations (ops) within a distance N of a given op and which are short execution latency ops. Other dependencies are tracked in a second dependency array. The first dependency array may evaluate quickly, to support back-to-back issuance of short execution latency ops and their dependent ops. The second array may evaluate more slowly than the first dependency array.",APPLE INC;;BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,,https://lens.org/063-152-882-222-068,Granted Patent,yes,9,4,4,4,0,G06F9/3838;;G06F9/384;;G06F9/3858;;G06F9/3838;;G06F9/384;;G06F9/3858,G06F9/30,712/217,0,0,,,,ACTIVE
280,KR,A,KR 20210116651 A,034-324-662-661-364,2021-09-27,2021,KR 20217027301 A,2020-02-23,US 201916286170 A;;US 2020/0019389 W,2019-02-26,"바이패스 최적화, 가변 그리드 아키텍처 및 융합된 벡터 동작들을 갖는 코프로세서들","일 실시예에서, 코프로세서는 주어진 프로세서 명령어에 의해 사용되지 않는 실행 회로를 식별하는 바이패스 표시를 포함할 수 있고, 따라서 바이패스될 수 있다. 대응하는 회로는 실행 동안 디스에이블되어, 회로의 출력이 명령어에 사용되지 않을 때 평가를 방지할 수 있다. 다른 실시예에서, 코프로세서는 행들 및 열들에서 프로세싱 요소들의 그리드를 구현할 수 있고, 여기서 주어진 코프로세서 명령어는 최대 모든 프로세싱 요소들이 입력 피연산자들의 벡터들 상에서 동작하게 하여 결과들을 생성하는 동작을 특정할 수 있다. 코프로세서의 구현들은 프로세싱 요소들의 부분을 구현할 수 있다. 코프로세서 제어 회로는 전체 그리드 또는 부분 그리드로 동작하도록 설계되어, 요청된 동작을 수행하기 위해 부분 그리드 케이스 내의 명령어들을 재발행할 수 있다. 또 다른 실시예에서, 코프로세서는 벡터 모드 동작들을 융합시킬 수 있다.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT SMITH ANDREW J;;ALVAREZ HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A;;BALASUBRAMANIAN SRIKANTH,,https://lens.org/034-324-662-661-364,Patent Application,no,2,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F9/38;;G06F7/57;;G06F9/30;;G06F15/80,,0,0,,,,ACTIVE
281,WO,A1,WO 1999/046230 A1,039-965-433-155-208,1999-09-16,1999,AU 1944/099001 W,1999-03-11,AU PP225398 A,1998-03-11,FLUORESCENT ORGANIC COMPOUNDS,The present invention is concerned with certain perylene diones which absorb light in the far-red region of the spectrum of general formula (I). These compounds are suitable for labels in biological systems.,DIATECH PTY LTD;;CASEY JOANNE LOIS;;DEADY LESLIE WILLIAM;;HUGHES ANDREW BEAUMONT;;KLONIS NECTARIOS;;QUAZI NURUL HUDA;;TILLEY LEANN MARGARET,CASEY JOANNE LOIS;;DEADY LESLIE WILLIAM;;HUGHES ANDREW BEAUMONT;;KLONIS NECTARIOS;;QUAZI NURUL HUDA;;TILLEY LEANN MARGARET,,https://lens.org/039-965-433-155-208,Patent Application,yes,0,1,2,3,0,C07C49/747;;C07C49/753;;C07C217/24;;C07C233/18;;C07D491/10;;C07F9/12;;C12Q1/42;;C07C2603/54;;C07C69/738,C07C49/747;;C07C49/753;;C07C69/00;;C07C217/24;;C07C233/18;;C07D491/10;;C07F9/12;;C12Q1/42,,3,0,,,"CHEMICAL ABSTRACTS, 110:66952, YAMAOKA T. et al., ""Optical Memory Materials""; & JP 63221191 A (14-09-1988).;;CHEMICAL ABSTRACTS, 93:58171, BRAUER H. et al., ""A New Photochromic System of Unusual High Thermal Stability""; & J. PHOTOCHEM., (1980), 12(4), 293-304.;;CHEMICAL ABSTRACTS, 93:94480, SCHMIDT R. et al., ""Photolysis of the Endoperoxide of Heterocoerdianthrone. A Concerted, Adiabatic Cycloreversion Originating from an Upper Excited Singlet State""; & J. AM. CHEM. SOC., (1980), 102(8), 2791-97.",PENDING
282,US,B2,US 8255671 B2,173-167-693-370-66X,2012-08-28,2012,US 33876908 A,2008-12-18,US 33876908 A,2008-12-18,"Processor employing split scheduler in which near, low latency operation dependencies are tracked separate from other operation dependencies","In an embodiment, a scheduler implements a first dependency array that tracks dependencies on instruction operations (ops) within a distance N of a given op and which are short execution latency ops. Other dependencies are tracked in a second dependency array. The first dependency array may evaluate quickly, to support back-to-back issuance of short execution latency ops and their dependent ops. The second array may evaluate more slowly than the first dependency array.",BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP;;APPLE INC,BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,APPLE INC (2008-12-09),https://lens.org/173-167-693-370-66X,Granted Patent,yes,8,3,4,4,0,G06F9/3838;;G06F9/384;;G06F9/3858;;G06F9/3838;;G06F9/384;;G06F9/3858,G06F9/30,712/217,0,0,,,,ACTIVE
283,EP,A1,EP 3931687 A1,167-171-360-026-339,2022-01-05,2022,EP 20711483 A,2020-02-23,US 201916286170 A;;US 2020/0019389 W,2019-02-26,"COPROCESSORS WITH BYPASS OPTIMIZATION, VARIABLE GRID ARCHITECTURE, AND FUSED VECTOR OPERATIONS",,APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A;;BALASUBRAMANIAN SRIKANTH,,https://lens.org/167-171-360-026-339,Patent Application,yes,0,0,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F9/30;;G06F9/38,,0,0,,,,PENDING
284,WO,A1,WO 2020/176366 A1,173-727-584-511-120,2020-09-03,2020,US 2020/0019389 W,2020-02-23,US 201916286170 A,2019-02-26,"COPROCESSORS WITH BYPASS OPTIMIZATION, VARIABLE GRID ARCHITECTURE, AND FUSED VECTOR OPERATIONS","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;CHACHICK RAN A;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;BALASUBRAMANIAN SRIKANTH,,https://lens.org/173-727-584-511-120,Patent Application,yes,3,1,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F9/30;;G06F9/38,,1,1,055-752-709-506-314,10.1109/icces.2007.4447064,"MOSTAFA I SOLIMAN ED - ANONYMOUS: ""Mat-core: A matrix core extension for general-purpose processors"", COMPUTER ENGINEERING&SYSTEMS, 2007. ICCES '07. INTERNATIONAL CONFERENCE ON, IEEE, PI, 1 November 2007 (2007-11-01), pages 304 - 310, XP031212365, ISBN: 978-1-4244-1365-2",PENDING
285,US,A1,US 2020/0272597 A1,179-259-746-537-045,2020-08-27,2020,US 201916286170 A,2019-02-26,US 201916286170 A,2019-02-26,"Coprocessors with Bypass Optimization, Variable Grid Architecture, and Fused Vector Operations","In an embodiment, a coprocessor may include a bypass indication which identifies execution circuitry that is not used by a given processor instruction, and thus may be bypassed. The corresponding circuitry may be disabled during execution, preventing evaluation when the output of the circuitry will not be used for the instruction. In another embodiment, the coprocessor may implement a grid of processing elements in rows and columns, where a given coprocessor instruction may specify an operation that causes up to all of the processing elements to operate on vectors of input operands to produce results. Implementations of the coprocessor may implement a portion of the processing elements. The coprocessor control circuitry may be designed to operate with the full grid or partial grid, reissuing instructions in the partial grid case to perform the requested operation. In still another embodiment, the coprocessor may be able to fuse vector mode operations.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;ALVAREZ-HEREDIA BORIS S;;KANAPATHIPILLAI PRADEEP;;CHACHICK RAN A;;BALASUBRAMANIAN SRIKANTH,APPLE INC (2019-02-25),https://lens.org/179-259-746-537-045,Patent Application,yes,0,8,10,10,0,G06F9/3893;;G06F9/3877;;G06F9/3867;;G06F9/30036;;G06F9/3873;;G06F9/3877;;G06F9/30036;;G06F9/3893;;G06F9/3818;;G06F9/3828;;G06F7/5443;;G06F7/57;;G06F15/8053;;G06F9/3873;;G06F7/5443;;G06F7/57;;G06F9/3818;;G06F9/3828;;G06F9/3877;;G06F15/8053,G06F15/80;;G06F7/544;;G06F7/57;;G06F9/38,,0,0,,,,ACTIVE
286,US,A1,US 2012/0290818 A1,054-587-163-283-16X,2012-11-15,2012,US 201213557725 A,2012-07-25,US 201213557725 A;;US 33876908 A,2008-12-18,Split Scheduler,"In an embodiment, a scheduler implements a first dependency array that tracks dependencies on instruction operations (ops) within a distance N of a given op and which are short execution latency ops. Other dependencies are tracked in a second dependency array. The first dependency array may evaluate quickly, to support back-to-back issuance of short execution latency ops and their dependent ops. The second array may evaluate more slowly than the first dependency array.",BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,BEAUMONT-SMITH ANDREW J;;TAM HONKAI;;MURRAY DANIEL C;;MYLIUS JOHN H;;BANNON PETER J;;KANAPATHIPILLAI PRADEEP,,https://lens.org/054-587-163-283-16X,Patent Application,yes,0,1,4,4,0,G06F9/3838;;G06F9/384;;G06F9/3858;;G06F9/3838;;G06F9/384;;G06F9/3858,G06F9/30,712/216;;X712E09028,0,0,,,,ACTIVE
287,AU,A,AU 1999/029116 A,107-675-478-124-703,1999-09-27,1999,AU 1999/029116 A,1999-03-11,AU PP225398 A;;AU 1944/099001 W;;AU 1999/029116 A,1998-03-11,Fluorescent organic compounds,,DIATECH PTY LTD,CASEY JOANNE LOIS;;DEADY LESLIE WILLIAM;;HUGHES ANDREW BEAUMONT;;KLONIS NECTARIOS;;QUAZI NURUL HUDA;;TILLEY LEANN MARGARET,,https://lens.org/107-675-478-124-703,Patent Application,no,0,0,1,3,0,,C07C49/727;;C07C49/755;;C07C59/13;;C07C69/16;;C07C69/712;;C07C217/24;;C07C233/18;;C07D207/40;;C07F9/09;;G01N33/52,,0,0,,,,PENDING
288,CN,A,CN 103092320 A,117-871-995-415-876,2013-05-08,2013,CN 201210366891 A,2012-09-28,US 201113285361 A,2011-10-31,Processor instruction issue throttling,"The invention relates to processor instruction issue throttling. A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/117-871-995-415-876,Patent Application,no,5,2,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F1/32;;G06F9/30,,0,0,,,,ACTIVE
289,BR,B1,BR 102012024721 B1,171-400-106-478-058,2021-01-05,2021,BR 102012024721 A,2012-09-27,US 201113285361 A,2011-10-31,processador e método de regulação de emissão de instruções de processador,"regulação de emissão de instruções de processador. a invenção refere-se a um sistema e método para reduzir o consumo de potência através de regulação de emissão de instruções problemáticas selecionadas. uma unidade de regulação de potência dentro de um processador mantém contagens de emissão de instruções para tipos de instrução associados. os tipos de instrução podem ser um subconjunto de tipos de instrução suportados executados por um núcleo de execução dentro do processador. os tipos de instrução podem ser escolhidos com base em estimativas de alto consumo de potência para processar as instruções destes tipos. a unidade de regulação de potência pode determinar que uma dada contagem de emissão de instrução excede um dado limite. em resposta, a unidade de regulação de potência pode selecionar dados tipos de instrução para limitar uma respectiva taxa de emissão. a unidade de regulação de potência pode escolher uma taxa de emissão para cada um dos dados tipos de instrução selecionados e limitar uma taxa de emissão associada para uma taxa de emissão escolhida. a seleção de dados tipos de instrução e limites de taxa de emissão associados é programável.",APPLE INC,ANDREW J BEAUMONT-SMITH;;DANIEL C MURRAY;;JOHN H MYLIUS;;JUNG WOOK CHO;;PETER J BANNON;;TOSHI TAKAYANAGI,,https://lens.org/171-400-106-478-058,Granted Patent,no,0,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G01R31/26;;G06F11/30;;H01L23/34,,0,0,,,,ACTIVE
290,EP,A1,EP 2587366 A1,182-983-228-190-016,2013-05-01,2013,EP 12185178 A,2012-09-20,US 201113285361 A,2011-10-31,Processor instruction issue throttling,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.
",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHINARI;;CHO JUNG WOOK,,https://lens.org/182-983-228-190-016,Patent Application,yes,4,6,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/38;;G06F1/32,,0,0,,,,ACTIVE
291,JP,A,JP 2013101605 A,062-213-550-176-755,2013-05-23,2013,JP 2012230295 A,2012-09-28,US 201113285361 A,2011-10-31,PROCESSOR INSTRUCTION ISSUE THROTTLING,"PROBLEM TO BE SOLVED: To provide a system and method for reducing power consumption through issue throttling of selected problematic instructions.SOLUTION: A power throttle unit within a processor maintains instruction issue counts for associated instruction types chosen based on high power consumption estimates. The power throttle unit may determine whether a given instruction issue count exceeds a given threshold. In response, the power throttle unit selects given instruction types to limit each issue rate. The power throttle unit chooses an issue rate for each of the selected given instruction types and limits its associated issue rate to a chosen issue rate. The selection of given instruction types and the associated issue rate limits is programmable.",APPLE INC,DANIEL C MURRAY;;ANDREW J BEAUMONT-SMITH;;JOHN H MYLIUS;;PETER J BANNON;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/062-213-550-176-755,Patent Application,no,11,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F15/78;;G06F9/38,,0,0,,,,ACTIVE
292,WO,A1,WO 2013/066519 A1,054-699-494-378-047,2013-05-10,2013,US 2012/0056831 W,2012-09-24,US 201113285361 A,2011-10-31,PROCESSOR INSTRUCTION ISSUE THROTTLING,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.",APPLE INC;;MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/054-699-494-378-047,Patent Application,yes,4,1,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F1/32,,0,0,,,,PENDING
293,US,A1,US 2013/0111191 A1,083-244-966-219-898,2013-05-02,2013,US 201113285361 A,2011-10-31,US 201113285361 A,2011-10-31,PROCESSOR INSTRUCTION ISSUE THROTTLING,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.",MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,APPLE INC (2011-10-27),https://lens.org/083-244-966-219-898,Patent Application,yes,1,24,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/30,712/214;;X712E09016,0,0,,,,ACTIVE
294,TW,B,TW I517043 B,052-786-714-021-449,2016-01-11,2016,TW 101135164 A,2012-09-25,US 201113285361 A,2011-10-31,Processor instruction issue throttling,,APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/052-786-714-021-449,Granted Patent,no,0,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,,,0,0,,,,ACTIVE
295,AU,A1,AU 2012/227209 A1,050-454-420-451-693,2013-05-16,2013,AU 2012/227209 A,2012-09-19,US 201113285361 A,2011-10-31,Processor instruction issue throttling,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable. Power Management 200 Power Manager 2 Power Processor Core Manager 100 State Machine Power State Table Power __ _ _ _ __ _ _ _ Powerr State Entry Power Code 240a Throttle Unit Entry 150 240b - Throttle Code, Other Throttle Entry Parameters Code, 240g Other Paramete Config u ration Power Operational Operational Throttle Register State Code Frequency Voltage Code 270 242 244 246 248 Throttle Code, Other Software Layer Parameters",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/050-454-420-451-693,Patent Application,no,0,2,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F1/32,,0,0,,,,ACTIVE
296,AU,B2,AU 2012/227209 B2,075-899-337-766-829,2014-01-23,2014,AU 2012/227209 A,2012-09-19,US 201113285361 A,2011-10-31,Processor instruction issue throttling,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable. Power Management 200 Power Manager 2 Power Processor Core Manager 100 State Machine Power State Table Power __ _ _ _ __ _ _ _ Powerr State Entry Power Code 240a Throttle Unit Entry 150 240b - Throttle Code, Other Throttle Entry Parameters Code, 240g Other Paramete Config u ration Power Operational Operational Throttle Register State Code Frequency Voltage Code 270 242 244 246 248 Throttle Code, Other Software Layer Parameters",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/075-899-337-766-829,Granted Patent,no,1,1,17,17,0,G06F1/3206;;G06F1/329;;G06F9/3838;;G06F9/384;;G06F9/3869;;H01L2924/0002;;G06F11/3024;;G06F11/3062;;G06F2201/81;;G06F2201/88;;G06F9/3836;;Y02D10/00;;G06F1/32;;G06F9/30;;G06F9/46;;G06F9/3838;;G06F9/384;;G06F9/3869;;H01L2924/0002;;G06F11/3024;;G06F11/3062;;G06F2201/81;;G06F2201/88;;G06F1/3206;;G06F1/329;;Y02D10/00;;G06F9/3836;;G06F11/30,G06F1/32,,0,0,,,,ACTIVE
297,EP,B1,EP 2587366 B1,053-633-980-446-924,2015-03-04,2015,EP 12185178 A,2012-09-20,US 201113285361 A,2011-10-31,Processor instruction issue throttling,,APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHINARI;;CHO JUNG WOOK,,https://lens.org/053-633-980-446-924,Granted Patent,yes,4,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/38;;G06F1/32,,0,0,,,,ACTIVE
298,US,B2,US 8501435 B2,041-988-768-999-908,2013-08-06,2013,US 58761409 A,2009-10-08,US 58761409 A;;US 19577108 P,2008-10-09,Process for preserving three dimensional orientation to allow registering histopathological diagnoses of tissue to images of that tissue,"A process for maintaining 3 dimensional orientation between a tissue specimen and images of the area of investigation, to register histopathologic diagnoses of multiple locations within the specimen with corresponding locations on the surface of said area of investigation.",GUSTAFSSON ULF PETER;;OYAMA JODY C;;BERGSTEN SARA MARIA;;WHITESELL ANDREW BEAUMONT;;LIEBERMAN RICHARD W;;ELDRED MICHAEL PAUL;;STI MEDICAL SYSTEMS LLC,GUSTAFSSON ULF PETER;;OYAMA JODY C;;BERGSTEN SARA MARIA;;WHITESELL ANDREW BEAUMONT;;LIEBERMAN RICHARD W;;ELDRED MICHAEL PAUL,STI MEDICAL SYSTEMS LLC (2010-03-08),https://lens.org/041-988-768-999-908,Granted Patent,yes,11,14,3,3,0,G01N1/286;;G01N1/286,G01N1/30,435/40.52,0,0,,,,INACTIVE
299,WO,A1,WO 2010/042217 A1,123-302-653-192-059,2010-04-15,2010,US 2009/0005557 W,2009-10-08,US 19577108 P,2008-10-09,PROCESS FOR PRESERVING THREE DIMENSIONAL ORIENTATION TO ALLOW REGISTERING HISTOPATHOLOGICAL DIAGNOSES OF TISSUE,"A process for maintaining three dimensional orientation between a tissue specimen and images of the area of investigation, to register histopathologic diagnoses of multiple locations within the specimen with corresponding locations on the surface of said area of investigation.",STI MEDICAL SYSTEMS LLC;;GUSTAFSSON ULF PETER;;BERGSTEN SARA MARIA;;WHITESELL ANDREW BEAUMONT;;LIEBERMAN RICHARD W;;OYAMA JODY C;;ELDRED MICHAEL PAUL,GUSTAFSSON ULF PETER;;BERGSTEN SARA MARIA;;WHITESELL ANDREW BEAUMONT;;LIEBERMAN RICHARD W;;OYAMA JODY C;;ELDRED MICHAEL PAUL,,https://lens.org/123-302-653-192-059,Patent Application,yes,5,4,3,3,0,G01N1/286;;G01N1/286,A61B5/05,,0,0,,,,PENDING
300,KR,A,KR 20130047577 A,144-500-591-285-047,2013-05-08,2013,KR 20120109532 A,2012-09-28,US 201113285361 A,2011-10-31,PROCESSOR INSTRUCTION ISSUE THROTTLING,"PURPOSE: Processor command publication throttling is provided to control publication throttling of selected problematic commands, thereby efficiently reducing power consumption. CONSTITUTION: A scheduler(124) selects and publishes commands. An execution core receives and executes the commands. A power throttle unit(150) maintains a command publication count for a command type. When the command publication count exceeds a threshold value, the power throttle unit selects the command type for a limited command publication rate and selects a new publication rate for the command type. The power throttle unit performs selection based on a power throttle code written by the software. [Reference numerals] (102) Select an address; (104) I-cache; (106) Predict next fetch; (108) Branch direction predictor; (110) Decoding unit; (112) Evaluate a control flow; (114) Dispatch queue; (116) Microcode; (118) Renamer array; (120) PR(freelist) allocator; (122) Dependency merge; (124) Scheduler; (130) Execution core; (132) Integer ALUR; (134) Integer ALU/branch; (136) Add SIMD and FP; (138) Multiply the SIMD and FP; (140) Load/store; (150) Power throttle unit; (AA) Pipe stage 1; (BB) Pipe stage 2; (CC) Pipe stage 3; (DD) Pipe stage 4; (EE) Pipe stage 5; (FF) Pipe stage 6; (GG) Pipe stage 7; (HH) Pipe stage 8; (II) Pipe stage 9; (JJ) Processor 100",APPLE INC,MURRAY DANIEL C;;BEAUMONT SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,,https://lens.org/144-500-591-285-047,Patent Application,no,0,6,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/30;;G06F9/46,,0,0,,,,ACTIVE
301,US,B2,US 9009451 B2,101-814-014-404-589,2015-04-14,2015,US 201113285361 A,2011-10-31,US 201113285361 A,2011-10-31,Instruction type issue throttling upon reaching threshold by adjusting counter increment amount for issued cycle and decrement amount for not issued cycle,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.",MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK;;APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG WOOK,APPLE INC (2011-10-27),https://lens.org/101-814-014-404-589,Granted Patent,yes,24,6,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/30;;G06F1/32;;G06F9/38;;G06F11/30,712/214;;X712 E9049;;713/320,7,0,,,"Extended Search Report in EP Application No. 12185178.6-1957, Mar. 4, 2013, pp. 1-5.;;International Search Report and Written Opinion in application No. PCT/US2012/056831 mailed Sep. 24 2012.;;Final Office Action in Japanese Patent Application No. 2012-230295, mailed Oct. 6, 2014, 8 pages.;;Notice of Allowance in Korean Patent Application No. 10-2012-109532, mailed Jun. 27, 2014, 2 pages.;;Office Action from Japanese Application No. 2012-230295, mailed Feb. 5, 2014, 10 pages.;;Office Action in Chinese Application No. 201210366891.3, mailed Nov. 19, 2014, 29 pages.;;Office Action in Taiwan Patent Application No. 101135164, mailed Nov. 26, 2014, 14 pages.",ACTIVE
302,TW,A,TW 201331835 A,197-949-117-993-065,2013-08-01,2013,TW 101135164 A,2012-09-25,US 201113285361 A,2011-10-31,Processor instruction issue throttling,"A system and method for reducing power consumption through issue throttling of selected problematic instructions. A power throttle unit within a processor maintains instruction issue counts for associated instruction types. The instruction types may be a subset of supported instruction types executed by an execution core within the processor. The instruction types may be chosen based on high power consumption estimates for processing instructions of these types. The power throttle unit may determine a given instruction issue count exceeds a given threshold. In response, the power throttle unit may select given instruction types to limit a respective issue rate. The power throttle unit may choose an issue rate for each one of the selected given instruction types and limit an associated issue rate to a chosen issue rate. The selection of given instruction types and associated issue rate limits is programmable.",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;TAKAYANAGI TOSHI;;CHO JUNG-WOOK,,https://lens.org/197-949-117-993-065,Patent of Addition,no,0,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G06F9/38;;G06F1/32,,0,0,,,,ACTIVE
303,DE,C2,DE 2917453 C2,034-066-497-686-170,1986-12-18,1986,DE 2917453 A,1979-04-30,DE 2917453 A,1979-04-30,DE 2917453 C2,,"UNILEVER N.V., ROTTERDAM, NL","HENDERSON, JOHN ANDREW, WESTBURY ON TRYM, GB;;LINDLEY, RAYMOND HUGHES, NAILSEA, BRISTOL, GB;;WHITELEY, KEITH BEAUMONT, BASINGSTOKE, HAMPSHIRE, GB",,https://lens.org/034-066-497-686-170,Granted Patent,no,0,2,2,2,0,B30B11/006;;B30B11/201,B30B11/20,,0,0,,,,EXPIRED
304,US,A1,US 2023/0092898 A1,067-157-543-731-712,2023-03-23,2023,US 202117643765 A,2021-12-10,US 202117643765 A;;US 202163247703 P,2021-09-23,Coprocessor Prefetcher,"A prefetcher for a coprocessor is disclosed. An apparatus includes a processor and a coprocessor that are configured to execute processor and coprocessor instructions, respectively. The processor and coprocessor instructions appear together in code sequences fetched by the processor, with the coprocessor instructions being provided to the coprocessor by the processor. The apparatus further includes a coprocessor prefetcher configured to monitor a code sequence fetched by the processor and, in response to identifying a presence of coprocessor instructions in the code sequence, capture the memory addresses, generated by the processor, of operand data for coprocessor instructions. The coprocessor is further configured to issue, for a cache memory accessible to the coprocessor, prefetches for data associated with the memory addresses prior to execution of the coprocessor instructions by the coprocessor.",APPLE INC,DWIEL BRANDON H;;BEAUMONT-SMITH ANDREW J;;FURBISH ERIC J;;PAPE JOHN D;;MEIER STEPHEN G;;HUBERTY TYLER J,APPLE INC (2021-12-07),https://lens.org/067-157-543-731-712,Patent Application,yes,3,0,2,2,0,G06F9/383;;G06F9/3877;;G06F9/3832;;G06F9/30145;;G06F9/3877;;G06F9/383;;G06F9/382;;G06F9/3881,G06F9/38;;G06F9/34;;G06F12/10,,0,0,,,,ACTIVE
305,US,B2,US 11755333 B2,189-532-656-963-590,2023-09-12,2023,US 202117643765 A,2021-12-10,US 202117643765 A;;US 202163247703 P,2021-09-23,Coprocessor prefetcher,"A prefetcher for a coprocessor is disclosed. An apparatus includes a processor and a coprocessor that are configured to execute processor and coprocessor instructions, respectively. The processor and coprocessor instructions appear together in code sequences fetched by the processor, with the coprocessor instructions being provided to the coprocessor by the processor. The apparatus further includes a coprocessor prefetcher configured to monitor a code sequence fetched by the processor and, in response to identifying a presence of coprocessor instructions in the code sequence, capture the memory addresses, generated by the processor, of operand data for coprocessor instructions. The coprocessor is further configured to issue, for a cache memory accessible to the coprocessor, prefetches for data associated with the memory addresses prior to execution of the coprocessor instructions by the coprocessor.",APPLE INC,DWIEL BRANDON H;;BEAUMONT-SMITH ANDREW J;;FURBISH ERIC J;;PAPE JOHN D;;MEIER STEPHEN G;;HUBERTY TYLER J,APPLE INC (2021-12-07),https://lens.org/189-532-656-963-590,Granted Patent,yes,6,0,2,2,0,G06F9/383;;G06F9/3877;;G06F9/3832;;G06F9/30145;;G06F9/3877;;G06F9/383;;G06F9/382;;G06F9/3881,G06F9/38,,0,0,,,,ACTIVE
306,BR,A2,BR 102012024721 A2,117-444-374-317-812,2013-11-26,2013,BR 102012024721 A,2012-09-27,US 201113285361 A,2011-10-31,REGULAÇÃO DE EMISSÃO DE INSTRUÇÕES DE PROCESSADOR,"REGULAÇÃO DE EMISSÃO DE INSTRUÇÕES DE PROCESSADOR. A invenção refere-se a um sistema e método para reduzir o consumo de potência através de regulação de emissão de instruções problemáticas selecionadas. Uma unidade de regulação de potência dentro de um processador mantém contagens de emissão de instruções para tipos de instrução associados. Os tipos de instrução podem ser um subconjunto de tipos de instrução suportados executados por um núcleo de execução dentro do processador. Os tipos de instrução podem ser escolhidos com base em estimativas de alto consumo de potência para processar as instruções destes tipos. A unidade de regulação de potência pode determinar que uma dada contagem de emissão de instrução excede um dado limite. Em resposta, a unidade de regulação de potência pode selecionar dados tipos de instrução para limitar uma respectiva taxa de emissão. A unidade de regulação de potência pode escolher uma taxa de emissão para cada um dos dados tipos de instrução selecionados e limitar uma taxa de emissão associada para uma taxa de emissão escolhida. A seleção de dados tipos de instrução e limites de taxa de emissão associados é programável.",APPLE INC,MURRAY DANIEL C;;BEAUMONT-SMITH ANDREW J;;MYLIUS JOHN H;;BANNON PETER J;;YANAGI TOSHI TAKA;;CHO JUNG WOOK,,https://lens.org/117-444-374-317-812,Patent Application,no,0,0,17,17,0,G06F1/32;;G06F9/3836;;G06F9/3836;;G06F1/3206;;G06F1/3206;;G06F1/329;;G06F1/329;;G06F9/30;;G06F9/3838;;G06F9/3838;;G06F9/384;;G06F9/384;;G06F9/3869;;G06F9/3869;;G06F9/46;;G06F11/30;;G06F11/3024;;G06F11/3024;;G06F11/3062;;G06F11/3062;;G06F2201/81;;G06F2201/81;;G06F2201/88;;G06F2201/88;;H01L2924/0002;;H01L2924/0002;;Y02D10/00;;Y02D10/00,G01R31/26;;G06F11/30;;H01L23/34,,0,0,,,,ACTIVE
307,CN,B,CN 103069400 B,005-222-752-259-193,2015-07-01,2015,CN 201180040267 A,2011-08-11,US 2011/0047389 W;;US 86050510 A,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,,APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/005-222-752-259-193,Granted Patent,no,0,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
308,AU,A1,AU 2011/292293 A1,138-698-003-908-383,2013-02-21,2013,AU 2011/292293 A,2011-08-11,US 86050510 A;;US 2011/0047389 W,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/138-698-003-908-383,Patent Application,no,0,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
309,AU,B2,AU 2011/292293 B2,158-670-174-390-575,2014-02-06,2014,AU 2011/292293 A,2011-08-11,US 86050510 A;;US 2011/0047389 W,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/158-670-174-390-575,Granted Patent,no,2,0,16,17,0,G06F12/0804;;G06F12/0897;;G06F12/127;;G06F2212/1016;;G06F2212/502;;G06F12/08;;G06F12/0804;;G06F2212/502;;G06F12/0897;;G06F12/127;;G06F2212/1016;;G06F12/0891,G06F13/00,,1,0,,,2009/0300288,ACTIVE
310,BR,B1,BR 112013003850 B1,169-940-390-557-532,2020-12-01,2020,BR 112013003850 A,2011-08-11,US 2011/0047389 W;;US 86050510 A,2010-08-20,aparelho e método de buffer de escrita de combinação com medidas de esvaziamento dinamicamente ajustáveis.,"buffer de escrita de combinação com medidas de esvaziamento dinamicamente ajustáveis. a presente invenção refere-se a um buffer de escrita de combinação que, em uma modalidade, é configurado para manter uma ou mais medidas de esvaziamento para determinar quando é para transmitir operações de escrita a partir de entradas de buffer. o buffer de escrita de combinação pode ser configurado para modificar dinamicamente as medidas de esvaziamento, em resposta a uma atividade no buffer de escrita, modificando as condições segundo as quais as operações de escrita são transmitidas a partir do buffer de escrita para o próximo nível mais baixo de memória. por exemplo, em uma implementação, as medidas de esvaziamento podem incluir entradas de buffer de escrita de categorização, tais como ""colapsado"". uma entrada de buffer de escrita colapsado e as operações de escrita colapsadas ali podem incluir pelo menos uma operação de escrita que tenha dados sobrescritos que foram escritos por uma operação de escrita prévia na entrada de buffer. em uma outra implementação, a combinação do buffer de escrita pode manter o limite de ocupação plena de buffer como uma medida de esvaziamento e pode ajustá-lo ao longo do tempo, com base na ocupação plena de buffer real.",APPLE INC,ANDREW J BEAUMONT-SMITH;;BRIAN P LILLY;;JAIDEV P PATWARDHAN;;PETER J BANNON;;RAMESH GUNNA;;SHIH-CHIEH R WEN;;TSE-YU YEH;;WEI-HAN LIEN,,https://lens.org/169-940-390-557-532,Granted Patent,no,0,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
311,CN,A,CN 103069400 A,023-459-632-028-09X,2013-04-24,2013,CN 201180040267 A,2011-08-11,US 2011/0047389 W;;US 86050510 A,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/023-459-632-028-09X,Patent Application,no,4,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
312,KR,A,KR 20120018100 A,073-197-344-743-415,2012-02-29,2012,KR 20110083108 A,2011-08-19,US 86050510 A;;US 2011/0047389 W,2010-08-20,COMBINING WRITE BUFFER WITH DYNAMICALLY ADJUSTABLE FLUSH METRICS,"PURPOSE: A combining write buffer with dynamically adjustable flush metrics is provided to determine the transmitting timing of writing operations from buffer entries by maintaining one or more flush metrics. CONSTITUTION: A controlling circuit monitors activities in a writing buffer(30). The controlling circuit modifies one or more flush metrics, which are maintained by the controlling circuit, by responding to the activities(34). The controlling circuit causes one or more writing operations from at least one buffer entry of the writing buffers by responding to the buffer fullness of the writing buffers and the flux metrics(38). The number of writing buffer entries is compared with the threshold value of the buffer fullness.",APPLE INC,BANNON PETER J;;BEAUMONT SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH CHIEH R;;YEH TSE YU,,https://lens.org/073-197-344-743-415,Patent Application,no,0,1,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F12/08,,0,0,,,,ACTIVE
313,US,B2,US 8352685 B2,079-976-547-572-928,2013-01-08,2013,US 86050510 A,2010-08-20,US 86050510 A,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as “collapsed.” A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,APPLE INC (2010-08-19),https://lens.org/079-976-547-572-928,Granted Patent,yes,14,14,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F12/00;;G06F13/00;;G06F13/28,711/135;;711/118,2,0,,,"European Search Report mailed Jan. 16, 2012 for European App. No. 11177983, 7 pages.;;International Search Report and Written Opinion from PCT/US 11/61197, dated Mar. 29, 2012, Apple Inc., 9 pages.",ACTIVE
314,SG,A,SG 11201803403X A,096-440-134-351-378,2018-06-28,2018,SG 11201803403X A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF",,BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/096-440-134-351-378,Unknown,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,PENDING
315,WO,A1,WO 2012/024158 A1,112-432-102-340-568,2012-02-23,2012,US 2011/0047389 W,2011-08-11,US 86050510 A,2010-08-20,COMBINING WRITE BUFFER WITH DYNAMICALLY ADJUSTABLE FLUSH METRICS,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;LILLY BRIAN P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/112-432-102-340-568,Patent Application,yes,3,1,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,PENDING
316,US,A1,US 2012/0047332 A1,044-308-165-293-903,2012-02-23,2012,US 86050510 A,2010-08-20,US 86050510 A,2010-08-20,Combining Write Buffer with Dynamically Adjustable Flush Metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as “collapsed.” A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,APPLE INC (2010-08-19),https://lens.org/044-308-165-293-903,Patent Application,yes,5,43,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F12/08;;G06F3/00;;G06F12/00,711/135;;710/57;;711/142;;X711E12001;;X711E12022,0,0,,,,ACTIVE
317,MX,A,MX 2013001941 A,138-215-305-726-404,2013-03-18,2013,MX 2013001941 A,2011-08-11,US 86050510 A;;US 2011/0047389 W,2010-08-20,COMBINING WRITE BUFFER WITH DYNAMICALLY ADJUSTABLE FLUSH METRICS.,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC,LILLY BRIAN P;;BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/138-215-305-726-404,Patent Application,no,0,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
318,EP,A1,EP 2420933 A1,174-008-171-457-694,2012-02-22,2012,EP 11177983 A,2011-08-18,US 86050510 A;;US 2011/0047389 W,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as ""collapsed."" A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.
",APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/174-008-171-457-694,Patent Application,yes,1,2,1,17,0,G06F12/0895,G06F12/08;;G06F12/0895,,0,0,,,,DISCONTINUED
319,BR,A2,BR 112013003850 A2,063-218-335-844-481,2016-07-05,2016,BR 112013003850 A,2011-08-11,US 2011/0047389 W;;US 86050510 A,2010-08-20,buffer de escrita de combinação com medidas de esvaziamento dinamicamente ajustáveis,"buffer de escrita de combinação com medidas de esvaziamento dinamicamente ajustáveis. a presente invenção refere-se a um buffer de escrita de combinação que, em uma modalidade, é configurado para manter uma ou mais medidas de esvaziamento para determinar quando é para transmitir operações de escrita a partir de entradas de buffer. o buffer de escrita de combinação pode ser configurado para modificar dinamicamente as medidas de esvaziamento, em resposta a uma atividade no buffer de escrita, modificando as condições segundo as quais as operações de escrita são transmitidas a partir do buffer de escrita para o próximo nível mais baixo de memória. por exemplo, em uma implementação, as medidas de esvaziamento podem incluir entradas de buffer de escrita de categorização, tais como ""colapsado"". uma entrada de buffer de escrita colapsado e as operações de escrita colapsadas ali podem incluir pelo menos uma operação de escrita que tenha dados sobrescritos que foram escritos por uma operação de escrita prévia na entrada de buffer. em uma outra implementação, a combinação do buffer de escrita pode manter o limite de ocupação plena de buffer como uma medida de esvaziamento e pode ajustá-lo ao longo do tempo, com base na ocupação plena de buffer real.",APPLE INC,BEAUMONT-SMITH ANDREW J;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;BANNON PETER J;;GUNNA RAMESH;;WEN SHIH-CHIEH R;;YEH TSE-YU;;LIEN WEI-HAN,,https://lens.org/063-218-335-844-481,Patent Application,no,0,0,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F13/00,,0,0,,,,ACTIVE
320,US,A1,US 2017/0165667 A1,065-306-597-276-202,2017-06-15,2017,US 201615359115 A,2016-11-22,US 201615359115 A;;US 201562258957 P;;US 201662423627 P,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/065-306-597-276-202,Patent Application,yes,3,17,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00;;B01J19/00;;G01N27/447,,0,0,,,,ACTIVE
321,WO,A1,WO 2017/091601 A1,095-964-688-624-607,2017-06-01,2017,US 2016/0063387 W,2016-11-22,US 201562258957 P;;US 201662423627 P,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/095-964-688-624-607,Patent Application,yes,5,12,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,2,2,006-661-858-020-00X;;009-280-318-383-117,19903557;;10.1016/s0076-6879(09)64011-8;;pmc4196316;;10.1038/nprot.2010.139;;pmc3897936;;21127482,"RITCHIE ET AL.: ""Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs"", METHODS ENZYMOL., vol. 464, 2009, pages 211 - 231, XP009191014, DOI: doi:10.1016/S0076-6879(09)64011-8;;KLOXIN, A. M.; TIBBITT, M. W.; ANSETH, K. S.: ""Synthesis of photodegradable hydrogels as dynamically tunable cell culture platforms"", NAT. PROTOC., vol. 5, no. 12, 2010, pages 1867 - 1887",PENDING
322,FR,B1,FR 2733995 B1,028-067-700-087-841,1997-07-25,1997,FR 9505489 A,1995-05-09,FR 9505489 A,1995-05-09,"INHIBITEURS DE L'INACTIVATION DE NEUROPEPTIDES ENDOGENES NOTAMMENT LA CHOLECYSTOKININE, LEURS PROCEDES DE PREPARATION LEUR UTILISATION COMME MEDICAMENTS ET PROCEDE DE CRIBLAGE DE MEDICAMENTS",A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE RECH MED,ROSE CHRISTIANE HARET;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW NJ;;CHAN SUZANNE,,https://lens.org/028-067-700-087-841,Granted Patent,no,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,EXPIRED
323,AU,A1,AU 2016/361413 A1,123-900-667-193-503,2018-05-17,2018,AU 2016/361413 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"In situ-generated microfluidic isolation structures, kits and methods of use thereof","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER LS;;LIONBERGER TROY A;;LOWE JR RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/123-900-667-193-503,Patent Application,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,ACTIVE
324,CA,A1,CA 3004919 A1,038-834-957-194-383,2017-06-01,2017,CA 3004919 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/038-834-957-194-383,Patent Application,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,PENDING
325,US,A1,US 2013/0103906 A1,150-302-349-816-698,2013-04-25,2013,US 201213709649 A,2012-12-10,US 201213709649 A;;US 86050510 A,2010-08-20,Combining Write Buffer with Dynamically Adjustable Flush Metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as “collapsed.” A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC;;APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/150-302-349-816-698,Patent Application,yes,3,10,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F12/08,711/135,0,0,,,,ACTIVE
326,FR,A1,FR 2733995 A1,120-993-421-083-423,1996-11-15,1996,FR 9505489 A,1995-05-09,FR 9505489 A,1995-05-09,"INHIBITEURS DE L'INACTIVATION DE NEUROPEPTIDES ENDOGENES NOTAMMENT LA CHOLECYSTOKININE, LEURS PROCEDES DE PREPARATION LEUR UTILISATION COMME MEDICAMENTS ET PROCEDE DE CRIBLAGE DE MEDICAMENTS",Inhibitors of a membrane tripeptidylpeptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinin are described.,INST NAT SANTE RECH MED,ROSE CHRISTIANE HARET;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW NJ;;CHAN SUZANNE,,https://lens.org/120-993-421-083-423,Patent Application,no,2,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,6,6,048-568-390-415-192;;066-934-244-944-221;;041-501-621-975-277;;107-622-901-027-275;;074-170-684-885-010;;001-782-576-334-018,10.1007/bf00966768;;8396212;;10.1073/pnas.85.21.8326;;3186727;;pmc282422;;10.1042/bj3040517;;pmc1137522;;7998988;;1670990;;10.1021/bi00215a025;;3511062;;10.1016/s0021-9258(17)35951-3;;10.1006/abbi.1994.1442;;7979365,"WILSON, C. ET AL: ""Purification and characterization of tripeptidylpeptidase-II from post-mortem human brain"", NEUROCHEM. RES. (1993), 18(7), 743-9 CODEN: NEREDZ;ISSN: 0364-3190;;C. ROSE ET AL: ""A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 85, WASHINGTON US, pages 8326 - 8330;;B. TOMKINSON: ""Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing"", BIOCHEMICAL JOURNAL, vol. 304, pages 517 - 523;;B. TOMKINSON AND A-K JONSSON: ""Characterization of cDNA for human tripeptidyl peptidase II"", BIOCHEMISTRY, vol. 30, pages 168 - 174;;R-M BALÖW ET AL: ""Purification, substrate specificity, and classification of tripeptidyl peptidase II"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 261, no. 5, MD US, pages 2409 - 2417;;TOMKINSON, BIRGITTA ET AL: ""Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II"", ARCH. BIOCHEM. BIOPHYS. (1994), 314(2), 276-9 CODEN: ABBIA4;ISSN: 0003-9861",EXPIRED
327,US,B2,US 8566528 B2,188-292-432-304-776,2013-10-22,2013,US 201213709649 A,2012-12-10,US 201213709649 A;;US 86050510 A,2010-08-20,Combining write buffer with dynamically adjustable flush metrics,"In an embodiment, a combining write buffer is configured to maintain one or more flush metrics to determine when to transmit write operations from buffer entries. The combining write buffer may be configured to dynamically modify the flush metrics in response to activity in the write buffer, modifying the conditions under which write operations are transmitted from the write buffer to the next lower level of memory. For example, in one implementation, the flush metrics may include categorizing write buffer entries as “collapsed.” A collapsed write buffer entry, and the collapsed write operations therein, may include at least one write operation that has overwritten data that was written by a previous write operation in the buffer entry. In another implementation, the combining write buffer may maintain the threshold of buffer fullness as a flush metric and may adjust it over time based on the actual buffer fullness.",APPLE INC,BANNON PETER J;;BEAUMONT-SMITH ANDREW J;;GUNNA RAMESH B;;LIEN WEI-HAN;;LILLY BRIAN P;;PATWARDHAN JAIDEV P;;WEN SHIH-CHIEH R;;YEH TSE-YU,,https://lens.org/188-292-432-304-776,Granted Patent,yes,17,1,16,17,0,G06F12/08;;G06F12/0804;;G06F12/0891;;G06F12/0804;;G06F12/0897;;G06F12/0897;;G06F12/127;;G06F12/127;;G06F2212/1016;;G06F2212/1016;;G06F2212/502;;G06F2212/502,G06F12/00;;G06F13/00;;G06F13/28,711/135;;711/118,3,0,,,"European Search Report mailed Jan. 16, 2012 for European Application No. 11177983, 7 pages.;;International Search Report and Written Opinion from related Application No. PCT/US11/61197, dated Mar. 29, 2012, 9 pages.;;Office Action and translation thereof in Korean Patent Application No. 10-2011-83108, Mar. 29, 2013, pp. 1-7.",ACTIVE
328,CN,A,CN 115532189 A,070-564-484-033-610,2022-12-30,2022,CN 202210895775 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;CN 201680079750 A;;US 2016/0063387 W,2015-11-23,"In-situ generated microfluidic isolation structures, kits and methods of use thereof","In situ generated microfluidic isolation structures including a cured polymer network, methods of making and using, compositions, and kits are described. The ability to introduce various isolation structures, including fences and barriers, in real time provides improved methods of micro-object manipulation in microfluidic devices. The isolation structure generated in situ can be installed permanently or temporarily.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D JR;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/070-564-484-033-610,Patent Application,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01J19/00;;B01L3/00;;G01N27/447,,0,0,,,,PENDING
329,AU,B2,AU 2016/361413 B2,084-786-235-827-526,2022-04-14,2022,AU 2016/361413 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"In situ-generated microfluidic isolation structures, kits and methods of use thereof","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE JR RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/084-786-235-827-526,Granted Patent,no,3,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,ACTIVE
330,US,A1,US 2023/0182136 A1,153-897-640-263-499,2023-06-15,2023,US 202318164124 A,2023-02-03,US 202318164124 A;;US 201615359115 A;;US 201562258957 P;;US 201662423627 P,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NON-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE JR RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/153-897-640-263-499,Patent Application,yes,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00;;B01J19/00;;G01N27/447,,0,0,,,,PENDING
331,AU,A1,AU 2022/205213 A1,042-679-135-592-494,2022-08-04,2022,AU 2022/205213 A,2022-07-13,AU 2022/205213 A;;AU 2016/361413 A;;US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"In situ-generated microfluidic isolation structures, kits and methods of use thereof","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE JR RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/042-679-135-592-494,Patent Application,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,PENDING
332,CN,A,CN 108495712 A,189-884-944-838-38X,2018-09-04,2018,CN 201680079750 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"In situ-generated microfluidic isolation structures, kits and methods of use thereof","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures maybe permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D JR;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/189-884-944-838-38X,Patent Application,no,4,8,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,PENDING
333,CA,A1,CA 3176018 A1,002-181-558-914-548,2016-10-27,2016,CA 3176018 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;CA 2982252 A,2015-04-22,MICROFLUIDIC DEVICE FOR CULTURING BIOLOGICAL CELLS AND METHODS OF USE THEREOF,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON;;WHITE MARK;;NEVILL J TAMER;;WANG GANG;;MCFARLAND ANDREW;;MALLEO DANIELE;;BREINLINGER KEITH;;GUAN XIAO;;CHAPMAN KEVIN,,https://lens.org/002-181-558-914-548,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,PENDING
334,EP,A1,EP 3380238 A1,169-363-122-247-602,2018-10-03,2018,EP 16810547 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"IN SITU-GENERATED MICROFLUIDIC ISOLATION STRUCTURES, KITS AND METHODS OF USE THEREOF",,BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D JR;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/169-363-122-247-602,Patent Application,yes,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00,,0,0,,,,PENDING
335,US,B2,US 11666913 B2,154-201-014-345-17X,2023-06-06,2023,US 201615359115 A,2016-11-22,US 201615359115 A;;US 201562258957 P;;US 201662423627 P,2015-11-23,"In situ-generated microfluidic isolation structures, kits and methods of use thereof","In situ-generated microfluidic isolation structures incorporating a solidified polymer network, methods of preparation and use, compositions and kits therefor are described. The ability to introduce in real time, a variety of isolating structures including pens and barriers offers improved methods of micro-object manipulation in microfluidic devices. The in situ-generated isolation structures may be permanently or temporarily installed.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN-LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE JR RANDALL D;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/154-201-014-345-17X,Granted Patent,yes,148,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01J19/00;;B01L3/00;;G01N27/447,,44,32,030-388-628-647-910;;001-348-008-504-03X;;050-937-189-884-416;;052-418-097-701-019;;007-005-133-654-671;;070-119-699-022-868;;137-846-480-770-896;;001-976-582-932-87X;;144-152-510-051-946;;052-079-447-710-123;;065-550-828-594-107;;080-293-702-821-06X;;000-407-812-114-172;;005-030-097-899-437;;108-875-032-328-894;;059-695-897-240-003;;025-552-981-335-839;;124-837-366-319-712;;007-105-444-215-64X;;014-519-804-283-974;;072-764-419-725-185;;007-614-808-197-290;;019-928-714-899-395;;005-203-528-116-83X;;024-092-156-625-86X;;035-843-961-892-251;;008-056-699-123-331;;070-117-249-244-878;;079-854-694-316-822;;034-411-322-041-738;;000-113-129-234-184;;056-570-790-812-579,10.1038/35007047;;10766238;;12217035;;10.1021/bm0255037;;10.1038/nature03831;;16034413;;10.1039/b505884h;;16372078;;10.1039/b711874k;;18030388;;10.1016/j.biomaterials.2008.04.040;;pmc2490817;;18486205;;19122836;;pmc2575411;;10.1016/j.mser.2008.04.004;;10.1109/tbcas.2009.2031329;;20543904;;pmc2883274;;10.1016/j.biomaterials.2009.08.055;;pmc2896013;;19783300;;pmc3006031;;10.1021/bm100792y;;21028794;;pmc3190639;;21809821;;10.1021/ac2011153;;10.1016/j.polymer.2013.02.023;;pmc3826471;;10.1089/ten.teb.2012.0716;;23541134;;10.1021/la203844v;;22081885;;10.1002/elps.201000208;;20872614;;10.1016/j.aca.2013.09.004;;24120162;;22437479;;10.1039/c2lc21273k;;17186633;;10.1021/ac069490p;;10.1109/28.585856;;20011619;;pmc2790288;;10.1109/28.585855;;10.1109/sensor.2009.5285764;;pmc3857040;;24310428;;10.3390/pharmaceutics3010107;;15580587;;10.1002/bit.20289;;10.1063/1.2747187;;10.1039/b704602b;;17538709;;10.1039/c1lc20019d;;21445442;;10.1016/j.jcis.2011.10.035;;22093871;;10.1007/s10404-013-1291-9;;10.1109/memsys.2013.6474200;;10.1039/c3an00946g;;23939026;;pmc3857027;;28809210;;pmc5452316;;10.3390/ma6041285;;10.1016/j.aca.2005.12.037;;10.1021/bm100137q;;pmc3050024;;20355705,"European Patent Office, International Search Report by the International Searching Authority for related PCT/US2016/063387, dated Mar. 31, 2017, 7 pgs.;;European Patent Office, Written Opinion by the International Searching Authority for related PCT/US2016/063387, dated May 29, 2018, 12 pgs.;;European Patent Office, International Report on Patentability by the International Searching Authority for related PCT/US2016/063387, dated , 13 pgs.;;Beebe et al., Functional Hydrogel Structures for Autonomous Flow Control inside Microfluidic Channels, Nature 404:588-90 (2000).;;Betre et al., Characterization of a Genetically Engineered Polypeptide for Cartilaginous Tissue Repair, Biomacromolecules 3:910-16 (2002).;;Folk et al., Hydrogel Microvalves with Short Response Time, 226 American Chemical Society National Meeting, New York (2003).;;Chiou et al., Massively parallel manipulation of single cells and microparticles using optical images, Nature 436:370-73 (2005).;;Fuchs, Lab on a Chip 6:121-26 (2006).;;Nevill et al., Integrated microfluidic cell culture and lysis on a chip, Lab on a Chip 7:1689-95 (2007).;;Jongpaiboonkit et al., An adaptable hydrogel array format for 3-dimensional cell culture and analysis , Biomaterials 29:3346-3356 (2008).;;Chow et al., Peptide-based polymers in biomedicine and biotechnology , Materials Science and Engineering 62:125-155 (2008).;;Valley et al., Optoelectronic Tweezers as a Tool for Parallel Single-Cell Manipulation and Stimulation, IEEE Transactions on Biomedical Circuits and Systems 3(6):424-30 (2009).;;Fairbanks et al., Photoinitiated Polymerization of Peg-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: polymerization rate and cytocompatibility, Biomaterials, 30(35): 6702-6707 (2009).;;Lee et al., Development of Macroporous PEG Hydrogel Arrays within Microfluidic Channels , Biomacromolecules 13:11(12): 3316-3324 (2010).;;Chung et al., Imaging single-cell signaling dynamics with a deterministic high-density single-cell trap array, Anal. Chem.83(18):7044-7052 (2011).;;Meng et al., A Review of Stimuli-responsive shape memory polymer composites , Polymer 54:2199-2221 (2013).;;Vats et al., Dynamic Manipulation of Hydrogels to Control Cell Behavior: A Review, Tissue Engineering: Part B 19(6): 455-469 (2013).;;Zhang et al., “Azide Functional Monolayers Grafted to a Germanium Surface: Model Substrates for ATR-IR Studies of Interfacial Click Reactions,” Langmuir, Vo. 28, No. 1, Nov. 14, 2011, abstract (2 pages).;;Zhang, Z. et al. “‘Click’ chemistry-based surface modification of poly(dimethylsiloxane) for protein separation in a microfluidic chaip” ELECTROPHORESIS, Sep. 20, 2010, vol. 31, No. 18, pp. 3129-3136.;;Kleparnik, K. et al., “Recent advances in the development of single cell analysis—A review,” Analytica Chimica Acta, 2013, 800, pp. 12-21.;;JP2007108087A, Sugiura et al. (machine translation), publication date Apr. 26, 2007, Photo-Responsive Gel Material, Micro Valve, and Microchip, 8 pages.;;Chen et al., Microfluidic approaches for cancer cell detection, characterization, and separation, Lab on a Chip 12:1753 (2012).;;Chiou_DisseilaLion UC Berkeley “Massively Parallel Optical Manipulation of Single Cells, Micro- and Nano-particles an Optoelectronic Devices” 2005.;;Dicarlo et al., “Dynamic Single Cell Analysis for Quantitative Biology,” Analytical Chemistry (Dec. 1, 2006), pp. 7918-7925.;;Gascoyne, Peter et al., “Dielectrophoretic Separation of Cancer Cells from Blood”, IEEE Trans Ind Appl. 1997, vol. 33(3), pp. 67-678, Dec. 2009.;;Hsu, Hy et al., “Sorting of Differentiated Neurons Using Phototransistor-Based Optoelectronic Tweezers for Cell Replacement Therapy of Neurodegenerative Diseases”, Transducers 2009, Denver, CO USA Jun. 2009, download fated Nov. 23, 2009 from IEEE Xplore, 4 pages.;;Hulkower, Keren I and Renee L. Herber “Cell Migration and Invasion Assays as Tools for Drug Discovery” Pharmaceutics (2011) 3, 107-124; doi:10.3390/pharmaceutics3010107.;;Hung et al., Continuous Perfusion Microfluidic Cell Culture Array for High-Throughput Cell-Based Assays, Biotech and Bioengineering 89(1): 1-8 (2004). Dec. 3, 2004.;;Liescu et al., Continuous Field-Flow Separation of Particle Populations in a Dielectrophoretic Chip with Three Dimensional Electrodes, Applied Physics Letters 90:234104 (2007).;;Jamshidi, Arash and Wu, Ming C.; Optoelectronic Manipulation, Assembly, and Patterning of Nanoparticles Dissertation (University of California, Berkeley); Technical Report No. UCB/EECS-2009-165 (Dec. 10, 2009).;;Kim et al., “A practical guide to microfluidic perfusion culture of adherent mammalian” Lab on a Chip 11(7): 681-684. Jun. 7, 2007.;;KIPO computer-generated English language translation of KR 20100008222A_Kyun, Nov. 3, 2010.;;Lee et al., Microfluidic Chemostat and Turbidostat with Flow Rate, Oxygen and Temperature Control for Dynamic Continuous Culture , Lab on a Chip 11:1730-39 (2011).;;Lee, Gi-Hun et al. “Separation and sorting of cells in microsystems using physical principles”, Journal of Micromechanics & Microengineering, Institute of Physics Publishing, Bristol, GB, vol. 26, No. 1, Dec. 16, 2015 (Dec. 16, 2015), p. 13003.;;Papageorgiou, D.P. et al. “Superior performance of multilayered fluoropolymer films in low voltage electrowetting” Journal of Colloid Interface Science, Oct. 25, 2011, vol. 368, No. 1, pp. 592-598.;;Sajeesh, P. et al., “Particle separation and sorting in microfluidic devices: a review” Microfluid Nanofluid (2014) vol. 17, pp. 1-52.;;Sochol, et al. (2013). Single-layer “domino” diodes via optofluidic lithography for ultra-low Reynolds number applications. Proceedings of the IEEE International Conference on Micro Electro Mechanical Systems (MEMS). 2. 153-156. 10.1109/MEMSYS.2013.6474200.;;Somaweera H. et al., Generation of a Chemical Gradient Across an Array of 256 Cell Cultures in a Single Chip. Analyst, Oct. 7, 2013, vol. 138, No. 19, pp. 5566-5571.;;Sun, Jinchen and Tan, Huaping; “Alginate-Based Biomaterials for Regenerative Medicine Applications”; Materials (2013) 6, 1285-1309.;;WO2010147078, University of Tokyo, Machine Translation, Dec. 23, 2010, 12 pages.;;Xu, Guoling et al.,. Recent Trends in Dielectrophoresis, Informacije MIDEM, 2010, vol. 40, Issue No. 4, pp. 253-262.;;Yi et al., “Microfluidics technology for manipulation and analysis of biological cells,” Analytica Chimica Acta 560 (2006), pp. 1-23.;;Zustiak, Silviya P. and Leach, Jennie B.; Hydrolytically degradable poly(ethylene glycol) hydrogelscaffolds with tunable degradation and mechanical properties; Biomacromolecules May 1, 20100; 11(5): 1348-1357.;;Decision to Grant issued in corresponding Japanese Patent Application No. 2021-193586 dated Jan. 5, 2023 (with Machine Translation).",ACTIVE
336,KR,A,KR 20180085783 A,112-722-921-765-434,2018-07-27,2018,KR 20187017925 A,2016-11-22,US 201562258957 P;;US 201662423627 P;;US 2016/0063387 W,2015-11-23,"인 시츄-생성된 미세유체 격리 구조체들, 키트들, 및 그 이용 방법들","고체화된 폴리머 네트워크를 편입시키는 인 시츄-생성된 미세유체 격리 구조체들, 준비 및 이용의 방법들, 이를 위한 조성물들, 및 키트들이 설명된다. 펜들 및 장벽들을 포함하는 다양한 격리 구조체들을 실시간으로 도입하기 위한 능력은 미세유체 디바이스들에서의 미세-객체 조작의 개선된 방법들을 제공한다. 인 시츄-생성된 격리 구조체들은 영구적으로 또는 일시적으로 설치될 수도 있다.",BERKELEY LIGHTS INC,BEAUMONT KRISTIN G;;DING NAN LINDA;;KURZ VOLKER L S;;LIONBERGER TROY A;;LOWE RANDALL D JR;;MALLEO DANIELE;;MCFARLAND ANDREW W;;NEVILL J TANNER;;WANG XIAOHUA,,https://lens.org/112-722-921-765-434,Patent Application,no,0,0,22,22,0,B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2300/16;;B01L2400/0424;;B01L2400/0677;;B01L2400/08;;B01L3/502738;;B01L3/502761;;B01L2200/0668;;B01L2300/0816;;B01L2300/0864;;B01L2400/0424;;B01L2400/0677;;B01L3/502738;;B01L2300/0816;;B01L2400/0677;;B01L2300/16;;B01L2400/08;;B01L3/5023;;B01L2200/0668;;B01L3/502753;;B01L3/502761;;B01L3/502707;;B01L2400/0424;;B01J19/0093;;G01N27/44791;;B01L2300/0864;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502738;;B01L3/502753;;B01L3/502761;;G01N27/44791;;B01L2300/0864;;B01L2300/16;;B01L2400/08;;B01L2400/0424;;B01L2400/0424;;B01L2300/0816;;B01L3/502761;;B01L2300/0864;;B01L2400/0677;;B01L3/502738;;B01L2200/0668;;B01J19/0093;;B01L3/5023;;B01L3/502707;;B01L3/502753;;B01L2300/16;;B01L2400/08;;G01N27/44791,B01L3/00;;B01J19/00;;G01N27/447,,0,0,,,,PENDING
337,CA,A1,CA 2221035 A1,000-563-812-473-823,1996-11-14,1996,CA 2221035 A,1996-05-09,FR 9505489 A,1995-05-09,TRIPEPTIDYLPEPTIDASE INHIBITORS,Inhibitors of a membrane tripeptidylpeptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinin are described.,INST NAT SANTE RECH MED,MOORE ANDREW N J;;BAMBAL RAMESH BABARAO;;LEBLOND BERTRAND;;CHAN SUZANNE;;BOURGEAT PIERRE;;ROSE CHRISTIANE;;GANELLIN CHARON ROBIN;;BISHOP PAUL BEAUMONT;;LIHUA ZHAO;;VARGAS FROYLAN;;SCHWARTZ JEAN-CHARLES,,https://lens.org/000-563-812-473-823,Patent Application,no,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,DISCONTINUED
338,US,B1,US 6403561 B1,190-275-273-858-444,2002-06-11,2002,US 93005598 A,1998-02-19,FR 9600700 W;;FR 9505489 A,1995-05-09,Tripeptidylpeptidase inhibitors,"
    A compound of formula 

    wherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin. 
",INST NAT SANTE RECH MED,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH B;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;ZHAO LIHUA;;CHAN SUZANNE,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (1998-02-10),https://lens.org/190-275-273-858-444,Granted Patent,yes,2,4,16,16,8,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,514/19;;562/553;;562/575;;540/476,10,9,048-568-390-415-192;;041-501-621-975-277;;001-782-576-334-018;;107-622-901-027-275;;074-170-684-885-010;;001-782-576-334-018;;048-568-390-415-192;;066-934-244-944-221;;041-501-621-975-277,10.1007/bf00966768;;8396212;;10.1042/bj3040517;;pmc1137522;;7998988;;10.1006/abbi.1994.1442;;7979365;;1670990;;10.1021/bi00215a025;;3511062;;10.1016/s0021-9258(17)35951-3;;10.1006/abbi.1994.1442;;7979365;;10.1007/bf00966768;;8396212;;10.1073/pnas.85.21.8326;;3186727;;pmc282422;;10.1042/bj3040517;;pmc1137522;;7998988,"Neurochemical Res. vol. 18, No. 7, 1993, Wilson et al,pp. 743-749.;;Proc.Natl,Acad Sci,USA,vol. 85, pp.8326-8330, 11/88 Neurobiology.;;Biochem, J. 1994, pp. 517-523, 304, Tomkinson.;;Archives of Biochemistry, vo. 314,No. 2, 11/1 pp. 276-279 1994.;;Biochemistry (1991), vol. 30, p. 168-174, Tomkinson et al, ""Characterization . . . Peptidase II"".;;Journal of Biological Chemistry (1986), vol. 261, No. 5 p. 2409-2417 Balow et al, ""Purification . . . Peptidase II"".;;Arch. Biochem. Biophy (1994), vol. 314, No. 2, p. 276-279, Tomkinson et al ""Use . . . Peptidase II"".;;Neurochem Res (1993), vol. 18, No. 7, 743-749, Wilson et al , ""Purification . . . Human Brain"".;;Proc. Natl. Acad. Sci USA, (1988), vol. 85, p. 8326-8330, Rose et al A Serine . . . Brain.;;Biochemical Journal, (1994), vol. 304, p. 517-523, Tomkinson, ""Characterization . . . Splicing"".",EXPIRED
339,WO,A3,WO 1996/035805 A3,042-319-307-061-405,1997-01-30,1997,FR 9600700 W,1996-05-09,FR 9505489 A,1995-05-09,TRIPEPTIDYLPEPTIDASE INHIBITORS,Inhibitors of a membrane tripeptidylpeptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinin are described.,INST NAT SANTE RECH MED;;ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,,https://lens.org/042-319-307-061-405,Search Report,yes,7,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,7,7,048-568-390-415-192;;066-934-244-944-221;;041-501-621-975-277;;107-622-901-027-275;;074-170-684-885-010;;001-782-576-334-018;;001-129-157-161-202,10.1007/bf00966768;;8396212;;10.1073/pnas.85.21.8326;;3186727;;pmc282422;;10.1042/bj3040517;;pmc1137522;;7998988;;1670990;;10.1021/bi00215a025;;3511062;;10.1016/s0021-9258(17)35951-3;;10.1006/abbi.1994.1442;;7979365;;10.1038/380403a0;;8602240,"WILSON, C. ET AL: ""Purification and characterization of tripeptidylpeptidase-II from post-mortem human brain"", NEUROCHEM. RES. (1993), 18(7), 743-9 CODEN: NEREDZ;ISSN: 0364-3190, XP000562808;;C. ROSE ET AL: ""A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brain"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 85, WASHINGTON US, pages 8326 - 8330, XP002018477;;B. TOMKINSON: ""Characterization of cDNA for murine tripeptidyl-peptidase II reveals alternative splicing"", BIOCHEMICAL JOURNAL, vol. 304, pages 517 - 523, XP000562825;;B. TOMKINSON AND A-K JONSSON: ""Characterization of cDNA for human tripeptidyl peptidase II"", BIOCHEMISTRY, vol. 30, pages 168 - 174, XP000561825;;R-M BALÖW ET AL: ""Purification, substrate specificity, and classification of tripeptidyl peptidase II"", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 261, no. 5, MD US, pages 2409 - 2417, XP002018480;;TOMKINSON, BIRGITTA ET AL: ""Use of a dehydroalanine-containing peptide as an efficient inhibitor of tripeptidyl peptidase II"", ARCH. BIOCHEM. BIOPHYS. (1994), 314(2), 276-9 CODEN: ABBIA4;ISSN: 0003-9861, XP000562811;;C.ROSE E.A.: ""Characterization and inhibition of a CCK-inactivating serine protease"", NATURE, vol. 380, 4 April 1996 (1996-04-04), LONDON GB, pages 403 - 409, XP002018482",PATENTED
340,PT,E,PT 828851 E,163-601-212-264-767,2005-11-30,2005,PT 96916181 T,1996-05-09,FR 9505489 A,1995-05-09,INIBIDORES DE TRIPEPTIDILPEPTIDASE,A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE RECH MED;;INSERM E,SCHWARTZ JEAN-CHARLES;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;CHRISTIANE ROSE;;FROYLAN VARGAS;;PIERRE BOURGEAT;;BEAUMONT BISHOP PAUL;;BABARAO BAMBAL RAMESH;;MOORE ANDREW N J;;SUZANNE CHAN;;ZHAO LIHUA,,https://lens.org/163-601-212-264-767,Granted Patent,no,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,EXPIRED
341,EP,A2,EP 0828851 A2,017-029-957-516-174,1998-03-18,1998,EP 96916181 A,1996-05-09,FR 9600700 W;;FR 9505489 A,1995-05-09,TRIPEPTIDYLPEPTIDASE INHIBITORS,A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE RECH MED,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,INSTITUT NATIONAL DE LA SANTE ETDE LA RECHERCHE ME (2004-04-07);;BIOPROJET (2004-04-07),https://lens.org/017-029-957-516-174,Patent Application,yes,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,EXPIRED
342,AT,T1,AT E299948 T1,030-557-334-308-90X,2005-08-15,2005,AT 96916181 T,1996-05-09,FR 9505489 A;;FR 9600700 W,1995-05-09,TRIPEPTIDYLPEPTIDASE-INHIBITOREN,A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE RECH MED;;BIOPROJET SOC CIV,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,,https://lens.org/030-557-334-308-90X,Granted Patent,no,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,EXPIRED
343,DK,T3,DK 0828851 T3,056-642-903-033-708,2005-10-24,2005,DK 96916181 T,1996-05-09,FR 9505489 A;;FR 9600700 W,1995-05-09,Tripeptidylpeptidaseinhibitorer,A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE RECH MED;;BIOPROJET SOC CIV,SCHWARTZ JEAN-CHARLES;;LEBLOND BERTRAND;;ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,,https://lens.org/056-642-903-033-708,Granted Patent,no,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,EXPIRED
344,EP,B1,EP 0828851 B1,127-880-412-335-987,2005-07-20,2005,EP 96916181 A,1996-05-09,FR 9600700 W;;FR 9505489 A,1995-05-09,TRIPEPTIDYLPEPTIDASE INHIBITORS,A compound of formulawherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin.,INST NAT SANTE ETDE LA RECH ME;;BIOPROJET SOC CIV,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,INSTITUT NATIONAL DE LA SANTE ETDE LA RECHERCHE ME (2004-04-07);;BIOPROJET (2004-04-07),https://lens.org/127-880-412-335-987,Granted Patent,yes,0,0,16,16,0,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,7,6,050-297-087-289-955;;024-128-406-080-80X;;032-933-257-046-123;;031-161-566-219-370;;023-121-462-981-647;;064-078-102-698-588,6694511;;10.1016/0024-3205(84)90331-x;;1791971;;10.1016/0304-3940(91)90353-u;;6288173;;10.1016/0006-8993(82)91135-0;;10.1002/ajmg.10408;;12116180;;8292682;;10.1016/0006-3223(93)90067-n;;1574565;;10.1017/s0033291700032700,"LIFE SCIENCES, vol. 34, 1984, pages 67 - 72;;J. CLIN. PSYCHIATRY, vol. 52, no. 10, October 1991 (1991-10-01), pages 21 - 28;;NEUROSCIENCE LETTERS, vol. 131, 1991, pages 129 - 134;;BRAIN RESEARCH, vol. 243, 1982, pages 176 - 179;;AM. JOURN. MEDICAL GENETICS, vol. 114, 2002, pages 479 - 482;;BIOL. PSYCHIATRY, vol. 34, 1993, pages 781 - 790;;PSYCHOLOGICAL MEDICINE, vol. 22, 1992, pages 37 - 43",EXPIRED
345,US,A1,US 2003/0027743 A1,174-751-094-201-927,2003-02-06,2003,US 96229801 A,2001-09-25,US 96229801 A;;FR 9505489 A;;US 93005598 A,1995-05-09,Tripeptidylpeptidase inhibitors,"
    A compound of the formula 

   wherein the substituents are defined as in the specification and salts or hydrates thereof is disclosed as well as a method of treating disorders associated with the inactivation or excessive degradation of cholecystokinin. 
",INST NAT SANTE RECH MED,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH B;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;ZHAO LIHUA;;CHAN SUZANNE,BIOPROJECT (2004-03-23),https://lens.org/174-751-094-201-927,Patent Application,yes,1,1,16,16,8,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,514/1;;435/24,0,0,,,,DISCONTINUED
346,WO,A2,WO 1996/035805 A2,105-649-110-042-791,1996-11-14,1996,FR 9600700 W,1996-05-09,FR 9505489 A,1995-05-09,TRIPEPTIDYLPEPTIDASE INHIBITORS,Inhibitors of a membrane tripeptidylpeptidase responsible for the inactivation of endogenous neuropeptides such as cholecystokinin are described.,INST NAT SANTE RECH MED;;ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,ROSE CHRISTIANE;;VARGAS FROYLAN;;BOURGEAT PIERRE;;SCHWARTZ JEAN-CHARLES;;BISHOP PAUL BEAUMONT;;BAMBAL RAMESH BABARAO;;GANELLIN CHARON ROBIN;;LEBLOND BERTRAND;;MOORE ANDREW N J;;CHAN SUZANNE;;LIHUA ZHAO,,https://lens.org/105-649-110-042-791,Patent Application,no,0,12,16,16,10,A61K38/00;;C07D209/42;;C07K5/06026;;C07K5/06052;;C07K5/06191;;C12Q1/37;;G01N2333/595;;A61P1/00;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;A61P3/00;;A61P3/04;;C07K5/06052;;C07K5/06026;;C07K5/06191;;C12Q1/37;;G01N2333/595;;C07D209/42;;A61K38/00,A61K31/00;;A61K38/00;;A61P1/00;;A61P3/00;;A61P3/04;;A61P21/00;;A61P25/00;;A61P25/16;;A61P25/18;;A61P25/24;;C07D209/42;;C07K5/06;;C07K5/062;;C07K5/078;;C12N15/57;;C12Q1/37,,0,0,,,,PATENTED
347,US,B2,US 11768690 B2,055-421-729-847-70X,2023-09-26,2023,US 202117532072 A,2021-11-22,US 202117532072 A;;US 202017018963 A,2020-09-11,Coprocessor context priority,"A system may include a plurality of processors and a coprocessor. A plurality of coprocessor context priority registers corresponding to a plurality of contexts supported by the coprocessor may be included. The plurality of processors may use the plurality of contexts, and may program the coprocessor context priority register corresponding to a context with a value specifying a priority of the context relative to other contexts. An arbiter may arbitrate among instructions issued by the plurality of processors based on the priorities in the plurality of coprocessor context priority registers. In one embodiment, real-time threads may be assigned higher priorities than bulk processing tasks, improving bandwidth allocated to the real-time threads as compared to the bulk tasks.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LILLY BRIAN P;;VASH JAMES;;KASSOFF JASON M;;POTNURU KRISHNA C;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;HUBERTY TYLER J;;KUMAR DEREK R,,https://lens.org/055-421-729-847-70X,Granted Patent,yes,17,0,3,3,0,G06F9/461;;G06F9/4887;;G06F9/30123;;G06F9/3851;;G06F9/3877;;G06F11/302;;G06F11/3419;;G06F11/3466;;G06F2201/88;;Y02D10/00;;G06F9/3877;;G06F9/3863;;G06F11/3024;;G06F9/4887;;G06F9/3009;;G06F9/3881;;G06F9/3836;;G06F9/3879,G06F9/38;;G06F9/30;;G06F9/48;;G06F11/30,,0,0,,,,ACTIVE
348,US,A1,US 2022/0083343 A1,177-376-498-361-713,2022-03-17,2022,US 202117532072 A,2021-11-22,US 202117532072 A;;US 202017018963 A,2020-09-11,Coprocessor Context Priority,"A system may include a plurality of processors and a coprocessor. A plurality of coprocessor context priority registers corresponding to a plurality of contexts supported by the coprocessor may be included. The plurality of processors may use the plurality of contexts, and may program the coprocessor context priority register corresponding to a context with a value specifying a priority of the context relative to other contexts. An arbiter may arbitrate among instructions issued by the plurality of processors based on the priorities in the plurality of coprocessor context priority registers. In one embodiment, real-time threads may be assigned higher priorities than bulk processing tasks, improving bandwidth allocated to the real-time threads as compared to the bulk tasks.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LILLY BRIAN P;;VASH JAMES;;KASSOFF JASON M;;POTNURU KRISHNA C;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;HUBERTY TYLER J;;KUMAR DEREK R,,https://lens.org/177-376-498-361-713,Patent Application,yes,12,2,3,3,0,G06F9/461;;G06F9/4887;;G06F9/30123;;G06F9/3851;;G06F9/3877;;G06F11/302;;G06F11/3419;;G06F11/3466;;G06F2201/88;;Y02D10/00;;G06F9/3877;;G06F9/3863;;G06F11/3024;;G06F9/4887;;G06F9/3009;;G06F9/3881;;G06F9/3836;;G06F9/3879,G06F9/38;;G06F9/30;;G06F9/48;;G06F11/30,,0,0,,,,ACTIVE
349,US,B1,US 11210104 B1,067-964-223-671-600,2021-12-28,2021,US 202017018963 A,2020-09-11,US 202017018963 A,2020-09-11,Coprocessor context priority,"A system may include a plurality of processors and a coprocessor. A plurality of coprocessor context priority registers corresponding to a plurality of contexts supported by the coprocessor may be included. The plurality of processors may use the plurality of contexts, and may program the coprocessor context priority register corresponding to a context with a value specifying a priority of the context relative to other contexts. An arbiter may arbitrate among instructions issued by the plurality of processors based on the priorities in the plurality of coprocessor context priority registers. In one embodiment, real-time threads may be assigned higher priorities than bulk processing tasks, improving bandwidth allocated to the real-time threads as compared to the bulk tasks.",APPLE INC,KESIRAJU ADITYA;;BEAUMONT-SMITH ANDREW J;;LILLY BRIAN P;;VASH JAMES;;KASSOFF JASON M;;POTNURU KRISHNA C;;BHUYAR RAJDEEP L;;CHACHICK RAN A;;HUBERTY TYLER J;;KUMAR DEREK R,APPLE INC (2020-09-09),https://lens.org/067-964-223-671-600,Granted Patent,yes,16,2,3,3,0,G06F9/461;;G06F9/4887;;G06F9/30123;;G06F9/3851;;G06F9/3877;;G06F11/302;;G06F11/3419;;G06F11/3466;;G06F2201/88;;Y02D10/00;;G06F9/3877;;G06F9/3863;;G06F11/3024;;G06F9/4887;;G06F9/3009;;G06F9/3881;;G06F9/3836;;G06F9/3879,G06F9/38;;G06F9/30;;G06F9/48;;G06F11/30,,0,0,,,,ACTIVE
350,SG,A,SG 10202100281R A,078-086-156-573-957,2021-02-25,2021,SG 10202100281R A,2016-04-22,US 201562151325 P;;US 201615135707 A,2015-04-22,MICROFLUIDIC CELL CULTURE,,BERKELEY LIGHTS INC,LOWE RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/078-086-156-573-957,Unknown,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,PENDING
351,AU,B2,AU 2016/250689 B2,078-091-559-908-850,2021-07-08,2021,AU 2016/250689 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;LOWE JR RANDALL D;;BEAUMONT KRISTIN;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/078-091-559-908-850,Granted Patent,no,2,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,ACTIVE
352,KR,A,KR 20220042490 A,124-510-727-490-618,2022-04-05,2022,KR 20227009780 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;KR 20177033726 A;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL CULTURE,"세포 성장, 생존성, 이동성, 또는 이들의 임의의 조합을 강화시키도록 구성된 기체 성분들 및 영양소들의 제공을 포함하는, 미세유체 디바이스에서 하나 이상의 생물학적 세포들을 배양하기 위한 시스템들, 방법들 및 키트들이 설명된다. 일부 실시형태들에서, 단일의 세포를 배양하는 것은 미세유체 디바이스에서 클론성 집단을 생성할 수도 있다.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/124-510-727-490-618,Patent Application,no,4,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;C12M1/00,,0,0,,,,ACTIVE
353,AU,A1,AU 2016/250689 A1,140-549-814-906-595,2017-10-26,2017,AU 2016/250689 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/140-549-814-906-595,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,ACTIVE
354,KR,A,KR 20230078838 A,016-170-454-809-529,2023-06-02,2023,KR 20237017904 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;KR 20227009780 A;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL CULTURE,"세포 성장, 생존성, 이동성, 또는 이들의 임의의 조합을 강화시키도록 구성된 기체 성분들 및 영양소들의 제공을 포함하는, 미세유체 디바이스에서 하나 이상의 생물학적 세포들을 배양하기 위한 시스템들, 방법들 및 키트들이 설명된다. 일부 실시형태들에서, 단일의 세포를 배양하는 것은 미세유체 디바이스에서 클론성 집단을 생성할 수도 있다.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/016-170-454-809-529,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;C12M1/00,,0,0,,,,DISCONTINUED
355,TW,B,TW I819383 B,030-448-455-466-960,2023-10-21,2023,TW 110136282 A,2016-04-22,US 201562151325 P,2015-04-22,Microfluidic device and method of culturing biological cells in the microfluidic device,,BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/030-448-455-466-960,Granted Patent,no,6,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,ACTIVE
356,TW,B,TW I744230 B,136-312-957-003-166,2021-11-01,2021,TW 105112686 A,2016-04-22,US 201562151325 P,2015-04-22,Microfluidic device and method of culturing biological cells in the microfluidic device,,BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/136-312-957-003-166,Granted Patent,no,6,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,ACTIVE
357,TW,A,TW 202233824 A,129-664-535-128-909,2022-09-01,2022,TW 110136282 A,2016-04-22,US 201562151325 P,2015-04-22,Microfluidic device and method of culturing biological cells in the microfluidic device,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG-FENG;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/129-664-535-128-909,Patent of Addition,no,0,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/00,,0,0,,,,ACTIVE
358,CA,A1,CA 2982252 A1,110-540-586-557-557,2016-10-27,2016,CA 2982252 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC DEVICE FOR CULTURING BIOLOGICAL CELLS AND METHODS OF USE THEROF,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/110-540-586-557-557,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
359,SG,A,SG 11201708429W A,143-966-206-877-264,2017-11-29,2017,SG 11201708429W A,2016-04-22,US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL CULTURE,,BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/143-966-206-877-264,Unknown,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
360,TW,A,TW 201643241 A,063-688-348-747-177,2016-12-16,2016,TW 105112686 A,2016-04-22,US 201562151325 P,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG-FENG;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/063-688-348-747-177,Patent of Addition,no,0,2,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/00,,0,0,,,,ACTIVE
361,AU,A1,AU 2023/201392 A1,032-669-114-559-116,2023-04-06,2023,AU 2023/201392 A,2023-03-07,AU 2023/201392 A;;AU 2021/245187 A;;AU 2016/250689 A;;US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/032-669-114-559-116,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
362,HK,A1,HK 1253068 A1,047-263-509-760-660,2019-06-06,2019,HK 18112450 A,2018-09-27,US 201562151325 P,2015-04-22,MICROFLUIDIC CELL CULTURE,,BERKELEY LIGHTS INC,RANDALL D JR LOWE;;KRISTIN BEAUMONT;;AATHAVAN KARUNAKARAN;;NATALIE MARKS;;JASON M MCEWEN;;MARK P WHITE;;J TANNER NEVILL;;GANG F WANG;;ANDREW W MCFARLAND;;DANIELE MALLEO;;KEITH J BREINLINGER;;XIAO GUAN;;KEVIN T CHAPMAN,,https://lens.org/047-263-509-760-660,Patent Application,no,0,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M/,,0,0,,,,PENDING
363,KR,A,KR 20170140305 A,173-933-755-140-238,2017-12-20,2017,KR 20177033726 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,미세유체 세포 배양,"세포 성장, 생존성, 이동성, 또는 이들의 임의의 조합을 강화시키도록 구성된 기체 성분들 및 영양소들의 제공을 포함하는, 미세유체 디바이스에서 하나 이상의 생물학적 세포들을 배양하기 위한 시스템들, 방법들 및 키트들이 설명된다. 일부 실시형태들에서, 단일의 세포를 배양하는 것은 미세유체 디바이스에서 클론성 집단을 생성할 수도 있다.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/173-933-755-140-238,Patent Application,no,4,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;B01L3/00;;C12M1/00;;C12M1/34,,0,0,,,,ACTIVE
364,CA,A1,CA 3176115 A1,050-817-501-194-609,2016-10-27,2016,CA 3176115 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;CA 2982252 A,2015-04-22,MICROFLUIDIC DEVICE FOR CULTURING BIOLOGICAL CELLS AND METHODS OF USE THEREOF,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/050-817-501-194-609,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,PENDING
365,CN,A,CN 107849505 A,085-412-546-647-602,2018-03-27,2018,CN 201680036332 A,2016-04-22,US 201562151325 P;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL STRUCTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth,viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/085-412-546-647-602,Patent Application,no,9,8,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,ACTIVE
366,EP,A1,EP 3286296 A1,001-896-313-278-574,2018-02-28,2018,EP 16783924 A,2016-04-22,US 201562151325 P;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL CULTURE,,BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/001-896-313-278-574,Patent Application,yes,0,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
367,AU,B2,AU 2021/245187 B2,074-153-019-484-781,2022-12-08,2022,AU 2021/245187 A,2021-10-07,AU 2021/245187 A;;AU 2016/250689 A;;US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured 5 to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/074-153-019-484-781,Granted Patent,no,3,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,ACTIVE
368,US,A1,US 2016/0312165 A1,120-225-186-400-940,2016-10-27,2016,US 201615135707 A,2016-04-22,US 201615135707 A;;US 201562151325 P,2015-04-22,MICROFLUIDIC CELL CULTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/120-225-186-400-940,Patent Application,yes,5,66,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;C12M1/00;;C12M3/00;;C12N5/0783;;C12N5/09;;C12N5/16,,0,0,,,,ACTIVE
369,WO,A1,WO 2016/172454 A1,171-856-706-947-247,2016-10-27,2016,US 2016/0028808 W,2016-04-22,US 201562151325 P;;US 201615135707 A,2015-04-22,MICROFLUIDIC CELL STRUCTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/171-856-706-947-247,Patent Application,yes,6,6,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
370,AU,A1,AU 2021/245187 A1,114-720-029-922-930,2021-11-04,2021,AU 2021/245187 A,2021-10-07,AU 2021/245187 A;;AU 2016/250689 A;;US 201562151325 P;;US 201615135707 A;;US 2016/0028808 W,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured 5 to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/114-720-029-922-930,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,ACTIVE
371,WO,A8,WO 2016/172454 A8,021-833-144-622-713,2017-09-08,2017,US 2016/0028808 W,2016-04-22,US 201562151325 P;;US 201615135707 A,2015-04-22,MICROFLUIDIC CELL CULTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/021-833-144-622-713,Amended Application,yes,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,0,0,,,,PENDING
372,US,B2,US 10723988 B2,043-503-181-416-827,2020-07-28,2020,US 201615135707 A,2016-04-22,US 201615135707 A;;US 201562151325 P,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/043-503-181-416-827,Granted Patent,yes,101,10,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;B01L3/00;;C12M3/00;;C12M3/06,,26,21,050-937-189-884-416;;000-113-129-234-184;;007-005-133-654-671;;014-519-804-283-974;;001-976-582-932-87X;;090-821-877-616-307;;018-037-144-133-236;;052-390-469-086-319;;024-092-156-625-86X;;065-550-828-594-107;;017-822-665-433-960;;079-854-694-316-822;;044-349-693-600-920;;007-614-808-197-290;;019-928-714-899-395;;114-395-916-459-747;;060-702-031-028-704;;124-837-366-319-712;;006-661-858-020-00X;;005-030-097-899-437;;035-843-961-892-251,10.1038/nature03831;;16034413;;10.1016/j.aca.2005.12.037;;10.1039/b711874k;;18030388;;10.1109/sensor.2009.5285764;;10.1109/tbcas.2009.2031329;;20543904;;pmc2883274;;20179823;;pmc2967183;;10.1039/b909900j;;20643968;;pmc2922239;;10.1073/pnas.0915169107;;21311817;;10.1039/c0lc00568a;;10.1039/c1lc20019d;;21445442;;pmc3190639;;21809821;;10.1021/ac2011153;;10.1016/j.aca.2013.01.025;;23622959;;10.1039/c3an00946g;;23939026;;pmc3857027;;10.1016/j.copbio.2013.10.005;;24484886;;15580587;;10.1002/bit.20289;;10.1063/1.2747187;;10.1093/humupd/dmr006;;21454356;;21515168;;10.1016/j.biomaterials.2011.02.029;;pmc3091033;;17186633;;10.1021/ac069490p;;19903557;;10.1016/s0076-6879(09)64011-8;;pmc4196316;;10.1021/la203844v;;22081885;;10.1016/j.jcis.2011.10.035;;22093871,"International Searching Authority, International Search Report and Written Opinion for PCT/US16/28808, dated Sep. 1, 2016.;;Chiou et al., Massively parallel manipulation of single cells and microparticles using optical images, Nature 436:370-73 (2005).;;Yi, Analytica Chimica Acta 560:1-23 (2006).;;Nevill et al., Integrated microfluidic cell culture and lysis on a chip, Lab on a Chip 7:1689-95 (2007).;;Hsu et al., Sorting of Differentiated Neurons using Phototransistor-based Optoelectronic Tweezers for Cell Replacement Therapy of Neurodegenerative Diseases, IEEE Conference on Transducers (Jun. 21-25, 2009).;;Valley et al., Optoelectronic Tweezers as a Tool for Parallel Single-Cell Manipulation and Stimulation, IEEE Transactions on Biomedical Circuits and Systems 3(6):424-30 (2009).;;Xu, Guolin et al,. Recent Trends in Dielectrophoresis, Informacije MIDEM, 2010, vol. 40, Issue No. 4, pp. 253-262.;;Young et al., Fundamentals of microfluidic cell culture in controlled microenvironments, Chem Soc Rev 39(3):1036-48 (2010).;;Dalvi et al., Molecular Origins of Fluorocarbon Hydrophobicity, Proceedings of the National Academy of Sciences, 107(31):13603-7 (2010).;;Valley et al., A unified platform for optoelectrowetting and optoelectronic tweezers, Lab on a Chip 11:1292-97 (2011).;;Lee et al., Microfluidic chemostat and Turbidostat with flow rate, oxygen and temperature control for dynamic continuous culture , Lab on a Chip 11:1730-39 (2011).;;Lowe,“Controlled Vapor Deposition of Azide-terminated Siloxane Monolayers: a Platform for Tailoring Oxide Surfaces”, Stanford University, Aug. 2011.;;Chung et al., Imaging single-cell signaling dynamics with a deterministic high-density single-cell trap array, Anal. Chem.83(18):7044-7052 (2011).;;Banuls et al. Chemical surface modifications for the development of silicon-based label-free integrated optical (IO) biosensors: A review.;;Somaweera et al., Generation of a Chemical Gradient Across an Array of 256 Cell Cultures in a Single Chip, Analyst., Oct. 7, 2013, vol. 138, No. 19, pp. 5566-5571.;;Mehling et al., Microfluidic Cell Culture, Curr. Op. Biotech. 25:95-102 (2014).;;Hung et al., Continuous Perfusion Microfluidic Cell Culture Array for High-Throughput Cell-Based Assays, Biotech and Bioengineering 89(1): 1-8 (2004).;;Iliescu et al., Continuous field-flow separation of particle populations in a dielectrophoretic chip with three dimensional electrodes, Applied Physics Letters 90:234104 (2007).;;Lagally et al., Parallel microfluidic arrays for SPRI detection, Proceedings of SPIE, vol. 7759, p. 77590J (2010).;;Swain et al., Advances in embryo culture platforms: novel approaches to improve preimplantation embryo development through modifications of the microenvironment, Human Reproduction Update 17(4):541-57 (2011).;;International Search Report and Written Opinion for PCT Application Serial No. PCT/US2016028808 (dated Sep. 1, 2016), 13 pages.;;Bellis S.L., Advantages of RGD Peptides for Directing Cell Association with Biomaterials, Jun. 2011, vol. 32, No. 18, pp. 4205-4210.;;Di Carlo et al.; Dynamic single-cell analysis for quantitative biology; Analytical Chemistry; pp. 7918-7925; Dec. 2006.;;Ritchie et al.; Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs; Methods Enzymol; 464; pp. 211-231; 23 pages; (Author Manuscript); Jan. 2009.;;Zhang et al., “Azide Functional Monolayers Grafted to a Germanium Surface: Model Substrates for ATR-IR Studies of Interfacial Click Reactions,” Langmuir, Vo. 28, No. 1, Nov. 14, 2011.;;Papageorgiou, D. P., et al., Superior Performance of Multilayered Fluoropolymer Films in Low Voltage Electrowetting. Journal f Colloid Interface Science, Oct. 25, 2011, vol. 368, No. 1, pp. 592-598.",ACTIVE
373,CN,A,CN 114085730 A,085-441-219-807-149,2022-02-25,2022,CN 202110967507 A,2016-04-22,US 201562151325 P;;CN 201680036332 A,2015-04-22,Microfluidic cell culture,"The application relates to microfluidic cell culture, in particular, describes systems, methods and kits for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;M P WHITE;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/085-441-219-807-149,Patent Application,no,6,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M1/36;;C12M3/00,,0,0,,,,PENDING
374,CA,A1,CA 3176084 A1,025-798-678-543-395,2016-10-27,2016,CA 3176084 A,2016-04-22,US 201562151325 P;;US 201615135707 A;;CA 2982252 A,2015-04-22,MICROFLUIDIC DEVICE FOR CULTURING BIOLOGICAL CELLS AND METHODS OF USE THEREOF,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/025-798-678-543-395,Patent Application,no,0,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,,,0,0,,,,PENDING
375,EP,A4,EP 3286296 A4,047-612-433-377-376,2019-01-09,2019,EP 16783924 A,2016-04-22,US 201562151325 P;;US 2016/0028808 W,2015-04-22,MICROFLUIDIC CELL CULTURE,,BERKELEY LIGHTS INC,LOWE RANDALL D JR;;BEAUMONT KRISTIN;;KARUNAKARAN AATHAVAN;;MARKS NATALIE;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,,https://lens.org/047-612-433-377-376,Search Report,no,3,0,10,96,0,C12M23/16;;C12M41/26;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10,C12M1/00;;C12M3/00,,1,0,,,See also references of WO 2016172454A1,PENDING
376,WO,A3,WO 2006/024965 A3,080-753-913-076-690,2007-04-26,2007,IB 2005003623 W,2005-08-31,US 60707204 P;;US 12206605 A,2004-09-03,"SYSTEM AND METHOD FOR CREATING, EDITING, AND USING MULTI-RELATIONAL ONTOLOGIES","The invention relates to a system and method for creating, editing, using one or more multi-relational ontologies and applying knowledge contained in one or more ontologies to one or more applications. The system may extract concepts, relationships, assertions and other information from a domain specific corpus of documents. The system may also create rule-based assertions that are then curated and published as one or more ontologies that can be used in various ways.",BIOWISDOM LTD;;GARDNER STEPHEN PHILIP;;BEAUMONT SIMON EDWIN;;MCMENAMIN CONOR;;BLUE NEIL ANDREW MILLER;;ELDRIDGE MATTHEW DAVID;;DAVIS BENJAMIN;;BARNES JULIE CHRISTINE;;BAXTER GORDON SMITH;;MAXWELL MICHELLE JOANNA;;TILFORD NICHOLAS SEAN;;HARTER JUERGEN;;HILL ROBIN DUNCAN;;CHAMBERS JONATHAN KIM,GARDNER STEPHEN PHILIP;;BEAUMONT SIMON EDWIN;;MCMENAMIN CONOR;;BLUE NEIL ANDREW MILLER;;ELDRIDGE MATTHEW DAVID;;DAVIS BENJAMIN;;BARNES JULIE CHRISTINE;;BAXTER GORDON SMITH;;MAXWELL MICHELLE JOANNA;;TILFORD NICHOLAS SEAN;;HARTER JUERGEN;;HILL ROBIN DUNCAN;;CHAMBERS JONATHAN KIM,,https://lens.org/080-753-913-076-690,Search Report,yes,2,0,4,20,0,G06N5/02;;G06N5/02,G06N5/02,,8,6,155-313-777-810-909;;135-924-002-254-123;;077-719-362-591-268;;036-466-552-521-797;;012-094-957-732-423;;034-236-883-631-505,10.1109/mis.2003.1179189;;10.1007/3-540-45422-5_28;;10.1109/5254.920601;;10.1007/978-3-540-30202-5_5;;10.1016/s1386-5056(01)00189-7;;11734393;;10.1109/dexa.2003.1231999,"HARITH ALANI, SANGHEE KIM, DAVID E. MILLARD, MARK J. WEAL, WENDY HALL, PAUL H. LEWIS, NIGEL SHADBOLT: ""Web based Knowledge Extraction andConsolidation for automatic Ontology Instantiation"", INTERNATIONAL CONFERENCE KNOWLEDGE CAPTURE KCAP'03 - WORKSHOP ON KNOWLEDGE MARKUP AND SEMANTIC ANNOTATION, 26 October 2003 (2003-10-26), USA, XP002397995;;UN YONG NAHM, RAYMOND J. MOONEY: ""Text Mining with Information extraction"", PROCEEDINGS OF THE AAAI 2002 SPRING SYMPOSIUM ON MINING ANSWERS FROM TEXTS AND KNOWLEDGE BASES, 31 March 2002 (2002-03-31), Stanford, CANADA, XP002397996, Retrieved from the Internet <URL:citeseer.ist.psu.edu/nahm02text.html> [retrieved on 20060906];;SEAN BECHHOFER, IAN HORROCKS, CAROLE GOBLE, ROBERT STEVENS: ""OilEd: a Reason-able Ontology Editor for the Semantic Web"", PROCEEDINGS OF JOINT AUSTRIAN/GERMAN CONFERENCE ON ARTIFICIAL INTELLIGENCE, 21 September 2001 (2001-09-21), Vienna, Austria, pages 396 - 408, XP002397997;;NATALAYA F NOY ET AL: ""Creating Semantic Web Contents with Protégé-2000"", IEEE INTELLIGENT SYSTEMS, IEEE SERVICE CENTER, NEW YORK, NY, US, 30 April 2001 (2001-04-30), pages 60 - 71, XP002388809, ISSN: 1094-7167;;IAN HORROCKS: ""DAML+OIL : a Description Logic for the Semantic Web"", IEEE DATA ENGINEERING BULLETIN, vol. 25, no. 1, 31 March 2002 (2002-03-31), pages 4 - 9, XP002397998, Retrieved from the Internet <URL:http://sites.computer.org/debull/A02mar/issue1.htm> [retrieved on 20060906];;MATTHEW HORRIDGE, HOLGER KNUBLAUCH, ALAN RECTOR, ROBERT STEVENS, CHRIS WROE: ""A Practical Guide To Building OWL Ontologies Using The Protégé-OWL Plugin and CO-ODE Tools Edition 1.0"", TUTORIAL, 27 August 2004 (2004-08-27), the University of Manchester, XP002397999, Retrieved from the Internet <URL:http://www.co-ode.org/resources/tutorials/ProtegeOWLTutorial.pdf#search=%22building%20owl%20ontologies%20using%20the%20prot%C3%A9g%C3%A9-owl%20plugin%22> [retrieved on 20060906];;DE CLERCQ P A ET AL: ""Design and implementation of a framework to support the development of clinical guidelines"", INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, ELSEVIER SCIENTIFIC PUBLISHERS, SHANNON, IR, vol. 64, no. 2-3, December 2001 (2001-12-01), pages 285 - 318, XP004329218, ISSN: 1386-5056;;UHLIR J ET AL: ""Creation of architectural ontology: user's experience"", DATABASE AND EXPERT SYSTEMS APPLICATIONS, 2003. PROCEEDINGS. 14TH INTERNATIONAL WORKSHOP ON 1-5 SEPT 2003, PISCATAWAY, NJ, USA,IEEE, 1 September 2003 (2003-09-01), pages 65 - 69, XP010658085, ISBN: 0-7695-1993-8",PENDING
377,US,B2,US 11365381 B2,157-231-708-527-61X,2022-06-21,2022,US 202016920365 A,2020-07-02,US 202016920365 A;;US 201615135707 A;;US 201562151325 P,2015-04-22,Microfluidic cell culture,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN G;;KARUNAKARAN AATHAVAN;;MARKS NATALIE C;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/157-231-708-527-61X,Granted Patent,yes,263,0,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/00;;B01L3/00;;C12M1/00;;C12M3/06,,72,38,108-828-605-872-802;;037-907-859-709-943;;108-875-032-328-894;;137-846-480-770-896;;011-948-044-030-689;;017-822-665-433-960;;060-702-031-028-704;;050-937-189-884-416;;065-550-828-594-107;;018-037-144-133-236;;124-837-366-319-712;;139-290-898-452-248;;044-113-372-894-277;;052-418-097-701-019;;078-440-791-744-531;;097-909-699-107-489;;014-519-804-283-974;;031-374-216-509-967;;058-371-003-547-181;;007-614-808-197-290;;019-928-714-899-395;;022-930-693-529-117;;024-092-156-625-86X;;024-365-912-711-984;;044-349-693-600-920;;007-005-133-654-671;;035-843-961-892-251;;021-464-130-690-095;;097-576-869-707-370;;006-661-858-020-00X;;079-854-694-316-822;;071-323-274-108-089;;114-395-916-459-747;;052-390-469-086-319;;001-976-582-932-87X;;090-821-877-616-307;;005-030-097-899-437;;166-982-748-232-895,25438296;;10.1021/am508120s;;10.1039/b816018j;;19370243;;10.1002/elps.201000208;;20872614;;19122836;;pmc2575411;;10.1016/j.mser.2008.04.004;;10.1088/0960-1317/26/1/013003;;10.1016/j.aca.2013.01.025;;23622959;;21515168;;10.1016/j.biomaterials.2011.02.029;;pmc3091033;;10.1038/nature03831;;16034413;;pmc3190639;;21809821;;10.1021/ac2011153;;20643968;;pmc2922239;;10.1073/pnas.0915169107;;17186633;;10.1021/ac069490p;;10.1006/jcis.1996.0186;;10.1039/b803204a;;18651075;;10.1039/b505884h;;16372078;;10.1016/j.apsusc.2011.10.051;;10.1246/cl.2012.23;;10.1109/sensor.2009.5285764;;pmc4416819;;25933003;;10.1371/journal.pone.0124196;;10.1039/c3lc50607j;;23884358;;15580587;;10.1002/bit.20289;;10.1063/1.2747187;;10.1021/la025616b;;10.1039/c1lc20019d;;21445442;;10.1039/c4ra16255b;;10.1016/j.copbio.2013.10.005;;24484886;;10.1039/b711874k;;18030388;;10.1016/j.jcis.2011.10.035;;22093871;;10.1039/c001324b;;20448870;;10.1109/memsys.2010.5442519;;19903557;;10.1016/s0076-6879(09)64011-8;;pmc4196316;;10.1039/c3an00946g;;23939026;;pmc3857027;;10.1016/j.egypro.2014.07.127;;10.1093/humupd/dmr006;;21454356;;21311817;;10.1039/c0lc00568a;;10.1109/tbcas.2009.2031329;;20543904;;pmc2883274;;20179823;;pmc2967183;;10.1039/b909900j;;10.1021/la203844v;;22081885;;10.1109/tbme.2012.2182673;;22231148,"Chiou; Massively parallel optical manipulation of single ceils, mirco- and nano-particles on optoelectronic devices; University of California at Berkeley; 147 pages (Dissertation); (year of pub. sufficiently earlier than effective US fiiing date and any foreign priority date) Fall 2005.;;Chen et al.; Regioselective Patterning ot Multiple SAMs and Applications in Surface-Guided Smart Microfluidics; ACS Applied Materials & Interfaces; 6(24); p. 21961-21969; Dec. 24, 2014.;;Yu et al.; Flow-Through Functionalized PDMS Microfluidic Channels with Dextran Derivative for ELISAs; Lab on a Chip; 9(9); p. 1243-1247; Jan. 20, 2009.;;Zhang et al.; “Click” Chemistry-Based Surface Modification of poly(dimethylsiloxane) for Protein Separation in a Microfluidic Chip; Electrophoresis; 31(18); p. 3129-3136; Sep. 20, 2010.;;Chow et al.; Peptide-based biopolymers in biomedicine and biotechnology; Materials Science and Engineering; 62(4); p. 125-155; Sep. 2008.;;Lee et al.; Separation and sorting of cellls in microsystems using physical principles; Journal of micromechanics and Microengineering; 26(1); dol: 10.10880960.1317/26/1/013003; 15 pages; Dec. 2015.;;Lowe et al.; U.S. Appl. No. 17/005,116 entitled “Microfludic apparatus having an optimized electrowetting surface and related systems and methods,” filed Aug. 27, 2020.;;Banuls et al. Chemical surface modifications for the development of silicon-based label-free integrated optical (IO) biosensors: A review; ?Analytica Chimica Acta; 777; pp. 1-16 ; May 13, 2013.;;Bellis; Advantages of RGD peptides for directing cell association with biomaterials; PMC manuscript of Biomaterials; 32; pp. 4205-4210; 12 pages (Author Manuscript); Jun. 2011.;;Chiou et al.; Massively Parallel Manipulation of Single Cells and Microparticles Using Optical Images; Nature; (436) pp. 370-372; Jul. 2005.;;Chung et al., Imaging single-cell signaling dynamics with a deterministic high-density singie-cell trap array; Anal.Chem.; 83(18); pp. 7044-7052; 14 pages (Author Manuscript); Aug. 23, 2011.;;Dalvi et al.; Molecular Origins of Fluorocarbon Hydrophobicity; Proc Natl Acad Sci USA; 107(31); pp. 13603-13607; Aug. 2010.;;Di Carlo et al.; Dynamic single-cell analysis for quantitative biology; Analytical Chemistry; pp. 7918-7925; Dec. 2006.;;Drelich et al.,; The effect of drop (bubble) size on advancing and receding contact angles for heterogeneous and rough solid surfaces as observed with sessile-drop and captive-bubble techniques; J.Colloid&Interface Science; 179(1); pp. 37-50; Apr. 15, 1996.;;Fan et al.; Cross-scale electric manipulation of cells and droplet by frequency-modulated dielectrophoresis and electrowetting; Lab on a Chip; 8(8); pp. 1325-1331; May 28, 2008.;;Fuchs; Electronic sorting and recovery of single live cells from microlitre sized samples; Lab on a Chip; 6(1); 1 pp. 121-126; (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2006.;;Furuta et al.: Wetting mode transition of nanoliter scale water droplets during evaporation on superhydrophobic surfaces with random roughness structure; Applied Surface Science; 258(7); pp. 2378-2383: Jan. 2012.;;Furuta et al.; Wetting mode transition of water droplets by electrowetting on highly hydrophobic surfaces coated with two different silanes; Chemistry Letters; 41(1); pp. 23-25; Dec. 24, 2011.;;Hsu et al.; Sorting of Differentiated Neurons Using Phototransistor-Based Optoelectronic Tweezers for Cell Replacement Therapy of Neurodegenerative Diseases; Transducers 2009 Conf.; pp. 1598-1601; Jun. 2009.;;Huang et al.; Digital Microfluidic Dynamic Culture of Mammalian Embryos on an Electrowetting on Dielectric (EWOD) Chip; PLOS one; 10(5):e0124196, 15 pages; May 2015.;;Huang et al.; Microfluidic integrated optoelectronic tweezers for single-cell preparation and analysis: Lab on a Chip; 13(18); pp. 3721-3727; (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2013.;;Hung et al.; Continuous Perfusion Microfluidic Cell Culture Array for High-Throughput Cell-Based Assays; Biotech and Bioengineering 89(1); pp. 1-8 ; Jan. 2005.;;Iliescu et al.; Continuous field-flow separation of particle populations in a dielectrophoretic chip with three dimensional electrodes; Applied Physics Letters 90(23); pp. 234104, 4pages; Jun. 2007.;;Jones; On the Relationship of Dielectrophoresis and Electrowetting; Langmuir; 18(11); pp. 4437-4443; May 28, 2002.;;Lagally et al.; Parallel microfluidic arrays for SPRI detection; Proceedings of SPIE, vol. 7759, p. 77590J; Aug. 2010.;;Lee et al.; Microfuidic Chemostat and Turbidostat with Flow Rate, Oxygen, and Temperature Control for Dynamic Continuous Culture; Lab Chip; 11(10); pp. 1730-1739, DOI: 10.1039/c1lc20019d, 10 pages; (Author Manuscript); (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2011.;;Lowe; Controlled Vapor Deposition of Azide-Terminated Siloxane Monolayers: A Platform for Tailoring Oxide Surfaces; (dissertation); Stanford University; 152 pgs.; published: Aug. 2011.;;Mazurek et al.; Preparing mono-dispersed liquid core PDMS microcapsules from thiol-ene-epoxy-tailored flow-focusing microfluidic devices; RSC Advances; 5(20); pp. 15379-15386; Jan. 26, 2015.;;Mehling et al.; Microfluidic Cell Culture, Current Opinion in Biotechnology; 25; pp. 95-102; Feb. 2014.;;Nevill et al.; Integrated Microfluidic Cell Culture and Lysis on a Chip: Lab Chip; (12) pp. 1689-1695; Oct. 2007.;;Papageorgiou et al.; Superior performance of multilayered fluoropolymer films in low voltage electrowetting: Journal of colloid and Interface Science; 368(1); pp. 592-598: 21 pages; (Author Manuscript); Feb. 2012.;;Park et al.; Single-sided continuous optoelectrowetting (SCOEW) for droplet manipulation with light patterns; Lab on a Chip; 10 (13); pp. 1655-1661 (year of pub. sufficiently earlier than effective US filing date and any foreign priority date) 2010.;;Pei et al.; Light-Actuated Digital Microfluidics for Largescale, Parallel Manipulation of Arbitrarily Sized Droplets; 2010 IEEE 23rd Int'l. Conf. on Micro. Electro. Mech. Sys.; 4 pages; Jan. 2010.;;Ritchie et al.; Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs; Methods Enzymol; 464; pp. 211-231; 23 pages; (Author Manuscript); Jan. 2009.;;Somaweera et al.; “Generation of a Chemical Gradient Across an Array of 256 Cell Cultures in a Single Chip”; Analyst; 138(19); 14 pgs.; (Author Manuscript); Oct. 2013.;;Srisuwan et al.; The Effects of Alkalized and Silanized Woven Sisal Fibers on Mechanical Properties of Natural Rubber Modified Epoxy Resin; Energy Pocedia; 56; pp. 19-25; Jan. 2014.;;Swain et al.; Advances In embryo culture platforms: novel approaches to Improve preimplantation embryo development through modifications of the microenvironment; Human Reproduction Update; 17(4); pp. 541-557; Mar. 31, 2011.;;Valley et al.; A Unified Platform for Optoelectrowetting and Optoelectronic Tweezers; Lab Chip; 11(7); pp. 1292-1297; Jan. 2011.;;Valley et al., An integrated platform for light-induced dielectro-phoresis and electrowetting: 14 th International conference on Miniaturized Systems for Chemistry and Life Sciences; Groningen, The Netherlands; pp. 2098-2100, 3 pages; Oct. 3-7, 2010.;;Valley et al.; Optoelectronic Tweezers as a Tool for Parallel Single-Cell Manipulation and Stimulation; IEEE Trans Biomed Circuits Syst.; 3(6); pp. 424-431; Dec. 2009.;;Xu et al.; Recent Trends In Dielectrophoresis; Informacije MIDEM; 40(4) pp. 253-262; 2010.;;Yi et al.; Microfluidics Technology for Manipulation and Analysis of Biological Cells; Anal Chim Acta; (560) pp. Feb. 1-23, 2006.;;Young et al.; Fundamentals of Microfluidic Cell Culture in Controlled Microenvironments: cited as Chem Soc Rev.; Mar. 2010; 39(3); pp. 1036-1048; pub online Feb. 2010; doi: 10.1039/b909900j; (24 pgs).;;Zhang et al.;Azide Functional Monolayers Grafted to a Germanium Surface Model Substrates for ATR-IR Studies of interfacial Click Reactions; Langmuir; 28(1); pp. 486-493; Dec. 8, 2011.;;Zhang et al.; Controlled Aspiration and Positioning of Biological Cells in a Micropipette; IEEE Transactions on Biomedical Engineering; 59(4); pp. 1032-1040; Apr. 2012.;;CN102500436A_Chen (Machine translation) Jun. 20, 2012, 11 pages.;;CN102671723A_Wang Machine Translation, Sep. 19, 2012, 21 pages.;;CN101275114A, Lou—Machine Translation, Oct. 1, 2008, 8 pages.;;Core BLI Chip Reference—BL000062US as published 20140116881A1.;;Core BLI Chip Reference—BL000092US as published 20140124370A1.;;Core BLI Chip Reference—BL000142US as published 20150151307A1.;;Core BLI Chip Reference—BL000153US as published 20150151298A1.;;Core BLI Chip Reference—BL000162US as published 20150165436A1.;;Core BLI Chip Reference—BL000192US as published 20160199837A1.;;Core BLI Chip Reference—BL000372US as published 20160312165A1.;;Core BLI Chip Reference—BL000912US as published 20160184821A1.;;Core BLI Chip Reference—BL001394US as published 20180298318A1.;;Core BLI Chip Reference—BL001553US as published 20190240665A1.;;File History LOWE et al.; U.S. Appl. No. 17/005,116 [BL001223-USCON] entitled “Microfluidic apparatus having an optimized electrowetting surface and related systems and methods,” filed Aug. 27, 2020 (Available as Jan. 6, 2022).;;JP2004117073A_Univ Waseda_Aisaka—Machine Translation, Apr. 15, 2004, 15 pages.;;JP2004117073A_Aisaka_ENG Abstract.;;KIPO computer-generated English language translation of KR 10-2012-0066100 Gwang-Seok Yang, patent published Jun. 22, 2012.;;KIPO computer-generated English language translation of KR 201000008222A_Kyun; 10 pages; Jan. 2010.;;TWI258456, Cheng—Machine Translation, Jul. 21, 2006, 11 pages.;;WO2010147078, University of Tokyo, Machine Translation, Dec. 23, 2010; 12 pages.;;Z Report_European Patent Office, Extended European Search Report for Application No. 17803724.8, dated Feb. 26, 2020, 15 pages.;;Z Report_Written Opinion and Search Report in Singapore Patent Application No. 11201809539R, dated Mar. 31, 2020, 12 pages.;;Z Report_International Searching Authority, International Search Report and Written Opinion for PCT/US16/28808, dated Sep. 1, 2016.;;Z Report_International Search Report and Written Opinion from PCT/US2017/034832 dated Sep. 27, 2017, 20 pages.;;Z Report_International Search Report and Written Opinion for PCT Application Serial No. PCT/US2015/027679 (dated Jul. 27, 2015), 11 pages.;;Z Report_International Search Report and Written Opinion for PCT Application Serial No. PCT/US2015/027680 (dated Jun. 29, 2015), 9 pages.;;Z Report_International Search Report and Written Opinion for PCT Application Serial No. PCT/US2016/059234 (dated Mar. 30, 2017), 20 pages.",ACTIVE
378,US,A1,US 2022/0356429 A1,112-249-830-194-022,2022-11-10,2022,US 202217743318 A,2022-05-12,US 202217743318 A;;US 202016920365 A;;US 201615135707 A;;US 201562151325 P,2015-04-22,MICROFLUIDIC CELL CULTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN G;;KARUNAKARAN AATHAVAN;;MARKS NATALIE C;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/112-249-830-194-022,Patent Application,yes,0,1,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;C12M1/00,,0,0,,,,PENDING
379,US,A1,US 2021/0071124 A1,055-326-319-634-642,2021-03-11,2021,US 202016920365 A,2020-07-02,US 202016920365 A;;US 201615135707 A;;US 201562151325 P,2015-04-22,MICROFLUIDIC CELL CULTURE,"Systems, methods and kits are described for culturing one or more biological cells in a microfluidic device, including provision of nutrients and gaseous components configured to enhance cell growth, viability, portability, or any combination thereof. In some embodiments, culturing a single cell may produce a clonal population in the microfluidic device.",BERKELEY LIGHTS INC,LOWE JR RANDALL D;;BEAUMONT KRISTIN G;;KARUNAKARAN AATHAVAN;;MARKS NATALIE C;;MCEWEN JASON M;;WHITE MARK P;;NEVILL J TANNER;;WANG GANG F;;MCFARLAND ANDREW W;;MALLEO DANIELE;;BREINLINGER KEITH J;;GUAN XIAO;;CHAPMAN KEVIN T,BRUKER CELLULAR ANALYSIS INC (2023-10-02);;PHENOMEX INC (2023-03-21),https://lens.org/055-326-319-634-642,Patent Application,yes,0,8,33,96,0,C12M23/16;;C12M29/10;;C12M23/16;;C12M29/10;;B01L3/502761;;C12M23/20;;C12M41/26;;B01L2200/0647;;B01L2300/16;;B01L2400/0424;;B01L3/502715;;C12M23/16;;C12M23/20;;C12M29/10;;C12M23/16;;C12M29/10,C12M3/06;;C12M1/00,,0,0,,,,ACTIVE
380,WO,A2,WO 2006/024965 A2,090-022-441-424-055,2006-03-09,2006,IB 2005003623 W,2005-08-31,US 60707204 P;;US 12206605 A,2004-09-03,"SYSTEM AND METHOD FOR CREATING, EDITING, AND USING MULTI-RELATIONAL ONTOLOGIES","The invention relates to a system and method for creating, editing, using one or more multi-relational ontologies and applying knowledge contained in one or more ontologies to one or more applications. The system may extract concepts, relationships, assertions and other information from a domain specific corpus of documents. The system may also create rule-based assertions that are then curated and published as one or more ontologies that can be used in various ways.",BIOWISDOM LTD;;GARDNER STEPHEN PHILIP;;BEAUMONT SIMON EDWIN;;MCMENAMIN CONOR;;BLUE NEIL ANDREW MILLER;;ELDRIDGE MATTHEW DAVID;;DAVIS BENJAMIN;;BARNES JULIE CHRISTINE;;BAXTER GORDON SMITH;;MAXWELL MICHELLE JOANNA;;TILFORD NICHOLAS SEAN;;HARTER JUERGEN;;HILL ROBIN DUNCAN;;CHAMBERS JONATHAN KIM,GARDNER STEPHEN PHILIP;;BEAUMONT SIMON EDWIN;;MCMENAMIN CONOR;;BLUE NEIL ANDREW MILLER;;ELDRIDGE MATTHEW DAVID;;DAVIS BENJAMIN;;BARNES JULIE CHRISTINE;;BAXTER GORDON SMITH;;MAXWELL MICHELLE JOANNA;;TILFORD NICHOLAS SEAN;;HARTER JUERGEN;;HILL ROBIN DUNCAN;;CHAMBERS JONATHAN KIM,,https://lens.org/090-022-441-424-055,Patent Application,yes,0,5,4,20,0,G06N5/02;;G06N5/02,G06N5/02,,0,0,,,,PENDING
381,EP,A2,EP 1787244 A2,175-176-050-513-492,2007-05-23,2007,EP 05806840 A,2005-08-31,IB 2005003623 W;;US 60707204 P;;US 12206605 A,2004-09-03,"SYSTEM AND METHOD FOR CREATING, EDITING, AND USING MULTI-RELATIONAL ONTOLOGIES",,BIOWISDOM LTD,GARDNER STEPHEN PHILIP;;BEAUMONT SIMON EDWIN;;MCMENAMIN CONOR;;BLUE NEIL ANDREW MILLER;;ELDRIDGE MATTHEW DAVID;;DAVIS BENJAMIN;;BARNES JULIE CHRISTINE;;BAXTER GORDON SMITH;;MAXWELL MICHELLE JOANNA;;TILFORD NICHOLAS SEAN;;HARTER JUERGEN;;HILL ROBIN DUNCAN;;CHAMBERS JONATHAN KIM,,https://lens.org/175-176-050-513-492,Patent Application,yes,0,0,4,20,0,G06N5/02;;G06N5/02,G06N5/02,,0,0,,,,DISCONTINUED
